Koninklijke Philips (PHG) 20-F 20 Feb 18 2017 FY Annual report (foreign) Financial data

Document and Entity Information

Document and Entity Information	12 Months Ended
	Dec. 31, 2017€ / sharesshares
Document and Entity Information [Abstract]
Entity Registrant Name	KONINKLIJKE PHILIPS NV
Entity Central Index Key	313,216
Entity Current Reporting Status	Yes
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Well Known Seasoned Issuer	Yes
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	FY
Document Type	20-F
Document Period End Date	Dec. 31, 2017
Amendment Flag	false
Entity Common Stock Shares Outstanding | shares	926,191,723
Entity listing par value per share | € / shares	€ 0.20

Consolidated statements of inco

Consolidated statements of income - EUR (€) € in Millions		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Profit or loss [Abstract]
Sales	[1]	€ 17,780	€ 17,422	€ 16,806
Cost of sales		(9,600)	(9,484)	(9,594)
Gross margin		8,181	7,939	7,212
Selling expenses		(4,398)	(4,142)	(4,048)
General and administrative expenses		(577)	(658)	(1,003)
Research and development expenses		(1,764)	(1,669)	(1,562)
Other business income		152	17	89
Other business expenses		(76)	(23)	(30)
Income (loss) from operations		1,517	1,464	658
Financial income		126	65	94
Financial expenses		(263)	(507)	(453)
Investments in associates, net of income taxes		(4)	11	30
Income before taxes		1,377	1,034	329
Income tax expense continuing operations		(349)	(203)	(169)
Income from continuing operations		1,028	831	160
Discontinued operations, net of income taxes		843	660	479
Net income		1,870	1,491	638
Attribution of net income [Abstract]
Net income attributable to Koninklijke Philips N.V. shareholders		1,657	1,448	624
Net income attributable to non-controlling interests		€ 214	€ 43	€ 14
Basic earnings per common share [Abstract]
Income from continuing operations attributable to shareholders		€ 0.88	€ 0.86	€ 0.16
Net income attributable to shareholders		1.78	1.58	0.68
Diluted earnings per common share [Abstract]
Income from continuing operations attributable to shareholders		0.86	0.85	0.16
Net income attributable to shareholders		€ 1.75	€ 1.56	€ 0.68
[1]	The sales are reported based on country of destination.

Consolidated statements of comp

Consolidated statements of comprehensive income - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Statement of comprehensive income [Abstract]
Net income	€ 1,870	€ 1,491	€ 638
Pensions and other post-employment plans [Abstract]
Remeasurements	102	(96)	(101)
Income tax effect on remeasurements	(78)	28	9
Revaluation reserve [Abstract]
Release revaluation reserve		(4)	(9)
Reclassification directly into retained earnings		4	9
Total of items that will not be reclassified to Income Statement	25	(68)	(92)
Currency translation differences [Abstract]
Net current period change, before tax	(1,177)	219	643
Income tax effect	39	2	187
Reclassification adjustment for gain realized	191		(1)
Available-for-sale financial assets [Abstract]
Net current period change, before tax	(66)	(44)	33
Income tax effect	(1)
Reclassification adjustment for gain realized	1	24	(4)
Cash flow hedges [Abstract]
Net current period change, before tax	33	3	(38)
Income tax effect	(3)	(9)	0
Reclassification adjustment for loss (gain) realized	(17)	5	63
Total of items that are or may be reclassified to Income Statement	(1,000)	200	883
Other comprehensive income	(975)	132	791
Total comprehensive income	895	1,623	1,429
Total comprehensive income attributable to [Abstract]
Shareholders of Koninklijke Philips N.V.	805	1,550	1,415
Non-controlling interests	€ 90	€ 73	€ 14

Consolidated balance sheets

Consolidated balance sheets - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Non-current assets [Abstract]
Property, plant and equipment	€ 1,591	€ 2,155
Goodwill	7,731	8,898
Intangible assets excluding goodwill	3,322	3,552
Non-current receivables	130	155
Investments in associates	142	190
Other non-current financial assets	587	335
Non-current derivative financial assets	22	59
Deferred tax assets	1,598	2,759
Other non-current assets	75	92
Total non-current assets	15,198	18,195
Current assets [Abstract]
Inventories	2,353	3,392
Current financial assets	2	101
Other current assets	392	486
Current derivative financial assets	57	101
Income tax receivable	109	154
Receivables	3,909	5,327
Assets classified as held for sale	1,356	2,180
Cash and cash equivalents	1,939	2,334
Total current assets	10,117	14,075
Total assets	25,315	32,270
Equity [Abstract]
Shareholders' equity	11,999	12,546
Common shares	188	186
Reserves	385	1,280
Other	11,426	11,080
Non-controlling interests	24	907
Group equity	12,023	13,453
Non-current liabilities [Abstract]
Long-term debt	4,044	4,021
Non-current derivative financial liabilities	216	590
Long-term provisions	1,659	2,926
Deferred tax liabilities	33	66
Other non-current liabilities	474	741
Total non-current liabilities	6,426	8,344
Current liabilities [Abstract]
Short-term debt	672	1,585
Derivative financial liabilities	167	283
Income tax payable	83	146
Accounts and notes payable	2,090	2,848
Accrued liabilities	2,319	3,034
Short-term provisions	400	680
Liabilities directly associated with assets held for sale	8	525
Other current liabilities	1,126	1,372
Total current liabilities	6,866	10,473
Total liabilities and group equity	€ 25,315	€ 32,270

Consolidated statements of cash

Consolidated statements of cash flows - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Cash flows from operating activities [Abstract]
Net income	€ 1,870	€ 1,491	€ 638
Income from discontinued operations	(843)	(660)	(479)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation, amortization, and impairment of fixed assets	1,025	976	972
Impairment of goodwill and other non-current financial assets	15	24	48
Net gain on sale of assets	(107)	(3)	(83)
Interest income	(40)	(43)	(44)
Interest expense	186	294	274
Income taxes	349	203	169
Investments in associates, net of income taxes	0	(11)	(10)
Decrease (increase) in working capital	101	131	(67)
Decrease (increase) in receivables and other current assets	64	(89)	97
Decrease (increase) in inventories	(144)	(63)	(6)
Increase (decrease) in accounts payable, accrued and other current liabilities	181	283	(158)
Decrease (increase) in non-current receivables, other assets and other liabilities	(358)	(160)	86
Increase (decrease) in provisions	(252)	(647)	(343)
Other items	377	76	(129)
Interest paid	(215)	(296)	(261)
Interest received	40	42	44
Dividends received from investments in associates	6	48	15
Income taxes paid	(284)	(295)	(232)
Net cash provided by (used for) operating activities	1,870	1,170	598
Cash flows from investing activities [Abstract]
Net capital expenditures	(685)	(741)	(752)
Purchase of intangible assets	(106)	(95)	(105)
Expenditures on development assets	(333)	(301)	(291)
Capital expenditures on property, plant and equipment	(420)	(360)	(432)
Proceeds from sales of property, plant and equipment	175	15	76
Net proceeds from (cash used for) derivatives and current financial assets	(198)	(117)	(72)
Purchase of other non-current financial assets	(42)	(53)	(20)
Proceeds from other non-current financial assets	6	14	39
Purchase of businesses, net of cash acquired	(2,344)	(197)	(1,118)
Proceeds from sale of interests in businesses, net of cash disposed of	64	0	71
Net cash used for investing activities	(3,199)	(1,092)	(1,852)
Cash flows from financing activities [Abstract]
Proceeds from issuance (payments) of short-term debt	12	(1,377)	1,249
Principal payments on short-term portion of long-term debt	(1,332)	(357)	(91)
Proceeds from issuance of long-term debt	1,115	123	94
Re-issuance of treasury shares	227	80	81
Purchse of treasury shares	(642)	(606)	(506)
IPO Philips Lighting proceeds	1,065	863
IPO Philips Lighting transaction costs paid	(5)	(38)
Dividends paid to shareholders	(384)	(330)	(298)
Dividends paid to non-controlling interests	(2)	(2)
Net cash provided by (used for) financing activities	55	(1,643)	529
Net cash provided by (used for) continuing operations	(1,274)	(1,566)	(724)
Net cash provided by (used for) discontinued operations	1,063	2,151	537
Net cash provided by (used for) continuing and discontinued operations	(211)	585	(187)
Effect of changes in exchange rates on cash and cash equivalents	(184)	(17)	80
Cash and cash equivalents at the beginning of the year	2,334	1,766	1,873
Cash and cash equivalents at the end of the year	€ 1,939	€ 2,334	€ 1,766

Consolidated statements of chan

Consolidated statements of changes in equity - EUR (€) € in Millions	Total	Common share [Member]	Revaluation reserve [Member]	Currency translation differences [Member]	[1]	Available-for-sale financial assets [Member]	Cash flow hedges [Member]	Capital in excess of par value [Member]	Retained earnings [Member]	[2]	Treasury shares [Member]	Shareholders' equity [Member]	Non-controlling interests [Member]
Equity at beginning of period at Dec. 31, 2014	€ 10,933	€ 187	€ 13	€ 229		€ 27	€ (13)	€ 2,181	€ 8,755		€ (547)	€ 10,832	€ 101
Comprehensive income	1,429		(9)	829		29	25		541			1,415	14
Dividends distributed	(298)	3						429	(730)			(298)
Non-controlling interests movement	3												3
Cancellation of treasury shares		(4)							(513)		517
Purchase of treasury shares	(507)								(12)		(495)	(507)
Re-issuance of treasury shares	82							(23)	(57)		162	82
Share-base compensation plans	101							101				101
Income tax share-based compensation plans	(19)							(19)				(19)
Equity at end of period at Dec. 31, 2015	11,725	186	4	1,058		56	12	2,669	7,985		(363)	11,607	118
Comprehensive income	1,623		€ (4)	191		(20)	(1)		1,384			1,550	73
Dividends distributed	(330)	4						398	(732)			(330)
Philips Lighting, IPO/Sale of shares	825			(15)			(1)		125			109	716
Cancellation of treasury shares		(4)							(446)		450
Purchase of treasury shares	(589)										(589)	(589)
Re-issuance of treasury shares	74							(122)	(35)		231	74
Share call option	(13)								(103)		90	(13)
Share-base compensation plans	119							119				119
Income tax share-based compensation plans	19							19				19
Equity at end of period at Dec. 31, 2016	13,453	186		1,234		36	10	3,083	8,178		(181)	12,546	907
Comprehensive income	895			(823)		(66)	12		1,681			805	90
Dividends distributed	(478)	2						356	(742)			(384)	(94)
Philips Lighting, IPO/Sale of shares	1,039			(19)					346			327	712
Non-controlling interests movement	(1,602)							(66)	54			(12)	(1,590)
Purchase of treasury shares	(318)										(318)	(318)
Re-issuance of treasury shares	133							(205)	3		334	133
Increase (decrease) forward contracts	(1,079)								(1,018)		(61)	(1,079)
Share call option	(160)								95		(255)	(160)
Share-base compensation plans	151							151				151
Income tax share-based compensation plans	(8)							(8)				(8)
Equity at end of period at Dec. 31, 2017	€ 12,023	€ 188		€ 392		€ (30)	€ 23	€ 3,311	€ 8,596		€ (481)	€ 11,999	€ 24
[1]	Cumulative translation adjustments related to Investments in associates were EUR 46 million at December 31, 2017 (2016: EUR 40 million, 2015: EUR 34 million).
[2]	The presentation of prior-year information has been updated to address two tax related adjustments as explained in Significant accounting policies

Consolidated statements of cha7

Consolidated statements of changes in equity (Parenthetical) - EUR (€) € in Millions		Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Equity		€ 12,023	€ 13,453	€ 11,725
Reserve of exchange differences on translation [Member]
Equity	[1]	392	1,234	1,058
Reserve of exchange differences on translation [Member] | Investment in associates [Member]
Equity		€ 46	€ 40	€ 34
[1]	Cumulative translation adjustments related to Investments in associates were EUR 46 million at December 31, 2017 (2016: EUR 40 million, 2015: EUR 34 million).

Significant accounting policies

Significant accounting policies	12 Months Ended
	Dec. 31, 2017
Disclosure of significant accounting policies [Abstract]
Significant accounting policies [Text block]	Table of Contents Note The Consolidated financial statements in the Group financial statements section have been prepared in accordance with International Financial Reporting Standards (IFRS) as endorsed by the European Union (EU) and with the statutory provisions of Part 9, Book 2 of the Dutch Civil Code. All standards and interpretations issued by the International Accounting Standards Board (IASB) and the IFRS Interpretations Committee effective 2017 have been endorsed by the EU; consequently, the accounting policies applied by Koninklijke Philips N.V. (hereafter: the ‘Company’ or ‘Philips’) also comply with IFRS as issued by the IASB. These accounting policies have been applied by group entities. The Consolidated financial statements have been prepared under the historical cost convention, unless otherwise indicated. The Consolidated financial statements are presented in euros, which is the presentation currency. Due to rounding, amounts may not add up precisely to totals provided. On February 20, 2018, the Board of Management authorized the Consolidated financial statements for issue. The Consolidated financial statements as presented in this report are subject to adoption by the Annual General Meeting of Shareholders, to be held on May 3, 2018. Use of estimates The preparation of the Consolidated financial statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. These estimates inherently contain a degree of uncertainty. Actual results may differ from these estimates under different assumptions or conditions. In the process of applying the accounting policies, management has made estimates and assumptions concerning the future and other key sources of estimation uncertainty at the reporting date that have a significant risk of causing a material adjustment to the reported amounts of assets and liabilities within the next financial year, as well as to the disclosure of contingent liabilities at the date of the Consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company evaluates these estimates and judgments on an ongoing basis and bases the estimates on historical experience, current and expected future outcomes, third-party evaluations and various other assumptions that Philips believes are reasonable under the circumstances. Existing circumstances and assumptions about future developments may change due to circumstances beyond the Company’s control and are reflected in the assumptions if and when they occur. The results of these estimates form the basis for making judgments about the carrying values of assets and liabilities as well as identifying and assessing the accounting treatment with respect to commitments and contingencies. The Company revises material estimates if changes occur in the circumstances or there is new information or experience on which an estimate was or can be based. The areas where the most significant judgments and estimates are made are goodwill, deferred tax asset recoverability including assessment on valuation adjustment following the enactment of the US Tax Cuts and Jobs Act in December 2017, impairments, financial instruments, the accounting for an arrangement containing a lease, revenue recognition (multiple element arrangements), tax risks and other contingencies, assessment of control (including ‘de facto’ control of Philips Lighting), classification of assets and liabilities held for sale and the presentation of items of profit and loss and cash flows as continued or discontinued, as well as when determining the fair values of acquired identifiable intangible assets and investments based on an assessment of future cash flows. For further discussion on these significant judgements and estimates, reference is made to the respective notes within these Consolidated financial statements that relate to the above topics. Further judgment is applied when analyzing impairments of goodwill and intangible assets not yet ready for use that are performed annually and whenever a triggering event has occurred to determine whether the carrying value exceeds the recoverable amount. These analyses are generally based on estimates of future cash flows. Furthermore, the Company applies judgment when actuarial assumptions are established to anticipate future events that are used in calculating post-employment benefit expenses and liabilities. These factors include assumptions with respect to interest rates, rates of increase in healthcare costs, rates of future compensation increases, turnover rates and life expectancy. Changes 2015 and 2016 Accounting policies have been applied consistently for all periods presented in these consolidated financial statements, except for the items mentioned below. In addition, certain prior-year amounts have been reclassified to conform to the current year presentation. Changes processed in 2017 affecting 2016 and 2015 Tax adjustments Two tax related adjustments were identified in 2017, relating to tax expense understatements for years prior to 2016. These adjustments affected the previously issued financial statements for a number of years up to and until December 31, 2015, including an impact on net income of EUR 20 million in 2015 and EUR 55 million to opening retained earnings in 2016. If these adjustments had been processed in 2017, the impact would have been material for 2017 and as such the adjustments were processed in 2015 and 2016, since it was concluded that the year-by-year understatements were immaterial for the years up to and including 2016. Change in Balance Sheet presentation Philips has changed the presentation of the Consolidated balance sheets by removing certain disaggregated line items and sub-totals, not affecting the totals presented. Since this information is already included in the relevant notes to the Consolidated financial statements, the line items have been removed to improve readability. Change in Investments in associates presentation In order to improve comparability and keep consistency with peer practice, Philips has changed the presentation of the line item Investments in associates and moved it into the subtotal Income before taxes in the Consolidated statements of income. This change did not impact the results of operations or financial position. Change in Cash Flows presentation IFRS 5 Non-current Assets Held for Sale and Discontinued Operations requires that the net cash flows attributable to the operating, investing and financing activities of discontinued operations are disclosed in the Consolidated financial statements of Philips. These disclosures may be presented either in the Consolidated statements of cash flows or in the notes to the Consolidated financial statements. In order to improve readability and enhance the focus of the cash flow statement on the HealthTech cash flows, in 2017 Philips made the policy choice to disclose the net cash provided by (used for) discontinued operations as one line in the Consolidated statements of cash flows. The breakdown of the operating, investing and financing cash flow activities included in Discontinued operations and assets classified as held for sale Changes processed in 2016 affecting 2015 Change in Segment reporting In 2016, Philips established two stand-alone companies focused on the HealthTech and Lighting opportunities. As part of this separation, Philips changed the way it allocated resources and analyzes its performance based on the revised segment structure. Accordingly, from 2016 the operational reportable segments for the purpose of the disclosures required by IFRS 8 Operating Segments were Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses and Lighting, each being responsible for the management of its business worldwide. Additionally, HealthTech Other and Legacy Items are included in Information by segment and main country Goodwill Consequential changes to comparative segment disclosures were processed in Other assets Receivables Provisions Information by segment and main country Specific choices within IFRS In certain instances IFRS allows alternative accounting treatments for measurement and/or disclosure. Philips has adopted one of the treatments as appropriate to the circumstances of the Company. The most important of these alternative treatments are mentioned below. Tangible and intangible fixed assets Under IFRS, an entity shall choose either the cost model or the revaluation model as its accounting for tangible and intangible fixed assets. In this respect, items of property, plant and equipment are measured at cost less accumulated depreciation and accumulated impairment losses. The useful lives and residual values are evaluated annually. Furthermore, the Company chose to apply the cost model, meaning that costs relating to product development, the development and purchase of software for internal use and other intangible assets are capitalized and subsequently amortized over the estimated useful life. Further information on Tangible and Intangible fixed assets can be found in Property, plant and equipment Intangible assets excluding goodwill Employee benefit accounting IFRS does not specify how an entity should present its service costs related to pensions and net interest on the net defined-benefit liability (asset) in the Statement of income. With regards to these elements, the Company presents service costs in Income from operations and the net interest expenses related to defined-benefit plans in Financial expense. Furthermore, when accounting for the settlement of defined-benefit plans the Company made the accounting policy choice to adjust the amount of the plan assets transferred for the effect of the asset ceiling. Further information on employee benefit accounting can be found in Post-employment benefits Cash flow statements Under IFRS, an entity shall report cash flows from operating activities using either the direct method (whereby major classes of gross cash receipts and gross cash payments are disclosed) or the indirect method (whereby profit or loss is adjusted for the effects of transactions of a non-cash nature, any deferrals or accruals of past or future operating cash receipts or payments, and items of income or expense associated with investing or financing cash flows). In this respect, the Company chose to prepare the cash flow statements using the indirect method. Furthermore, interest cash flows are presented in cash flows from operating activities rather than in cash flows from financing or investing activities, because they enter into the determination of profit or loss. The Company chose to present dividends paid to shareholders of Koninklijke Philips N.V. as a component of cash flows from financing activities, rather than to present such dividends as cash flows from operating activities, which is an allowed alternative under IFRS. Consolidated statements of cash flows can be found in Consolidated statements of cash flows Policies that are more critical in nature Revenue recognition Revenue from the sale of goods in the course of the ordinary activities is measured at the fair value of the consideration received or receivable, net of returns, trade discounts and volume rebates. Revenue for sale of goods is recognized when the significant risks and rewards of ownership have been transferred to the buyer, recovery of the consideration is probable, the associated costs and possible return of the goods can be estimated reliably, there is no continuing involvement with goods, and the amount of revenue can be measured reliably. If it is probable that discounts will be granted and the amount can be measured reliably, then the discount is recognized as a reduction of revenue as the sales are recognized. Transfer of risks and rewards varies depending on the individual terms of the contract of sale. For consumer-type products in the segment of Personal Health businesses these criteria are met at the time the product is shipped and delivered to the customer and title and risk have passed to the customer (depending on the delivery conditions) and acceptance of the product has been obtained. Examples of delivery conditions are ‘Free on Board point of delivery’ and ‘Costs, Insurance Paid point of delivery’, where the point of delivery may be the shipping warehouse or any other point of destination as agreed in the contract with the customer and where title and risk for the goods pass to the customer. Revenues of transactions that have separately identifiable components are recognized based on their relative fair values. These transactions mainly occur in the segments Diagnosis & Treatment businesses and Connected Care & Health Informatics businesses and include arrangements that require subsequent installation and training activities in order to become operable for the customer. Revenue recognition is deferred until the installation has been completed and the product is ready to be used by the customer in the way contractually agreed. Revenues are recorded net of sales taxes, customer discounts, rebates and similar charges. For products for which a right of return exists during a defined period, revenue recognition is determined based on the historical pattern of actual returns, or in cases where such information is not available, revenue recognition is postponed until the return period has lapsed. Return policies are typically based on customary return arrangements in local markets. In the case of loss under a sales agreement, the loss is recognized immediately. Expenses incurred for shipping and handling of internal movements of goods are recorded as cost of sales. Shipping and handling related to sales to third parties are recorded as selling expenses. When shipping and handling is part of a project and billed to the customer, then the related expenses are recorded as cost of sales. Shipping and handling billed to customers is recognized as revenues. Service revenue related to repair and maintenance activities for goods sold is recognized ratably over the service period or as services are rendered. A provision for product warranty is made at the time of revenue recognition and reflects the estimated costs of replacement and free-of-charge services that will be incurred by the Company with respect to the products. For certain products, the customer has the option to purchase an extension of the warranty, which is subsequently billed to the customer. Revenue recognition occurs on a straight-line basis over the extended warranty contract period. Revenue from services is recognized when the Company can reliably measure the amount of revenue and the associated cost related to the stage of completion of a contract or transaction, and the recovery of the consideration is considered probable. Royalty income from intellectual property rights, which is generally earned based upon a percentage of sales or a fixed amount per product sold, is recognized on an accrual basis based on actual or reliably estimated sales made by a licensee. Royalty income from an agreement with lump-sum consideration is recognized on accrual basis based on the contractual terms and substance of the relevant agreement with a licensee. Grants from governments are recognized at their fair value where there is a reasonable assurance that the grant will be received and the Company will comply with all attached conditions. Government grants relating to costs are deferred and recognized in the Statement of income as a reduction of the related costs over the period necessary to match them with the costs that they are intended to compensate. Grants related to assets are deducted from the cost of the asset and presented net in the Consolidated balance sheets Income taxes Income taxes comprises current and deferred tax. Income tax is recognized in the Statement of income except to the extent that it relates to items recognized directly within equity or in other comprehensive income. Current tax is the expected taxes payable on the taxable income for the year, using tax rates enacted or substantively enacted at the reporting date, and any adjustment to tax payable in respect of previous years. Tax liabilities are recognized when it is considered probable that there will be a future outflow of funds to a taxing authority. In such cases, provision is made for the amount that is expected to be settled, where this can be reasonably estimated. This assessment relies on estimates and assumptions and may involve a series of judgments about future events. New information may become available that causes the Company to change its judgment regarding the adequacy of existing tax liabilities. Such changes to tax liabilities will impact the income tax expense in the period that such a determination is made. Deferred tax assets and liabilities are recognized, using the balance sheet method, for the expected tax consequences of temporary differences between the carrying amounts of assets and liabilities and the amounts used for taxation purposes. Deferred tax is not recognized for the following temporary differences: the initial recognition of goodwill; the initial recognition of assets and liabilities in a transaction that is not a business combination and that affects neither accounting nor taxable profit; and differences relating to investments in subsidiaries, joint ventures and associates where the reversal of the respective temporary difference can be controlled by the Company and it is probable that it will not reverse in the foreseeable future. Deferred taxes are measured at the tax rates that are expected to be applied to temporary differences when they reverse, based on the laws that have been enacted or substantively enacted by the reporting date. Deferred tax assets and liabilities are offset if there is a legally enforceable right to offset current tax liabilities and assets, and they relate to income taxes levied by the same tax authority on the same taxable entity or on different taxable entities, but they intend to settle current tax liabilities and assets on a net basis or their tax assets and liabilities will be realized simultaneously. A deferred tax asset is recognized for unused tax losses, tax credits and deductible temporary differences, to the extent that it is probable that future taxable profits will be available against which they can be utilized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income in the countries where the deferred tax assets originated and during the periods when the deferred tax assets become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. Deferred tax liabilities for withholding taxes are recognized for subsidiaries in situations where the income is to be paid out as dividend in the foreseeable future and for undistributed earnings of unconsolidated companies to the extent that these withholding taxes are not expected to be refundable or deductible. Changes in tax rates and tax laws are reflected in the period when the change has been enacted or substantively enacted by the reporting date. Any subsequent adjustment to a tax asset or liability that originated in discontinued operations, due to a change in the tax base or its measurement, is allocated to discontinued operations (i.e. backwards tracing). Examples are a tax rate change or change in retained assets or liabilities directly relating to the discontinued operation. Any subsequent change to the recognition of deferred tax assets is allocated to the component in which the taxable gain is or will be recognized. The above principles are applied to the extent the ‘discontinued operations’ is sufficiently separable from continuing operations. Further information on income tax can be found in Income taxes Provisions Provisions are recognized if, as a result of a past event, the Company has a present legal or constructive obligation, the amount can be estimated reliably, and it is probable that an outflow of economic benefits will be required to settle the obligation. Provisions are measured at the present value of the expenditures expected to be required to settle the obligation using a pre-tax discount rate that reflects current market assessments of the time value of money. The increase in the provision due to passage of time is recognized as interest expense. The accounting and presentation for some of the Company’s provisions is as follows: Product warranty – A provision for warranties is recognized when the underlying products or services are sold. The provision is based on historical warranty data and a weighing of possible outcomes against their associated probabilities. Environmental provisions – Measurement of liabilities associated with environmental obligations is based on current legal and constructive requirements. Liabilities and expected insurance recoveries, if any, are recorded separately. The carrying amount of environmental liabilities is regularly reviewed and adjusted for new facts and changes in law. Restructuring-related provisions – The provision for restructuring mainly relates to the estimated costs of initiated restructurings, the most significant of which have been approved by the Executive Committee, and which generally involve the realignment of certain parts of the industrial and commercial organization. When such restructurings require discontinuance and/or closure of lines of activities, the anticipated costs of closure or discontinuance are included in restructuring provisions. A liability is recognized for those costs only when the Company has a detailed formal plan for the restructuring and has raised a valid expectation with those affected that it will carry out the restructuring by starting to implement that plan or announcing its main features to those affected by it. Before a provision is established, the Company recognizes any impairment loss on the assets associated with the restructuring. Litigation provisions – In relation to legal claim provisions and settlements, the relevant balances are transferred to Other liabilities at the point the amount and timing of cash outflows are no longer uncertain. Settlements which are agreed for amounts in excess of existing provisions are reflected as increases of Other liabilities. Further information on provisions can be found in Provisions Goodwill The measurement of goodwill at initial recognition is described under Basis of consolidation note. Goodwill is subsequently measured at cost less accumulated impairment losses. Further information on goodwill can also be found in Goodwill Intangible assets other than goodwill Acquired finite-lived intangible assets are amortized using the straight-line method over their estimated useful life. The useful lives are evaluated annually. Intangible assets are initially capitalized at cost, with the exception of intangible assets acquired as part of a business combination, which are capitalized at their acquisition date fair value. The Company expenses all research costs as incurred. Expenditure on development activities, whereby research findings are applied to a plan or design for the production of new or substantially improved products and processes, is capitalized as an intangible asset if the product or process is technically and commercially feasible, the Company has sufficient resources and the intention to complete development and can measure the attributable expenditure reliably. The capitalized development expenditure comprises of all directly attributable costs (including the cost of materials and direct labor). Other development expenditures and expenditures on research activities are recognized in the Statement of income. Capitalized development expenditure is stated at cost less accumulated amortization and impairment losses. Amortization of capitalized development expenditure is charged to the Statement of income on a straight-line basis over the estimated useful lives of the intangible assets. Further information on intangible assets other than goodwill can be found in Intangible assets excluding goodwill Discontinued operations and non-current assets held for sale Non-current assets and disposal groups comprising assets and liabilities that are expected to be recovered primarily through sale rather than through continuing use are classified as held for sale. Non-current assets classified as held for sale and the assets of a disposal group classified as held for sale are presented separately from the other assets in the balance sheet. The liabilities of a disposal group classified as held for sale are presented separately from other liabilities in the balance sheet. A discontinued operation is a component of an entity that either has been disposed of, or is classified as held for sale, and represents a separate major line of business or geographical area of operations; is a part of a single coordinated plan to dispose of a separate major line of business or geographical area of operations; or is a subsidiary acquired exclusively with a view to sell. In case a discontinued operation is sold in stages as part of a single coordinated plan until completely sold, then the Investment in associate that is recognized upon sale of a portion that results in Philips having significant influence in the operation (rather than control), is continued to be treated as discontinued operation provided that the held for sale criteria are met. Non-current assets held for sale and discontinued operations are carried at the lower of carrying amount or fair value less cost of disposal. Any gain or loss from disposal, together with the results of these operations until the date of disposal, is reported separately as discontinued operations. The financial information of discontinued operations is excluded from the respective captions in the Consolidated financial statements and related notes for all periods presented. Comparatives in the balance sheet are not represented when a non-current asset or disposal group is classified as held for sale. Comparatives are represented for presentation of discontinued operations in the Statement of cash flow and Statement of income. Adjustments in the current period to amounts previously presented in discontinued operations that are directly related to the disposal of a discontinued operation in a prior period are classified separately in Discontinued operations. Circumstances to which these adjustments may relate include resolution of uncertainties that arise from the terms of the disposal transaction, such as the resolution of purchase price adjustments and indemnifications, resolution of uncertainties that arise from and are directly related to the operations of the component before its disposal, such as environmental and product warranty obligations retained by the Company, or the settlement of employee benefit plan obligations provided that the settlement is directly related to the disposal transaction. Further information on discontinued operations and non-current assets held for sale can be found in Discontinued operations and assets classified as held for sale Impairment Impairment of goodwill and intangible assets not yet ready for use Goodwill and intangible assets not yet ready for use are not amortized but tested for impairment annually and whenever impairment indicators require. In case of goodwill and intangible assets not yet ready for use, either internal or external sources of information are considered indicators that an asset or a CGU may be impaired. In most cases the Company identified its cash-generating units for goodwill at one level below that of an operating segment. Cash flows at this level are substantially independent from other cash flows and this is the lowest level at which goodwill is monitored by the Executive Committee. In 2017 the Company performed and completed goodwill annual impairment tests in the fourth quarter, in line with 2016. In prior year, the Company also performed goodwill annual impairment tests in the second quarter, which was in line with 2015. An impairment loss is recognized in the Statement of income whenever and to the extent that the carrying amount of a cash-generating unit exceeds the unit’s recoverable amount, which is the greater of its value in use and fair value less cost of disposal. Value in use is measured as the present value of future cash flows expected to be generated by the asset. Fair value less cost of disposal is measured as the amount obtained from a sale of an asset in an arm’s length transaction, less costs of disposal. Further information on impairment of goodwill and intangible assets not yet ready for use can be found in Goodwill Intangible assets excluding goodwill Impairment of non-financial assets other than goodwill, intangible assets not yet ready for use, inventories and deferred tax assets Non-financial assets other than goodwill, intangible assets not yet ready for use, inventories and deferred tax assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is assessed by a comparison of the carrying amount of an asset with the greater of its value in use and fair value less cost of disposal. Value in use is measured as the present value of future cash flows expected to be generated by the asset. Fair value less cost of disposal is measured as the amount obtained from a sale of an asset in an arm’s length transaction, less costs of disposal. If the carrying amount of an asset is deemed not recoverable, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the recoverable amount. The review for impairment is carried out at the level where cash flows occur that are independent of other cash flows. Impairment losses recognized in prior periods are assessed at each reporting date for any indications that the loss has decreased or no longer exists. An impairment loss is reversed if and to the extent there has been a change in the estimates used to determine the recoverable amount. The loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized. Reversals of impairment are recognized in the Consolidated statements of income Impairment of financial assets A financial asset is considered to be impaired if objective evidence indicates that one or more events have had a negative effect on the estimated future cash flows of that asset. In the case of available-for-sale financial assets, a significant or prolonged decline in the fair value of the financial asset below its cost is considered an indicator that the financial assets are impaired. If any such evidence exists for available-for sale financial assets, the cumulative loss - measured as the difference between the acquisition cost and the current fair value, less any impairment loss on that financial asset previously recognized in the Statement of income - is reclassified from the fair value reserve in equity (through Other comprehensive income) to the Statement of income. If objective evidence indicates that financial assets that are carried at cost, such as loans and receivables, need to be tested for impairment, calculations are based on information derived from business plans and other information available for estimating their fair value, which is based on estimated future cash flows discounted at the asset’s original effective interest rate. Any impairment loss is charged to the Statement of income. An impairment loss related to financial assets is reversed if in a subsequent period the fair value increases and the increase can be related objectively to an event occurring after the impairment loss was recognized. The loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined if no impairment loss had been recognized. Reversals of impairment are recognized in the Statement of income except for reversals of impairment of available-for-sale equity securities, which are recognized in Other comprehensive income. Further information on financial assets can be found in Oth

Information by segment and main

Information by segment and main country	12 Months Ended
	Dec. 31, 2017
Disclosure of information by segment and main country [Abstract]
Information by segment and main country [Text block]	Table of Contents Note Philips Group Information on income statement in millions of EUR unless otherwise stated 2015 - 2017 sales sales including intercompany depreciation and amortization 1 ) Adjusted EBITA 2 ) 2017 Personal Health 7,310 7,333 ( 371) 1,221 Diagnosis & Treatment 6,891 6,953 ( 267) 716 Connected Care & Health Informatics 3,163 3,200 ( 208) 372 HealthTech Other 415 559 ( 177) ( 109) Legacy Items 1 6 ( 2) ( 48) Inter-segment eliminations ( 269) Philips Group 17,780 17,780 ( 1,025) 2,153 2016 Personal Health 7,099 7,119 ( 385) 1,108 Diagnosis & Treatment 6,686 6,741 ( 229) 631 Connected Care & Health Informatics 3,158 3,213 ( 184) 324 HealthTech Other 478 635 ( 177) ( 66) Legacy Items 1 6 ( 2) ( 76) Inter-segment eliminations ( 292) Philips Group 17,422 17,422 ( 976) 1,921 2015 Personal Health 6,751 6,764 ( 375) 966 Diagnosis & Treatment 6,484 6,531 ( 249) 515 Connected Care & Health Informatics 3,022 3,080 ( 198) 294 HealthTech Other 503 670 ( 156) 8 Legacy Items 46 84 7 ( 95) Inter-segment eliminations ( 323) Philips Group 16,806 16,806 ( 972) 1,688 1) 2) In 2016, Philips established two stand-alone companies focused on the HealthTech and Lighting opportunities. Following this separation, Philips changed the way it allocates resources and analyzes its performance based on a new segment structure. Accordingly, from 2016 the reportable segments for the purpose of the disclosures required by IFRS 8, Operating Segments, are Personal Health, Diagnosis & Treatment, and Connected Care & Health Informatics, each being responsible for the management of its business worldwide. Additionally, HealthTech Other and Legacy Items are included. From 2017, Lighting is reported as part of Discontinued Operations (refer to Discontinued operations and assets classified as held for sale Philips focuses on improving people’s lives through meaningful innovation across the health continuum – from healthy living and prevention to diagnosis, treatment and home care. The Personal Health businesses deliver integrated, connected solutions that support healthier lifestyles and those living with chronic disease. The Diagnosis & Treatment businesses deliver precision medicine and least-invasive treatment and therapy to improve outcomes, lower the cost of care delivery and enhance the patient experience. The Connected Care & Health Informatics businesses deliver digital solutions that facilitate value-based care through consumer technology, patient monitoring and clinical informatics. The Executive Committee of Philips is deemed to be the chief operating decision maker (CODM) for IFRS 8 segment reporting purposes. The key segmental performance measure is Adjusted EBITA, which Management believes is the most relevant measure to evaluate the results of the segments. The term Adjusted EBITA is used to evaluate the performance of Philips and its segments. EBITA represents Income from operations excluding amortization and impairment of acquired intangible assets and impairment of goodwill. Adjusted EBITA represents EBITA excluding gains or losses from restructuring costs, acquisition-related charges and other items. Adjusted EBITA is not a recognized measure of financial performance under IFRS. Below is a reconciliation of Adjusted EBITA to the most directly comparable IFRS measure, Net income, for the years indicated. Net income is not allocated to segments as certain income and expense line items are monitored on a centralized basis, resulting in them being shown on a Philips Group level only. Philips Group Reconciliation from net income to Adjusted EBITA in millions of EUR 2015 - 2017 Philips Group Personal Health Diagnosis & Treatment Connected Care & Health Informatics HealthTech Other Legacy Items 2017 Net Income 1,870 Discontinued operations, net of income taxes ( 843) Income tax expense 349 Investments in associates, net of income taxes 4 Financial expenses 263 Financial income ( 126) Income from operations 1,517 1,075 488 206 ( 149) ( 103) Amortization of acquired intangible assets 260 135 55 44 26 Impairment of goodwill 9 9 EBITA 1,787 1,211 543 250 ( 114) ( 103) Restructuring and acquisition-related charges 316 11 151 91 64 Other items 50 22 31 ( 59) 55 Adjusted EBITA 2,153 1,221 716 372 ( 109) ( 48) 2016 Net Income 1,491 Discontinued operations, net of income taxes ( 660) Income tax expense 203 Investments in associates, net of income taxes ( 11) Financial expenses 507 Financial income ( 65) Income from operations 1,464 953 546 275 ( 129) ( 181) Amortization of acquired intangible assets 242 139 48 46 9 Impairment of goodwill 1 1 EBITA 1,707 1,092 594 322 ( 120) ( 181) Restructuring and acquisition-related charges 94 16 37 14 28 ( 1) Other items 120 ( 12) 26 106 Adjusted EBITA 1,921 1,108 631 324 ( 66) ( 76) 2015 Net Income 638 Discontinued operations, net of income taxes ( 479) Income tax expense 169 Investments in associates, net of income taxes ( 30) Financial expenses 453 Financial income ( 94) Income from operations 658 736 322 173 49 ( 622) Amortization of acquired intangible assets 273 149 55 54 15 EBITA 931 885 377 227 64 ( 622) Restructuring and acquisition-related charges 186 37 131 38 ( 19) ( 1) Other items 571 44 7 29 ( 37) 528 Adjusted EBITA 1,688 966 515 294 8 ( 95) Transactions between the segments are mainly related to components and parts included in the product portfolio of the other segments. The pricing of such transactions was at cost or determined on an arm’s length basis. Philips has no single external customer that represents 10% or more of sales. Philips Group Main countries in millions of EUR 2015 - 2017 sales 1 ) tangible and intangible assets 2 ) 2017 Netherlands 414 1,154 United States 6,084 8,408 China 2,322 959 Germany 1,011 270 Japan 1,059 457 France 530 33 India 425 100 Other countries 5,935 1,263 Total main countries 17,780 12,644 2016 Netherlands 393 1,007 United States 5,948 9,425 China 2,210 1,167 Germany 965 201 Japan 1,103 492 France 513 45 India 399 121 Other countries 5,891 2,147 Total main countries 17,422 14,605 2015 Netherlands 374 970 United States 5,742 9,291 China 2,132 1,194 Germany 929 170 Japan 962 455 France 487 48 India 431 134 Other countries 5,749 2,276 Total main countries 16,806 14,538 1) 2)

Discontinued operations and ass

Discontinued operations and assets classified as held for sale	12 Months Ended
	Dec. 31, 2017
Disclosure of discontinued operations [Abstract]
Disclosure of discontinued operations [Text block]	Table of Contents Note Discontinued operations included in the Consolidated statements of income and cash flows consist of the segment Lighting, the combined Lumileds and Automotive businesses and certain divestments formerly reported as discontinued operations. The below table summarizes the discontinued operations, net of income taxes results reported in the consolidated statements of income. Philips Group Discontinued operations, net of income taxes in millions of EUR 2015 - 2017 2015 2016 2017 Lighting 247 244 896 The combined Lumileds and Automotive businesses 233 282 ( 29) Other ( 1) 134 ( 24) Discontinued operations, net of income taxes 479 660 843 Lighting In the course of 2017, Philips completed several transactions in Philips Lighting shares, which reduced the interest in this company from 71.23% as of December 31, 2016 to 29.01% as of December 31, 2017. For further details, please refer to Interests in entities On April 28, 2017, triggered by a sale of Philips Lighting shares, we concluded that a loss of control was highly probable due to further sell-downs of shares within one year. From that date Lighting was presented as a discontinued operation. On November 28, 2017, triggered by an additional sale of Philips Lighting shares, Philips lost control, resulting in the deconsolidation of Philips Lighting. Upon deconsolidation, the Company recognized a gain of EUR 599 million, including a tax benefit of EUR 61 million, which was recorded in Discontinued operations. This gain is the net effect of (i) a cash consideration for shares sold in this transaction (EUR 545 million) In determining the EUR 599 million, a gain of EUR 638 million was attributable to measuring the retained interest at its fair value. In addition, Philips recognized a valuation loss of EUR 104 million related to the retained interest in Philips Lighting subsequent to deconsolidation (see other assets classified as assets held for sale in this paragraph). The following table, summarizes the results of Lighting included in the Consolidated statements of income as discontinued operations. Results of Lighting in millions of EUR 2015-2017 2015 2016 2017 Sales 7,438 7,094 6,319 Costs and expenses ( 7,114) ( 6,726) ( 5,776) Result on the deconsolidation of discontinued operations 538 Value adjustment retained interest ( 104) Income before tax 324 368 977 Income tax expense ( 77) ( 124) ( 150) Income tax on the deconsolidation of discontinued operations 61 US Tax Cuts and Jobs Act 8 Results from discontinued operations 247 244 896 As a result of Lighting being classified as a discontinued operation, the 2015 and 2016 financial statements have been restated. Apart from these changes, consequential restatements were processed in Income from operations Financial income and expenses Income taxes Earnings per share Post-employment benefits Discontinued operations: Combined Lumileds and Automotive businesses On June 30, 2017, Philips completed the sale of an 80.1% interest in the combined Lumileds and Automotive businesses to certain funds managed by affiliates of Apollo Global Management, LLC. The combined businesses of Lumileds and Automotive were reported as discontinued operations as from the end of November 2014. During 2017, discontinued operations results of the combined businesses of Lumileds and Automotive amounted to a loss of EUR 29 million, which consisted of a loss of EUR 72 million, net of EUR 26 million tax benefit from the sale of the majority stake, operational results of EUR 159 million, net of EUR 25 million tax expense and a tax expense of EUR 107 million as a result of the US Tax Cuts and Jobs Act. The net of tax loss of EUR 72 million related to the sale mainly comprises of (i) net cash proceeds associated with the sale (EUR 1,067 million), (ii) plus the fair value of the retained investment (EUR 305 million), (iii) plus a tax benefit (EUR 26 million), (iv) less the book value of business-related assets and liabilities (EUR 1,533 million) and (v) plus the release of cumulative translation differences (EUR 63 million). Furthermore, a gain related to the sale of real estate was recognized in Other business income in Q1 2017. In addition, trademark license revenue is recognized in income from continuing operations as of December 2017. In determining the EUR 72 million, a gain of EUR 13 million was attributable to measuring the retained interest at its fair value. For details on the retained interest in the combined Lumileds and Automotive businesses we refer to Other financial assets The following table summarizes the results of the combined businesses of Lumileds and Automotive in the Consolidated statements of income as discontinued operations. Philips Group Results of combined Lumileds and Automotive businesses in millions of EUR 2015 - 2017 2015 2016 2017 Sales 1,619 1,711 804 Costs and expenses ( 1,320) ( 1,376) ( 630) Result on the sale of discontinued operations ( 98) Income before taxes 299 335 76 Income tax expense ( 66) ( 53) ( 25) Income tax on the sale of discontinued operations 26 US Tax Cuts and Jobs Act ( 107) Results from discontinued operations 233 282 ( 29) Discontinued operations: Other Certain other divestments reported as discontinued operations, resulted in a net loss of EUR 24 million in 2017 (2016: a net gain of EUR 134 million; 2015: a net loss of EUR 1 million). The main result in 2016 related to the court decision in favor of Philips in an arbitration case against Funai Electric Co., Ltd. Philips started the arbitration after it terminated the agreement to transfer the Audio, Video, Media & Accessories business to Funai following a breach of contract by Funai. As a consequence the court ordered Funai to pay EUR 144 million, which includes disbursements and interest, as compensation for damages. The amount was received in the second quarter of 2016. Discontinued operations cash flows The following table presents the net cash flows of operating, investing and financing activities reported in the Consolidated cash flow statements. Discontinued operations cash flows in millions of EUR 2015 -2017 2015 2016 2017 Cash flows from operating activities 761 1,037 350 Cash flows from investing activities ( 203) ( 112) 856 Cash flows from financing activities ( 20) 1,226 ( 144) Total discontinued operations cash flows 537 2,151 1,063 In 2017, cash flows from operating activities reflect the period prior to the divestment of the combined Lumileds and Automotive business (six months of cash flows) and prior to the deconsolidation of Lighting (eleven months of cash flows). In 2017, cash flows from investing activities includes the net cash outflow related to the deconsolidation of Philips Lighting of EUR 175 million, consisting of EUR 545 million proceeds from the sale of shares on November 28, 2017, offset by the deconsolidation of EUR 720 million of cash and cash equivalents, and proceeds of EUR 1,067 million received from the sale of the combined Lumileds and Automotive businesses. In 2016, cash flows from investing activities includes EUR 144 million cash inflow related to the Funai arbitration and cash flows from financing activities includes new funding of EUR 1.2 billion attracted by Philips Lighting. Assets classified as held for sale As of December 31, 2017, assets held for sale consisted of the retained interest in Philips Lighting for an amount of EUR 1,264 million, property, plant and equipment for an amount of EUR 40 million, and assets and liabilities directly associated with assets held for sale businesses of EUR 44 million. Philips will sell down its retained interest in Philips Lighting within one year. Therefore, the current position of 29.01% is a temporary position which fits in our single coordinated plan to sell Philips Lighting in its entirety. Consequently any results related to the retained interest - such as value adjustments, results upon disposal and dividends - will be reflected in discontinued operation. The valuation basis for the retained interest in Philips Lighting shares is the lower of the carrying value as per November 28, 2017 (based on the closing share price of EUR 32.975) or the value based on the stock price, less cost to sell, at reporting date. Based on the share price of Philips Lighting as of December 31, 2017 of EUR 30.60 and taking into account expected cost to sell, we recognized a loss in discontinued operations of EUR 104 million.

Acquisitions and divestments

Acquisitions and divestments	12 Months Ended
	Dec. 31, 2017
Disclosure of acquisitions and divestments [Abstract]
Disclosure of acquisitions and divestments [Text block]	Table of Contents Note 2017 Philips completed ten acquisitions in 2017. The acquisitions involved an aggregated net cash outflow of EUR 2,333 million. These acquisitions had an aggregated impact on Goodwill and Other intangible assets of EUR 1,548 million and EUR 926 million respectively. The Spectranetics Corporation (Spectranetics) is the most notable acquisition and is discussed below. The remaining nine acquisitions involved an aggregated net cash outflow of EUR 425 million. Separately, the net cash outflow ranged from EUR 3 million to EUR 117 million. These remaining acquisitions had an aggregated impact on Goodwill and Other intangible assets of EUR 293 million and EUR 252 million respectively. On August 9, 2017 Philips completed the acquisition of Spectranetics, by acquiring all of the issued and outstanding shares of Spectranetics for USD 38.50 per share, paid in cash at completion. As of the date of acquisition, Spectranetics became a wholly owned subsidiary of Philips and was consolidated within Philips Image-Guided Therapy business as part of the Diagnosis & Treatment businesses segment. Spectranetics is a US-based global leader in vascular intervention and lead management solutions, present in 11 countries and employs over 900 employees. The acquisition involved a net cash outflow of EUR 1,908 million. This amount comprised the purchase price of shares (EUR 1,441 million), the settlement of share-based compensation plans (EUR 94 million), the redemption of debt (EUR 378 million) and the settlement of various other items (EUR 48 million). The overall cash position of Spectranetics on the transaction date was EUR 53 million. Acquisition-related costs of EUR 25 million were recognized in General and administrative expenses. The condensed opening balance sheet of Spectranetics as of August 9, 2017 was as follows: Spectranetics Balance sheet in millions of EUR 2017 at acquisition date Goodwill 1,255 Other intangible assets 674 Property, plant and equipment 69 Deferred tax assets 135 Inventories 38 Receivables and other current assets 42 Cash 53 Accounts payable and other payables ( 49) Deferred tax liabilities ( 257) Total assets and liabilities 1,960 Financed by equity ( 1,960) Opening balance positions are subject to final purchase price adjustments, expected to be processed in the first quarter of 2018. Main pending final purchase price adjustments concern Goodwill, Other Intangible assets (Customer relationships, Technology) and Deferred tax liabilities. Goodwill recognized in the amount of EUR 1,255 million, which at the date of this report is treated as non-deductible for tax purposes, mainly represents the impact of cost synergies. Cost synergies relate to expected lower General and administrative expenses and Selling expenses subsequent to the integration of Spectranetics. Receivables and other current assets include value adjustments of EUR 3 million, representing the best estimate at the acquisition date of the contractual cash flows not expected to be received. Other intangible assets were comprised of the following: Spectranetics Other intangible assets in millions of EUR unless otherwise stated 2017 amount amortization period Customer relationships 372 20 Technology 297 15 Brand names 5 3 Total other intangible assets 674 The main categories of Other intangible assets (Customer relationships and Technology) are determined using an ‘income approach’, which is a valuation technique that estimates the fair value of an asset based on market participants’ expectations of the cash flows generated by that asset over its remaining useful life. The fair value of the Customer relationships relates to an estimate of positive cash flows associated with incremental profits related to excess earnings until 2038, discounted at a rate of 10.5%. The fair value of Technology is based on the assumption that certain savings in royalty payments can be achieved until 2032, which are discounted at a rate ranging from 11.5% to 13.0%. As from August 9, 2017, Spectranetics contributed sales of EUR 114 million and generated a negative net income of EUR 37 million. Pro-forma disclosure The following table presents 2017 year-to-date unaudited pro-forma results of Philips, assuming Spectranetics had been consolidated as of January 1, 2017. Philips Group Pro-forma Statements of income for Spectranetics acquisition (unaudited) in millions of EUR 2017 Philips Group Pro forma adjustments Pro-forma Philips Group Sales 17,780 156 17,936 Net income 1,870 ( 40) 1,830 Pro-forma information is based on historical Spectranetics and Philips performance. The following main adjustments were made to arrive at pro-forma information: exclusion of acquisition-related costs incurred by Spectranetics; inclusion of purchase price allocation effects; exclusion of stock based compensation costs; exclusion of interest costs related to debt; inclusion of tax benefits related to operating losses. Divestments Apart from the sale of the Combined Lumileds and Automotive businesses and the deconsolidation of Philips Lighting, Philips completed two divestments during 2017 at an aggregate cash consideration of EUR 54 million. For details regarding the sale of the Combined Lumileds and Automotive businesses and the deconsolidation of Philips Lighting, reference is made to Discontinued operations and assets classified as held for sale 2016 Acquisitions Philips completed two acquisitions in 2016, which involved an aggregated net cash outflow of EUR 168 million. Divestments Philips completed six divestments during 2016. The six divestments involved an aggregated cash consideration of EUR 43 million.

Interests in entities

Interests in entities	12 Months Ended
	Dec. 31, 2017
Disclosure of associates [Abstract]
Disclosure of interests in other entities [Text block]	Table of Contents Note In this section we discuss the nature of the Company’s interests in its consolidated entities and associates, and the effects of those interests on the Company’s financial position and financial performance. Transactions in Philips Lighting shares In the course of 2017, Philips completed three separate transactions in Philips Lighting shares which reduced the interest in this company from 71.23% as of December 31, 2016 to 29.01% as of December 31, 2017. In February and April 2017, the Company sold 48,250,000 shares through two accelerated bookbuild offerings to institutional investors, which resulted in a net cash inflow of EUR 1,060 million. These divestment transactions did not impact the profit and loss account of the Company because subsequent to these transactions Philips Lighting continued to be fully consolidated as it was controlled by Royal Philips. The two offerings had a positive impact on Shareholders’ equity of the Company of EUR 327 million. This amount includes (i) the difference between the proceeds and the carrying value of the shares sold in these transactions (increase of EUR 352 million), (ii) costs related to the accelerated bookbuild offering which were directly recognized in Shareholders’ equity (decrease of EUR 6 million) and (iii) certain reallocations of currency translation adjustments to Non-controlling interests (decrease of EUR 19 million). On November 28, 2017, the Company sold 17,100,000 shares through an accelerated bookbuild offering to institutional investors. This transaction triggered a loss of control by the Company, resulting in a deconsolidation of Philips Lighting. Upon deconsolidation of Philips Lighting, the Company recognized a gain of EUR 599 million before tax, which was recorded in Discontinued operations. For further details regarding this result, reference is made to Discontinued operations and assets classified as held for sale Group companies Set out below is a list of material subsidiaries as per December 31, 2017 representing greater than 5% of either the consolidated group Sales, Income from operations or Net income (before any intra-group eliminations) of Group legal entities. All of the entities are fully consolidated in the group accounts of the Company. Philips Group Interests in group companies in alphabetical order 2017 Legal entity name Principal country of business 370 West Trimble Road LLC United States Metaaldraadlampenfabriek “Volt” B.V. Netherlands Philips (China) Investment Company, Ltd. China Philips Consumer Lifestyle B.V. Netherlands Philips Domestic Appliances and Personal Care Company of Zhuhai SEZ, Ltd. China Philips Electronics Hong Kong Limited Hong Kong Philips Electronics Nederland B.V. Netherlands Philips Electronics UK Limited United Kingdom Philips GmbH Germany Philips Japan, Ltd. Japan Philips Medical Systems Nederland B.V. Netherlands Philips Medizin Systeme Hofheim-Wallau GmbH Germany Philips North America LLC United States Philips Oral Healthcare, LLC United States Philips Ultrasound, Inc. United States Respironics, Inc. United States RI Finance, Inc. United States RIC Investments, LLC United States Information related to Non-controlling interests As of December 31, 2017, four consolidated subsidiaries are not wholly owned by Philips (December 31, 2016: five). Until November 28, 2017, a significant subsidiary that was consolidated but not wholly owned was Philips Lighting. Due to the deconsolidation of Philips Lighting, the Non-controlling interest related to this company was derecognized. The following is unaudited summarized financial information extracted from Philips Lighting’s consolidated statements of income for 2016 and 2017. Philips Group Summarized financial information for Philips Lighting (unaudited) in millions of EUR 2016 2017 Philips Lighting Philips Lighting Sales to thirds 7,115 6,965 Net income 185 281 Investments in associates Philips has investments in a number of associates. None of them (except Philips Lighting) are regarded as individually material. The interest in Philips Lighting is treated as an asset classified as held for sale. For further details on the accounting treatment, we refer to Discontinued operations and assets classified as held for sale The summarized financial information of Philips Lighting, not adjusted for the percentage of ownership held by Philips, is presented below and is based on the unaudited published financial results for the full year on February 2, 2018. Summarized income statement of Philips Lighting (unaudited) in millions of EUR 2017 Sales to thirds 6,965 Income before taxes 441 Net financial income/expense ( 43) Income taxes ( 117) Net income 281 Summarized net asset value of Philips Lighting (unaudited) in millions of EUR 2017 Current assets 3,372 Non-current assets 3,306 Total assets 6,678 Current liabilities ( 2,216) Non-current liabilities ( 2,140) Net assets value 2,321 Involvement with unconsolidated structured entities Philips founded three Philips Medical Capital (PMC) entities, in the United States, France and Germany, in which Philips holds a minority interest. Philips Medical Capital, LLC in the United States is the most significant entity. PMC entities provide healthcare equipment financing and leasing services to Philips customers for diagnostic imaging equipment, patient monitoring equipment, and clinical IT systems. The Company concluded that it does not control, and therefore should not consolidate the PMC entities. In the United States, PMC operates as a subsidiary of De Lage Landen Financial Services, Inc. The same structure and treatment is applied to the PMC entities in the other countries, with other majority shareholders. Operating agreements are in place for all PMC entities, whereby acceptance of sales and financing transactions resides with the respective majority shareholder. After acceptance of a transaction by PMC, Philips transfers significant risk and rewards and does not retain any obligations towards PMC or its customers, from the sales contracts. At December 31, 2017, Philips’ stake in Philips Medical Capital, LLC amounted to EUR 29 million (December 31, 2016: EUR 25 million).

Income from operations

Income from operations	12 Months Ended
	Dec. 31, 2017
Disclosure of income from operations [Abstract]
Disclosure of income from operations [Text block]	Table of Contents Note For information related to Sales on a segment and geographical basis, see Information by segment and main country Philips Group Sales and costs by nature in millions of EUR 2015 - 2017 2015 2016 2017 Sales 16,806 17,422 17,780 Costs of materials used ( 5,188) ( 5,030) ( 4,918) Employee benefit expenses ( 5,638) ( 5,298) ( 5,824) Depreciation and amortization ( 972) ( 976) ( 1,025) Shipping and handling ( 547) ( 545) ( 602) Advertising and promotion ( 862) ( 915) ( 939) Lease expense, net 1 ) ( 250) ( 223) ( 227) Other operational costs 2 ) ( 2,751) ( 2,963) ( 2,804) Other business income (expenses) 60 ( 6) 76 Income from operations 658 1,464 1,517 1) 2) rd) Sales composition Philips Group Sales composition in millions of EUR 2015 - 2017 2015 2016 2017 Goods 1 ) 13,175 13,568 13,974 Services 1 ) 3,215 3,478 3,477 Royalties 416 375 329 Sales 16,806 17,422 17,780 1) Costs of materials used Cost of materials used represents the inventory recognized in cost of sales. Employee benefit expenses Philips Group Employee benefit expenses in millions of EUR 2015 - 2017 2015 2016 2017 Salaries and wages 1 ) 4,342 4,422 4,856 Post-employment benefits costs 705 279 347 Other social security and similar charges: Required by law 480 489 514 Voluntary 110 108 108 Employee benefit expenses 5,638 5,298 5,824 1) The employee benefit expenses relate to employees who are working on the payroll of Philips, both with permanent and temporary contracts. For further information on post-employment benefit costs, see Post-employment benefits For details on the remuneration of the members of the Board of Management and the Supervisory Board, see Information on remuneration Employees The average number of employees by category is summarized as follows: Philips Group Employees in FTEs 2015 - 2017 2015 2016 2017 Production 26,524 27,899 27,697 Research and development 8,242 9,087 9,787 Other 23,216 24,565 26,314 Employees 57,982 61,552 63,798 3rd party workers 7,900 8,050 8,098 Continuing operations 65,882 69,602 71,895 Discontinued operations 48,330 43,971 43,497 Philips Group 114,211 113,572 115,392 Employees consist of those persons working on the payroll of Philips and whose costs are reflected in the Employee benefit expenses table. 3 rd Philips Group Employees per geographical location in FTEs 2015 - 2017 2015 2016 2017 Netherlands 7,589 11,199 11,308 Other countries 58,292 58,403 60,587 Continuing operations 65,882 69,602 71,895 Discontinued operations 48,330 43,971 43,497 Philips Group 114,211 113,572 115,392 Depreciation and amortization Depreciation of property, plant and equipment and amortization of intangible assets, including impairments, are as follows: Philips Group Depreciation and amortization 1 ) in millions of EUR 2015 - 2017 2015 2016 2017 Depreciation of property, plant and equipment 422 458 437 Amortization of software 35 49 50 Amortization of other intangible assets 273 244 260 Amortization of development costs 242 225 277 Depreciation and amortization 972 976 1,025 1) Depreciation of property, plant and equipment is primarily included in cost of sales. Amortization of the categories of other intangible assets are reported in selling expenses for brand names and customer relationships and are reported in cost of sales for technology based and other intangible assets. Amortization of development cost is included in research and development expenses. Shipping and handling Shipping and handling costs are included in cost of sales and selling expenses in Consolidated statements of income Significant accounting policies Advertising and promotion Advertising and promotion costs are included in selling expenses in Consolidated statements of income Audit fees The table below shows the fees attributable to the fiscal years 2015, 2016 and 2017 for services rendered by the respective Group auditors. Philips Group Fees in millions of EUR 2015 2016 2017 Audit fees 15.3 18.4 16.7 consolidated financial statements 9.8 13.4 12.5 statutory financial statements 5.5 5.0 4.2 Audit-related fees 4.9 2.3 1.5 acquisitions and divestments 3.6 0.9 0.0 sustainability assurance 0.6 0.7 0.7 other 0.7 0.7 0.8 Tax fees 1.1 0.0 0.0 tax compliance services 1.1 0.0 0.0 Other fees 0.0 0.0 0.0 other 0.0 0.0 0.0 Fees 1 ) 21.3 20.7 18.3 1) Other business income (expenses) Other business income (expenses) consists of the following: Philips Group Other business income (expenses) in millions of EUR 2015 - 2017 2015 2016 2017 Result on disposal of businesses: income 1 1 15 expense ( 2) ( 4) ( 5) Result on disposal of fixed assets: income 44 4 96 expense ( 1) ( 1) ( 1) Result on other remaining business: income 44 13 41 expense ( 27) ( 17) ( 62) Impairment of goodwill 1 ) ( 1) ( 9) Other business income (expenses) 60 ( 6) 76 Total other business income 89 17 152 Total other business expense ( 30) ( 23) ( 76) 1) Goodwill The result on disposal of businesses was mainly due to divestment of non-strategic businesses. The result on disposal of fixed assets was mainly due to sale of real estate assets. In 2017 income on disposal of fixed assets amounted to EUR 96 million of which EUR 59 million relates to a disposal of real estate in the US. The result on other remaining businesses mainly relates to non-core revenue and various legal matters.

Financial income and expenses

Financial income and expenses	12 Months Ended
	Dec. 31, 2017
Disclosure of Financial income and expenses [Abstract]
Financial income and expenses [Text block]	Table of Contents Note Philips Group Financial income and expenses in millions of EUR 2015 - 2017 2015 2016 2017 Interest income 44 43 40 Interest income from loans and receivables 18 15 12 Interest income from cash and cash equivalents 26 28 28 Dividend income from available for sale financial assets 6 4 64 Net gains from disposal of financial assets 20 3 1 Net change in fair value of financial assets at fair value through profit or loss 4 7 Other financial income 20 15 14 Financial income 94 65 126 Interest expense ( 344) ( 342) ( 222) Interest on debt and borrowings ( 267) ( 288) ( 177) Finance charges under finance lease contract ( 6) ( 7) ( 8) Interest expenses - pensions ( 70) ( 48) ( 37) Provision-related accretion and interest ( 31) 44 ( 22) Net foreign exchange losses ( 10) ( 1) ( 2) Impairment loss of financial assets ( 46) ( 24) ( 2) Net change in fair value of financial assets at fair value through profit or loss ( 4) Other financial expenses ( 23) ( 180) ( 15) Financial expense ( 453) ( 507) ( 263) Financial income and expenses ( 359) ( 442) ( 137) Net financial income and expense showed a EUR 137 million expense in 2017, which was EUR 305 million lower than in 2016. Net interest expense in 2017 was EUR 117 million lower than in 2016, mainly due to lower interest expenses on net debt following the bond redemptions in October 2016 and January 2017. Higher dividend income was mainly related to the retained interest in the combined businesses of Lumileds and Automotive. Net interest expense in 2016 was EUR 2 million lower than in 2015. The impairment charges in 2016 amounted to EUR 24 million mainly due to Corindus Vascular Robotics. Lower provision-related accretion and interest in 2016 is primarily due to the release of accrued interest as a result of the settlement of the Masimo litigation. Other financial expenses included financial charges related to the early redemption of USD bonds in October 2016 and January 2017 of EUR 91 million and EUR 62 million respectively. Net financial income and expense showed a EUR 359 million expense in 2015. Total financial income of EUR 94 million included EUR 44 million of interest income.

Income taxes

Income taxes	12 Months Ended
	Dec. 31, 2017
Disclosure of Income taxes [Abstract]
Income taxes [Text block]	Table of Contents Note The income tax expense of continuing operations amounted to EUR 349 million (2016: EUR 203 million, 2015: EUR 169 million). The components of income before taxes and income tax expense are as follows: Philips Group Income tax expense in millions of EUR 2015 - 2017 2015 2016 2017 Netherlands 93 137 929 Foreign 206 886 451 Income before taxes of continuing operations 1 ) 299 1,023 1,381 Netherlands: Current tax (expense) benefit 47 10 ( 15) Deferred tax (expense) benefit 6 ( 95) ( 150) Total tax (expense) benefit of continuing operations (Netherlands) 53 ( 85) ( 165) Foreign: Current tax (expense) benefit ( 157) ( 155) ( 258) Deferred tax (expense) benefit ( 65) 37 73 Total tax (expense) benefit of continuing operations (foreign) ( 222) ( 118) ( 184) Income tax expense of continuing operations ( 169) ( 203) ( 349) 1) Income tax expense of continuing operations excludes the tax expense of the discontinued operations of EUR 182 million (2016: EUR 181 million, 2015: EUR 144 million), further detailed in section Discontinued operations and assets classified as held for sale The components of income tax expense of continuing operations are as follows: Philips Group Current income tax expense in millions of EUR 2015 - 2017 2015 2016 2017 Current year tax (expense) benefit ( 121) ( 165) ( 275) Prior year tax (expense) benefit 11 20 3 Current tax (expense) ( 110) ( 145) ( 272) Philips Group Deferred income tax expense in millions of EUR 2015 - 2017 2015 2016 2017 Recognition of previously unrecognized 4 19 32 (Unrecognized) tax loss and credit carryforwards 1 ) ( 9) ( 56) ( 9) (Unrecognized) recognition of temporary differences 1 ) ( 35) 31 35 Prior year tax ( 6) ( 1) 6 Tax rate changes ( 19) 5 ( 72) Origination and reversal of temporary differences, tax losses and tax credits 6 ( 56) ( 69) Deferred tax (expense) benefit ( 59) ( 58) ( 77) 1) Philips’ operations are subject to income taxes in various foreign jurisdictions. The statutory income tax rates varies up to 40.0%, which results in a difference between the weighted average statutory income tax rate and the Netherlands’ statutory income tax rate of 25.0% (2016: 25.0%; 2015: 25.0%). A reconciliation of the weighted average statutory income tax rate to the effective income tax rate of continuing operations is as follows: Philips Group Effective income tax rate in % 2015 - 2017 2015 2016 2017 Weighted average statutory income tax rate in % 43.6 23.3 24.5 Recognition of previously unrecognized ( 1.4) ( 1.9) ( 2.3) Unrecognized tax loss and credit carryforwards 2.9 5.5 0.6 Unrecognized (recognition of) temporary differences 11.4 ( 3.1) ( 2.6) Non-taxable income and tax incentives ( 35.5) ( 8.2) ( 9.8) Non-deductible expense 33.8 9.3 6.4 Withholding and other taxes 8.3 1.2 4.0 Tax rate changes 5.9 ( 0.5) 5.2 Prior year tax 1.0 ( 1.8) ( 0.6) Tax expense (benefit) due to other tax liabilities ( 12.7) ( 2.6) ( 1.7) Others, net ( 1.0) ( 1.3) 1.5 Effective income tax rate 56.4 19.9 25.3 The effective income tax rate was higher than the weighted average statutory income tax rate in 2017, largely due to a tax charge recorded for the re-measurement of Philips’ US deferred tax assets as a result of the enactment of the US Tax Cuts and Jobs Act in December 2017. This effect was partly offset by tax benefits from the recognition of deferred tax assets which were previously unrecognized. Deferred tax assets and liabilities Deferred tax assets are recognized for temporary differences, unused tax losses, and unused tax credits to the extent that realization of the related tax benefits is probable. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income in the countries where the deferred tax assets originated and during the periods when the deferred tax assets become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. Net deferred tax assets relate to the following underlying assets and liabilities and tax loss carryforwards (including tax credit carryforwards) and their movements during the years 2017 and 2016 respectively are presented in the tables below. The net deferred tax assets of EUR 1,565 million (2016: EUR 2,692 million) consist of deferred tax assets of EUR 1,598 million (2016: EUR 2,758 million) and deferred tax liabilities of EUR 33 million (2016: EUR 66 million). The decrease in the net deferred tax assets by EUR 1,127 million is predominantly attributable to the deconsolidation of Philips Lighting (EUR 437 million) the tax rate change in the US (EUR 200 million), acquisitions (EUR 186 million) and the impact of foreign currency translation (EUR 177 million). The tax rate change as a result of the enactment of the US Tax Cuts and Jobs Act in December 2017 resulted in EUR 200 million decrease of deferred tax assets, of which EUR 171 million is recognized as a tax expense in net income and EUR 29 million in equity. Of the total expense, EUR 99 million is presented within net income from Discontinued operations following the Company’s policy to present and recognize re-measurements of deferred taxes as a result of tax rate changes based on the origin of the deferred tax (backwards tracing). As the originating tax result was based on the Lumileds and Lighting discontinued operations, the impact of the tax rate change is also recognized in Discontinued operations. The impact of the tax rate change relating to discontinued operations and equity, acquisitions and foreign currency translation are presented as ‘Other’ in the table below. Of the total deferred tax assets of EUR 1,598 million at December 31, 2017 (2016: EUR 2,758 million), EUR 161 million (2016: EUR 2,054 million) is recognized in respect of entities in various countries where there have been tax losses in the current or preceding period. Management’s projections support the assumption that it is probable that the results of future operations will generate sufficient taxable income to utilize these deferred tax assets. At December 31, 2017 the temporary differences associated with investments, including potential income tax consequences on dividends, for which no deferred tax liabilities are recognized, aggregate to EUR 290 million (2016: EUR 685 million). Philips Group Deferred tax assets and liabilities in millions of EUR 2017 Balance as of January 1, 2017 recognized in income statement Transfer to assets held for sale other 1 ) Balance as of December 31, 2017 Assets Liabilities Intangible assets ( 676) 549 ( 28) ( 228) ( 383) 423 ( 806) Property, plant and equipment 10 15 ( 2) 23 39 ( 16) Inventories 347 ( 34) ( 52) ( 29) 231 235 ( 4) Other assets 138 7 ( 82) 12 74 96 ( 22) Pension and other employee benefits 597 ( 126) ( 149) ( 57) 265 265 - Other liabilities 989 ( 288) ( 8) ( 158) 536 596 ( 61) Deferred tax assets on tax loss carryforwards 1,288 ( 201) ( 125) ( 144) 819 819 - Set-off deferred tax positions - ( 876) 876 Net deferred tax assets 2,692 ( 77) ( 444) ( 606) 1,565 1,598 ( 33) 1) Philips Group Deferred tax assets and liabilities in millions of EUR 2016 Balance as of January 1, 2016 recognized in income statement other 1 ) Balance as of December 31, 2016 Assets Liabilities Intangible assets ( 1,089) 450 ( 36) ( 676) 542 ( 1,218) Property, plant and equipment 19 1 ( 10) 10 64 ( 54) Inventories 312 24 11 347 353 ( 6) Other assets 68 32 37 138 161 ( 23) Pensions and other employee benefits 707 ( 138) 27 597 598 ( 1) Other liabilities 981 ( 32) 40 989 1,107 ( 118) Deferred tax assets on tax loss carryforwards 1,562 ( 368) 93 1,288 1,288 - Set-off deferred tax positions ( 1,355) 1,355 Net deferred tax assets 2,560 ( 30) 162 2,692 2,758 ( 66) 1) The company has available tax loss and credit carryforwards, which expire as follows: Philips Group Expiry years of net operating loss and credit carryforwards in millions of EUR Total Total Balance as of December 31, 2016 Unrecognized balance as of December 31, 2016 Total Balance as of December 31, 2017 Unrecognized balance as of December 31, 2017 2017 14 - - - 2018 4 3 3 3 2019 58 10 5 2 2020 137 21 15 6 2021 37 3 14 2 2022 - - 1,843 1,809 Later than 2021, respectively 2022 3,503 14 2,134 410 Unlimited 2,077 1,118 1,812 1,118 Total 5,830 1,170 5,827 3,351 At December 31, 2017, the amount of deductible temporary differences for which no deferred tax asset has been recognized in the balance sheet was EUR 42 million (2016: EUR 868 million) Tax risks Philips is exposed to tax risks. With regard to these tax risks a liability is recognized if, as a result of a past event, Philips has an obligation that can be estimated reliably and it is probable that an outflow of economic benefits will be required to settle the obligation. These uncertain positions are presented as Other tax liabilities in Other liabilities US Tax Cuts and Jobs Act Philips assessed the impact of the material aspects of the US Tax Cuts and Jobs Act on its current and deferred tax assets and liabilities. These reported amounts may be subject to estimation uncertainty and measurement adjustments may need to be made in subsequent reporting periods as Philips will get more accurate information on the impact of the Act and the modalities of its application. The main uncertainties relate to the availability of net interest expense carryforwards and the amount of tax earnings and profits subject to tax under the mandatory deemed repatriation provisions. Transfer pricing risks Philips has issued transfer pricing directives, which are in accordance with international guidelines such as those of the Organization of Economic Co-operation and Development. In order to reduce the transfer pricing uncertainties, monitoring procedures are carried out by Group Tax to safeguard the correct implementation of the transfer pricing directives. Tax risks on general and specific service agreements and licensing agreements Due to the centralization of certain activities (such as research and development, IT and group functions), costs are also centralized. As a consequence, these costs and/or revenues must be allocated to the beneficiaries, i.e. the various Philips entities. For that purpose, service contracts such as intra-group service agreements and licensing agreements are signed with a large number of group entities. Tax authorities review these intra-group service and licensing agreements, and may reject the implemented intra-group charges. Furthermore, buy in/out situations in the case of (de)mergers could affect the cost allocation resulting from the intragroup service agreements between countries. The same applies to the specific service agreements. Tax risks due to disentanglements and acquisitions When a subsidiary of Philips is disentangled, or a new company is acquired, tax risks may arise. Philips creates merger and acquisition (M&A) teams for these disentanglements or acquisitions. In addition to representatives from the involved business, these teams consist of specialists from various group functions and are formed, among other things, to identify tax risks and to reduce potential tax claims related to disentangled entities. Examples of tax risks are: applicability of participation exemptions, cost allocation issues, and issues related to (non-)deductibility. Tax risks due to permanent establishments A permanent establishment may arise when operations in a country involve a Philips organization in another country, there is a risk that tax claims will arise in the former country as well as in the latter country; potentially leading to double taxation.

Earnings per share

Earnings per share	12 Months Ended
	Dec. 31, 2017
Earnings per share [Abstract]
Disclosure of earnings per share [Text block]	Table of Contents Note Philips Group Earnings per share in millions of EUR unless otherwise stated 1 ) 2015 - 2017 2015 2016 2017 Income from continuing operations 160 831 1,028 Income (loss) attributable to non-controlling interest 14 43 214 Income from continuing operations attributable to shareholders 146 788 814 Income from Discontinued operations 479 660 843 Net income attributable to shareholders 624 1,448 1,657 Weighted average number of common shares outstanding (after deduction of treasury shares) during the year 916,086,943 918,015,863 928,797,650 Plus incremental shares from assumed conversions of: Options 3,565,682 2,456,616 3,161,267 Performance shares 2,479,923 6,985,509 10,757,785 Restricted share rights 1,491,960 1,331,163 2,008,162 Forward contracts 407,193 Dilutive potential common shares 7,537,565 10,773,289 16,334,406 Diluted weighted average number of shares (after deduction of treasury shares) during the year 923,624,508 928,789,152 945,132,056 Basic earnings per common share in EUR 2 ) Income from continuing operations 0.17 0.90 1.11 Income from Discontinued operations 0.52 0.72 0.91 Income from continuing operations attributable to shareholders 0.16 0.86 0.88 Net income attributable to shareholders 0.68 1.58 1.78 Diluted earnings per common share in EUR 2 3 ) Income from continuing operations 0.17 0.89 1.09 Income from Discontinued operations 0.52 0.71 0.89 Income from continuing operations attributable to shareholders 0.16 0.85 0.86 Net income attributable to shareholders 0.68 1.56 1.75 Dividend distributed per common share in euros 0.80 0.80 0.80 1) 2) 3)

Property, plant and equipment

Property, plant and equipment	12 Months Ended
	Dec. 31, 2017
Disclosure of detailed information about property, plant and equipment [Abstract]
Disclosure of property, plant and equipment [Text block]	Table of Contents Note Philips Group Property, plant and equipment in millions of EUR 2017 land and buildings machinery and installations other equipment prepayments and construction in progress total Balance as of January 1, 2017: Cost 1,766 3,222 1,897 179 7,064 Accumulated depreciation ( 912) ( 2,546) ( 1,451) ( 4,909) Book value 854 676 446 179 2,155 Change in book value: Capital expenditures 17 128 86 320 551 Assets available for use 63 117 129 ( 309) - Acquisitions - 71 3 74 Depreciation ( 60) ( 205) ( 169) ( 434) Impairments ( 1) ( 32) ( 11) - ( 44) Reclassifications 39 ( 47) 9 3 4 Transfer (to) from assets classified as held for sale ( 284) ( 186) ( 82) ( 44) ( 596) Translation differences and other ( 44) ( 32) ( 35) ( 9) ( 120) Total changes ( 270) ( 185) ( 70) ( 39) ( 564) Balance as of December 31, 2017: Cost 1,111 1,708 1,449 140 4,408 Accumulated depreciation ( 527) ( 1,217) ( 1,074) ( 2,818) Book value 584 491 376 140 1,591 Philips Group Property, plant and equipment in millions of EUR 2016 land and buildings machinery and installations other equipment prepayments and construction in progress total Balance as of January 1, 2016: Cost 1,864 3,260 1,873 220 7,217 Accumulated depreciation ( 951) ( 2,525) ( 1,419) ( 4,895) Book value 913 735 454 220 2,322 Change in book value: Capital expenditures 14 142 101 318 575 Assets available for use 112 108 137 ( 357) Depreciation ( 80) ( 257) ( 191) ( 528) Impairments ( 25) ( 40) ( 13) - ( 78) Transfer (to) from assets classified as held for sale ( 92) ( 4) ( 2) ( 2) ( 100) Translation differences and other 12 ( 8) ( 40) - ( 36) Total changes ( 59) ( 59) ( 8) ( 41) ( 167) Balance as of December 31, 2016: Cost 1,766 3,222 1,897 179 7,064 Accumulated depreciation ( 912) ( 2,546) ( 1,451) ( 4,909) Book value 854 676 446 179 2,155 Land with a book value of EUR 50 million at December 31, 2017 (2016: EUR 73 million) is not depreciated. Property, plant and equipment includes financial lease assets with a book value of EUR 281 million at December 31, 2017 (2016: EUR 271 million). The expected useful lives of property, plant and equipment are as follows: Philips Group Useful lives of property, plant and equipment in years Buildings from 5 to 50 years Machinery and installations from 3 to 20 years Other equipment from 1 to 10 years The operating lease obligations are mainly related to the rental of buildings. A number of these leases originate from sale-and-leaseback arrangements. Operating lease payments under sale-and-leaseback arrangements for 2017 totaled EUR 31 million (2016: EUR 32 million). The remaining minimum payments under sale-and-leaseback arrangements included in operating lease obligations above are as follows: Philips Group Operating lease - minimum payments under sale-and-leaseback arrangements in millions of EUR 2017 2018 31 2019 30 2020 24 2021 23 2022 20 Thereafter 91

Goodwill

Goodwill	12 Months Ended
	Dec. 31, 2017
Disclosure of goodwill [Abstract]
Disclosure of goodwill [Text block]	Table of Contents Note The changes in 2016 and 2017 were as follows: Philips Group Goodwill in millions of EUR 2016 - 2017 2016 2017 Balance as of January 1: Cost 10,704 11,151 Impairments ( 2,181) ( 2,253) Book value 8,523 8,898 Changes in book value: Acquisitions 140 1,548 Divestments and transfers to assets classified as held for sale ( 13) ( 1,878) Translation differences and other 248 ( 836) Balance as of December 31: Cost 11,151 9,074 Impairments ( 2,253) ( 1,343) Book value 8,898 7,731 In 2017, the movement of goodwill for the amount of EUR 1,548 million relates to Spectranetics for an amount of EUR 1,255 million and other acquisitions for an amount of EUR 293 million. Information on the divestment of Lighting can be found in Discontinued operations and assets classified as held for sale In 2016, goodwill increased by EUR 140 million mainly due to the acquisition of Wellcentive and PathXL. The increase of EUR 248 million is mainly due to translation differences which impacted the goodwill denominated in USD. For impairment testing, goodwill is allocated to (groups of) cash-generating units (typically one level below segment level), which represent the lowest level at which the goodwill is monitored internally for management purposes. Goodwill allocated to the cash-generating units Image-Guided Therapy, Patient Care & Monitoring Solutions and Sleep & Respiratory Care is considered to be significant in comparison to the total book value of goodwill for the Group at December 31, 2017. In 2016 the cash-generating unit Professional was considered to be significant in comparison to the total book value of goodwill for the Group, but this is no longer included in goodwill as at December 31, 2017 due to the divestment of Lighting. The amounts associated as of December 31, 2017, are presented below: Philips Group Goodwill allocated to the cash-generating units in millions of EUR 2016 - 2017 2016 2017 Image-Guided Therapy 1,106 2,242 Patient Care & Monitoring Solutions 1,506 1,349 Sleep & Respiratory Care 1,958 1,819 Professional 1,671 Other (units carrying a non-significant goodwill balance) 2,657 2,321 Book value 8,898 7,731 The basis of the recoverable amount used in the annual impairment tests for the units disclosed in this note is the value in use. In the annual impairment test performed in the fourth quarter of 2017, the estimated recoverable amounts of the cash-generating units tested approximated or exceeded the carrying value of the units, therefore no impairment loss was recognized. Key assumptions - general Key assumptions used in the impairment tests for the units were sales growth rates, EBITA and the rates used for discounting the projected cash flows. These cash flow projections were determined using the Royal Philips managements’ internal forecasts that cover an initial period from 2018 to 2020. Projections were extrapolated with stable or declining growth rates for a period of 5 years, after which a terminal value was calculated. For terminal value calculation, growth rates were capped at a historical long-term average growth rate. The sales growth rates and EBITA used to estimate cash flows are based on past performance, external market growth assumptions and industry long-term growth averages. EBITA in all units mentioned in this note is expected to increase over the projection period as a result of volume growth and cost efficiencies. Key assumptions and sensitivity analysis relating to cash-generating units to which a significant amount of goodwill is allocated Cash flow projections of Image-Guided Therapy, Patient Care & Monitoring Solutions and Sleep & Respiratory Care are based on the key assumptions included in the table below, which were used in the annual impairment test performed in the fourth quarter: Philips Group Key assumptions in % 2017 compound sales growth rate 1 ) initial forecast period extra-polation period 2 ) used to calculate terminal value 3 ) pre-tax discount rates Image-Guided Therapy 5.3 4.0 2.3 10.9 Patient Care & Monitoring Solutions 3.8 4.8 2.3 12.3 Sleep & Respiratory Care 7.2 5.6 2.3 12.1 1) 2) 3) The assumptions used for the 2016 cash flow projections were as follows: Philips Group Key assumptions in % 2016 compound sales growth rate 1 ) initial forecast period extra-polation period 2 ) used to calculate terminal value 3 ) pre-tax discount rates Image-Guided Therapy 7.1 5.6 2.7 12.1 Patient Care & Monitoring Solutions 6.4 4.6 2.7 14.3 Sleep & Respiratory Care 6.8 4.6 2.7 12.6 Professional 5.0 4.3 2.7 13.9 1) 2) 3) The results of the annual impairment test of Image-Guided Therapy, Patient Care & Monitoring Solutions and Sleep & Respiratory Care indicate that a reasonably possible change in key assumptions would not cause the value in use to fall to the level of the carrying value. Additional information relating to cash-generating units to which a non-significant amount relative to the total goodwill is allocated In addition to the significant goodwill recorded at the units mentioned above, Home Monitoring, Population Health Management and Healthcare Informatics are sensitive to fluctuations in the assumptions as set out above. Based on the most recent impairment test of the cash-generating unit Home Monitoring, it was noted that an increase of 90 points in the pre-tax discount rate, a 140 basis points decline in the compound long-term sales growth rate or a 12% decrease in terminal value would, individually, cause its recoverable amount to fall to the level of its carrying value. The goodwill allocated to Home Monitoring at December 31, 2017 amounts to EUR 32 million. Based on the annual impairment test of the cash-generating unit Population Health Management, it was noted that an increase of 120 points in the pre-tax discount rate, a 400 basis points decline in the compound long-term sales growth rate or a 24% decrease in terminal value would, individually, cause its recoverable amount to fall to the level of its carrying value. The goodwill allocated to Population Health Management at December 31, 2017 amounts to EUR 187 million. Also based on the annual impairment test of the cash-generating unit Healthcare Informatics, it was noted that an increase of 70 points in the pre-tax discount rate, a 150 basis points decline in the compound long-term sales growth rate or a 11% decrease in terminal value would, individually, cause its recoverable amount to fall to the level of its carrying value. The goodwill allocated to Healthcare Informatics at December 31, 2017 amounts to EUR 174 million.

Intangible assets excluding goo

Intangible assets excluding goodwill	12 Months Ended
	Dec. 31, 2017
Disclosure of intangible assets excluding goodwill [Abstract]
Disclosure of intangible assets excluding goodwill [Text block]	Table of Contents Note The changes were as follows: Philips Group Intangible assets excluding goodwill in millions of EUR 2017 brand names customer relationships technology product development product development construction in progress software other total Balance as of January 1, 2017: Cost 1,088 3,429 2,074 1,899 578 580 134 9,782 Amortization/ impairments ( 633) ( 2,188) ( 1,491) ( 1,362) ( 36) ( 421) ( 99) ( 6,230) Book value 455 1,241 583 537 542 159 34 3,552 Changes in book value: Additions - 23 338 86 3 450 Acquisitions 7 431 470 2 16 926 Amortization ( 40) ( 142) ( 100) ( 213) - ( 52) ( 3) ( 550) Impairments ( 12) ( 43) ( 27) ( 1) ( 83) Assets available for use 363 ( 363) Divestments and transfers to assets classified as held for sale ( 120) ( 438) ( 103) ( 23) ( 11) ( 19) ( 6) ( 721) Translations differences ( 24) ( 89) ( 37) ( 35) ( 43) ( 1) ( 23) ( 252) Total changes ( 178) ( 238) 241 49 ( 106) 15 ( 13) ( 230) Balance as of December 31, 2017: Cost 670 2,342 1,985 1,848 487 605 105 8,042 Amortization/ impairments ( 392) ( 1,338) ( 1,161) ( 1,262) ( 51) ( 431) ( 84) ( 4,720) Book value 278 1,004 824 586 436 174 21 3,322 Philips Group Intangible assets excluding goodwill in millions of EUR 2016 brand names customer relationships technology product development product development construction in progress software other total Balance as of January 1, 2016: Cost 1,102 3,324 1,977 1,668 522 522 135 9,251 Amortization/ impairments ( 582) ( 1,925) ( 1,373) ( 1,167) ( 31) ( 367) ( 112) ( 5,558) Book value 520 1,399 604 501 491 155 24 3,693 Changes in book value: Additions 41 318 56 5 420 Acquisitions 1 7 21 8 37 Amortization ( 50) ( 201) ( 98) ( 229) ( 55) ( 2) ( 635) Impairments ( 1) ( 20) ( 4) ( 2) - ( 27) Assets available for use 270 ( 270) Translations differences ( 15) 36 15 15 7 5 1 64 Total changes ( 65) ( 157) ( 21) 36 51 4 11 ( 141) Balance as of December 31, 2016: Cost 1,088 3,429 2,074 1,899 578 580 134 9,782 Amortization/ impairments ( 633) ( 2,188) ( 1,491) ( 1,362) ( 36) ( 421) ( 99) ( 6,230) Book value 455 1,241 583 537 542 159 34 3,552 The additions for 2017 contain internally generated assets of EUR 77 million (2016: EUR 52 million) for software. The acquisitions through business combinations in 2017 mainly consist of the acquired intangible assets of Spectranetics. For more information, please refer to Acquisitions and divestments The amortization of intangible assets is specified in Income from operations The estimated amortization expense for other intangible assets for each of the next five years is: Philips Group Estimated amortization expense for other intangible assets in millions of EUR 2018 252 2019 243 2020 218 2021 192 2022 185 The expected useful lives of the intangible assets excluding goodwill are as follows: Philips Group Expected useful lives of intangible assets excluding goodwill in years Brand names 2-20 Customer relationships 2-25 Technology 3-20 Other 1-10 Software 1-10 Product development 3-7 The weighted average expected remaining life of brand names, customer relationships, technology and other intangible assets is 9.6 years as of December 31, 2017 (2016: 7.9 years). At December 31, 2017 the carrying amount of customer relationships of Sleep & Respiratory Care was EUR 315 million with a remaining amortization period of 6 years (2016: EUR 427 million; 7.2 years). For the intangibles relating to the acquisition of Spectranetics refer to Acquisitions and divestments

Other financial assets

Other financial assets	12 Months Ended
	Dec. 31, 2017
Disclosure of other financial assets [Abstract]
Disclosure of other financial assets [Text block]	Table of Contents Note The changes during 2017 were as follows: Philips Group Other non-current financial assets in millions of EUR 2017 available-for-sale financial assets loans and receivables held-to-maturity investments financial assets at fair value through profit or loss total Balance as of January 1, 2017 172 134 2 27 335 Changes: Reclassifications (1) 2 - 1 2 Acquisitions/additions 368 5 - - 374 Sales/redemptions (23) (8) - (3) (34) Impairment (1) - (1) Value adjustments (46) - 8 (39) Translation differences and other (24) (20) (1) (6) (50) Balance as of December 31, 2017 446 114 1 27 587 Philips Group Other non-current financial assets in millions of EUR 2016 available-for-sale financial assets loans and receivables held-to-maturity investments financial assets at fair value through profit or loss total Balance as of January 1, 2016 232 222 2 33 489 Changes: Reclassifications (56) (100) - (156) Acquisitions/additions 44 26 - 3 73 Sales/redemptions (3) (22) (1) (26) Impairment (27) - - (27) Value adjustments (19) (2) (8) (29) Translation differences and other 1 10 - - 11 Balance as of December 31, 2016 172 134 2 27 335 Available-for-sale financial assets The Company’s investments in available-for-sale financial assets mainly consist of investments in common shares of companies in various industries. In 2017, the main movements in available-for-sale financial assets can be explained by transactions following the divestment of the combined Lumileds and Automotive businesses as further described in Discontinued operations and assets classified as held for sale The Company sold the majority stake in the combined Lumileds and Automotive businesses on June 30, 2017. The retained investment in Luminescence Coöperatief U.A., a Dutch cooperative with excluded liability ( coöperatie met uitgesloten aansprakelijkheid Contractual obligations The Company has entered into contracts with venture capitalists where it committed itself to make, under certain conditions, capital contributions to their investment funds to an aggregated amount of EUR 83 million (2016: EUR 90 million) until June 30, 2021. As at December 31, 2017 capital contributions already made to these investment funds are recorded as available-for-sale financial assets within Other non-current financial assets. Current financial assets Current financial assets decreased by EUR 99 million from EUR 101 million in 2016 to EUR 2 million in 2017. This is mainly due to the repayment of EUR 90 million of loans by TPV Technology limited.

Other assets

Other assets	12 Months Ended
	Dec. 31, 2017
Disclosure of other assets [Abstract]
Disclosure of other assets [Text block]	Table of Contents Note Other non-current assets Other non-current assets in 2017 mainly related to prepaid expenses of EUR 74 million (2016: EUR 90 million). Other current assets Other current assets include EUR 186 million (2016: EUR 228 million) accrued income, mainly related to Diagnosis & Treatment businesses and Connected Care & Health Informatics businesses, and EUR 206 million (2016: EUR 258 million) prepaid expense mainly related to Diagnosis & Treatment businesses and Connected Care & Health Informatics businesses.

Inventories

Inventories	12 Months Ended
	Dec. 31, 2017
Disclosure of Inventories [Abstract]
Disclosure of inventories [Text block]	Table of Contents Note Inventories are summarized as follows: Philips Group Inventories in millions of EUR 2016 - 2017 2016 2017 Raw materials and supplies 1,040 715 Work in process 446 358 Finished goods 1,906 1,280 Inventories 3,392 2,353 The write-down of inventories to net realizable value was EUR 150 million in 2017 (2016: EUR 105 million). The write-down is included in cost of sales.

Receivables

Receivables	12 Months Ended
	Dec. 31, 2017
Trade and other receivables [Abstract]
Disclosure of receivables [Text block]	Table of Contents Note Non-current receivables Non-current receivables are associated mainly with customer financing in Diagnosis & Treatment businesses amounting to EUR 47 million (2016: EUR 47 million) and insurance receivables in Legacy Items in the US amounting to EUR 47 million (2016: EUR 55 million). Current receivables Current receivables at December 31, 2017 included accounts receivable net of EUR 3,609 million, accounts receivable other of EUR 278 million and accounts receivable from investments in associates of EUR 22 million. The accounts receivable, net, per segment are as follows: Philips Group Accounts receivables-net in millions of EUR 2016 - 2017 2016 2017 Personal Health 1,266 1,341 Diagnosis & Treatment 1,476 1,489 Connected Care & Health Informatics 664 706 HealthTech Other 81 72 Lighting 1,477 Legacy Items 28 Accounts receivable-net 4,992 3,609 The aging analysis of accounts receivable, net, is set out below: Philips Group Aging analysis in millions of EUR 2016 - 2017 2016 2017 Current 4,273 3,046 Overdue 1-30 days 267 256 Overdue 31-180 days 310 242 Overdue > 180 days 142 63 Accounts receivable-net 4,992 3,609 The above net accounts receivable represent current and overdue but not impaired receivables. The changes in the allowance for doubtful accounts receivable are as follows: Philips Group Allowance for doubtful accounts receivable in millions of EUR 2015 - 2017 2015 2016 2017 Balance as of January 1 227 301 318 Additions charged to expense 78 76 41 Deductions from allowance 1 ) ( 25) ( 64) ( 36) Transfer to assets held for sale ( 92) Other movements 21 5 ( 16) Balance as of December 31 301 318 215 1) The allowance for doubtful accounts receivable has been primarily established for receivables that are past due. Included in the above balances as per December 31, 2017 are allowances for individually impaired receivables of EUR 197 million (2016: EUR 289 million; 2015: EUR 272 million).

Equity

Equity	12 Months Ended
	Dec. 31, 2017
Disclosure of equity [Abstract]
Disclosure of equity [Text block]	Table of Contents Note Common shares As of December 31, 2017, authorized common shares consist of 2 billion shares (December 31, 2016: 2 billion; December 31, 2015: 2 billion) and the issued and fully paid share capital consists of 940,909,027 common shares, each share having a par value of EUR 0.20 (December 31, 2016: 929,644,864; December 31, 2015: 931,130,387). Preference shares As a means to protect the Company and its stakeholders against an unsolicited attempt to obtain (de facto) control of the Company, the General Meeting of Shareholders in 1989 adopted amendments to the Company’s articles of association that allow the Board of Management and the Supervisory Board to issue (rights to acquire) preference shares to a third party. The ‘Stichting Preferente Aandelen Philips’ has been granted the right to acquire preference shares in the Company. Such right has not been exercised as of December 31, 2017 and no preference shares have been issued. Authorized preference shares consist of 2 billion shares as of December 31, 2017 (December 31, 2016: 2 billion; December 31, 2015: 2 billion). Options, restricted and performance shares The Company has granted stock options on its common shares and rights to receive common shares in the future (see Share-based compensation Treasury shares In connection with the Company’s share repurchase programs (see next paragraph for Share repurchase methods for the purposes of share deliveries under share-based compensation plans and capital reduction), shares which have been repurchased and are held in Treasury for the purpose of (i) delivery upon exercise of options, restricted and performance share programs, and (ii) capital reduction, are accounted for as a reduction of shareholders’ equity. Treasury shares are recorded at cost, representing the market price on the acquisition date. When issued, shares are removed from treasury shares on a first-in, first-out (FIFO) basis. When treasury shares are reissued under the Company’s option plans, the difference between the cost and the cash received is recorded in retained earnings. When treasury shares are reissued under the Company’s share plans, the difference between the market price of the shares issued and the cost is recorded in retained earnings, the market price is recorded in capital in excess of par value. Dividend withholding tax in connection with the Company’s purchase of treasury shares for capital reduction purposes is recorded in retained earnings. The following table shows the movements in the outstanding number of shares over the last three years: Philips Group Outstanding number of shares in number of shares 2015 - 2017 2015 2016 2017 Balance as of January 1 914,388,869 917,103,586 922,436,563 Dividend distributed 17,671,990 17,344,462 11,264,163 Purchase of treasury shares ( 20,296,016) ( 25,193,411) ( 19,841,595) Re-issuance of treasury shares 5,338,743 13,181,926 12,332,592 Balance as of December 31 917,103,586 922,436,563 926,191,723 The following transactions took place resulting from employee option and share plans: Philips Group Employee option and share plan transactions 2015 - 2017 2015 2016 2017 Shares acquired 8,601,426 15,222,662 Average market price EUR 24.73 EUR 31.81 Amount paid EUR 213 million EUR 484 million Shares delivered 5,338,743 13,181,926 12,332,592 Average price (FIFO) EUR 30.35 EUR 25.86 EUR 27.07 Cost of delivered shares EUR 162 million EUR 341 million EUR 334 million Total shares in treasury at year-end 11,788,801 7,208,301 10,098,371 Total cost EUR 308 million EUR 181 million EUR 331 million In order to reduce share capital, the following transactions took place: Philips Group Share capital transactions 2015 - 2017 2015 2016 2017 Shares acquired 20,296,016 16,591,985 4,618,933 Average market price EUR 24.39 EUR 23.84 EUR 32.47 Amount paid EUR 495 million EUR 396 million EUR 150 million Reduction of treasury shares (shares) 21,361,016 18,829,985 Cancellation of treasury shares EUR 517 million EUR 450 million Total shares in treasury at year-end 2,238,000 4,618,933 Total cost EUR 55 million EUR 150 million Share purchase transactions related to employee option and share plans, as well as transactions related to the reduction of share capital, involved a cash outflow of EUR 642 million, which includes the impact of taxes. A cash inflow of EUR 227 million from treasury shares mainly includes settlements of share-based compensation plans. Share repurchase methods for the purposes of share deliveries under share-based compensation plans and capital reduction During 2017, Royal Philips repurchased shares for covering obligations resulting from past and present share-based compensation programs via three different share repurchase methods: (i) daily share buy-back repurchases in the open market via an intermediary (ii) repurchase of shares via forward contracts for future delivery of shares (iii) the unwinding of call options on own shares. In 2017, Royal Philips also entered into forward contracts with several banks to repurchase shares for capital reduction purposes. The methods (ii) and (iii) are detailed below. Forward share repurchase contracts In order to hedge commitments under share-based compensation plans, Philips entered into a forward contract in the first quarter of 2017. This transaction involved 3 million shares. This resulted in a reduction of Retained earnings of EUR 81 million against Short-term liabilities. In 2017, there were three exercises under the forward share buy-back contract involving 2,250,000 shares, resulting in a EUR 61 million increase in Retained earnings against Treasury shares. The remaining 750,000 shares, with a forward price of EUR 27.03, will be repurchased in the first quarter of 2018. In order to reduce its share capital, Royal Philips also entered into six forward contracts. In 2017, EUR 998 million was deducted from Retained earnings and was recorded against Short-term liabilities. The forward contacts involved 31,020,000 shares with a settlement date varying between October 2018 and June 2019 and a weighted average forward price of EUR 32.22. For further information on the forward contracts please refer to Debt Share call options During 2016 Philips bought EUR and USD-denominated call options to hedge options granted under share-based compensation plans before 2013. In 2017, the Company unwound 5,268,741 EUR-denominated and 2,661,016 USD-denominated call options against the transfer of the same number of Royal Philips shares ( 7,929,757 shares) and an additional EUR 160 million cash payment to the buyer of the call options. The number of outstanding EUR denominated options were 3,287,125 and USD-denominated options were 2,974,344, as of December 2017. Dividend distribution 2017 In June 2017, Philips settled a dividend of EUR 0.80 per common share, representing a total value of EUR 742 million including costs. Shareholders could elect for a cash dividend or a share dividend. Approximately 48% of the shareholders elected for a share dividend, resulting in the issuance of 11,264,163 new common shares. The settlement of the cash dividend involved an amount of EUR 384 million (including costs). A proposal will be submitted to the 2018 Annual General Meeting of Shareholders to pay a dividend of EUR 0.80 per common share, in cash or shares at the option of the shareholders, against the net income of the Company for 2017. 2016 In June 2016, Philips settled a dividend of EUR 0.80 per common share, representing a total value of EUR 732 million including costs. Shareholders could elect for a cash dividend or a share dividend. Approximately 55% of the shareholders elected for a share dividend, resulting in the issuance of 17,344,462 new common shares. The settlement of the cash dividend involved an amount of EUR 330 million (including costs) 2015 In June 2015, Philips settled a dividend of EUR 0.80 per common share, representing a total value of EUR 730 million including costs. Shareholders could elect for a cash dividend or a share dividend. Approximately 59% of the shareholders elected for a share dividend, resulting in the issuance of 17,671,990 new common shares. The settlement of the cash dividend involved an amount of EUR 298 million (including costs). Limitations in the distribution of shareholders’ equity As at December 31, 2017, pursuant to Dutch law, certain limitations exist relating to the distribution of shareholders’ equity of EUR 1,306 million. Such limitations relate to common shares of EUR 188 million, as well as to legal reserves required by Dutch law included under retained earnings of EUR 703 million, unrealized currency translation differences of EUR 393 million and unrealized gains related to cash flow hedges of EUR 23 million. The unrealized losses related to available-for-sale financial assets of EUR 30 million, qualify as a legal reserve and reduce the distributable amount due to the fact that this reserve is negative. The legal reserve required by Dutch law of EUR 703 million included under retained earnings relates to any legal or economic restrictions on the ability of affiliated companies to transfer funds to the parent company in the form of dividends. As at December 31, 2016, these limitations in distributable amounts were EUR 2,181 million and related to common shares of EUR 186 million, as well as to legal reserves required by Dutch law included under retained earnings of EUR 715 million, unrealized currency translation differences of EUR 1,234 million, available-for-sale financial assets of EUR 36 million and unrealized gains related to cash flow hedges of EUR 10 million. Non-controlling interests Non-controlling interests relate to minority stakes held by third parties in consolidated group companies. In the course of 2017 non-controlling interests reduced significantly due to the deconsolidation of Philips Lighting. For further details reference is made to Interests in entities Capital management Philips manages capital based upon the IFRS measures, net cash provided by operating activities and net cash used for investing activities as well as the non-IFRS measure net debt. The definition of this non-IFRS measure and a reconciliation to the IFRS measure is included below. Net debt is defined as the sum of long and short-term debt minus cash and cash equivalents. Group equity as defined as the sum of shareholders’ equity and non-controlling interests. This measure is used by Philips Treasury management and investment analysts to evaluate financial strength and funding requirements. The Philips net debt position is managed with the intention of retaining a strong investment grade credit rating. Furthermore, Philips’ aim when managing the net debt position is dividend stability and a pay-out ratio of 40% to 50% of continuing net income after adjustments. Philips Group Composition of net debt and group equity in millions of EUR unless otherwise stated 2015-2017 2015 2016 2017 Long-term debt 4,095 4,021 4,044 Short-term debt 1,665 1,585 672 Total debt 5,760 5,606 4,715 Cash and cash equivalents 1,766 2,334 1,939 Net debt 3,994 3,272 2,776 Shareholders’ equity 11,607 12,546 11,999 Non-controlling interests 118 907 24 Group equity 11,725 13,453 12,023 Net debt : group equity ratio 25:75 20:80 19:81

Debt

Debt	12 Months Ended
	Dec. 31, 2017
Disclosure of debt [Abstract]
Disclosure of debt [Text block]	Table of Contents Note Royal Philips has a USD 2.5 billion Commercial Paper Programme and a EUR 1 billion committed revolving credit facility that can be used for general group purposes, such as a backstop of its Commercial Paper Programme. As of December 31, 2017, Royal Philips did not have any loans outstanding under either facility. The EUR 1 billion committed revolving credit facility was signed effective April 21, 2017, replacing the former EUR 1.8 billion facility of the Company. The new facility has a tenor of five years and contains two 1-year extension options. In line with the previous facility, it does not have a material adverse change clause, has no financial covenants and no credit-rating-related acceleration possibilities. The provisions applicable to all corporate USD denominated bonds issued by the Company in March 2008 and March 2012 (due 2022, 2038 and 2042) contain a ‘Change of Control Triggering Event’. If the Company would experience such an event with respect to a series of corporate bonds the Company might be required to offer to purchase the bonds that are still outstanding at a purchase price equal to 101% of their principal amount, plus accrued and unpaid interest, if any. Furthermore, the conditions applicable to the EUR denominated corporate bonds issued in 2017 (due 2019 and 2023) contain a similar provision (‘Change of Control Put Event’). Upon the occurrence of such an event, the Company might be required to redeem or purchase any of such bonds at their principal amount together with interest accrued. In January 2017, Philips entered into a USD 1,000 million and EUR 300 million credit facility with a consortium of international banks. Under this credit facility Philips drew USD 1,000 million in January 2017; the facility was used for the early redemption of the 5.750% bonds due 2018 in the aggregate principal amount of USD 1,250 million. In Q2 2017, the drawn amount was repaid in full and the facility was cancelled. In May 2017, EUR 1,341 million of mainly long-term Lighting debt was transferred to liabilities directly associated with assets held for sale. In August 2017, Philips entered into a EUR 1,000 million loan for the purpose of financing The Spectranetics Corporation acquisition and for general purposes. In September 2017, Philips successfully issued EUR 500 million floating-rate bonds due 2019 and EUR 500 million fixed-rate bonds due 2023. The net proceeds of the offering were used for the repayment of the EUR 1,000 million loan entered into August 2017. On June 28, 2017, Royal Philips announced a EUR 1.5 billion share buyback program. Philips started the program in the third quarter of 2017, and intends to complete it in two years. As the program was initiated for capital reduction purposes, Philips intends to cancel all of the shares acquired under the program. Under this program, Royal Philips has entered into a number of forward transactions with a number of financial institutions, to be settled at future dates over the course of the program. Over the second half of 2017, the nominal amount was equal to EUR 998 million. These forward contracts are accounted for as debt. Long-term debt Philips Group Long-term debt in millions of EUR unless otherwise stated 2016 - 2017 (range of) interest rates average rate of interest average remaining term (in years) amount outstanding in 2017 amount due in 1 year amount due after 1 year amount due after 5 years amount outstanding in 2016 USD bonds 3.8 - 7.8% 5.4% 13.3 2,137 2,137 1,305 3,608 EUR bonds 0.0 - 0.5% 0.3% 3.7 997 997 496 Bank borrowings 0.2 - 11.0% 1.3% 2.1 190 52 138 1,470 Other long-term debt 0.0 - 2.6% 0.9% 1.1 20 19 1 - 39 Institutional financing 3,344 71 3,273 1,801 5,117 Finance leases 0 - 16.1% 3.4% 4.8 281 87 195 24 279 Forward contracts 1.2 970 394 576 Long-term debt 2.8% 7.6 4,595 552 4,044 1,825 5,396 Corresponding data of previous year 4.1% 7.8 5,396 1,375 4,021 2,454 4,245 The following amounts of long-term debt as of December 31, 2017, are due in the next five years: Philips Group Long-term debt due in the next five years in millions of EUR 2016 - 2017 2018 552 2019 1,190 2020 103 2021 80 2022 846 Long-term debt 2,770 Corresponding amount of previous year 2,942 Philips Group Unsecured Bonds in millions of EUR unless otherwise stated 2016 - 2017 effective rate 2016 2017 Unsecured EUR Bonds Due 9/06/2023; 1/2% 0.634% 500 Due 9/06/2019; 3M Euribor +20bps 500 Unsecured USD Bonds Due 5/15/25; 7 3/4% 7.429% 60 53 Due 6/01/26; 7 1/5% 6.885% 130 114 Due 5/15/25; 7 1/8% 6.794% 80 70 Due 3/11/18; 5 3/4% 1 ) 1,187 Due 3/11/38; 6 7/8% 7.210% 758 668 Due 3/15/22; 3 3/4% 3.906% 949 837 Due 3/15/42; 5% 5.273% 475 418 Adjustments 2 ) ( 31) ( 26) Unsecured Bonds 3,608 3,134 1) 2) Finance lease liabilities The below table discloses the reconciliation between the total of future minimum lease payments and their present value. Philips Group Finance lease liabilities in millions of EUR 2016 - 2017 2016 2017 future minimum lease payments interest present value of minimum lease payments future minimum lease payments interest present value of minimum lease payments Less than one year 93 8 85 93 6 87 Between one and five years 181 15 166 184 14 170 More than five years 33 5 28 29 4 24 Finance lease 307 28 279 306 24 281 Short-term debt Philips Group Short-term debt in millions of EUR 2016 - 2017 2016 2017 Short-term bank borrowings 207 71 Forward contracts 49 Other short-term loans 3 Current portion of long-term debt 1,375 552 Short-term debt 1,585 672 During 2017, the weighted average interest rate on the bank borrowings was 3.3% (2016: 5.4%). The decrease was mainly driven by a repayment of debt in Q4 2016 with high interest rate.

Provisions

Provisions	12 Months Ended
	Dec. 31, 2017
Disclosure of provisions [Abstract]
Disclosure of provisions [Text block]	Table of Contents Note Philips Group Provisions in millions of EUR 2016 - 2017 2016 2017 long-term short-term total long-term short-term total Post-employment benefit 20 1,996 1,996 973 973 Product warranty 66 193 259 44 157 201 Environmental provisions 252 69 321 140 19 160 Restructuring-related provisions 27 174 201 25 87 112 Litigation provisions 40 56 96 26 24 50 Other provisions 545 188 733 451 113 564 Provisions 2,926 680 3,606 1,659 400 2,059 Product warranty The provisions for product warranty reflect the estimated costs of replacement and free-of-charge services that will be incurred by the Company with respect to products sold. The Company expects the provisions to be utilized mainly within the next year. Philips Group Provisions for product warranty in millions of EUR 2015 - 2017 2015 2016 2017 Balance as of January 1 302 289 259 Changes: Additions 327 325 283 Utilizations ( 357) ( 357) ( 270) Transfer to liabilities directly associated with assets held for sale ( 56) Translation differences and other 17 2 ( 16) Balance as of December 31 289 259 201 Environmental provisions The environmental provisions include accrued costs recorded with respect to environmental remediation in various countries. In the United States, subsidiaries of the Company have been named as potentially responsible parties in state and federal proceedings for the clean-up of certain sites. Provisions for environmental remediation can change significantly due to the emergence of additional information regarding the extent or nature of the contamination, the need to utilize alternative technologies, actions by regulatory authorities as well as changes in judgments and discount rates. Approximately EUR 55 million is expected to be utilized within the next five years, with the remainder being long term. For more details on the environmental remediation reference is made to Contingent assets and liabilities Philips Group Environmental provisions in millions of EUR 2015 - 2017 2015 2016 2017 Balance as of January 1 360 335 321 Changes: Additions 27 18 18 Utilizations ( 24) ( 24) ( 21) Releases ( 36) ( 36) ( 8) Changes in discount rate ( 7) 11 11 Accretion 7 7 6 Translation differences and other 8 10 ( 20) Transfer to liabilities directly associated with assets held for sale ( 146) Balance as of December 31 335 321 160 The release of the provisions originates from additional insights in relation to factors like the estimated cost of remediation, changes in regulatory requirements and efficiencies in completion of various site work phases. Restructuring-related provisions Philips Group Restructuring-related provisions in millions of EUR 2017 Jan. 1, 2017 additions utilizations releases other changes 1 ) Dec. 31, 2017 Personal Health 5 14 ( 5) ( 6) ( 1) 7 Diagnosis & Treatment 13 46 ( 16) ( 5) ( 1) 38 Connected Care & Health Informatics 13 27 ( 12) ( 6) ( 1) 20 HealthTech Other 37 55 ( 27) ( 16) ( 1) 47 Lighting 133 9 ( 35) ( 3) ( 104) Philips Group 201 150 ( 96) ( 37) ( 107) 112 1) In 2017, the most significant restructuring projects impacted Diagnosis & Treatment and HealthTech Other businesses and mainly took place in the Netherlands and the US. The restructuring comprised mainly product portfolio rationalization and the reorganization of global support functions. The Company expects the provisions will be utilized mainly within the next year. 2016 The movements in the provisions for restructuring in 2016 by segment are presented as follows: Philips Group Restructuring-related provisions in millions of EUR 2016 Jan. 1, 2016 additions utilizations releases other changes 1 ) Dec. 31, 2016 Personal Health 32 7 ( 29) ( 2) ( 3) 5 Diagnosis & Treatment 28 11 ( 19) ( 6) ( 1) 13 Connected Care & Health Informatics 21 11 ( 14) ( 6) 1 13 HealthTech Other 38 35 ( 16) ( 19) ( 1) 37 Lighting 178 95 ( 118) ( 27) 5 133 Legacy Items ( 1) ( 1) ( 1) 3 Philips Group 297 158 ( 197) ( 61) 4 201 1) In 2016, restructuring projects at HealthTech Other mainly took place in the Netherlands. 2015 The movements in the provisions for restructuring in 2015 are presented by segment as follows: Philips Group Restructuring-related provisions in millions of EUR 2015 Jan. 1, 2015 additions utilizations releases other changes 1 ) Dec. 31, 2015 Personal Health 13 30 ( 7) ( 4) 32 Diagnosis & Treatment 29 30 ( 24) ( 7) 28 Connected Care & Health Informatics 16 20 ( 12) ( 3) 21 HealthTech Other 87 25 ( 32) ( 41) ( 1) 38 Lighting 235 89 ( 114) ( 33) 1 178 Legacy Items Philips Group 380 194 ( 189) ( 88) 297 1) In 2015, restructuring projects at Diagnosis & Treatment businesses, Connected Care & Health Informatics and HealthTech Other mainly took place in the US and France. Personal Health restructuring projects were mainly in Italy. Litigation provisions The Company and certain of its group companies and former group companies are involved as a party in legal proceedings, including regulatory and other governmental proceedings. Philips Group Litigation provisions in millions of EUR 2015 - 2017 2015 2016 2017 Balance as of January 1 653 578 96 Changes: Additions 66 31 40 Utilizations 1 ) ( 186) ( 313) ( 52) Releases ( 25) ( 98) ( 11) Reclassifications 1 ) - ( 125) 2 Changes in discount rate 8 5 Accretion 12 8 3 Translation differences 50 10 ( 7) Transfer to liabilities directly associated with assets held for sale ( 21) Balance as of December 31 578 96 50 1) The most significant proceedings The majority of the movements in the above schedule related to the Cathode Ray Tube (CRT) antitrust litigation and Masimo Corporation (Masimo) patent litigation. Cathode Ray Tube (CRT) antitrust litigation In 2015, 2016 and 2017, the majority of the movements in relation to the CRT antitrust litigation were utilizations due to the transfer to other liabilities for which the Company was able to reach a settlement. These settlements were subsequently paid out in the respective following year. For more details reference is made to Contingent assets and liabilities Masimo Corporation (Masimo) patent litigation On October 1, 2014, a jury awarded USD 467 million to Masimo Corporation (Masimo) in a trial held before the United States District Court for the District of Delaware. The decision by the jury completed an initial phase of a three-phase trial regarding a first lawsuit started by Masimo against the Company in 2009. A second lawsuit was started by Masimo against the Company in 2016. Between the two lawsuits, claims were raised by the parties against each other relating to patent infringement and antitrust violations in the field of pulse oximetry. On November 5, 2016, the Company and Masimo entered into a wide-ranging, multi-year business partnership involving both companies’ innovations in patient monitoring and therapy solutions, ending all pending lawsuits between the two companies, including releasing the Company from paying the USD 467 million jury verdict. The Company and Masimo also agreed to: a USD 300 million cash payment by Philips to Masimo; a one-time donation to the Masimo Foundation of USD 5 million to support the Masimo Foundation’s project on patient safety and better outcomes; commitments of the Company with respect to sales targets, marketing and product integration over the coming years of about USD 136 million. Entering into the agreements resulted in a payment of USD 305 million (EUR 280 million) in November 2016, a release of litigation provisions of USD 86 million (EUR 79 million) and a liability reclassification from litigation provisions to other provisions of USD 136 million (EUR 125 million). The utilizations and reclassifications in 2016 mainly related to Masimo. Reclassifications include reclassification from litigation provisions to other provisions. Other The translation differences in the schedule above are mainly explained by the movements in the USD/EUR rate which impacted the litigation provisions denominated in USD. The Company expects to use the provisions mainly within the next three years. Other provisions Philips Group Other provisions in millions of EUR 2015 - 2017 2015 2016 2017 Balance as of January 1 575 604 733 Changes: Additions 198 183 304 Utilizations ( 186) ( 167) ( 238) Releases ( 35) ( 61) ( 88) Reclassification 14 142 4 Transfer to liabilities directly associated with assets held for sale ( 156) Accretion 7 8 - Acquisitions 24 - 62 Translation differences and other 7 24 ( 56) Balance as of December 31 604 733 564 The main elements of other provisions are: provisions for possible taxes/social security of EUR 97 million (2016: EUR 131 million); onerous contract provisions for unfavorable supply contracts as part of divestment transactions, onerous (sub)lease contracts and expected losses on existing projects /orders totaling EUR 31 million (2016: EUR 85 million); provisions for employee jubilee funds EUR 57 million (2016: EUR 84 million); self-insurance provisions of EUR 48 million (2016: EUR 77 million); provisions for decommissioning costs of EUR 32 million (2016: EUR 48 million); provisions for rights of return of EUR 37 million (2016: EUR 46 million); provisions for other employee benefits and obligatory severance payments of EUR 24 million (2016: EUR 38 million); provisions for contingent considerations of EUR 66 million (2016: EUR 11 million); the release in 2017 of EUR 88 million is due to the reassessment of our positions in other provisions. Other provisions are expected to be utilized mainly within the next five years, except for: provisions for employee jubilee funds of which a quarter is expected to be utilized within the next five years; provisions for contingent considerations of which nearly half is expected to be utilized after five years; provisions for decommissioning costs of which over half is expected to be utilized after five years; provisions for rights of return to be utilized mainly within the next year.

Post-employment benefits

Post-employment benefits	12 Months Ended
	Dec. 31, 2017
Disclosure of post-employment benefits [Abstract]
Disclosure of post-employment benefits [Text block]	Table of Contents Note Employee post-employment plans have been established in many countries in accordance with the legal requirements, customs and the local practice in the countries involved. All funded post-employment plans are considered to be related parties. Most employees that take part in a Company pension plan are covered by defined-contribution (DC) pension plans. The main DC plans are in the Netherlands and the United States. The Company also sponsors a number of defined-benefit (DB) pension plans. The benefits provided by these plans are based on employees’ years of service and compensation levels. The Company also sponsors a limited number of DB retiree medical plans. The benefits provided by these plans typically cover a part of the healthcare costs after retirement. The larger funded DB and DC plans are governed by independent Trustees who have a legal obligation to protect the interests of all plan members and operate under the local regulatory framework. The average duration of the defined-benefit obligation (DBO) of the DB plans is 12 years (2016: 11 years). The largest DB plans in 2017 are in the United States and Germany. These plans account for approximately 89% of the total DBO. The United States The US DB pension plans are closed plans without future pension accrual. For the funding of any deficit in the US plan the Group adheres to the minimum funding requirements of the US Pension Protection Act. The assets of the US funded pension plans are in Trusts governed by Trustees. The excess pension plans that covered accrual above the maximum salary of the funded plan are unfunded. Company’s qualified pension commitments in the United States are partly protected via the Pension Benefit Guaranty Corporation (PBGC) which charges a fee to US companies providing DB pension plans. The fee is also dependent on the amount of unfunded liabilities. In 2017, the Company performed an additional de-risking contribution into the US plan of EUR 219 million. Germany The Company has several DB plans in Germany which for the largest part are unfunded, meaning that after retirement the Company is responsible for the benefit payments to retirees. Due to the relatively high level of social security in Germany, the Company’s pension plans mainly provide benefits for the higher earners and are open for future pension accrual. Indexation is mandatory due to legal requirements. Some of the German plans have a DC design, but are accounted for as DB plans due to a legal minimum return requirement. Company pension commitments in Germany are partly protected against employer bankruptcy via the “Pensions Sicherungs Verein” which charges a fee to all German companies providing pension promises. Philips is one of the sponsors of Philips Pensionskasse VVaG in Germany, which is a multi-employer plan. The plan is accounted for as a DC plan. Settlement of the Brazil pension plans in 2017 The DB and DC pension plans in Brazil that were operated by the multi-employer plan in Brazil, Philips Seguridade Social, have been fully terminated in 2017. All Philips’ employees in Brazil have been transferred to an insured DC pension plan for future service. Since all risks for the Company with respect to the DB pension plan have been eliminated, the Company recognized a settlement in 2017. The decrease of the DBO due to the settlement amounts to EUR 345 million. At the moment of the settlement the plan had a surplus. As the surplus was not recognized in the balance sheet due to the asset ceiling test, the Company only recognized the additional payments of EUR 1 million as settlement loss, as per the Company’s accounting policy. Risks related to DB plans DB plans expose the Company to various demographic and economic risks such as longevity risk, investment risks, currency and interest rate risk and in some cases inflation risk. The latter plays a role in the assumed wage increase but more importantly in some countries where indexation of pensions is mandatory. Pension fund Trustees are responsible for and have full discretion over the investment strategy of the plan assets. In general Trustees manage pension fund risks by diversifying the investments of plan assets and by (partially) matching interest rate risk of liabilities. The Company has an active de-risking strategy in which it constantly looks for opportunities to reduce the risks associated with its DB plans. Liability-driven investment strategies, lump sum cash-out options, buy-ins, buy-outs and a change to DC are examples of the strategy. Investment policy in our largest pension plans The trustees of the Philips pension plans are responsible for and have full discretion over the investment strategy of the plan assets. The plan assets of the Philips pension plans are invested in well diversified portfolios. The interest rate sensitivity of the fixed income portfolio is closely aligned to that of the plan’s pension liabilities. Any contributions from the sponsoring company are used to further increase the fixed income part of the assets. As part of the investment strategy, any additional investment returns of the return portfolio are used to further decrease the interest rate mismatch between the plan assets and the pension liabilities. Summary of pre-tax costs for post-employment benefits and reconciliations The adjacent table contains the total of current and past service costs, administration costs and settlement results as included in Income from operations and the interest cost as included in Financial expenses. Philips Group Pre-tax costs for post-employment benefits in millions of EUR 2015 - 2017 2015 2016 2017 Defined-benefit plans 566 58 95 included in Income from operations 467 ( 19) 1 ) 32 included in Financial expense 70 48 37 included in Discontinued operations 29 29 26 Defined-contribution plans 299 392 397 included in Income from operations 240 299 315 included in Discontinued operations 59 93 82 Post-employment benefits costs 865 450 492 1) Reconciliations for the DBO and plan assets for DB plans: Philips Group Defined-benefit obligations in millions of EUR 2016 - 2017 2016 2017 Balance as of January 1 4,757 4,987 Service cost 44 34 Interest cost 189 126 Employee contributions 5 4 Actuarial (gains) / losses demographic assumptions ( 45) ( 14) financial assumptions 208 75 experience adjustment ( 7) ( 15) (Negative) past service cost ( 8) 1 Settlements ( 85) ( 348) Benefits paid from plan ( 239) ( 172) Benefits paid directly by employer ( 76) ( 52) Transfer to Liabilities directly associated with assets held for sale 1 ) ( 1,210) Translation differences and other 244 ( 307) Balance as of December 31 4,987 3,109 Present value of funded obligations at December 31 3,850 2,476 Present value of unfunded obligations at December 31 1,137 633 1) Philips Group Plan assets in millions of EUR 2016 - 2017 2016 2017 Balance as of January 1 2,710 3,095 Interest income on plan assets 137 87 Admin expenses paid ( 3) ( 2) Return on plan assets excluding interest income 41 70 Employee contributions 5 4 Employer contributions 246 263 Settlements ( 33) ( 348) Benefits paid from plan ( 239) ( 172) Transfer to Liabilities directly associated with assets held for sale 1 ) ( 642) Translation differences and other 231 ( 218) Balance as of December 31 3,095 2,137 Funded status ( 1,892) ( 972) Unrecognized net assets ( 105) Net balance sheet position ( 1,997) ( 972) 1) Reconciliation for the effect of the asset ceiling: Philips Group Changes in the effect of the asset ceiling in millions of EUR 2016 - 2017 2016 2017 Balance as of January 1 90 105 Interest on unrecognized assets 14 4 Remeasurements ( 21) ( 100) Translation differences 22 ( 9) Balance as of December 31 105 Due to the settlement of the Brazil pension plan there is no effect of the asset ceiling remaining as at 31 December 2017. Plan assets allocation The asset allocation in the Company’s pension plans at December 31 was as follows: Philips Group Plan assets allocation in millions of EUR 2016 - 2017 2016 2017 Assets quoted in active markets Debt securities 1,085 1,142 Equity securities 91 69 Other 126 137 Assets not quoted in active markets Debt securities 561 14 Equity securities 811 457 Other 421 318 Total assets 3,095 2,137 The assets in 2017 contain 37 % (2016: 58 %) unquoted assets. Plan assets in 2017 do not include property occupied by or financial instruments issued by the Company. Assumptions The mortality tables used for the Company’s largest DB plans are: US: RP2014 with MP2017 improvement scale; RP2006 with MP2017 improvement scale + white collar adjustment for the unfunded excess plans Germany: Richttafeln 2005 Generational K.Heubeck The weighted averages of the assumptions used to calculate the DBO as of December 31 were as follows: Philips Group Assumptions used for defined-benefit obligations in % 2016 - 2017 2016 2017 Discount rate 3.8% 2.8% Inflation rate 2.6% 2.1% Salary increase 3.3% 2.4% Sensitivity analysis The tables below illustrates the approximate impact on the DBO from movements in key assumptions. The DBO was recalculated using a change in the assumptions of 1% which overall is considered a reasonably possible change. The impact on the DBO because of changes in discount rate is normally accompanied by offsetting movements in plan assets, especially when using matching strategies. Philips Group Sensitivity of key assumptions in millions of EUR 2017 Defined benefit obligation Increase Discount rate (1% movement) ( 323) Inflation rate (1% movement) 85 Salary increase (1% movement) 20 Longevity (see explanation) 72 Decrease Discount rate (1% movement) 394 Inflation rate (1% movement) ( 86) Salary increase (1% movement) ( 19) Philips Group Sensitivity of key assumptions in millions of EUR 2016 Defined benefit obligation Increase Discount rate (1% movement) ( 544) Inflation rate (1% movement) 139 Salary increase (1% movement) 27 Longevity (see explanation) 143 Decrease Discount rate (1% movement) 645 Inflation rate (1% movement) ( 126) Salary increase (1% movement) ( 23) The mortality table (i.e. longevity) also impacts the DBO. The above sensitivity table illustrates the impact on the DBO of a further 10% decrease in the assumed rates of mortality for the Company’s major schemes. A 10% decrease in assumed mortality rates equals improvement of life expectancy by 0.5 - 1 year. Cash flows and costs in 2018 The Company expects considerable cash outflows in relation to post-employment benefits which are estimated to amount to EUR 399 million in 2018, consisting of: EUR 30 million employer contributions to funded DB plans (US: EUR 0 million, DE: EUR 23 million, Other: EUR 7 million); EUR 40 million cash outflows in relation to unfunded DB plans (US: EUR 9 million, DE: EUR 19 million, Other: EUR 12 million); and EUR 329 million employer contributions to DC plans (NL: EUR 166 million, US: EUR 109 million, Other: EUR 54 million). The service and administration cost for 2018 is expected to amount to EUR 28 million for DB plans. The net interest cost for 2018 for the DB plans is expected to amount to EUR 25 million. The cost for DC pension plans in 2018 is equal to the expected DC cash flow.

Accrued liabilities

Accrued liabilities	12 Months Ended
	Dec. 31, 2017
Disclosure of accrued liabilities [Abstract]
Disclosure of accrued liabilities [Text block]	Table of Contents Note Accrued liabilities are summarized as follows: Philips Group Accrued liabilities in millions of EUR 2016 - 2017 2016 2017 Personnel-related costs: Salaries and wages 684 529 Accrued holiday entitlements 154 109 Other personnel-related costs 108 71 Fixed-asset-related costs: Gas, water, electricity, rent and other 52 52 Communication and IT costs 75 42 Distribution costs 123 83 Sales-related costs: Commission payable 22 7 Advertising and marketing-related costs 183 174 Other sales-related costs 55 38 Material-related costs 142 110 Interest-related accruals 68 38 Deferred income 957 791 Other accrued liabilities 411 273 Accrued liabilities 3,034 2,319 Deferred income is mainly related to Diagnosis & Treatment businesses and Connected Care & Health Informatics businesses, in both 2017 and 2016.

Other liabilities

Other liabilities	12 Months Ended
	Dec. 31, 2017
Disclosure of other liabilities [Abstract]
Disclosure of other liabilities [Text block]	Table of Contents Note Other non-current liabilities Other non-current liabilities are summarized as follows: Philips Group Other non-current liabilities in millions of EUR 2016 - 2017 2016 2017 Deferred income 251 249 Other tax liability 417 161 Other liabilities 73 65 Other non-current liabilities 741 474 For further details on tax related liabilities refer to Income taxes Other current liabilities Other current liabilities are summarized as follows: Philips Group Other current liabilities in millions of EUR 2016 - 2017 2016 2017 Accrued customer rebates that cannot be offset with accounts receivables for those customers 593 435 Advances received from customers on orders not covered by work in process 451 372 Other taxes including social security premiums 208 164 Other liabilities 120 155 Other current liabilities 1,372 1,126 The other liabilities per December 31, 2016 and 2017 include reclassifications from litigation provisions to liabilities due to settlements reached. For more details reference is made to Litigation provisions in Provisions Contingent assets and liabilities

Cash flow statement supplementa

Cash flow statement supplementary information	12 Months Ended
	Dec. 31, 2017
Disclosure of cash flow statement supplementary information (obsolete) [Abstract]
Disclosure of cash flow statement supplementary information [Text block]	Table of Contents Note Net cash used for derivatives and current financial assets In 2017, a total of EUR 295 million cash was paid with respect to foreign exchange derivative contracts related to activities for liquidity management and funding (2016: EUR 128 million outflow; 2015: EUR 194 million outflow). Philips also received EUR 90 million regarding the loans to TPV Technology Limited in 2017 (2016: nil Purchase and proceeds from non-current financial assets In 2017, the net cash outflow of EUR 36 million was mainly due to capital contribution in Gilde and Abraaj Growth Market Fund and the acquisition of other stakes. In 2016, the net cash outflow of EUR 39 million was mainly due to the acquisition of stakes in Abraaj Growth Markets Fund. In 2015, the net cash inflow of EUR 19 million was mainly due to net cash received from loans and sale of other stakes. Reconciliation of liabilities arising from financing activities Philips Group Reconciliation of liabilities arising from financing activities in millions of EUR 2016 - 2017 Balance as of Dec. 31, 2016 Cash flow 1 ) Transfer to liabilities directly associated with assets held for sale Currency effects and consolidation change Other non-cash Balance as of Dec. 31, 2017 Long-term debt 2 ) 5,396 ( 217) ( 1,255) ( 327) 998 4,595 USD bonds 3,608 ( 1,184) ( 287) 1 2,137 EUR bonds 997 - 997 Bank borrowings 1,470 ( 22) ( 1,238) ( 21) - 190 Other long-term debt 39 ( 20) - 1 ( 1) 20 Finance leases 279 12 ( 18) ( 20) 29 281 Forward contracts 3 ) 970 970 Short-term debt 2 ) 210 ( 4) ( 86) ( 49) 49 120 Short-term bank borrowings 207 ( 3) ( 84) ( 49) 71 Other short-term loans 2 ( 1) ( 2) - Forward contracts 3 ) 49 49 Equity ( 181) 168 ( 1,487) ( 1,500) Sale of Lighting shares net of costs 1,060 ( 1,060) Dividend payable ( 478) 478 Forward contracts 3 ) ( 1,018) ( 1,018) Treasury shares ( 181) ( 414) 114 ( 481) 1) 2) 3)

Contingent assets and liabiliti

Contingent assets and liabilities	12 Months Ended
	Dec. 31, 2017
Disclosure of contingent liabilities [Abstract]
Disclosure of contingent liabilities [Text block]	Table of Contents Note Contingent assets As per December 31, 2017, the Company had no material contingent assets. Contingent liabilities Guarantees Philips’ policy is to provide guarantees and other letters of support only in writing. Philips does not stand by other forms of support. The total fair value of guarantees recognized on the balance sheet amounts to EUR nil Environmental remediation The Company and its subsidiaries are subject to environmental laws and regulations. Under these laws, the Company and/or its subsidiaries may be required to remediate the effects of certain manufacturing activities on the environment. Legal proceedings The Company and certain of its group companies and former group companies are involved as a party in legal proceedings, regulatory and other governmental proceedings, including discussions on potential remedial actions, relating to such matters as competition issues, commercial transactions, product liability, participations and environmental pollution. While it is not feasible to predict or determine the ultimate outcome of all pending or threatened legal proceedings, regulatory and governmental proceedings, the Company is of the opinion that the cases described below may have, or have had in the recent past, a significant impact on the Company’s consolidated financial position, results of operations and cash flows. Cathode Ray Tubes (CRT) Starting in 2007, competition law authorities in several jurisdictions had commenced investigations into possible anticompetitive activities in the Cathode Ray Tubes, or CRT industry. On December 5, 2012, this lead to a European Commission decision imposing fines on (former) CRT manufacturers including the Company. The European Commission imposed a fine of EUR 313 million on the Company and a fine of EUR 392 million jointly and severally on the Company and LG Electronics, Inc. In total a payable of EUR 509 million was recognized in 2012 and the fine was paid in the first quarter of 2013. The Company appealed the decision of the European Commission with the General Court and later with European Court of Justice. These appeals were denied on September 9, 2015 and September 15, 2017 respectively. No further appeals are pending. United States Subsequent to the public announcement of these investigations in 2007, certain Philips Group companies were named as defendants in class action antitrust complaints by direct and indirect purchasers of CRTs filed in various federal district courts in the United States. These actions alleged anticompetitive conduct by manufacturers of CRTs and sought treble damages on a joint and several liability basis. In addition, sixteen individual plaintiffs, principally large retailers of CRT products who opted out of the direct purchaser class, filed separate complaints against the Company and other defendants based on the same substantive allegations. All these actions were consolidated for pre-trial proceedings in the United States District Court for the Northern District of California. In addition, the state attorneys general of California, Florida, Illinois, Oregon and Washington filed actions against the Company and other defendants seeking to recover damages on behalf of the states and, acting as parens patriae, their consumers. With the exception of the action brought by the state attorney of Washington, which remains pending, all other actions have been settled or otherwise resolved. The indirect purchaser settlement was approved by the United States District Court for the Northern District of California in 2016 and is now pending before the Ninth Circuit Court of Appeals. Canada In 2007, certain Philips Group companies were also being named as defendants in proposed class proceedings in Ontario, Quebec and British Columbia, Canada, along with numerous other participants in the industry. After years of inactivity, in 2014, plaintiffs in the Ontario action initiated the class certification proceedings leading to class certification in the second half of 2016. In 2017, a settlement in principle has been reached for all three proposed class actions. Other jurisdictions In 2014, the Company was named as a defendant in a consumer class action lawsuit filed in Israel in which damages are claimed against several defendants based on alleged anticompetitive activities in the CRT industry. In addition, an electronics manufacturer filed a claim against the Company and several co- defendants with a court in the Netherlands and Turkey, also seeking compensation for the alleged damage sustained as a result from the alleged anticompetitive activities in the CRT industry. In 2015 and 2016, the Company became involved in further civil CRT antitrust litigation with previous CRT customers in the United Kingdom, Germany, Brazil and Denmark. In all cases, the same substantive allegations about anticompetitive activities in the CRT industry are made and damages are sought. The Company has received indications that more civil claims may be filed in due course. Except for what has been provided or accrued for as disclosed in Provisions Other liabilities Personal Health In December 2013, the European Commission commenced an investigation into alleged restrictions of online sales of consumer electronics products and small domestic appliances. The Company was one of several companies involved in the investigation. In February 2017, the European Commission completed its preliminary investigation and opened its formal proceedings. Philips is fully cooperating with the European Commission. Due to the considerable uncertainty associated with this matter, on the basis of current knowledge, the Company has concluded that potential losses cannot be reliably estimated with respect to these matters. In April 2017, the Company received a Civil Investigative Demand (CID) out of the US Attorney’s Office in Northern District of Iowa. The CID relates to an evaluation of the appropriateness of certain sleep and respiratory care equipment financing programs available for Respironics’ products. In addition, in late 2017, the Company received an information request from the Department of Justice regarding the relationship between Respironics’ business and certain sleep centers that use Respironics’ products. The Company has not been advised that any claim has been asserted by the US government in connection with these matters and it continues to cooperate fully in both inquiries. Miscellaneous As part of the divestment of the Television and Audio, Video, Multimedia & Accessories businesses in 2012 and 2014, the Company transferred economic ownership and control in some legal entities or divisions thereof, while retaining (partial) legal ownership. Considering the current challenging business environment, the Company might face employee and operational liabilities in case of certain adverse events. Given the uncertain nature of the relevant events and liabilities, it is not practicable to provide information on the estimate of the financial effect, if any, or timing. The outcome of the uncertain events could have a material impact on the Company’s consolidated financial position, results of operations and cash flows.

Related-party transactions

Related-party transactions	12 Months Ended
	Dec. 31, 2017
Disclosure of related-party transactions [Abstract]
Disclosure of related-party transactions [Text block]	Table of Contents Note In the normal course of business, Philips purchases and sells goods and services from/to various related parties in which Philips typically holds between 20% 50% From November 28, 2017, Philips lost control over Philips Lighting but still has significant influence. This has resulted in Philips Lighting becoming a non-consolidated related party which is reported in the table below for the time period November 28 to December 31, 2017. Philips and Philips Lighting have several agreements in place which impact the related party balances disclosed. There is a Transitional Service Level Agreement, based on which Philips provides Philips Lighting with services such as IT, real estate and human resources among others. Additionally, a Trademark License Agreement was signed in which Philips Lighting uses the Philips brand name. For details of these parties in which Philips typically holds between 20% and 50% equity interest, refer to the Investments in associates section of Interests in entities Discontinued operations and assets classified as held for sale Philips Group Related-party transactions in millions of EUR 2015 - 2017 2015 2016 2017 Sales of goods and services 222 207 196 Purchases of goods and services 87 81 62 Receivables from related parties 16 33 127 Payables to related parties 4 3 36 In addition to the table above, as part of its operations in the US, Philips sold non-recourse third-party receivables to PMC US amounting to EUR 151 million in 2017 (2016: EUR 139 million; 2015: EUR 129 million). In light of the composition of the Executive Committee, the Company considers the members of the Executive Committee and the Supervisory Board to be the key management personnel as defined in IAS 24 ‘Related parties’. For remuneration details of the Executive Committee, the Board of Management and the Supervisory Board see Information on remuneration For Post-employment benefit plans see Post-employment benefits

Share-based compensation

Share-based compensation	12 Months Ended
	Dec. 31, 2017
Disclosure of share-based compensation [Abstract]
Disclosure of share-based payment arrangements explanatory [Text block]	Table of Contents Note The purpose of the share-based compensation plans is to align the interests of management with those of shareholders by providing incentives to improve the Company’s performance on a long-term basis, thereby increasing shareholder value. The Company has the following plans: performance shares: rights to receive common shares in the future based on performance and service conditions; restricted shares: rights to receive common shares in the future based on a service condition; and options on its common shares, including the 2012 and 2013 Accelerate! grant. Since 2013 the Board of Management and other members of the Executive Committee are only granted performance shares. Restricted shares are granted to executives, certain selected employees and new employees. Prior to 2013 options were also granted. Under the terms of employee stock purchase plans established by the Company in various countries, employees are eligible to purchase a limited number of Philips shares at discounted prices through payroll withholdings. Share-based compensation costs from continuing operations were EUR 122 million (2016: EUR 95 million; 2015: EUR 82 million). This includes the employee stock purchase plan of EUR 7 million, which is not a share-based compensation that affects equity. The share-based compensation costs for staff belonging to Philips Lighting and the combined businesses of Lumileds and Automotive of EUR 42 million are included in Discontinued operations. In the Consolidated statements of changes in equity EUR 151 million is recognized in 2017 and represent the costs of the share-based compensation plans. The amount recognized as an expense is adjusted for forfeiture. USD-denominated performance shares, restricted shares and options are granted to employees in the United States only. Performance shares The performance is measured over a three-year performance period. The performance shares have two performance conditions, relative Total Shareholders’ Return compared to a peer group of 20 companies (2016: 20 companies, 2015: 21 companies) and adjusted Earnings Per Share growth. The performance shares vest three years after the grant date. The number of performance shares that will vest is dependent on achieving the two performance conditions, which are equally weighted, and provided that the grantee is still employed with the Company. The amount recognized as an expense is adjusted for actual performance of adjusted Earnings Per Share growth since this is a non-market performance condition. It is not adjusted for non-vesting or extra vesting of performance shares due to a relative Total Shareholders’ Return performance that differs from the performance anticipated at the grant date, since this is a market-based performance condition. The fair value of the performance shares is measured based on Monte-Carlo simulation, which takes into account dividend payments between the grant date and the vesting date by including reinvested dividends, the market conditions expected to impact relative Total Shareholders’ Return performance in relation to selected peers. The following weighted-average assumptions were used for the 2017 grants: Risk-free rate: ( 0.60)% Expected share price volatility: 23% The assumptions were used for these calculations only and do not necessarily represent an indication of Management’s expectation of future developments for other purposes. The Company has based its volatility assumptions on historical experience measured over a ten-year period. A summary of the status of the Company’s performance share plans as of December 31, 2017 and changes during the year are presented below: Philips Group Performance shares 2017 shares 1 ) weighted average grant-date fair value EUR-denominated Outstanding at January 1, 2017 2 ) 7,866,754 25.24 Granted 1,419,518 38.02 Vested/Issued 2,853,745 22.48 Forfeited 557,229 27.80 Adjusted Quantity 3 ) 526,142 26.69 Outstanding at December 31, 2017 6,401,440 29.20 USD-denominated Outstanding at January 1, 2017 2 ) 5,162,084 29.56 Granted 953,897 41.69 Vested/Issued 1,901,252 30.07 Forfeited 441,395 30.83 Adjusted Quantity 3 ) 341,279 30.23 Outstanding at December 31, 2017 4,114,615 32.06 1) 2) 3) At December 31, 2017, a total of EUR 103 million of unrecognized compensation costs relate to non-vested performance shares. These costs are expected to be recognized over a weighted-average period of 1.7 years. Restricted shares The fair value of restricted shares is equal to the share price at grant date. The Company issues restricted shares that, in general, have a 3 year cliff-vesting period. For grants up to and including January 2013 the Company granted 20% additional (premium) shares, provided the grantee still holds the shares after three years from the delivery date and the grantee is still with the Company on the respective delivery dates. As of December 31, 2017 all restricted share plans granted before 2013 have vested except their premium shares. A summary of the status of the Company’s restricted shares as of December 31, 2017 and changes during the year are presented below: Philips Group Restricted shares 2017 shares 1 ) 2 ) weighted average grant-date fair value EUR-denominated Outstanding at January 1, 2017 1,666,960 24.40 Granted 754,374 32.84 Vested/Issued 557,603 25.04 Forfeited 133,031 25.51 Outstanding at December 31, 2017 1,730,699 27.79 USD-denominated Outstanding at January 1, 2017 1,711,903 27.78 Granted 758,368 36.61 Vested/Issued 521,055 28.63 Forfeited 266,590 28.74 Outstanding at December 31, 2017 1,682,625 31.35 1) 2) At December 31, 2017, a total of EUR 40 million of unrecognized compensation costs relate to non-vested restricted shares. These costs are expected to be recognized over a weighted-average period of 1.4 years. Option plans The Company granted options that expire after ten years. These options vest after three years, provided that the grantee is still employed with the Company. All outstanding options have vested as of December 31, 2017. The following tables summarize information about the Company’s options as of December 31, 2017 and changes during the year: Philips Group Options on EUR-denominated listed share 2017 options weighted average exercise price Outstanding at January 1, 2017 7,052,065 22.49 Exercised 2,591,755 20.42 Forfeited 60,027 20.55 Expired 1,628,073 30.96 Outstanding at December 31, 2017 2,772,210 19.49 Exercisable at December 31, 2017 2,772,210 19.49 The exercise prices range from EUR 12.63 to EUR 32.04. The weighted average remaining contractual term for options outstanding and options exercisable at December 31, 2017, was 3.0 years. The aggregate intrinsic value of the options outstanding and options exercisable at December 31, 2017, was EUR 33 million. The total intrinsic value of options exercised during 2017 was EUR 29 million (2016: EUR 20 million, 2015: EUR 21 million). Philips Group Options on USD-denominated listed share 2017 options weighted average exercise price Outstanding at January 1, 2017 7,725,221 31.27 Exercised 2,818,363 29.12 Forfeited 122,154 32.82 Expired 1,474,938 41.66 Outstanding at December 31, 2017 3,309,766 28.41 Exercisable at December 31, 2017 3,309,766 28.41 The exercise prices range from USD 16.76 to USD 44.15. The weighted average remaining contractual term for options outstanding and options exercisable at December 31, 2017, was 2.5 years. The aggregate intrinsic value of the options outstanding and options exercisable at December 31, 2017, was USD 31 million. The total intrinsic value of options exercised during 2017 was USD 22 million (2016: USD 6 million, 2015: USD 8 million). At December 31, 2017 there were no unrecognized compensation costs related to outstanding options. Cash received from exercises under the Company’s option plans amounted to EUR 128 million in 2017 (2016: EUR 65 million, 2015: EUR 72 million). The actual tax deductions realized as a result of option exercises totaled approximately EUR 5 million in 2017 (2016: EUR 2 million, 2015: EUR 3 million). The outstanding options as of December 31, 2017 are categorized in exercise price ranges as follows: Philips Group Outstanding options 2017 exercise price options intrinsic value in millions weighted average remaining contractual term EUR-denominated 10-15 1,013,941 17.4 3.7 yrs 15-20 27,042 0.4 4.0 yrs 20-25 1,731,227 15.6 2.6 yrs Outstanding options 2,772,210 33.4 3.0 yrs USD-denominated 15-20 993,732 18.8 3.6 yrs 20-25 42,728 0.7 3.4 yrs 25-30 860,950 7.0 3.3 yrs 30-35 834,242 3.8 1.9 yrs 35-40 578,114 0.7 0.3 yrs Outstanding options 3,309,766 31.1 2.5 yrs The aggregate intrinsic value in the tables and text above represents the total pre-tax intrinsic value (the difference between the Company’s closing share price on the last trading day of 2017 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders if the options had been exercised on December 31, 2017. The following table summarizes information about the Company’s Accelerate! options as of December 31, 2017 and changes during the year: Philips Group Accelerate! options 2017 options weighted average exercise price EUR-denominated Outstanding at January 1, 2017 860,300 16.02 Exercised 379,100 15.97 Outstanding at December 31, 2017 481,200 16.06 Exercisable at December 31, 2017 481,200 16.06 USD-denominated Outstanding at January 1, 2017 257,800 20.02 Exercised 87,000 20.02 Outstanding at December 31, 2017 170,800 20.02 Exercisable at December 31, 2017 170,800 20.02 The exercise prices of the Accelerate! options are EUR 15.24 and EUR 22.43 for EUR-denominated options and is USD 20.02 for USD-denominated options. The weighted average remaining contractual term for EUR-denominated Accelerate! options outstanding and exercisable at December 31, 2017 was 4.2 years. The weighted average remaining contractual term for USD-Accelerate! options outstanding and exercisable at December 31, 2017 was 4.1 years. The aggregate intrinsic value of the EUR-denominated Accelerate! options outstanding and exercisable at December 31, 2017, was EUR 7 million. The aggregate intrinsic value of the USD-denominated Accelerate! options outstanding and exercisable at December 31, 2017 was USD 3 million. The total intrinsic value of Accelerate! options exercised during 2017 was EUR 6 million for EUR-denominated options (2016: EUR 4 million) and USD 1 million for USD-denominated options (2016: USD 1 million). Cash received from exercises for EUR-denominated and USD-denominated Accelerate! options amounted to EUR 8 million in 2017 (2016: EUR 9 million). The actual tax deductions realized as a result of Accelerate! USD options exercises totaled approximately EUR 0.3 million in 2017 (2016: EUR 0.3 million).

Information on remuneration

Information on remuneration	12 Months Ended
	Dec. 31, 2017
Disclosure of information on remuneration [Abstract]
Disclosure of information on remuneration [Text block]	Table of Contents Note Information on remuneration Remuneration of the Executive Committee In 2017, the total remuneration costs relating to the members of the Executive Committee (consisting of 12 members, including the members of the Board of Management) amounted to EUR 25,848,741 (2016: EUR 22,433,827; 2015: EUR 15,098,023) consisting of the elements in the following table. Philips Group Remuneration costs of the Executive Committee 1 ) in EUR 2015 - 2017 2015 2016 2017 Base salary/Base compensation 5,974,928 6,388,667 8,089,063 Annual incentive 2 ) 2,705,560 5,746,347 6,345,576 Performance shares 3 ) 2,740,004 5,943,782 6,371,297 Stock options 3 ) 88,775 - - Restricted share rights 3 ) 91,339 764,311 885,343 Pension allowances 4 ) 2,193,409 1,854,129 1,886,963 Pension scheme costs 209,462 180,077 408,695 Other compensation 5 ) 1,094,546 1,556,514 1,861,803 1) 2) 3) 4) 5) At December 31, 2017, the members of the Executive Committee (including the members of the Board of Management) held 541,400 (2016: 750,631; 2015: 843,461) stock options at a weighted average exercise price of EUR 19.82 (2016: EUR 21.17; 2015: EUR 18.67). Remuneration of the Board of Management In 2017, the total remuneration costs relating to the members of the Board of Management amounted to EUR 7,808,117 (2016: EUR 8,904,859; 2015: EUR 6,612,092), see table below. Note that Pieter Nota was succeeded as a member of the Board of Management by Marnix van Ginneken as per November 1, 2017. Philips Group Remuneration costs of individual members of the Board of Management in EUR 2015 - 2017 base salary annual 1 ) perfor­ 2 ) stock 2 ) restricted share 2 ) pension 3 ) pension other 4 ) total 2017 F.A. van Houten 1,205,000 1,270,166 1,975,277 - 4,034 537,621 25,278 84,053 5,101,429 A. Bhattacharya 687,500 553,392 669,396 - 888 210,450 25,278 100,918 2,247,822 P.A.J. Nota 5 ) 606,250 429,886 ( 1,203,992) - ( 188) 236,208 21,065 63,576 152,805 M.J. van Ginneken 91,667 69,168 100,022 - 75 27,796 4,213 13,120 306,061 2,590,417 2,322,612 1,540,703 - 4,809 1,012,075 75,834 261,667 7,808,117 2016 F.A. van Houten 1,197,500 1,354,227 1,423,538 - 12,041 536,195 24,838 126,703 4,675,042 A. Bhattacharya 650,000 540,072 362,758 - 3,341 201,524 24,838 73,642 1,856,175 P.A.J. Nota 702,500 619,745 683,101 - 9,251 277,649 24,838 56,558 2,373,642 2,550,000 2,514,044 2,469,397 - 24,633 1,015,368 74,514 256,903 8,904,859 2015 F.A. van Houten 1,168,750 768,920 1,273,940 17,713 28,279 529,387 25,241 78,035 3,890,265 A. Bhattacharya 23,551 11,937 8,968 - 183 7,315 886 998 53,838 R.H. Wirahadiraksa 664,583 239,250 ( 652,049) 12,045 ( 37,210) 290,772 24,002 29,477 570,870 P.A.J. Nota 672,500 383,112 605,749 12,045 21,964 270,529 26,302 104,918 2,097,119 2,529,384 1,403,219 1,236,608 41,803 13,216 1,098,003 76,431 213,428 6,612,092 1) 2017 Annual Incentive 2) 3) 4) 5) For further information on remuneration costs, see Remuneration costs The tables below give an overview of the performance share plans and the stock option plans of the Company, held by the members of the Board of Management: Philips Group Number of performance shares (holdings) in number of shares 2017 January 1, awarded awarded realized December 31, vesting date F.A. van Houten 65,299 - - 69,544 - 04.28.2017 58,636 - 1,476 - 60,112 05.05.2018 61,336 - 1,544 - 62,880 04.29.2019 - 73,039 1,839 - 74,878 05.11.2020 A. Bhattacharya 11,830 1 ) - - 12,598 - 04.28.2017 12,476 1 ) - 314 - 12,790 05.05.2018 27,571 - 694 - 28,265 04.29.2019 - 31,822 801 - 32,623 05.11.2020 M.J. van Ginneken 16,267 1 ) - - 19,150 - 04.28.2017 18,714 1 ) - 471 - 19,185 05.05.2018 21,697 1 ) - 546 - 22,243 04.29.2019 - 18,563 1 ) 467 - 19,030 05.11.2020 Performance shares (holdings 293,826 123,424 8,152 101,292 332,006 1) At December 31, 2017, the members of the Board of Management held 333,670 stock options (2016: 476,200; 2015: 479,881) at a weighted average exercise price of EUR 18.99 (2016: EUR 19.47; 2015: EUR 19.52). Philips Group Stock options (holdings) in number of shares 2017 January 1, 2017 granted exercised expired December 31, 2017 grant share (closing) price on exercise date expiry date F.A. van Houten 20,400 1 ) - - - 20,400 22.88 - 10.18.2020 75,000 - - - 75,000 20.90 - 04.18.2021 75,000 - - - 75,000 14.82 - 04.23.2022 55,000 - - - 55,000 22.43 - 01.29.2023 A. Bhattacharya 16,500 1 ) - - - 16,500 22.88 - 10.18.2020 16,500 1 ) - - - 16,500 20.90 - 04.18.2021 20,000 1 ) - - - 20,000 15.24 - 01.30.2022 16,500 1 ) - - - 16,500 14.82 - 04.23.2022 M.J. van Ginneken 5,250 1 ) - - - 5,250 12.63 - 04.14.2019 6,720 1 ) - - - 6,720 24.90 - 04.19.2020 8,400 1 ) - - - 8,400 20.90 - 04.18.2021 10,000 1 ) - - - 10,000 15.24 - 01.30.2022 8,400 1 ) - - - 8,400 14.82 - 04.23.2022 Stock options (holdings) 333,670 - - - 333,670 1) Under the Long-Term Incentive Plan operative until 2013, members of the Board of Management were granted restricted share rights. During 2015 the last release of these restricted share rights took place. However, if the shares from the restricted share rights release were kept for another 3 years, members of the Board of Management received so-called ‘premium shares’. As at December 31, 2017, awarded premium shares amounted to 1,334 for F.A. van Houten, 140 for A. Bhattacharya and 150 for M.J. van Ginneken (all to be released in 2018). The premium shares to A. Bhattacharya and M.J. van Ginneken result from restricted share rights grants awarded before date of appointment as a member of the Board of Management. See Share-based compensation 2017 Long-Term Incentive Plan The accumulated annual pension entitlements and the pension costs of individual members of the Board of Management are as follows (in EUR): Philips Group Accumulated annual pension entitlements and pension-related costs in EUR 2017 age at December 31, 2017 accumulated annual pension as of December 31, 2017 1 ) total 2 ) F.A. van Houten 57 295,007 562,899 A. Bhattacharya 56 25,539 235,728 P.A.J. Nota 53 45,442 257,273 M.J. van Ginneken 44 37,359 32,009 Pension costs 1,087,909 1) 2) When pension rights are granted to members of the Board of Management, necessary payments (if insured) and all necessary provisions are made in accordance with the applicable accounting principles. In 2017, no (additional) pension benefits were granted to former members of the Board of Management. Remuneration of the Supervisory Board The remuneration of the members of the Supervisory Board amounted to EUR 950,500 (2016: EUR 1,037,209; 2015: EUR 1,083,667). Former members received no remuneration. At December 31, 2017 the members of the Supervisory Board held no stock options, performance shares or restricted shares. The individual members of the Supervisory Board received, by virtue of the positions they held, the following remuneration (in EUR): Philips Group Remuneration of the Supervisory Board in EUR 2015 - 2017 membership committees other compensation 1 ) total 2017 2 ) J.A. van der Veer 135,000 25,000 7,000 167,000 C. Poon 90,000 32,500 17,000 139,500 H. von Prondzynski 80,000 32,500 19,500 132,000 J.P. Tai 80,000 32,500 32,000 144,500 N. Dhawan 80,000 13,000 27,000 120,000 O. Gadiesh 80,000 13,000 19,500 112,500 D.E.I. Pyott 80,000 23,000 32,000 135,000 625,000 171,500 154,000 950,500 2016 2 ) J.A. van der Veer 135,000 26,667 7,000 168,667 C. Poon 90,000 32,500 22,000 144,500 C.J.A. van Lede (Jan.-May) 3 ) 33,333 4,375 2,000 39,708 E. Kist (Jan.-May) 40,000 4,167 2,000 46,167 H. von Prondzynski 80,000 25,000 19,500 124,500 J.P. Tai 80,000 34,167 32,000 146,167 N. Dhawan 80,000 13,000 27,000 120,000 O. Gadiesh 80,000 13,000 19,500 112,500 D.E.I. Pyott 80,000 23,000 32,000 135,000 698,333 175,876 163,000 1,037,209 2015 2 ) J.A. van der Veer 135,000 31,667 7,000 173,667 C. Poon 90,000 17,500 15,000 122,500 C.J.A. van Lede 80,000 14,333 7,000 101,333 E. Kist 80,000 10,000 2,000 92,000 H. von Prondzynski 80,000 26,833 19,500 126,333 J.P. Tai 80,000 29,167 35,000 144,167 N. Dhawan 80,000 13,000 20,000 113,000 O. Gadiesh 80,000 13,000 17,000 110,000 D.E.I. Pyott (May-Dec.) 80,000 8,667 12,000 100,667 785,000 164,167 134,500 1,083,667 1) 2) 3) Supervisory Board members’ and Board of Management members’ interests in Philips shares Members of the Supervisory Board and of the Executive Committee are prohibited from writing call and put options or similar derivatives of Philips securities. Philips Group Shares held by Board members 1 ) in number of shares 2017 December 31, 2016 December 31, 2017 J. van der Veer 18,366 18,366 H. von Prondzynski 3,758 3,851 J.P. Tai 3,844 3,844 F.A. van Houten 189,824 233,119 A. Bhattacharya 42,913 53,974 M.J. van Ginneken 19,792 30,246 1)

Fair value of financial assets

Fair value of financial assets and liabilities	12 Months Ended
	Dec. 31, 2017
Disclosure of fair value of financial assets and liabilities [Abstract]
Disclosure of fair value of financial assets and liabilities [Text block]	Table of Contents Note The estimated fair value of financial instruments has been determined by the Company using available market information and appropriate valuation methods. The estimates presented are not necessarily indicative of the amounts that will ultimately be realized by the Company upon maturity or disposal. The use of different market assumptions and/or estimation methods may have a material effect on the estimated fair value amounts. For cash and cash equivalents, current receivables, accounts payable, interest accrual and short-term debts, the carrying amounts approximate fair value because of the short maturity of these instruments, and therefore fair value information is not included in the table below. The fair value of Philips’ debt is estimated on the basis of the quoted market prices for certain issues, or on the basis of discounted cash flow analysis based upon market rates plus Philips’ spread for the particular tenors of the borrowing arrangement. Accrued interest is not included within the carrying amount or estimated fair value of debt. The following table shows the carrying amounts and fair values of financial assets and financial liabilities, including their levels in the fair value hierarchy. It does not include fair value information for financial assets and financial liabilities not measured at fair value if the carrying amount is a reasonable approximation of fair value. Philips Group Fair value of financial assets and liabilities in millions of EUR 2017 carrying amount estimated fair value Level 1 Level 2 Level 3 Financial assets Carried at fair value: Available-for-sale financial assets 446 446 49 29 368 Securities classified as assets held for sale 1,264 1,264 1,264 Fair value through profit and loss 27 27 23 4 Derivative financial instruments 78 78 78 Financial assets carried at fair value 1,815 1,815 1,313 130 372 Carried at (amortized) cost: Cash and cash equivalents 1,939 Loans and receivables Current loans receivable 2 Other non-current loans and receivables 114 Receivables - current 3,909 Receivables - non-current 130 Held-to-maturity investments 1 Financial assets carried at (amortized) costs 6,095 Total financial assets 7,909 1,815 1,313 130 372 Financial liabilities Carried at fair value: Derivative Financial instruments ( 383) ( 383) ( 383) Financial liabilities carried at fair value ( 383) ( 383) ( 383) Carried at (amortized) cost: Accounts payable ( 2,090) Interest accrual ( 38) Debt (Corporate bond and finance lease) ( 3,378) ( 3,860) ( 3,579) ( 281) Debt (other bank loans, overdraft, forward contracts etc.) ( 1,337) Financial liabilities carried at (amortized) costs ( 6,843) ( 3,860) ( 3,579) ( 281) Total financial liabilities ( 7,226) ( 4,243) ( 3,579) ( 665) Philips Group Fair value of financial assets and liabilities in millions of EUR 2016 carrying amount estimated fair value Level 1 Level 2 Level 3 Carried at fair value: Available-for-sale financial assets 172 172 36 29 107 Securities classified as assets held for sale 1 1 1 Fair value through profit and loss 27 27 24 3 Derivative financial instruments 160 160 160 Financial assets carried at fair value 360 360 36 213 111 Carried at (amortized) cost: Cash and cash equivalents 2,334 Loans and receivables Current loans receivable 101 101 101 Non-current loans and receivables 134 Loans to investment in associates Loans held for sale Receivables - current 5,327 Receivables - non-current 155 Held-to-maturity investments 2 Financial assets carried at (amortized) costs 8,053 101 101 Total financial assets 8,413 461 36 314 111 Financial liabilities Carried at fair value: Derivative financial instruments ( 873) ( 873) ( 873) Financial liabilities carried at fair value ( 873) ( 873) ( 873) Carried at (amortized) cost: Accounts payable ( 2,848) Interest accrual ( 68) Debt (Corporate bond and finance lease) ( 5,095) ( 5,474) ( 3,990) ( 1,484) Debt (other bank loans, overdraft etc.) ( 511) Financial liabilities carried at (amortized) costs ( 8,522) ( 5,474) ( 3,990) ( 1,484) Total financial liabilities ( 9,395) ( 6,347) ( 3,990) ( 2,357) The table above represents categorization of measurement of the estimated fair values of financial assets and liabilities. Specific valuation techniques used to value financial instruments include: Level 1 Instruments included in level 1 are comprised primarily of listed equity investments classified as available-for-sale financial assets, investees and financial assets designated at fair value through profit and loss, including the investment in Philips Lighting which is held for sale as of December 31, 2017. The fair value of financial instruments traded in active markets is based on quoted market prices at the balance sheet date. A market is regarded as active if quoted prices are readily and regularly available from an exchange, dealer, broker, industry group, pricing service, or regulatory agency, and those prices represent actual and regularly occurring market transactions on an arm’s length basis. Level 2 The fair value of financial instruments that are not traded in an active market (for example, over-the-counter derivatives or convertible bond instruments) are determined by using valuation techniques. These valuation techniques maximize the use of observable market data where it is available and rely as little as possible on entity-specific estimates. If all significant inputs required to fair value an instrument are based on observable market data, the instrument is included in level 2. The fair value of derivatives is calculated as the present value of the estimated future cash flows based on observable interest yield curves, basis spread and foreign exchange rates. The valuation of convertible bond instruments uses observable market quoted data for the options and present value calculations using observable yield curves for the fair value of the bonds. Level 3 If one or more of the significant inputs are not based on observable market data, such as third-party pricing information without adjustments, the instrument is included in level 3. The retained investment in the combined businesses of Lumileds and Automotive is classified as an available-for-sale financial asset recognized at fair value of EUR 243 million, based on a valuation model with inputs, including discount rates and multiples, which are market-corroborated to the extent possible, and hence classified as Level 3 in the fair value hierarchy. A sensitivity analysis conducted for the combined businesses of Lumileds and Automotive as of January 2018 shows that if the earnings were to increase instantaneously by 10% from the assumption at December 31, 2017, with all other variables (including foreign exchange rates) held constant, the fair value of the asset would increase by 28%. If there was a decrease of 10% in earnings, this would reduce the market value of the asset by approximately 26%. If the valuation multiples were to increase instantaneously by 10% from the assumption at December 31, 2017, with all other variables (including foreign exchange rates) held constant, the fair value of the asset would increase by 18% while if there was a decrease of 10% in valuation multiples, this would reduce the market value of the asset by approximately 17%. The table below shows the reconciliation from the beginning balance to the end balance for fair value measured in Level 3 of the fair value hierarchy. Philips Group Reconciliation of the fair value hierarchy in millions of EUR 2017 financial assets Balance as of January 1, 2017 111 Gains and losses recognized in: in profit or loss 2 in other comprehensive income ( 83) Purchase 356 Sales ( 10) Transfer to assets held for sale ( 4) Balance as of December 31, 2017 372 The section below elaborates on transactions in derivatives. Transactions in derivatives are subject to master netting and set-off agreements. In the case of certain termination events, under the terms of the Master Agreement, Philips can terminate the outstanding transactions and aggregate their positive and negative values to arrive at a single net termination sum (or close-out amount). This contractual right is subject to the following: The right may be limited by local law if the counterparty is subject to bankruptcy proceedings; The right applies on a bilateral basis. Philips Group Financial assets subject to offsetting, enforceable master netting arrangements or similar agreements in millions of EUR 2016 - 2017 2016 2017 Derivatives Gross amounts of recognized financial assets 160 78 Gross amounts of recognized financial liabilities offset in the balance sheet Net amounts of financial assets presented in the balance sheet 160 78 Related amounts not offset in the balance sheet Financial instruments ( 92) ( 38) Cash collateral received Net amount 68 39 Philips Group Financial liabilities subject to offsetting, enforceable master netting arrangements or similar agreements in millions of EUR 2016 - 2017 2016 2017 Derivatives Gross amounts of recognized financial liabilities ( 873) ( 383) Gross amounts of recognized financial assets offset in the balance sheet Net amounts of financial liabilities presented in the balance sheet ( 873) ( 383) Related amounts not offset in the balance sheet Financial instruments 92 38 Cash collateral received Net amount ( 781) ( 345)

Details of treasury risks

Details of treasury risks	12 Months Ended
	Dec. 31, 2017
Disclosure of details of treasury risks [Abstract]
Disclosure of details of treasury risks [Text block]	Table of Contents Note Philips is exposed to several types of financial risks. This note further analyzes financial risks. Philips does not purchase or hold derivative financial instruments for speculative purposes. Information regarding financial instruments is included in Fair value of financial assets and liabilities Liquidity risk Liquidity risk is the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities. Liquidity risk for the group is monitored through the Treasury liquidity committee, which tracks the development of the actual cash flow position for the group and uses input from a number of sources in order to forecast the overall liquidity position on both a short and long-term basis. Group Treasury invests surplus cash in money market deposits with appropriate maturities to ensure sufficient liquidity is available to meet liabilities when due. The rating of the Company’s debt by major rating services may improve or deteriorate. As a result, Philips’ future borrowing capacity may be influenced and its financing costs may fluctuate. Philips has various sources to mitigate the liquidity risk for the group. At December 31, 2017, Philips had EUR 1,939 million in cash and cash equivalents (2016: EUR 2,334 million), within which short-term deposits of EUR 1,302 million (2016: EUR 1,299 million). Philips pools cash from subsidiaries to the extent legally and economically feasible; cash not pooled remains available for the Company’s operational or investment needs. Philips faces cross-border foreign exchange controls and/or other legal restrictions in a few countries that could limit its ability to make these balances available on short notice for general use by the group. Furthermore, Royal Philips has a USD 2.5 billion Commercial Paper Programme and a EUR 1 billion committed revolving credit facility that can be used for general group purposes, such as a backstop for its Commercial Paper Programme. As of December 31, 2017, Royal Philips did not have any amounts outstanding under any of these facilities. A description of Philips’ credit facilities can be found in Debt Additionally, Philips also held EUR 49 million of equity investments in available-for-sale financial assets (fair value at December 31, 2017). Furthermore, Philips is also a shareholder in Philips Lighting (EUR 1,264 million at year-end 2017) which is publicly listed and classified as asset held for sale. The table below presents a summary of the Group’s fixed contractual cash obligations and commitments at December 31, 2017. These amounts are an estimate of future payments which could change as a result of various factors such as a change in interest rates, contractual provisions, as well as changes in our business strategy and needs. Therefore, the actual payments made in future periods may vary from those presented in the following table: Philips Group Contractual cash obligations 1 2 ) in millions of EUR 2017 payments due by period total less than 1 year 1-3 years 3-5 years after 5 years Long-term debt 3 ) 4,314 465 1,170 878 1,801 Finance lease obligations 306 93 131 53 29 Short-term debt 120 120 Operating leases 741 172 226 147 196 Derivative liabilities 370 167 109 95 Interest on debt 1,785 132 252 226 1,175 Purchase obligations 4 ) 480 145 217 86 31 Trade and other payables 2,090 2,090 Contractual cash obligations 10,205 3,383 2,105 1,389 3,328 1) 2) 3) 4) Certain Philips suppliers factor their trade receivables from Philips with third parties through supplier finance arrangements. At December 31, 2017 approximately EUR 286 million of the Philips accounts payable were known to have been sold onward under such arrangements whereby Philips confirms invoices. Philips continues to recognize these liabilities as trade payables and will settle the liabilities in line with the original payment terms of the related invoices. Currency risk Currency risk is the risk that reported financial performance or the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. Philips operates in many countries and currencies and therefore currency fluctuations may impact Philips’ financial results. Philips is exposed to currency risk in the following areas: Transaction exposures, related to anticipated sales and purchases and on-balance-sheet receivables/payables resulting from such transactions Translation exposure of foreign-currency intercompany and external debt and deposits Translation exposure of net income in foreign entities Translation exposure of foreign-currency-denominated equity invested in consolidated companies Translation exposure to equity interests in non-functional-currency investments in associates and available-for-sale financial assets. It is Philips’ policy to reduce the potential year-on-year volatility caused by foreign-currency movements on its net earnings by hedging the anticipated net exposure of foreign currencies resulting from foreign-currency sales and purchases. In general, net anticipated exposures for the Group are hedged during a period of 15 months in layers of 20% up to a maximum hedge of 80%, using forwards and currency options. Philips’ policy requires significant committed foreign currency exposures to be fully hedged, generally using forwards. However, not every foreign currency can or shall be hedged as there may be regulatory barriers or prohibitive hedging cost preventing Philips from effectively and/or efficiently hedging its currency exposures. As a result, hedging activities cannot and will not eliminate all currency risks for anticipated and committed transaction exposures. The following table outlines the estimated nominal value in millions of EUR for committed and anticipated transaction exposure and related hedges for Philips’ most significant currency exposures consolidated as of December 31, 2017: Philips Group Estimated transaction exposure and related hedges in millions of EUR 2017 Receivables Payables exposure hedges exposure hedges Balance as of December 31, 2017 Exposure currency USD 1,217 ( 857) ( 583) 488 JPY 666 ( 369) ( 6) 5 CAD 272 ( 153) ( 8) 8 GBP 245 ( 147) ( 20) 20 CNY 178 ( 98) ( 86) 86 AUD 175 ( 100) CHF 117 ( 65) ( 1) 1 PLN 122 ( 73) SEK 73 ( 42) ( 1) 1 CZK 45 ( 25) RUB 41 ( 41) ( 2) 1 Others 244 ( 219) ( 160) 150 Total 2017 3,395 ( 2,189) ( 867) 760 Total 2016 4,211 ( 2,412) ( 1,764) 1,344 The change in exposures and related hedges compared to 2016 is mainly driven by the deconsolidation of Philips Lighting. Philips uses foreign exchange spot and forward contracts, as well as zero cost collars in hedging the exposure. The derivatives related to transactions are, for hedge accounting purposes, split into hedges of on-balance-sheet accounts receivable/payable and forecasted sales and purchases. Changes in the value of on-balance-sheet foreign-currency accounts receivable/payable, as well as the changes in the fair value of the hedges related to these exposures, are reported in the income statement under costs of sales. Hedges related to forecasted transactions, where hedge accounting is applied, are accounted for as cash flow hedges. The results from such hedges are deferred in other comprehensive income within equity to the extent that the hedge is effective. As of December 31, 2017, a gain of EUR 23 million was deferred in equity as a result of these hedges (2016: EUR 10 million gain). The result deferred in equity will be released to earnings mostly during 2018 at the time when the related hedged transactions affect the income statement. During 2017, a net gain of EUR 0.1 million (2016: EUR 5 million net gain) was recorded in the consolidated statement of income as a result of ineffectiveness on certain anticipated cash flow hedges. The total net fair value of hedges related to transaction exposure as of December 31, 2017, was an unrealized asset of EUR 21 million. An instantaneous 10% increase in the value of the EUR against all currencies would lead to an increase of EUR 102 million in the value of the derivatives; including a EUR 53 million increase related to foreign exchange transactions of the USD against the EUR, a EUR 17 million increase related to foreign exchange transactions of the JPY against the EUR, a EUR 10 million increase related to foreign exchange transactions of the GBP against the EUR, a EUR 6 million increase related to foreign exchange transactions of the PLN against the EUR and a EUR 5 million increase related to foreign exchange transactions of the CHF against the EUR. The EUR 102 million increase includes a gain of EUR 10 million that would impact the income statement, which would largely offset the opposite revaluation effect on the underlying accounts receivable and payable, and the remaining gain of EUR 92 million would be recognized in equity to the extent that the cash flow hedges were effective. The total net fair value of hedges related to transaction exposure as of December 31, 2016, was an unrealized asset of EUR 15 million. An instantaneous 10% increase in the value of the EUR against all currencies would lead to an increase of EUR 98 million in the value of the derivatives; including a EUR 46 million increase related to foreign exchange transactions of the USD against the EUR, a EUR 18 million increase related to foreign exchange transactions of the JPY against the EUR, a EUR 10 million increase related to foreign exchange transactions of the GBP against the EUR, and a EUR 5 million increase related to foreign exchange transactions of the AUD against the EUR. Foreign exchange exposure also arises as a result of inter-company loans and deposits. Where the Company enters into such arrangements, the financing is generally provided in the functional currency of the subsidiary entity. The currency of the Company’s external funding and liquid assets is matched with the required financing of subsidiaries, either directly through external foreign currency loans and deposits, or synthetically by using foreign exchange derivatives, including cross currency interest rate swaps and foreign exchange forward contracts. In certain cases where group companies may also have external foreign currency debt or liquid assets, these exposures are also hedged through the use of foreign exchange derivatives. Changes in the fair value of hedges related to this exposure are recognized within financial income and expenses in the statements of income. When such loans would be considered part of the net investment in the subsidiary, net investment hedging would be applied. Translation exposure of foreign-currency equity invested in consolidated entities may be hedged. If a hedge is entered into, it is accounted for as a net investment hedge. Net current-period change, before tax, of the currency translation reserve of EUR 1,177 million relates mainly to the negative impact of the stronger EUR against the foreign currencies of countries in which Philips’ operations are located. The change in currency translation reserve was mostly related to the development of the USD. As of December 31, 2017, cross-currency interest rate swaps with a fair value liability of EUR 330 million and external bond funding for a nominal value of USD 2,535 million were designated as net investment hedges of our financing investments in foreign operations. During 2017 a total gain of EUR 1.4 million was recognized in the income statement as ineffectiveness on net investment hedges. The total net fair value of financing derivatives as of December 31, 2017, was a liability of EUR 326 million. An instantaneous 10% increase in the value of the EUR against all currencies would lead to an increase of EUR 213 million in the value of the derivatives, including a EUR 208 million increase related to the USD. As of December 31, 2016, cross-currency interest rate swaps with a fair value liability of EUR 726 million and external bond funding for a nominal value of USD 3,774 million were designated as net investment hedges of our financing investments in foreign operations. During 2016 a total gain of EUR 0.2 million was recognized in the income statement as ineffectiveness on net investment hedges. The total net fair value of financing derivatives as of December 31, 2016, was a liability of EUR 728 million. An instantaneous 10% increase in the value of the EUR against all currencies would lead to an increase of EUR 53 million in the value of the derivatives, including a EUR 62 million increase related to the USD. Philips does not currently hedge the foreign exchange exposure arising from equity interests in non-functional-currency investments in associates and available-for-sale financial assets. Interest rate risk Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. Philips had outstanding debt of EUR 4,715 million (2016: EUR 5,606 million), which created an inherent interest rate risk. Failure to effectively hedge this risk could negatively impact financial results. At year-end, Philips held EUR 1,939 million in cash and cash equivalents (2016: EUR 2,334 million), and had total long-term debt of EUR 4,044 million (2016: EUR 4,021 million) and total short-term debt of EUR 672 million (2016: EUR 1,585 million). At December 31, 2017, Philips had a ratio of fixed-rate long-term debt to total outstanding debt of approximately 72%, compared to 47% one year earlier (figure updated to align definition). A sensitivity analysis conducted as of January 2018 shows that if long-term interest rates were to decrease instantaneously by 1% from their level of December 31, 2017, with all other variables (including foreign exchange rates) held constant, the fair value of the fixed-rate long-term debt (excluding forward contracts) would increase by approximately EUR 271 million. If there was an increase of 1% in long-term interest rates, this would reduce the market value of the fixed-rate long-term debt (excluding forward contracts) by approximately EUR 271 million. If interest rates were to increase instantaneously by 1% from their level of December 31, 2017, with all other variables held constant, the annualized net interest expense would decrease by approximately EUR 12 million. This impact was based on the outstanding net cash position (after excluding fixed-rate debt) at December 31, 2017. A sensitivity analysis conducted as of January 2017 shows that if long-term interest rates were to decrease instantaneously by 1% from their level of December 31, 2016, with all other variables (including foreign exchange rates) held constant, the fair value of the long-term debt would increase by approximately EUR 260 million. If there was an increase of 1% in long-term interest rates, this would reduce the market value of the long-term debt by approximately EUR 259 million. If interest rates were to increase instantaneously by 1% from their level of December 31, 2016, with all other variables held constant, the annualized net interest expense would decrease by approximately EUR 7 million. This impact was based on the outstanding net cash position (after excluding fixed-rate debt) at December 31, 2016. Equity price risk Equity price risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in equity prices. Philips is a shareholder in some publicly listed companies, including Philips Lighting and Corindus Vascular Robotics. As a result, Philips is exposed to potential financial loss through movements in their share prices. The aggregate equity price exposure in such financial assets amounted to approximately EUR 1,313 million at year-end 2017 (2016: EUR 36 million). Philips does not hold derivatives in the above-mentioned listed companies. Philips also has shareholdings in several privately-owned companies amounting to EUR 397 million, mainly consisting of the combined businesses in Lumileds and Automotive. As a result, Philips is exposed to potential value adjustments. Commodity price risk Commodity price risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in commodity prices. Philips is a purchaser of certain base metals, precious metals and energy. Philips may hedge certain commodity price risks using derivative instruments to minimize significant, unanticipated earnings fluctuations caused by commodity price volatility. The commodity price derivatives that Philips may enter into are accounted for as cash flow hedges to offset forecasted purchases. As of December 2017, Philips does not have any outstanding commodity derivatives. As of December 2016, Philips did not have any outstanding commodity derivatives. Credit risk Credit risk represents the loss that would be recognized at the reporting date, if counterparties failed completely to perform their payment obligations as contracted. Credit risk is present within Philips trade receivables. To have better insights into the credit exposures, Philips performs ongoing evaluations of the financial and non-financial condition of its customers and adjusts credit limits when appropriate. In instances where the creditworthiness of a customer is determined not to be sufficient to grant the credit limit required, there are a number of mitigation tools that can be utilized to close the gap, including reducing payment terms, cash on delivery, pre-payments and pledges on assets. Philips invests available cash and cash equivalents with various financial institutions and is exposed to credit risk with these counterparties. Philips is also exposed to credit risks in the event of non-performance by financial institutions with respect to financial derivative instruments. Philips actively manages concentration risk and on a daily basis measures the potential loss under certain stress scenarios, should a financial institution default. These worst-case scenario losses are monitored and limited by the Company. The Company does not enter into any financial derivative instruments to protect against default by financial institutions. However, where possible the Company requires all financial institutions with which it deals in derivative transactions to complete legally enforceable netting agreements under an International Swap Dealers Association master agreement or otherwise prior to trading, and whenever possible, to have a strong credit rating from Fitch and Standard & Poor’s Investor Services. Philips also regularly monitors the development of the credit risk of its financial counterparties. Wherever possible, cash is invested and financial transactions are concluded with financial institutions with strong credit ratings or with governments or government-backed institutions. The table below shows the number of financial institutions with credit rating A- and above with which Philips has cash at hand and short-term deposits above EUR 10 million as of December 31, 2017. Philips Group Credit risk with number of counterparties for deposits above EUR 10 million 2017 10-100 million 100-500 million AA- rated bank counterparties 2 A+ rated bank counterparties 2 A rated bank counterparties 1 3 A- rated bank counterparties 1 1 8 For an overview of the overall maximum credit exposure of the group’s financial assets, please refer to Fair value of financial assets and liabilities Country risk Country risk is the risk that political, legal, or economic developments in a single country could adversely impact our performance. The country risk per country is defined as the sum of the equity of all subsidiaries and associated companies in country cross-border transactions, such as intercompany loans, accounts receivable from third parties and intercompany accounts receivable. The country risk is monitored on a regular basis. As of December 31, 2017, the Company had country risk exposure of EUR 9.3 billion in the United States, EUR 4.4 billion in the Netherlands and EUR 1.3 billion in China (including Hong Kong). Other countries higher than EUR 500 million are Japan (EUR 598 million) and the United Kingdom (EUR 534 million). Germany exceeded EUR 300 million but was less than EUR 500 million. The degree of risk of a country is taken into account when new investments are considered. The Company does not, however, use financial derivative instruments to hedge country risk. Other insurable risks Philips is covered for a broad range of losses by global insurance policies in the areas of property damage/business interruption, general and product liability, transport, directors’ and officers’ liability, employment practice liability, crime and cyber security. The counterparty risk related to the insurance companies participating in the above-mentioned global insurance policies is actively managed. As a rule, Philips only selects insurance companies with an S&P credit rating of at least A-. Throughout the year the counterparty risk is monitored on a regular basis. To lower exposures and to avoid potential losses, Philips has a global Risk Engineering program in place. The main focus of this program is on property damage and business interruption risks including company interdependencies. Regular on-site assessments take place at Philips locations and business-critical suppliers by risk engineers of the insurer in order to provide an accurate assessment of the potential loss and its impact. The results of these assessments are shared across the Company’s stakeholders. On-site assessments are carried out against the predefined Risk Engineering standards, which are agreed between Philips and the insurers. Recommendations are made in a Risk Improvement report and are monitored centrally. This is the basis for decision-making by the local management of the business as to which recommendations will be implemented. For all policies, deductibles are in place, which vary from EUR 0.25 million to EUR 5 million per occurrence and this variance is designed to differentiate between the existing risk categories within Philips. Above this first layer of working deductibles, Philips operates its own re-insurance captive, which during 2017 retained EUR 2.5 million per occurrence for property damage and business interruption losses and EUR 5 million in the aggregate per year. For general and product liability claims, the captive retained EUR 1.5 million per claim and EUR 6 million in the aggregate. New contracts were signed on December 31, 2017, for the coming year, whereby the re-insurance captive retentions changed. Property damage and business interruption insurance is no longer re-insured by the captive and the captive retention for general, product and cyber liability claims is set at EUR 5 million per occurrence and EUR 10 million in the annual aggregate.

Subsequent events

Subsequent events	12 Months Ended
	Dec. 31, 2017
Disclosure of subsequent events [Abstract]
Disclosure of subsequent events [Text block]	Table of Contents Note There are no significant subsequent events which require disclosure.

Significant accounting polici38

Significant accounting policies (Policies)	12 Months Ended
	Dec. 31, 2017
Disclosure of significant accounting policies [Abstract]
Statement of IFRS compliance [Text block]	All standards and interpretations issued by the International Accounting Standards Board (IASB) and the IFRS Interpretations Committee effective 2017 have been endorsed by the EU; consequently, the accounting policies applied by Koninklijke Philips N.V. (hereafter: the ‘Company’ or ‘Philips’) also comply with IFRS as issued by the IASB. These accounting policies have been applied by group entities.
Description of presentation currency [Text block]	The Consolidated financial statements are presented in euros, which is the presentation currency. Due to rounding, amounts may not add up precisely to totals provided.
Disclosure of accounting judgements and estimates [Text block]	Use of estimates The preparation of the Consolidated financial statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. These estimates inherently contain a degree of uncertainty. Actual results may differ from these estimates under different assumptions or conditions. In the process of applying the accounting policies, management has made estimates and assumptions concerning the future and other key sources of estimation uncertainty at the reporting date that have a significant risk of causing a material adjustment to the reported amounts of assets and liabilities within the next financial year, as well as to the disclosure of contingent liabilities at the date of the Consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company evaluates these estimates and judgments on an ongoing basis and bases the estimates on historical experience, current and expected future outcomes, third-party evaluations and various other assumptions that Philips believes are reasonable under the circumstances. Existing circumstances and assumptions about future developments may change due to circumstances beyond the Company’s control and are reflected in the assumptions if and when they occur. The results of these estimates form the basis for making judgments about the carrying values of assets and liabilities as well as identifying and assessing the accounting treatment with respect to commitments and contingencies. The Company revises material estimates if changes occur in the circumstances or there is new information or experience on which an estimate was or can be based. The areas where the most significant judgments and estimates are made are goodwill, deferred tax asset recoverability including assessment on valuation adjustment following the enactment of the US Tax Cuts and Jobs Act in December 2017, impairments, financial instruments, the accounting for an arrangement containing a lease, revenue recognition (multiple element arrangements), tax risks and other contingencies, assessment of control (including ‘de facto’ control of Philips Lighting), classification of assets and liabilities held for sale and the presentation of items of profit and loss and cash flows as continued or discontinued, as well as when determining the fair values of acquired identifiable intangible assets and investments based on an assessment of future cash flows. For further discussion on these significant judgements and estimates, reference is made to the respective notes within these Consolidated financial statements that relate to the above topics. Further judgment is applied when analyzing impairments of goodwill and intangible assets not yet ready for use that are performed annually and whenever a triggering event has occurred to determine whether the carrying value exceeds the recoverable amount. These analyses are generally based on estimates of future cash flows. Furthermore, the Company applies judgment when actuarial assumptions are established to anticipate future events that are used in calculating post-employment benefit expenses and liabilities. These factors include assumptions with respect to interest rates, rates of increase in healthcare costs, rates of future compensation increases, turnover rates and life expectancy.
Disclosure of reclassifications or changes in presentation [Text block]	Changes 2015 and 2016 Accounting policies have been applied consistently for all periods presented in these consolidated financial statements, except for the items mentioned below. In addition, certain prior-year amounts have been reclassified to conform to the current year presentation. Changes processed in 2017 affecting 2016 and 2015 Tax adjustments Two tax related adjustments were identified in 2017, relating to tax expense understatements for years prior to 2016. These adjustments affected the previously issued financial statements for a number of years up to and until December 31, 2015, including an impact on net income of EUR 20 million in 2015 and EUR 55 million to opening retained earnings in 2016. If these adjustments had been processed in 2017, the impact would have been material for 2017 and as such the adjustments were processed in 2015 and 2016, since it was concluded that the year-by-year understatements were immaterial for the years up to and including 2016. Change in Balance Sheet presentation Philips has changed the presentation of the Consolidated balance sheets by removing certain disaggregated line items and sub-totals, not affecting the totals presented. Since this information is already included in the relevant notes to the Consolidated financial statements, the line items have been removed to improve readability. Change in Investments in associates presentation In order to improve comparability and keep consistency with peer practice, Philips has changed the presentation of the line item Investments in associates and moved it into the subtotal Income before taxes in the Consolidated statements of income. This change did not impact the results of operations or financial position. Change in Cash Flows presentation IFRS 5 Non-current Assets Held for Sale and Discontinued Operations requires that the net cash flows attributable to the operating, investing and financing activities of discontinued operations are disclosed in the Consolidated financial statements of Philips. These disclosures may be presented either in the Consolidated statements of cash flows or in the notes to the Consolidated financial statements. In order to improve readability and enhance the focus of the cash flow statement on the HealthTech cash flows, in 2017 Philips made the policy choice to disclose the net cash provided by (used for) discontinued operations as one line in the Consolidated statements of cash flows. The breakdown of the operating, investing and financing cash flow activities included in Discontinued operations and assets classified as held for sale Changes processed in 2016 affecting 2015 Change in Segment reporting In 2016, Philips established two stand-alone companies focused on the HealthTech and Lighting opportunities. As part of this separation, Philips changed the way it allocated resources and analyzes its performance based on the revised segment structure. Accordingly, from 2016 the operational reportable segments for the purpose of the disclosures required by IFRS 8 Operating Segments were Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses and Lighting, each being responsible for the management of its business worldwide. Additionally, HealthTech Other and Legacy Items are included in Information by segment and main country Goodwill Consequential changes to comparative segment disclosures were processed in Other assets Receivables Provisions Information by segment and main country
Specific choices within IFRS [Text block]	Specific choices within IFRS In certain instances IFRS allows alternative accounting treatments for measurement and/or disclosure. Philips has adopted one of the treatments as appropriate to the circumstances of the Company. The most important of these alternative treatments are mentioned below.
Tangible and intangible fixed assets [Text block]	Tangible and intangible fixed assets Under IFRS, an entity shall choose either the cost model or the revaluation model as its accounting for tangible and intangible fixed assets. In this respect, items of property, plant and equipment are measured at cost less accumulated depreciation and accumulated impairment losses. The useful lives and residual values are evaluated annually. Furthermore, the Company chose to apply the cost model, meaning that costs relating to product development, the development and purchase of software for internal use and other intangible assets are capitalized and subsequently amortized over the estimated useful life. Further information on Tangible and Intangible fixed assets can be found in Property, plant and equipment Intangible assets excluding goodwill
Revenue recognition [Text block]	Revenue recognition Revenue from the sale of goods in the course of the ordinary activities is measured at the fair value of the consideration received or receivable, net of returns, trade discounts and volume rebates. Revenue for sale of goods is recognized when the significant risks and rewards of ownership have been transferred to the buyer, recovery of the consideration is probable, the associated costs and possible return of the goods can be estimated reliably, there is no continuing involvement with goods, and the amount of revenue can be measured reliably. If it is probable that discounts will be granted and the amount can be measured reliably, then the discount is recognized as a reduction of revenue as the sales are recognized. Transfer of risks and rewards varies depending on the individual terms of the contract of sale. For consumer-type products in the segment of Personal Health businesses these criteria are met at the time the product is shipped and delivered to the customer and title and risk have passed to the customer (depending on the delivery conditions) and acceptance of the product has been obtained. Examples of delivery conditions are ‘Free on Board point of delivery’ and ‘Costs, Insurance Paid point of delivery’, where the point of delivery may be the shipping warehouse or any other point of destination as agreed in the contract with the customer and where title and risk for the goods pass to the customer. Revenues of transactions that have separately identifiable components are recognized based on their relative fair values. These transactions mainly occur in the segments Diagnosis & Treatment businesses and Connected Care & Health Informatics businesses and include arrangements that require subsequent installation and training activities in order to become operable for the customer. Revenue recognition is deferred until the installation has been completed and the product is ready to be used by the customer in the way contractually agreed. Revenues are recorded net of sales taxes, customer discounts, rebates and similar charges. For products for which a right of return exists during a defined period, revenue recognition is determined based on the historical pattern of actual returns, or in cases where such information is not available, revenue recognition is postponed until the return period has lapsed. Return policies are typically based on customary return arrangements in local markets. In the case of loss under a sales agreement, the loss is recognized immediately. Expenses incurred for shipping and handling of internal movements of goods are recorded as cost of sales. Shipping and handling related to sales to third parties are recorded as selling expenses. When shipping and handling is part of a project and billed to the customer, then the related expenses are recorded as cost of sales. Shipping and handling billed to customers is recognized as revenues. Service revenue related to repair and maintenance activities for goods sold is recognized ratably over the service period or as services are rendered. A provision for product warranty is made at the time of revenue recognition and reflects the estimated costs of replacement and free-of-charge services that will be incurred by the Company with respect to the products. For certain products, the customer has the option to purchase an extension of the warranty, which is subsequently billed to the customer. Revenue recognition occurs on a straight-line basis over the extended warranty contract period. Revenue from services is recognized when the Company can reliably measure the amount of revenue and the associated cost related to the stage of completion of a contract or transaction, and the recovery of the consideration is considered probable. Royalty income from intellectual property rights, which is generally earned based upon a percentage of sales or a fixed amount per product sold, is recognized on an accrual basis based on actual or reliably estimated sales made by a licensee. Royalty income from an agreement with lump-sum consideration is recognized on accrual basis based on the contractual terms and substance of the relevant agreement with a licensee. Grants from governments are recognized at their fair value where there is a reasonable assurance that the grant will be received and the Company will comply with all attached conditions. Government grants relating to costs are deferred and recognized in the Statement of income as a reduction of the related costs over the period necessary to match them with the costs that they are intended to compensate. Grants related to assets are deducted from the cost of the asset and presented net in the Consolidated balance sheets
Income taxes [Text block]	Income taxes Income taxes comprises current and deferred tax. Income tax is recognized in the Statement of income except to the extent that it relates to items recognized directly within equity or in other comprehensive income. Current tax is the expected taxes payable on the taxable income for the year, using tax rates enacted or substantively enacted at the reporting date, and any adjustment to tax payable in respect of previous years. Tax liabilities are recognized when it is considered probable that there will be a future outflow of funds to a taxing authority. In such cases, provision is made for the amount that is expected to be settled, where this can be reasonably estimated. This assessment relies on estimates and assumptions and may involve a series of judgments about future events. New information may become available that causes the Company to change its judgment regarding the adequacy of existing tax liabilities. Such changes to tax liabilities will impact the income tax expense in the period that such a determination is made. Deferred tax assets and liabilities are recognized, using the balance sheet method, for the expected tax consequences of temporary differences between the carrying amounts of assets and liabilities and the amounts used for taxation purposes. Deferred tax is not recognized for the following temporary differences: the initial recognition of goodwill; the initial recognition of assets and liabilities in a transaction that is not a business combination and that affects neither accounting nor taxable profit; and differences relating to investments in subsidiaries, joint ventures and associates where the reversal of the respective temporary difference can be controlled by the Company and it is probable that it will not reverse in the foreseeable future. Deferred taxes are measured at the tax rates that are expected to be applied to temporary differences when they reverse, based on the laws that have been enacted or substantively enacted by the reporting date. Deferred tax assets and liabilities are offset if there is a legally enforceable right to offset current tax liabilities and assets, and they relate to income taxes levied by the same tax authority on the same taxable entity or on different taxable entities, but they intend to settle current tax liabilities and assets on a net basis or their tax assets and liabilities will be realized simultaneously. A deferred tax asset is recognized for unused tax losses, tax credits and deductible temporary differences, to the extent that it is probable that future taxable profits will be available against which they can be utilized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income in the countries where the deferred tax assets originated and during the periods when the deferred tax assets become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. Deferred tax liabilities for withholding taxes are recognized for subsidiaries in situations where the income is to be paid out as dividend in the foreseeable future and for undistributed earnings of unconsolidated companies to the extent that these withholding taxes are not expected to be refundable or deductible. Changes in tax rates and tax laws are reflected in the period when the change has been enacted or substantively enacted by the reporting date. Any subsequent adjustment to a tax asset or liability that originated in discontinued operations, due to a change in the tax base or its measurement, is allocated to discontinued operations (i.e. backwards tracing). Examples are a tax rate change or change in retained assets or liabilities directly relating to the discontinued operation. Any subsequent change to the recognition of deferred tax assets is allocated to the component in which the taxable gain is or will be recognized. The above principles are applied to the extent the ‘discontinued operations’ is sufficiently separable from continuing operations. Further information on income tax can be found in Income taxes
Provisions [Text block]	Provisions Provisions are recognized if, as a result of a past event, the Company has a present legal or constructive obligation, the amount can be estimated reliably, and it is probable that an outflow of economic benefits will be required to settle the obligation. Provisions are measured at the present value of the expenditures expected to be required to settle the obligation using a pre-tax discount rate that reflects current market assessments of the time value of money. The increase in the provision due to passage of time is recognized as interest expense. The accounting and presentation for some of the Company’s provisions is as follows: Product warranty – A provision for warranties is recognized when the underlying products or services are sold. The provision is based on historical warranty data and a weighing of possible outcomes against their associated probabilities. Environmental provisions – Measurement of liabilities associated with environmental obligations is based on current legal and constructive requirements. Liabilities and expected insurance recoveries, if any, are recorded separately. The carrying amount of environmental liabilities is regularly reviewed and adjusted for new facts and changes in law. Restructuring-related provisions – The provision for restructuring mainly relates to the estimated costs of initiated restructurings, the most significant of which have been approved by the Executive Committee, and which generally involve the realignment of certain parts of the industrial and commercial organization. When such restructurings require discontinuance and/or closure of lines of activities, the anticipated costs of closure or discontinuance are included in restructuring provisions. A liability is recognized for those costs only when the Company has a detailed formal plan for the restructuring and has raised a valid expectation with those affected that it will carry out the restructuring by starting to implement that plan or announcing its main features to those affected by it. Before a provision is established, the Company recognizes any impairment loss on the assets associated with the restructuring. Litigation provisions – In relation to legal claim provisions and settlements, the relevant balances are transferred to Other liabilities at the point the amount and timing of cash outflows are no longer uncertain. Settlements which are agreed for amounts in excess of existing provisions are reflected as increases of Other liabilities. Further information on provisions can be found in Provisions
Goodwill [Text block]	Goodwill The measurement of goodwill at initial recognition is described under Basis of consolidation note. Goodwill is subsequently measured at cost less accumulated impairment losses. Further information on goodwill can also be found in Goodwill
Intangible assets other than goodwill [Text block]	Intangible assets other than goodwill Acquired finite-lived intangible assets are amortized using the straight-line method over their estimated useful life. The useful lives are evaluated annually. Intangible assets are initially capitalized at cost, with the exception of intangible assets acquired as part of a business combination, which are capitalized at their acquisition date fair value. The Company expenses all research costs as incurred. Expenditure on development activities, whereby research findings are applied to a plan or design for the production of new or substantially improved products and processes, is capitalized as an intangible asset if the product or process is technically and commercially feasible, the Company has sufficient resources and the intention to complete development and can measure the attributable expenditure reliably. The capitalized development expenditure comprises of all directly attributable costs (including the cost of materials and direct labor). Other development expenditures and expenditures on research activities are recognized in the Statement of income. Capitalized development expenditure is stated at cost less accumulated amortization and impairment losses. Amortization of capitalized development expenditure is charged to the Statement of income on a straight-line basis over the estimated useful lives of the intangible assets. Further information on intangible assets other than goodwill can be found in Intangible assets excluding goodwill
Discontinued operations and non-current assets held for sale [Text block]	Discontinued operations and non-current assets held for sale Non-current assets and disposal groups comprising assets and liabilities that are expected to be recovered primarily through sale rather than through continuing use are classified as held for sale. Non-current assets classified as held for sale and the assets of a disposal group classified as held for sale are presented separately from the other assets in the balance sheet. The liabilities of a disposal group classified as held for sale are presented separately from other liabilities in the balance sheet. A discontinued operation is a component of an entity that either has been disposed of, or is classified as held for sale, and represents a separate major line of business or geographical area of operations; is a part of a single coordinated plan to dispose of a separate major line of business or geographical area of operations; or is a subsidiary acquired exclusively with a view to sell. In case a discontinued operation is sold in stages as part of a single coordinated plan until completely sold, then the Investment in associate that is recognized upon sale of a portion that results in Philips having significant influence in the operation (rather than control), is continued to be treated as discontinued operation provided that the held for sale criteria are met. Non-current assets held for sale and discontinued operations are carried at the lower of carrying amount or fair value less cost of disposal. Any gain or loss from disposal, together with the results of these operations until the date of disposal, is reported separately as discontinued operations. The financial information of discontinued operations is excluded from the respective captions in the Consolidated financial statements and related notes for all periods presented. Comparatives in the balance sheet are not represented when a non-current asset or disposal group is classified as held for sale. Comparatives are represented for presentation of discontinued operations in the Statement of cash flow and Statement of income. Adjustments in the current period to amounts previously presented in discontinued operations that are directly related to the disposal of a discontinued operation in a prior period are classified separately in Discontinued operations. Circumstances to which these adjustments may relate include resolution of uncertainties that arise from the terms of the disposal transaction, such as the resolution of purchase price adjustments and indemnifications, resolution of uncertainties that arise from and are directly related to the operations of the component before its disposal, such as environmental and product warranty obligations retained by the Company, or the settlement of employee benefit plan obligations provided that the settlement is directly related to the disposal transaction. Further information on discontinued operations and non-current assets held for sale can be found in Discontinued operations and assets classified as held for sale
Impairment of non-financial assets [Text block]	Impairment of goodwill and intangible assets not yet ready for use Goodwill and intangible assets not yet ready for use are not amortized but tested for impairment annually and whenever impairment indicators require. In case of goodwill and intangible assets not yet ready for use, either internal or external sources of information are considered indicators that an asset or a CGU may be impaired. In most cases the Company identified its cash-generating units for goodwill at one level below that of an operating segment. Cash flows at this level are substantially independent from other cash flows and this is the lowest level at which goodwill is monitored by the Executive Committee. In 2017 the Company performed and completed goodwill annual impairment tests in the fourth quarter, in line with 2016. In prior year, the Company also performed goodwill annual impairment tests in the second quarter, which was in line with 2015. An impairment loss is recognized in the Statement of income whenever and to the extent that the carrying amount of a cash-generating unit exceeds the unit’s recoverable amount, which is the greater of its value in use and fair value less cost of disposal. Value in use is measured as the present value of future cash flows expected to be generated by the asset. Fair value less cost of disposal is measured as the amount obtained from a sale of an asset in an arm’s length transaction, less costs of disposal. Further information on impairment of goodwill and intangible assets not yet ready for use can be found in Goodwill Intangible assets excluding goodwill Impairment of non-financial assets other than goodwill, intangible assets not yet ready for use, inventories and deferred tax assets Non-financial assets other than goodwill, intangible assets not yet ready for use, inventories and deferred tax assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is assessed by a comparison of the carrying amount of an asset with the greater of its value in use and fair value less cost of disposal. Value in use is measured as the present value of future cash flows expected to be generated by the asset. Fair value less cost of disposal is measured as the amount obtained from a sale of an asset in an arm’s length transaction, less costs of disposal. If the carrying amount of an asset is deemed not recoverable, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the recoverable amount. The review for impairment is carried out at the level where cash flows occur that are independent of other cash flows. Impairment losses recognized in prior periods are assessed at each reporting date for any indications that the loss has decreased or no longer exists. An impairment loss is reversed if and to the extent there has been a change in the estimates used to determine the recoverable amount. The loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized. Reversals of impairment are recognized in the Consolidated statements of income
Impairment of financial assets [Text block]	Impairment of financial assets A financial asset is considered to be impaired if objective evidence indicates that one or more events have had a negative effect on the estimated future cash flows of that asset. In the case of available-for-sale financial assets, a significant or prolonged decline in the fair value of the financial asset below its cost is considered an indicator that the financial assets are impaired. If any such evidence exists for available-for sale financial assets, the cumulative loss - measured as the difference between the acquisition cost and the current fair value, less any impairment loss on that financial asset previously recognized in the Statement of income - is reclassified from the fair value reserve in equity (through Other comprehensive income) to the Statement of income. If objective evidence indicates that financial assets that are carried at cost, such as loans and receivables, need to be tested for impairment, calculations are based on information derived from business plans and other information available for estimating their fair value, which is based on estimated future cash flows discounted at the asset’s original effective interest rate. Any impairment loss is charged to the Statement of income. An impairment loss related to financial assets is reversed if in a subsequent period the fair value increases and the increase can be related objectively to an event occurring after the impairment loss was recognized. The loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined if no impairment loss had been recognized. Reversals of impairment are recognized in the Statement of income except for reversals of impairment of available-for-sale equity securities, which are recognized in Other comprehensive income. Further information on financial assets can be found in Other financial assets
Basis of consolidation [Text block]	Basis of consolidation The Consolidated financial statements comprise the financial statements of Koninklijke Philips N.V. and all subsidiaries that the Company controls, i.e. when it is exposed, or has rights, to variable returns from its involvement with the investee and has the ability to affect those returns through its power over the investee. Generally, there is a presumption that a majority of voting rights results in control. To support this presumption and when Philips has less than a majority of the voting or similar rights of an investee, Philips considers all relevant facts and circumstances in assessing whether it has power over an investee, including the contractual arrangement(s) with the other vote holders of the investee, rights arising from other contractual arrangements and the Company’s voting rights and potential voting rights. Subsidiaries are fully consolidated from the date that control commences until the date that control ceases. All intercompany balances and transactions have been eliminated in the Consolidated financial statements. Unrealized losses are eliminated in the same way as unrealized gains, but only to the extent that there is no evidence of impairment.
Loss of control [Text block]	Loss of control Upon the loss of control, the Company derecognizes the assets and liabilities of the subsidiary, any non-controlling interests and the other components of equity related to the subsidiary. Any surplus or deficit arising on the loss of control is recognized in the Statement of income. If the Company retains any interest in the previous subsidiary, then such interest is measured at fair value at the date the control is lost. Subsequently it is accounted for as either an equity accounted investee (associate) or as an available-for-sale financial asset, depending on the level of influence retained. Further information on loss of control can be found in Discontinued operations and assets classified as held for sale
Business combinations [Text block]	Business combinations Business combinations are accounted for using the acquisition method. Under the acquisition method, the identifiable assets acquired, liabilities assumed and any non-controlling interest in the acquiree are recognized at the acquisition date, which is the date on which control is transferred to the Company. The Company measures goodwill at the acquisition date as: the fair value of the consideration transferred; plus the recognized amount of any non-controlling interest in the acquiree; plus if the business combination is achieved in stages, the fair value of the existing equity interest in the acquiree; less the net recognized amount (generally fair value) of the identifiable assets acquired and liabilities assumed. Costs related to the acquisition, other than those associated with the issue of debt or equity securities, that the Company incurs are expensed as incurred. Any contingent consideration payable is recognized at fair value at the acquisition date and initially is presented in Long-term provisions. When the timing and amount of the consideration become more certain, it is reclassified to Accrued liabilities. If the contingent consideration that meets the definition of a financial instrument is classified as equity, it is not remeasured and settlement is accounted for within equity. Otherwise, subsequent changes to the fair value of the contingent consideration are recognized in the Statement of income. Non-controlling interests are measured at their proportionate share of the acquiree’s identifiable net assets at the date of acquisition. Further information on business combinations can be found in Acquisitions and divestments
Investment in associates (equity-accounted investees) [Text block]	Investments in associates (equity-accounted investees) Associates are all entities over which the Company has significant influence, but no control. Significant influence is presumed with a shareholding of between 20% and 50% of the voting rights. Investments in associates are accounted for using the equity method of accounting and are initially recognized at cost. The carrying amount of an investment includes the carrying amount of goodwill identified on acquisition. An impairment loss on such investment is allocated to the investment as a whole. The Company’s share of the net income of these companies is included in Investments in associates, net of income taxes in the Statement of income, after adjustments to align the accounting policies with those of the Company, from the date that significant influence commences until the date that significant influence ceases. Dilution gains and losses arising from investments in associates are recognized in the Statement of income as part of Investments in associates, net of income taxes. When the Company’s share of losses exceeds its interest in an associate, the carrying amount of that interest (including any long-term loans) is reduced to zero and recognition of further losses is discontinued except to the extent that the Company has incurred legal or constructive obligations or made payments on behalf of the associate. Unrealized gains on transactions between the Company and its associates are eliminated to the extent of the Company’s interest in the associates. Unrealized losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred. Remeasurement differences of an equity stake resulting from gaining control over the investee previously recorded as associate are recorded under Investments in associates. Further information on investments in associates can be found in Interests in entities
Acquisitions of and adjustments to non-controlling interests [Text block]	Acquisitions of and adjustments to non-controlling interests Acquisitions of non-controlling interests are accounted for as transactions with owners in their capacity as owners and therefore no goodwill is recognized. Adjustments to non-controlling interests arising from transactions that do not involve the loss of control are based on a proportionate amount of the net assets of the subsidiary.
Foreign currencies [Text block]	Foreign currencies Foreign currency transactions The financial statements of all group entities are measured using the currency of the primary economic environment in which the entity operates (functional currency). The euro (EUR) is the functional currency of the Company and presentation currency of the Group financial statements. Foreign currency transactions are translated into the functional currency using the exchange rates prevailing at the dates of the transactions or valuation where items are remeasured. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at year-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognized in the Statement of income, except when deferred in Other comprehensive income as qualifying cash flow hedges and qualifying net investment hedges. Foreign currency differences arising from translations are recognized in the Statement of income, except for available-for-sale equity investments which are recognized in Other comprehensive income. If there is an impairment which results in foreign currency differences being recognized, then these differences are reclassified from Other comprehensive income to the Statement of income. All exchange difference items are presented as part of Cost of sales, with the exception of tax items and financial income and expense, which are recognized in the same line item as they relate to in the Statement of income. Non-monetary assets and liabilities denominated in foreign currencies that are measured at fair value are retranslated to the functional currency using the exchange rate at the date the fair value was determined. Non-monetary items in a foreign currency that are measured based on historical cost are translated using the exchange rate at the transaction date. Foreign operations The assets and liabilities of foreign operations, including goodwill and fair value adjustments arising on acquisition, are translated to euros at exchange rates at the reporting date. The income and expenses of foreign operations are translated to euros at exchange rates at the dates of the transactions. Foreign currency differences arising on translation of foreign operations into euros are recognized in Other comprehensive income, and presented as part of Currency translation differences in Equity. However, if the operation is a non-wholly owned subsidiary, then the relevant proportionate share of the translation difference is allocated to Non-controlling interests. When a foreign operation is disposed of such that control, significant influence or joint control is lost, the cumulative amount in the Currency translation differences related to the foreign operation is reclassified to the Statement of income as part of the gain or loss on disposal. When the Company disposes of only part of its interest in a subsidiary that includes a foreign operation while retaining control, the respective proportion of the cumulative amount is reattributed to Non-controlling interests. When the Company disposes of only part of its investment in an associate or joint venture that includes a foreign operation while retaining significant influence or joint control, the relevant proportion of the cumulative amount is reclassified to the Statement of income.
Financial instruments [Text block]	Financial instruments Non-derivative financial instruments Non-derivative financial instruments are recognized initially at fair value when the Company becomes a party to the contractual provisions of the instrument. Purchases and sales of financial assets in the normal course of business are accounted for at the trade date. Dividend and interest income are recognized when earned. Gains or losses, if any, are recorded in Financial income and expense. Non-derivative financial instruments comprise cash and cash equivalents, receivables, other non-current financial assets, debt and other financial liabilities that are not designated as hedges. Cash and cash equivalents Cash and cash equivalents include all cash balances, money market funds and short-term highly liquid investments with an original maturity of three months or less that are readily convertible into known amounts of cash. Further information on cash and cash equivalents can be found in Cash flow statement supplementary information Receivables Receivables are carried at the lower of amortized cost or the present value of estimated future cash flows, taking into account discounts given or agreed. The present value of estimated future cash flows is determined through the use of value adjustments for uncollectible amounts. As soon as individual trade accounts receivable can no longer be collected in the normal way and are expected to result in a loss, they are designated as doubtful trade accounts receivable and valued at the expected collectible amounts. They are written off when they are deemed to be uncollectible because of bankruptcy or other forms of receivership of the debtors. The allowance for the risk of non-collection of trade accounts receivable takes into account credit-risk concentration, collective debt risk based on average historical losses, and specific circumstances such as serious adverse economic conditions in a specific country or region. The Company derecognizes receivables on entering into factoring transactions if the Company has transferred substantially all risks and rewards or if Philips does not retain control over receivables. Further information on receivables can be found in Receivables Other non-current financial assets Other non-current financial assets include held-to-maturity investments, loans receivable and available-for-sale financial assets and financial assets at fair value through profit or loss. Held-to-maturity investments are those debt securities which the Company has the ability and intent to hold until maturity. Held-to-maturity debt investments are recorded at amortized cost, adjusted for the amortization or accretion of premiums or discounts using the effective interest method. Loans receivable are stated at amortized cost, less impairment. Available-for-sale financial assets are non-derivative financial assets that are designated as available-for-sale and that are not classified in any of the other categories of financial assets. Subsequent to initial recognition, they are measured at fair value and changes therein, other than impairment losses and foreign currency differences on available-for-sale debt instruments, are recognized in Other comprehensive income and presented in the fair value reserve in equity. When an investment is derecognized, the gain or loss accumulated in equity is reclassified to the Statement of income. Available-for-sale financial assets including investments in privately-held companies that are not associates, and do not have a quoted market price in an active market and whose fair value could not be reliably determined, are carried at cost. A financial asset is classified as fair value through profit or loss if it is classified as held for trading or is designated as such upon initial recognition. Financial assets are designated as fair value through profit or loss if the Company manages such investments and makes purchase and sale decisions based on their fair value in accordance with the Company’s documented risk management or investment strategy. Financial assets at fair value through profit or loss are measured at fair value, and changes therein are recognized in the Statement of income. Attributable transaction costs are recognized in the Statement of income as incurred. Further information on other non-current financial assets can be found in Other financial assets Derivative financial instruments, including hedge accounting The Company uses derivative financial instruments principally to manage its foreign currency risks and, to a more limited extent, for managing interest rate and commodity price risks. All derivative financial instruments are accounted for at the trade date and classified as current or non-current assets or liabilities based on the maturity date or the earlier termination date. Embedded derivatives are separated from the host contract and accounted for separately if the economic characteristics and risks of the host contract and the embedded derivative are not closely related. The Company measures all derivative financial instruments at fair value derived from market prices of the instruments, or calculated as the present value of the estimated future cash flows based on observable interest yield curves, basis spread, credit spreads and foreign exchange rates, or from option pricing models, as appropriate. Gains or losses arising from changes in fair value of derivatives are recognized in the Statement of income, except for derivatives that are highly effective and qualify for cash flow or net investment hedge accounting. Changes in the fair value of a derivative that is highly effective and that is designated and qualifies as a cash flow hedge are recorded in Other comprehensive income until the Statement of income is affected by the variability in cash flows of the designated hedged item. To the extent that the hedge is ineffective, changes in the fair value are recognized in the Statement of income. The Company formally assesses, both at the hedge’s inception and on an ongoing basis, whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in fair values or cash flows of hedged items. When it is established that a derivative is not highly effective as a hedge or that it has ceased to be a highly effective hedge, the Company discontinues hedge accounting prospectively. When hedge accounting is discontinued because it is expected that a forecasted transaction will not occur, the Company continues to carry the derivative on the Balance sheet at its fair value, and gains and losses that were accumulated in Other comprehensive income are recognized immediately in the same line item as they relate to in the Statement of income. Foreign currency differences arising on the retranslation of financial instruments designated as a hedge of a net investment in a foreign operation are recognized directly as a separate component of equity through Other comprehensive income, to the extent that the hedge is effective. To the extent that the hedge is ineffective, such differences are recognized in the Statement of income.
Description of accounting policy for equity [Text block]	Equity Common shares are classified as equity. Incremental costs directly attributable to the issuance of shares are recognized as a deduction from equity. Where the Company purchases the Company’s equity share capital (treasury shares), the consideration paid, including any directly attributable incremental transaction costs (net of income taxes), is deducted from equity attributable to the Company’s equity holders until the shares are cancelled or reissued. Where such ordinary shares are subsequently reissued, any consideration received, net of any directly attributable incremental transaction costs and the related income tax effects, is included in equity attributable to the Company’s equity holders. Call options on own shares are treated as equity instruments. Dividends are recognized as a liability in the period in which they are declared and approved by Shareholders. The income tax consequences of dividends are recognized when a liability to pay the dividend is recognized. Further information on equity can be found in Equity
Debt and other liabilities [Text block]	Debt and other liabilities Debt and liabilities other than provisions are stated at amortized cost.
Offsetting and master netting agreements [Text block]	Offsetting and master netting agreements The Company presents financial assets and financial liabilities on a gross basis as separate line items in the Consolidated balance sheet. Master netting agreements may be entered into when the Company undertakes a number of financial instrument transactions with a single counterparty. Such an agreement provides for a net settlement of all financial instruments covered by the agreement in the event of default or certain termination events on any of the transactions. A master netting agreement may create a right of offset that becomes enforceable and affects the realization or settlement of individual financial assets and financial liabilities only following a specified termination event. However, if this contractual right is subject to certain limitations then it does not necessarily provide a basis for offsetting unless both of the offsetting criteria are met, i.e. there is a legally enforceable right and an intention to settle net or simultaneously.
Property, plant and equipment [Text block]	Property, plant and equipment The costs of property, plant and equipment comprise all directly attributable costs (including the cost of material and direct labor). Depreciation is generally calculated using the straight-line method over the useful life of the asset. Gains and losses on the sale of property, plant and equipment are included in Other Business Income. Costs related to repair and maintenance activities are expensed in the period in which they are incurred unless leading to an extension of the original lifetime or capacity. Plant and equipment under finance leases and leasehold improvements are amortized using the straight-line method over the shorter of the lease term or the estimated useful life of the asset. The gain realized on sale and operating leaseback transactions that are concluded based upon market conditions is recognized at the time of the sale in Other Business Income, in the Consolidated statements of income. Further information on property, plant and equipment can be found in Property, plant and equipment
Leased assets [Text block]	Leased assets Leases in which the Company is the lessee and has substantially all the risks and rewards of ownership are classified as finance leases. Finance leases are capitalized at the commencement of the lease at the lower of the fair value of the leased assets and the present value of the minimum lease payments. Each lease payment is allocated between the liability and finance charges. The interest element of the finance cost is charged to the Statement of income over the lease period so as to produce a constant periodic rate of interest on the remaining balance of the liability for each period. The corresponding rental obligations, net of finance charges, are included in other short-term and other non-current liabilities. The property, plant and equipment acquired under finance leases is depreciated over the shorter of the useful life of the assets and the lease term. Leases in which the Company is the lessee and in which substantially all risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases (net of any incentives received from the lessor) are recognized in the Statement of income on a straight-line basis over the term of the lease.
Inventories [Text block]	Inventories Inventories are stated at the lower of cost or net realizable value. The cost of inventories comprises all costs of purchase, costs of conversion and other costs incurred in bringing the inventories to their present location and condition. The costs of conversion of inventories include direct labor and fixed and variable production overheads, taking into account the stage of completion and the normal capacity of production facilities. Costs of idle facility and abnormal waste are expensed. The cost of inventories is determined using the first-in, first-out (FIFO) method. Inventory is reduced for the estimated losses due to obsolescence. This reduction is determined for groups of products based on sales in the recent past and/or expected future demand. Further information on inventories can be found in Inventories
Employee benefit accounting [Text block]	Employee benefit accounting IFRS does not specify how an entity should present its service costs related to pensions and net interest on the net defined-benefit liability (asset) in the Statement of income. With regards to these elements, the Company presents service costs in Income from operations and the net interest expenses related to defined-benefit plans in Financial expense. Furthermore, when accounting for the settlement of defined-benefit plans the Company made the accounting policy choice to adjust the amount of the plan assets transferred for the effect of the asset ceiling. Further information on employee benefit accounting can be found in Post-employment benefits Employee benefit accounting A defined-contribution plan is a post-employment benefit plan under which an entity pays fixed contributions into a separate entity and will have no legal or constructive obligation to pay further amounts. Obligations for contributions to defined-contribution pension plans are recognized as an employee benefit expense in the Statement of income in the periods during which services are rendered by employees. A defined-benefit plan is a post-employment benefit plan other than a defined-contribution plan. Plans for which the Company has no legal or constructive obligation to pay further amounts, but to which it does pay non-fixed contributions, are also treated as a defined-benefit plan. The net pension asset or liability recognized in the Consolidated balance sheets in respect of defined-benefit post-employment plans is the fair value of plan assets less the present value of the projected defined-benefit obligation at the balance sheet date. The defined-benefit obligation is calculated annually by qualified actuaries using the projected unit credit method. Recognized assets are limited to the present value of any reductions in future contributions or any future refunds. The net pension liability is presented as a long-term provision, no distinction is made for the short-term portion. For the Company’s major plans, a full discount rate curve of high-quality corporate bonds is used to determine the defined-benefit obligation. The curves are based on Towers Watson’s rate methodology which uses data of corporate bonds rated AA or equivalent. For the other plans a single point discount rate is used based on corporate bonds for which there is a deep market and the plan’s maturity. Plans in countries without a deep corporate bond market use a discount rate based on the local sovereign curve and the plan’s maturity. Pension costs in respect of defined-benefit post-employment plans primarily represent the increase of the actuarial present value of the obligation for post-employment benefits based on employee service during the year and the interest on the net recognized asset or liability in respect of employee service in previous years. Remeasurements of the net defined-benefit asset or liability comprise actuarial gains and losses, the return on plan assets (excluding interest) and the effect of the asset ceiling (excluding interest). The Company recognizes all remeasurements in Other comprehensive income. The Company recognizes gains and losses on the settlement of a defined-benefit plan when the settlement occurs. The gain or loss on settlement is the difference between the present value of the defined-benefit obligation being settled, as determined on the date of settlement, and the settlement price, including any plan assets transferred and any payments made directly by the Company in connection with the settlement. In this respect, the amount of the plan assets transferred is adjusted for the effect of the asset ceiling. Past service costs following from the introduction of a change to the benefit payable under a plan or a significant reduction of the number of employees covered by a plan (curtailment), are recognized in full in the Statement of income. Further information on post-employment benefit accounting can be found in Post-employment benefits Short-term employee benefit obligations are measured on an undiscounted basis and are expensed as the related service is provided. The Company recognizes a liability and an expense for bonuses and incentives based on a formula that takes into consideration the profit attributable to the Company’s shareholders after certain adjustments. The Company’s net obligation in respect of long-term employee benefits is the amount of future benefit that employees have earned in return for their service in the current and prior periods, such as jubilee entitlements. That benefit is discounted to determine its present value. Remeasurements are recognized in the Statement of income in the period in which they arise. Further information on other employee benefits can be found in Provisions
Share-based payment [Text block]	Share-based payment Equity-settled transactions The cost of equity-settled transactions is determined by the fair value at the date when the grant is made using an appropriate valuation model, further details of which are given in Share-based compensation The grant-date fair value of equity-settled share-based payment awards granted to employees is recognized as personnel expense, with a corresponding increase in equity, over the vesting period of the award. The cumulative expense recognized for equity-settled transactions at each reporting date until the vesting date reflects the extent to which the vesting period has expired and the Company’s best estimate of the number of equity instruments that will ultimately vest. The expense or credit in the statement of profit or loss for a period represents the movement in cumulative expense recognized as at the beginning and end of that period. Service and non-market performance conditions are not taken into account when determining the grant-date fair value of awards, but the likelihood of the conditions being met is assessed as part of the Company’s best estimate of the number of equity instruments that will ultimately vest. Market performance conditions are reflected within the grant-date fair value. No expense is recognized for awards that do not ultimately vest because non-market performance and/or service conditions have not been met. When an award is cancelled by the entity or by the counterparty, any remaining element of the fair value of the award is expensed immediately through profit or loss. The dilutive effect of outstanding options and shares is reflected as additional share dilution in the computation of diluted earnings per share (further details are given in Earnings per share
Financial income and expenses [Text block]	Financial income and expenses Financial income comprises interest income on funds invested (including available-for-sale financial assets), dividend income, net gains on the disposal of available-for-sale financial assets, net fair value gains on financial assets at fair value through profit or loss, net gains on the remeasurement to fair value of any preexisting available-for-sale interest in an acquiree, and net gains on foreign exchange impacts that are recognized in the Statement of income. Interest income is recognized on accrual basis in the Statement of income, using the effective interest method. Dividend income is recognized in the Statement of income on the date that the Company’s right to receive payment is established, which in the case of quoted securities is normally the ex-dividend date. Financial expenses comprise interest expenses on borrowings, unwinding of the discount on provisions and contingent consideration, losses on disposal of available-for-sale financial assets, net fair value losses on financial assets at fair value through profit or loss, impairment losses recognized on financial assets (other than trade receivables), net interest expenses related to defined-benefit plans and net losses on foreign exchange impacts that are recognized in the Statement of income. Further information on financial income and expenses can be found in Financial income and expenses
Financial guarantees [Text block]	Financial guarantees The Company recognizes a liability at the fair value of the obligation at the inception of a financial guarantee contract if it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation. The guarantee is subsequently measured at the higher of the best estimate of the obligation or the amount initially recognized less, when appropriate, cumulative amortization.
Cash flow statements [Text block]	Cash flow statements Under IFRS, an entity shall report cash flows from operating activities using either the direct method (whereby major classes of gross cash receipts and gross cash payments are disclosed) or the indirect method (whereby profit or loss is adjusted for the effects of transactions of a non-cash nature, any deferrals or accruals of past or future operating cash receipts or payments, and items of income or expense associated with investing or financing cash flows). In this respect, the Company chose to prepare the cash flow statements using the indirect method. Furthermore, interest cash flows are presented in cash flows from operating activities rather than in cash flows from financing or investing activities, because they enter into the determination of profit or loss. The Company chose to present dividends paid to shareholders of Koninklijke Philips N.V. as a component of cash flows from financing activities, rather than to present such dividends as cash flows from operating activities, which is an allowed alternative under IFRS. Consolidated statements of cash flows can be found in Consolidated statements of cash flows Cash flow statements Cash flows arising from transactions in a foreign currency are translated in the Company’s functional currency using the exchange rate at the date of the cash flow. Cash flows from derivative instruments that are accounted for as cash flow hedges are classified in the same category as the cash flows from the hedged items. Cash flows from other derivative instruments are classified as investing cash flows.
Segment information [Text block]	Segment information Operating segments are components of the Company’s business activities about which separate financial information is available that is evaluated regularly by the chief operating decision maker (the Executive Committee of the Company). The Executive Committee decides how to allocate resources and assesses performance. Reportable segments comprise the operating segments Personal Health businesses, Diagnosis & Treatment businesses and Connected Care & Health Informatics businesses. Additionally, Philips identifies HealthTech Other and Legacy Items. Segment accounting policies are the same as the accounting policies applied by the Company.
Earnings per share [Text block]	Earnings per Share The Company presents basic and diluted earnings per share (EPS) data for its common shares. Basic EPS is calculated by dividing the Net income (loss) attributable to shareholders by the weighted average number of common shares outstanding during the period, adjusted for own shares held. Diluted EPS is determined by adjusting the Net income (loss) attributable to shareholders and the weighted average number of common shares outstanding during the period, adjusted for own shares held, for the effects of all dilutive potential common shares, which comprises forward purchase contracts entered into in 2017, restricted shares, performance shares and share options granted to employees. Further information on earnings per share can be found in Earnings per share
New standards and interpretations [Text block]	New standards and interpretations IFRS accounting standards adopted as from 2017 Changes to policies, following from amendments to standards, interpretations and the annual improvement cycles, effective 2017, did not have a material impact on the Group financial statements. IFRS accounting standards to be adopted as from 2018 and onwards A number of new standards and amendments to existing standards have been published and are mandatory for the Company beginning on or after January 1, 2018 or later periods, and the Company has not early-adopted them. Those which may be the most relevant to the Company are set out below. Changes to other standards, following from amendments and the annual improvement cycles, are not expected to have a material impact on the Company’s financial statements. IFRS 9 Financial Instruments IFRS 9 Financial Instruments brings together the classification and measurement, impairment and hedge accounting phases of the IASB’s project to replace IAS 39 Financial Instruments: Recognition and Measurement. The new standard also introduces expanded disclosure requirements to IFRS 7 Financial Instruments: Disclosures and changes in presentation to IAS 1 Presentation of Financial Statements. These are expected to change the nature and extent of the Company’s disclosures about its financial instruments particularly in the year of the adoption of the new standard. The Company finalized the implementation of IFRS 9, except for the determination of the final IFRS 7 disclosures to be included in the Annual Report for 2018. These will be finalized in the coming year. The Company will adopt the new standard on the required effective date and will not restate comparative information. During 2017, Philips performed a detailed impact assessment of all three aspects of IFRS 9. Overall, the Company expects no significant impact on its statement of financial position and equity. Classification and measurement The Company noted no significant impact on its balance sheet or equity on applying the classification and measurement requirements of IFRS 9. The investments in equity shares are currently classified as available-for-sale financial assets with gains and losses recorded in other comprehensive income. Upon adopting IFRS 9, certain financial investments amounting to EUR 21 million (impact on Company financial statements is EUR 14 million) will change classification and measurement from Other comprehensive income to Fair value through profit or loss (FVPL). The related fair value gains of EUR 5 million (impact on Company financial statements is EUR 5 million) will be transferred from the available-for-sale financial assets reserve to Retained earnings on January 1, 2018. The remaining available-for-sale equity investments amounting to EUR 396 million (impact on Company financial statements is EUR 130 million) will continue to be measured at fair value through Other comprehensive income as the Company has chosen the fair value through other comprehensive income (FVOCI) election for such investments. Accordingly, the new guidance will not affect the classification and measurement of these financial assets. However, gains or losses realized on the sale of financial assets at FVOCI will no longer be transferred to profit or loss on sale, but instead reclassified below the line from the FVOCI reserve to Retained earnings. The debt investments of the Company amounting to EUR 29 million (impact on Company financial statements is nil The Company has debt investment amounting to EUR 0.6 million (impact on Company financial statements is nil Loans as well as trade receivables are held to collect contractual cash flows and are expected to give rise to cash flows representing solely payments of principal and interest. The Company analyzed the contractual cash flow characteristics of those instruments and concluded that they meet the criteria for amortized cost measurement under IFRS 9. Therefore, reclassification for these instruments is not required except for receivables which are factored. The business model for such factored receivables amounting to EUR 48 million (impact on Company financial statements is nil There will be no impact on the Company’s accounting for financial liabilities, as the new requirements only affect the accounting for financial liabilities that are designated at fair value through profit or loss, and the Company does not have any such liabilities. The derecognition rules have been transferred from IAS 39 Financial Instruments: Recognition and Measurement and have not been changed. Impairment The new impairment model requires the recognition of impairment provisions based on expected credit losses (ECL) rather than only incurred credit losses as is the case under IAS 39. The expected credit losses include forward-looking elements on all possible default events as well as historical loss data. It applies to financial assets classified at amortized cost, debt instruments measured at FVOCI, contract assets under IFRS 15 Revenue from Contracts with Customers, lease receivables, loan commitments and certain financial guarantee contracts. The Company will apply the simplified approach and record lifetime-expected losses on all trade receivables. Based on the assessments undertaken to date, the Company expects no material increase in the loss allowance for debt investments and financial assets held at amortized cost. Additionally the Company also assessed the impact of the new impairment model on its intercompany financial assets (including receivables) recognized in the Company financial statements and concluded that there is no material increase in the loss allowance. Hedge accounting The Company has completed updates to its internal documentation and monitoring processes and concluded that all existing hedge relationships that are currently designated in effective hedging relationships will continue to qualify for hedge accounting under IFRS 9. Changes in the fair value of foreign exchange forward contracts attributable to forward points and in the time value of the option contracts will in future be deferred in costs of hedging reserve within equity. The deferred amounts will be recognized against the related hedged transaction when it occurs. The Company has chosen not to retrospectively apply IFRS 9 on transition regarding the forward points of the forward contracts under IAS 39. As IFRS 9 does not change the general principles of how an entity accounts for effective hedges, applying the hedging requirements of IFRS 9 will not have a significant impact on Philips’ financial statements. Transition IFRS 9 must be applied for financial years commencing on or after January 1, 2018 and it is fully endorsed by the EU. The Company will apply the new rules retrospectively from January 1, 2018, with the practical expedients permitted under the standard. Comparatives for 2017 will not be restated in 2018. IFRS 15 Revenue from Contracts with Customers The IASB has issued a new standard that specifies how and when revenue is recognized and prescribes more informative and relevant disclosures. The standard supersedes IAS 18 Revenue, IAS 11 Construction Contracts and a number of revenue-related interpretations. The new standard provides a single, principles-based five-step model to be applied to all contracts with customers and is based on the principle that revenue is recognized when control of a good or service transfers to a customer. Furthermore, it provides new guidance on whether revenue should be recognized at a point in time or over time. The standard also introduces new guidance on costs of fulfilling and obtaining a contract, specifying the circumstances in which such costs should be capitalized. Costs that do not meet the criteria must be expensed when incurred. The actions needed to implement IFRS 15 in the organization have been finalized and the quantitative impacts determined, except for the determination of the final IFRS 15 disclosures to be included in the Annual Report for 2018. These will be finalized in the coming year. The following main impacted areas were identified. Royalty income Currently the Company recognizes revenue from intellectual property (IP) royalties, which is normally generated based upon a percentage of sales or a fixed amount per product sold, on an accrual basis based on actual or reliably estimated sales made by the licensees. Revenue generated from an agreement with lump-sum consideration is recognized on accrual basis based on the contractual terms and substance of the relevant agreement with a licensee. Under IFRS 15, revenues from the licensing of intellectual property should be recognized based on a right to access the intellectual property or a right to use the intellectual property approach. Under the first option revenue is recognized over time while under the second option revenue is recognized at a point in time. As a result, this will have an impact on revenues originating from the Company’s IP royalties with lump-sum consideration (within segment HealthTech Other) since under IFRS 15 such revenues will be recognized in the Statement of income at an earlier point in time rather than over time under the current methodology. An amount of EUR 34 million of deferred revenue will be recorded as an increase in retained earnings upon transition and a deferred tax asset of EUR 7 million will be released as a consequence. The net impact in equity will be EUR 25 million. Costs of obtaining a contract Under IFRS 15, the incremental costs of obtaining a contract with a customer are recognized as an asset if the entity expects to recover them. The Company identified that certain sales commissions paid to third parties and internal employees that are typical for transactions in the segments Diagnosis & Treatment businesses and Connected Care & Health Informatics businesses qualify as incremental costs of obtaining a contract. These costs are mostly paid and capitalized as prepayment upon issuance of sales orders and recognition of revenue related to the sale of goods or rendering of services. Such costs are commonly expensed in line with the revenue recognition pattern of the related goods or services. Due to these sales commissions being largely amortized within a year, the Company decided to adopt the practical expedient of expensing sales commissions when incurred. An impact of EUR 68 million will be recorded as a retained earnings decrease in equity originating from the asset derecognition upon transition, and a deferred tax liability of EUR 17 million will be released as a consequence. The net impact in equity will be EUR 51 million. Transition IFRS 15 must be applied for periods beginning on or after January 1, 2018 and it is fully endorsed by the EU. The Company decided to adopt IFRS 15 in its consolidated financial statements for the year ending December 31, 2018, using the modified retrospective transition approach which means that the cumulative impact of the adoption will be recognized in retained earnings as of January 1, 2018 and that comparatives will not be restated. The standard will only be applied to contracts that are not completed as of the date of initial application. IFRS 16 Leases IFRS 16 was issued in January 2016 and is endorsed by the EU. It will supersede IAS 17 Leases and a number of lease-related interpretations and will result in almost all leases being recognized on the balance sheet, as the distinction between operating and finance leases is removed. Under the new standard, an asset (the right to use the leased item) and a financial liability to pay rentals are recognized. The only exceptions are short-term and low-value leases. The accounting for lessors will not change significantly. The Company is in the process of implementing IFRS 16: the complete overview of existing operating lease contracts was determined (mainly real estate and car leases) and the investigation for an IT tool supporting IFRS 16 calculations and journal entries is ongoing. The new standard was discussed with management and internal stakeholders such as Treasury, Investor Relations and Human Resources so that they can work on potential adjustments to their processes, if needed. The Company is analyzing the preliminary quantitative impact of IFRS 16. The standard will affect primarily the accounting for the Company’s operating leases. As at the reporting date, Philips has non-cancellable operating lease commitments of EUR 741 million (undiscounted) as further explained in Details of treasury / other financial risks Philips has not yet assessed what other adjustments, if any, are necessary, such as following the change in the definition of the lease term, the different treatment of variable lease payments, and of extension and termination options. It is therefore not yet possible to estimate the amount of right-of-use assets and lease liabilities that will have to be recognized on adoption of the new standard and how this may affect the Company’s profit or loss and classification of cash flows going forward. The standard is mandatory for financial years commencing on or after January 1, 2019. The Company decided not to adopt the standard before its effective date. Philips intends to apply the modified retrospective approach. Therefore, the cumulative effect of adopting IFRS 16 will be recognized as an adjustment to the opening balance of retained earnings at January 1, 2019, with no restatement of comparative information. When applying the modified retrospective approach to leases previously classified as operating leases under IAS 17, the lessee can elect, on a lease by lease basis whether to apply a number of practical expedients on the transition. The Company is assessing the potential impact of using these practical expedients.

Information by segment and ma39

Information by segment and main country (Tables)	12 Months Ended
	Dec. 31, 2017
Disclosure of operating segments [Abstract]
Information on income statement [Text block]	Philips Group Information on income statement in millions of EUR unless otherwise stated 2015 - 2017 sales sales including intercompany depreciation and amortization 1 ) Adjusted EBITA 2 ) 2017 Personal Health 7,310 7,333 ( 371) 1,221 Diagnosis & Treatment 6,891 6,953 ( 267) 716 Connected Care & Health Informatics 3,163 3,200 ( 208) 372 HealthTech Other 415 559 ( 177) ( 109) Legacy Items 1 6 ( 2) ( 48) Inter-segment eliminations ( 269) Philips Group 17,780 17,780 ( 1,025) 2,153 2016 Personal Health 7,099 7,119 ( 385) 1,108 Diagnosis & Treatment 6,686 6,741 ( 229) 631 Connected Care & Health Informatics 3,158 3,213 ( 184) 324 HealthTech Other 478 635 ( 177) ( 66) Legacy Items 1 6 ( 2) ( 76) Inter-segment eliminations ( 292) Philips Group 17,422 17,422 ( 976) 1,921 2015 Personal Health 6,751 6,764 ( 375) 966 Diagnosis & Treatment 6,484 6,531 ( 249) 515 Connected Care & Health Informatics 3,022 3,080 ( 198) 294 HealthTech Other 503 670 ( 156) 8 Legacy Items 46 84 7 ( 95) Inter-segment eliminations ( 323) Philips Group 16,806 16,806 ( 972) 1,688 1) 2)
Reconciliation from net income to Adjusted EBITA [Text block]	Philips Group Reconciliation from net income to Adjusted EBITA in millions of EUR 2015 - 2017 Philips Group Personal Health Diagnosis & Treatment Connected Care & Health Informatics HealthTech Other Legacy Items 2017 Net Income 1,870 Discontinued operations, net of income taxes ( 843) Income tax expense 349 Investments in associates, net of income taxes 4 Financial expenses 263 Financial income ( 126) Income from operations 1,517 1,075 488 206 ( 149) ( 103) Amortization of acquired intangible assets 260 135 55 44 26 Impairment of goodwill 9 9 EBITA 1,787 1,211 543 250 ( 114) ( 103) Restructuring and acquisition-related charges 316 11 151 91 64 Other items 50 22 31 ( 59) 55 Adjusted EBITA 2,153 1,221 716 372 ( 109) ( 48) 2016 Net Income 1,491 Discontinued operations, net of income taxes ( 660) Income tax expense 203 Investments in associates, net of income taxes ( 11) Financial expenses 507 Financial income ( 65) Income from operations 1,464 953 546 275 ( 129) ( 181) Amortization of acquired intangible assets 242 139 48 46 9 Impairment of goodwill 1 1 EBITA 1,707 1,092 594 322 ( 120) ( 181) Restructuring and acquisition-related charges 94 16 37 14 28 ( 1) Other items 120 ( 12) 26 106 Adjusted EBITA 1,921 1,108 631 324 ( 66) ( 76) 2015 Net Income 638 Discontinued operations, net of income taxes ( 479) Income tax expense 169 Investments in associates, net of income taxes ( 30) Financial expenses 453 Financial income ( 94) Income from operations 658 736 322 173 49 ( 622) Amortization of acquired intangible assets 273 149 55 54 15 EBITA 931 885 377 227 64 ( 622) Restructuring and acquisition-related charges 186 37 131 38 ( 19) ( 1) Other items 571 44 7 29 ( 37) 528 Adjusted EBITA 1,688 966 515 294 8 ( 95)
Main countries [Text block]	Philips Group Main countries in millions of EUR 2015 - 2017 sales 1 ) tangible and intangible assets 2 ) 2017 Netherlands 414 1,154 United States 6,084 8,408 China 2,322 959 Germany 1,011 270 Japan 1,059 457 France 530 33 India 425 100 Other countries 5,935 1,263 Total main countries 17,780 12,644 2016 Netherlands 393 1,007 United States 5,948 9,425 China 2,210 1,167 Germany 965 201 Japan 1,103 492 France 513 45 India 399 121 Other countries 5,891 2,147 Total main countries 17,422 14,605 2015 Netherlands 374 970 United States 5,742 9,291 China 2,132 1,194 Germany 929 170 Japan 962 455 France 487 48 India 431 134 Other countries 5,749 2,276 Total main countries 16,806 14,538 1) 2)

Discontinued operations and a40

Discontinued operations and assets classified as held for sale (Tables)	12 Months Ended
	Dec. 31, 2017
Disclosure of discontinued operations [Abstract]
Discontinued operations, net of income taxes [Text block]	Philips Group Discontinued operations, net of income taxes in millions of EUR 2015 - 2017 2015 2016 2017 Lighting 247 244 896 The combined Lumileds and Automotive businesses 233 282 ( 29) Other ( 1) 134 ( 24) Discontinued operations, net of income taxes 479 660 843 Philips Group Discontinued operations, net of income taxes in millions of EUR 2015 - 2017 2015 2016 2017 Lighting 247 244 896 The combined Lumileds and Automotive businesses 233 282 ( 29) Other ( 1) 134 ( 24) Discontinued operations, net of income taxes 479 660 843
Results of Lighting [Text block]	Results of Lighting in millions of EUR 2015-2017 2015 2016 2017 Sales 7,438 7,094 6,319 Costs and expenses ( 7,114) ( 6,726) ( 5,776) Result on the deconsolidation of discontinued operations 538 Value adjustment retained interest ( 104) Income before tax 324 368 977 Income tax expense ( 77) ( 124) ( 150) Income tax on the deconsolidation of discontinued operations 61 US Tax Cuts and Jobs Act 8 Results from discontinued operations 247 244 896
Results of combined Lumileds and Automotive Lighting businesses [Text block]	Philips Group Results of combined Lumileds and Automotive businesses in millions of EUR 2015 - 2017 2015 2016 2017 Sales 1,619 1,711 804 Costs and expenses ( 1,320) ( 1,376) ( 630) Result on the sale of discontinued operations ( 98) Income before taxes 299 335 76 Income tax expense ( 66) ( 53) ( 25) Income tax on the sale of discontinued operations 26 US Tax Cuts and Jobs Act ( 107) Results from discontinued operations 233 282 ( 29)
Discontinued operations cash flows [Text block]	Discontinued operations cash flows in millions of EUR 2015 -2017 2015 2016 2017 Cash flows from operating activities 761 1,037 350 Cash flows from investing activities ( 203) ( 112) 856 Cash flows from financing activities ( 20) 1,226 ( 144) Total discontinued operations cash flows 537 2,151 1,063 Discontinued operations cash flows in millions of EUR 2015 -2017 2015 2016 2017 Cash flows from operating activities 761 1,037 350 Cash flows from investing activities ( 203) ( 112) 856 Cash flows from financing activities ( 20) 1,226 ( 144) Total discontinued operations cash flows 537 2,151 1,063

Acquisitions and divestments (T

Acquisitions and divestments (Tables)	12 Months Ended
	Dec. 31, 2017
Disclosure of acquisitions and divestments [Abstract]
Balance sheet Spectranetics [Text block]	Spectranetics Balance sheet in millions of EUR 2017 at acquisition date Goodwill 1,255 Other intangible assets 674 Property, plant and equipment 69 Deferred tax assets 135 Inventories 38 Receivables and other current assets 42 Cash 53 Accounts payable and other payables ( 49) Deferred tax liabilities ( 257) Total assets and liabilities 1,960 Financed by equity ( 1,960)
Other intangible assets Spectranetics [Text block]	Spectranetics Other intangible assets in millions of EUR unless otherwise stated 2017 amount amortization period Customer relationships 372 20 Technology 297 15 Brand names 5 3 Total other intangible assets 674
Income statement Spectranetics pro forma [Text block]	Philips Group Pro-forma Statements of income for Spectranetics acquisition (unaudited) in millions of EUR 2017 Philips Group Pro forma adjustments Pro-forma Philips Group Sales 17,780 156 17,936 Net income 1,870 ( 40) 1,830

Interests in entities (Tables)

Interests in entities (Tables)	12 Months Ended
	Dec. 31, 2017
Interests in entities [Abstract]
Summarized financial information for Philips Lighting (unaudited) [Text block]	Philips Group Summarized financial information for Philips Lighting (unaudited) in millions of EUR 2016 2017 Philips Lighting Philips Lighting Sales to thirds 7,115 6,965 Net income 185 281
Summarized income statement of Philips Lighting (unaudited) [Text block]	Summarized income statement of Philips Lighting (unaudited) in millions of EUR 2017 Sales to thirds 6,965 Income before taxes 441 Net financial income/expense ( 43) Income taxes ( 117) Net income 281
Summarized net asset value of Philips Lighting (unaudited) [Text block]	Summarized net asset value of Philips Lighting (unaudited) in millions of EUR 2017 Current assets 3,372 Non-current assets 3,306 Total assets 6,678 Current liabilities ( 2,216) Non-current liabilities ( 2,140) Net assets value 2,321

Income from operations (Tables)

Income from operations (Tables)	12 Months Ended
	Dec. 31, 2017
Analysis of income and expense [Abstract]
Sales and costs by nature [Text block]	Philips Group Sales and costs by nature in millions of EUR 2015 - 2017 2015 2016 2017 Sales 16,806 17,422 17,780 Costs of materials used ( 5,188) ( 5,030) ( 4,918) Employee benefit expenses ( 5,638) ( 5,298) ( 5,824) Depreciation and amortization ( 972) ( 976) ( 1,025) Shipping and handling ( 547) ( 545) ( 602) Advertising and promotion ( 862) ( 915) ( 939) Lease expense, net 1 ) ( 250) ( 223) ( 227) Other operational costs 2 ) ( 2,751) ( 2,963) ( 2,804) Other business income (expenses) 60 ( 6) 76 Income from operations 658 1,464 1,517 1) 2) rd)
Sales composition [Text block]	Philips Group Sales composition in millions of EUR 2015 - 2017 2015 2016 2017 Goods 1 ) 13,175 13,568 13,974 Services 1 ) 3,215 3,478 3,477 Royalties 416 375 329 Sales 16,806 17,422 17,780 1)
Employee benefit expenses [Text block]	Philips Group Employee benefit expenses in millions of EUR 2015 - 2017 2015 2016 2017 Salaries and wages 1 ) 4,342 4,422 4,856 Post-employment benefits costs 705 279 347 Other social security and similar charges: Required by law 480 489 514 Voluntary 110 108 108 Employee benefit expenses 5,638 5,298 5,824 1)
Employees [Text block]	Philips Group Employees in FTEs 2015 - 2017 2015 2016 2017 Production 26,524 27,899 27,697 Research and development 8,242 9,087 9,787 Other 23,216 24,565 26,314 Employees 57,982 61,552 63,798 3rd party workers 7,900 8,050 8,098 Continuing operations 65,882 69,602 71,895 Discontinued operations 48,330 43,971 43,497 Philips Group 114,211 113,572 115,392
Employees per geographical location [Text block]	Philips Group Employees per geographical location in FTEs 2015 - 2017 2015 2016 2017 Netherlands 7,589 11,199 11,308 Other countries 58,292 58,403 60,587 Continuing operations 65,882 69,602 71,895 Discontinued operations 48,330 43,971 43,497 Philips Group 114,211 113,572 115,392
Depreciation and amortization [Text block]	Philips Group Depreciation and amortization 1 ) in millions of EUR 2015 - 2017 2015 2016 2017 Depreciation of property, plant and equipment 422 458 437 Amortization of software 35 49 50 Amortization of other intangible assets 273 244 260 Amortization of development costs 242 225 277 Depreciation and amortization 972 976 1,025 1)
Audit fees [Text block]	Philips Group Fees in millions of EUR 2015 2016 2017 Audit fees 15.3 18.4 16.7 consolidated financial statements 9.8 13.4 12.5 statutory financial statements 5.5 5.0 4.2 Audit-related fees 4.9 2.3 1.5 acquisitions and divestments 3.6 0.9 0.0 sustainability assurance 0.6 0.7 0.7 other 0.7 0.7 0.8 Tax fees 1.1 0.0 0.0 tax compliance services 1.1 0.0 0.0 Other fees 0.0 0.0 0.0 other 0.0 0.0 0.0 Fees 1 ) 21.3 20.7 18.3 1)
Other business income (expenses) [Text block]	Philips Group Other business income (expenses) in millions of EUR 2015 - 2017 2015 2016 2017 Result on disposal of businesses: income 1 1 15 expense ( 2) ( 4) ( 5) Result on disposal of fixed assets: income 44 4 96 expense ( 1) ( 1) ( 1) Result on other remaining business: income 44 13 41 expense ( 27) ( 17) ( 62) Impairment of goodwill 1 ) ( 1) ( 9) Other business income (expenses) 60 ( 6) 76 Total other business income 89 17 152 Total other business expense ( 30) ( 23) ( 76) 1) Goodwill

Financial income and expenses (

Financial income and expenses (Tables)	12 Months Ended
	Dec. 31, 2017
Disclosure of Financial income and expenses [Abstract]
Financial income and expenses [Table text block]	Philips Group Financial income and expenses in millions of EUR 2015 - 2017 2015 2016 2017 Interest income 44 43 40 Interest income from loans and receivables 18 15 12 Interest income from cash and cash equivalents 26 28 28 Dividend income from available for sale financial assets 6 4 64 Net gains from disposal of financial assets 20 3 1 Net change in fair value of financial assets at fair value through profit or loss 4 7 Other financial income 20 15 14 Financial income 94 65 126 Interest expense ( 344) ( 342) ( 222) Interest on debt and borrowings ( 267) ( 288) ( 177) Finance charges under finance lease contract ( 6) ( 7) ( 8) Interest expenses - pensions ( 70) ( 48) ( 37) Provision-related accretion and interest ( 31) 44 ( 22) Net foreign exchange losses ( 10) ( 1) ( 2) Impairment loss of financial assets ( 46) ( 24) ( 2) Net change in fair value of financial assets at fair value through profit or loss ( 4) Other financial expenses ( 23) ( 180) ( 15) Financial expense ( 453) ( 507) ( 263) Financial income and expenses ( 359) ( 442) ( 137)

Income taxes (Tables)

Income taxes (Tables)	12 Months Ended
	Dec. 31, 2017
Disclosure of Income taxes [Abstract]
Income tax expense [Text block]	Philips Group Income tax expense in millions of EUR 2015 - 2017 2015 2016 2017 Netherlands 93 137 929 Foreign 206 886 451 Income before taxes of continuing operations 1 ) 299 1,023 1,381 Netherlands: Current tax (expense) benefit 47 10 ( 15) Deferred tax (expense) benefit 6 ( 95) ( 150) Total tax (expense) benefit of continuing operations (Netherlands) 53 ( 85) ( 165) Foreign: Current tax (expense) benefit ( 157) ( 155) ( 258) Deferred tax (expense) benefit ( 65) 37 73 Total tax (expense) benefit of continuing operations (foreign) ( 222) ( 118) ( 184) Income tax expense of continuing operations ( 169) ( 203) ( 349) 1)
Current income tax expense [Text block]	Philips Group Current income tax expense in millions of EUR 2015 - 2017 2015 2016 2017 Current year tax (expense) benefit ( 121) ( 165) ( 275) Prior year tax (expense) benefit 11 20 3 Current tax (expense) ( 110) ( 145) ( 272)
Deferred income tax expense [Text block]	Philips Group Deferred income tax expense in millions of EUR 2015 - 2017 2015 2016 2017 Recognition of previously unrecognized 4 19 32 (Unrecognized) tax loss and credit carryforwards 1 ) ( 9) ( 56) ( 9) (Unrecognized) recognition of temporary differences 1 ) ( 35) 31 35 Prior year tax ( 6) ( 1) 6 Tax rate changes ( 19) 5 ( 72) Origination and reversal of temporary differences, tax losses and tax credits 6 ( 56) ( 69) Deferred tax (expense) benefit ( 59) ( 58) ( 77) 1)
Effective income tax rate [Text block]	Philips Group Effective income tax rate in % 2015 - 2017 2015 2016 2017 Weighted average statutory income tax rate in % 43.6 23.3 24.5 Recognition of previously unrecognized ( 1.4) ( 1.9) ( 2.3) Unrecognized tax loss and credit carryforwards 2.9 5.5 0.6 Unrecognized (recognition of) temporary differences 11.4 ( 3.1) ( 2.6) Non-taxable income and tax incentives ( 35.5) ( 8.2) ( 9.8) Non-deductible expense 33.8 9.3 6.4 Withholding and other taxes 8.3 1.2 4.0 Tax rate changes 5.9 ( 0.5) 5.2 Prior year tax 1.0 ( 1.8) ( 0.6) Tax expense (benefit) due to other tax liabilities ( 12.7) ( 2.6) ( 1.7) Others, net ( 1.0) ( 1.3) 1.5 Effective income tax rate 56.4 19.9 25.3
Deferred tax assets and liabilities [Text block]	Philips Group Deferred tax assets and liabilities in millions of EUR 2017 Balance as of January 1, 2017 recognized in income statement Transfer to assets held for sale other 1 ) Balance as of December 31, 2017 Assets Liabilities Intangible assets ( 676) 549 ( 28) ( 228) ( 383) 423 ( 806) Property, plant and equipment 10 15 ( 2) 23 39 ( 16) Inventories 347 ( 34) ( 52) ( 29) 231 235 ( 4) Other assets 138 7 ( 82) 12 74 96 ( 22) Pension and other employee benefits 597 ( 126) ( 149) ( 57) 265 265 - Other liabilities 989 ( 288) ( 8) ( 158) 536 596 ( 61) Deferred tax assets on tax loss carryforwards 1,288 ( 201) ( 125) ( 144) 819 819 - Set-off deferred tax positions - ( 876) 876 Net deferred tax assets 2,692 ( 77) ( 444) ( 606) 1,565 1,598 ( 33) 1) Philips Group Deferred tax assets and liabilities in millions of EUR 2016 Balance as of January 1, 2016 recognized in income statement other 1 ) Balance as of December 31, 2016 Assets Liabilities Intangible assets ( 1,089) 450 ( 36) ( 676) 542 ( 1,218) Property, plant and equipment 19 1 ( 10) 10 64 ( 54) Inventories 312 24 11 347 353 ( 6) Other assets 68 32 37 138 161 ( 23) Pensions and other employee benefits 707 ( 138) 27 597 598 ( 1) Other liabilities 981 ( 32) 40 989 1,107 ( 118) Deferred tax assets on tax loss carryforwards 1,562 ( 368) 93 1,288 1,288 - Set-off deferred tax positions ( 1,355) 1,355 Net deferred tax assets 2,560 ( 30) 162 2,692 2,758 ( 66) 1)
Expiry years of net operating loss and credit carryforwards [Text block]	Philips Group Expiry years of net operating loss and credit carryforwards in millions of EUR Total Total Balance as of December 31, 2016 Unrecognized balance as of December 31, 2016 Total Balance as of December 31, 2017 Unrecognized balance as of December 31, 2017 2017 14 - - - 2018 4 3 3 3 2019 58 10 5 2 2020 137 21 15 6 2021 37 3 14 2 2022 - - 1,843 1,809 Later than 2021, respectively 2022 3,503 14 2,134 410 Unlimited 2,077 1,118 1,812 1,118 Total 5,830 1,170 5,827 3,351

Earnings per share (Tables)

Earnings per share (Tables)	12 Months Ended
	Dec. 31, 2017
Earnings per share [Abstract]
Earnings per share [Text block]	Philips Group Earnings per share in millions of EUR unless otherwise stated 1 ) 2015 - 2017 2015 2016 2017 Income from continuing operations 160 831 1,028 Income (loss) attributable to non-controlling interest 14 43 214 Income from continuing operations attributable to shareholders 146 788 814 Income from Discontinued operations 479 660 843 Net income attributable to shareholders 624 1,448 1,657 Weighted average number of common shares outstanding (after deduction of treasury shares) during the year 916,086,943 918,015,863 928,797,650 Plus incremental shares from assumed conversions of: Options 3,565,682 2,456,616 3,161,267 Performance shares 2,479,923 6,985,509 10,757,785 Restricted share rights 1,491,960 1,331,163 2,008,162 Forward contracts 407,193 Dilutive potential common shares 7,537,565 10,773,289 16,334,406 Diluted weighted average number of shares (after deduction of treasury shares) during the year 923,624,508 928,789,152 945,132,056 Basic earnings per common share in EUR 2 ) Income from continuing operations 0.17 0.90 1.11 Income from Discontinued operations 0.52 0.72 0.91 Income from continuing operations attributable to shareholders 0.16 0.86 0.88 Net income attributable to shareholders 0.68 1.58 1.78 Diluted earnings per common share in EUR 2 3 ) Income from continuing operations 0.17 0.89 1.09 Income from Discontinued operations 0.52 0.71 0.89 Income from continuing operations attributable to shareholders 0.16 0.85 0.86 Net income attributable to shareholders 0.68 1.56 1.75 Dividend distributed per common share in euros 0.80 0.80 0.80 1) 2) 3)

Property, plant and equipment (

Property, plant and equipment (Tables)	12 Months Ended
	Dec. 31, 2017
Disclosure of detailed information about property, plant and equipment [Abstract]
Property, plant and equipment [Text block]	Philips Group Property, plant and equipment in millions of EUR 2017 land and buildings machinery and installations other equipment prepayments and construction in progress total Balance as of January 1, 2017: Cost 1,766 3,222 1,897 179 7,064 Accumulated depreciation ( 912) ( 2,546) ( 1,451) ( 4,909) Book value 854 676 446 179 2,155 Change in book value: Capital expenditures 17 128 86 320 551 Assets available for use 63 117 129 ( 309) - Acquisitions - 71 3 74 Depreciation ( 60) ( 205) ( 169) ( 434) Impairments ( 1) ( 32) ( 11) - ( 44) Reclassifications 39 ( 47) 9 3 4 Transfer (to) from assets classified as held for sale ( 284) ( 186) ( 82) ( 44) ( 596) Translation differences and other ( 44) ( 32) ( 35) ( 9) ( 120) Total changes ( 270) ( 185) ( 70) ( 39) ( 564) Balance as of December 31, 2017: Cost 1,111 1,708 1,449 140 4,408 Accumulated depreciation ( 527) ( 1,217) ( 1,074) ( 2,818) Book value 584 491 376 140 1,591 Philips Group Property, plant and equipment in millions of EUR 2016 land and buildings machinery and installations other equipment prepayments and construction in progress total Balance as of January 1, 2016: Cost 1,864 3,260 1,873 220 7,217 Accumulated depreciation ( 951) ( 2,525) ( 1,419) ( 4,895) Book value 913 735 454 220 2,322 Change in book value: Capital expenditures 14 142 101 318 575 Assets available for use 112 108 137 ( 357) Depreciation ( 80) ( 257) ( 191) ( 528) Impairments ( 25) ( 40) ( 13) - ( 78) Transfer (to) from assets classified as held for sale ( 92) ( 4) ( 2) ( 2) ( 100) Translation differences and other 12 ( 8) ( 40) - ( 36) Total changes ( 59) ( 59) ( 8) ( 41) ( 167) Balance as of December 31, 2016: Cost 1,766 3,222 1,897 179 7,064 Accumulated depreciation ( 912) ( 2,546) ( 1,451) ( 4,909) Book value 854 676 446 179 2,155
Useful lives of property, plant and equipment [Text block]	Philips Group Useful lives of property, plant and equipment in years Buildings from 5 to 50 years Machinery and installations from 3 to 20 years Other equipment from 1 to 10 years
Operating lease - minimum payments under sale-and-leaseback arrangements [Text block]	Philips Group Operating lease - minimum payments under sale-and-leaseback arrangements in millions of EUR 2017 2018 31 2019 30 2020 24 2021 23 2022 20 Thereafter 91

Goodwill (Tables)

Goodwill (Tables)	12 Months Ended
	Dec. 31, 2017
Disclosure of goodwill [Abstract]
Goodwill [Table text block]	Philips Group Goodwill in millions of EUR 2016 - 2017 2016 2017 Balance as of January 1: Cost 10,704 11,151 Impairments ( 2,181) ( 2,253) Book value 8,523 8,898 Changes in book value: Acquisitions 140 1,548 Divestments and transfers to assets classified as held for sale ( 13) ( 1,878) Translation differences and other 248 ( 836) Balance as of December 31: Cost 11,151 9,074 Impairments ( 2,253) ( 1,343) Book value 8,898 7,731
Goodwill allocated to the cash-generating units [Text block]	Philips Group Goodwill allocated to the cash-generating units in millions of EUR 2016 - 2017 2016 2017 Image-Guided Therapy 1,106 2,242 Patient Care & Monitoring Solutions 1,506 1,349 Sleep & Respiratory Care 1,958 1,819 Professional 1,671 Other (units carrying a non-significant goodwill balance) 2,657 2,321 Book value 8,898 7,731
Key assumptions and sensitivity analysis [Text block]	Philips Group Key assumptions in % 2017 compound sales growth rate 1 ) initial forecast period extra-polation period 2 ) used to calculate terminal value 3 ) pre-tax discount rates Image-Guided Therapy 5.3 4.0 2.3 10.9 Patient Care & Monitoring Solutions 3.8 4.8 2.3 12.3 Sleep & Respiratory Care 7.2 5.6 2.3 12.1 1) 2) 3) Philips Group Key assumptions in % 2016 compound sales growth rate 1 ) initial forecast period extra-polation period 2 ) used to calculate terminal value 3 ) pre-tax discount rates Image-Guided Therapy 7.1 5.6 2.7 12.1 Patient Care & Monitoring Solutions 6.4 4.6 2.7 14.3 Sleep & Respiratory Care 6.8 4.6 2.7 12.6 Professional 5.0 4.3 2.7 13.9 1) 2) 3)

Intangible assets excluding g49

Intangible assets excluding goodwill (Tables)	12 Months Ended
	Dec. 31, 2017
Disclosure of intangible assets excluding goodwill [Abstract]
Intangible assets excluding goodwill [Text block]	Philips Group Intangible assets excluding goodwill in millions of EUR 2017 brand names customer relationships technology product development product development construction in progress software other total Balance as of January 1, 2017: Cost 1,088 3,429 2,074 1,899 578 580 134 9,782 Amortization/ impairments ( 633) ( 2,188) ( 1,491) ( 1,362) ( 36) ( 421) ( 99) ( 6,230) Book value 455 1,241 583 537 542 159 34 3,552 Changes in book value: Additions - 23 338 86 3 450 Acquisitions 7 431 470 2 16 926 Amortization ( 40) ( 142) ( 100) ( 213) - ( 52) ( 3) ( 550) Impairments ( 12) ( 43) ( 27) ( 1) ( 83) Assets available for use 363 ( 363) Divestments and transfers to assets classified as held for sale ( 120) ( 438) ( 103) ( 23) ( 11) ( 19) ( 6) ( 721) Translations differences ( 24) ( 89) ( 37) ( 35) ( 43) ( 1) ( 23) ( 252) Total changes ( 178) ( 238) 241 49 ( 106) 15 ( 13) ( 230) Balance as of December 31, 2017: Cost 670 2,342 1,985 1,848 487 605 105 8,042 Amortization/ impairments ( 392) ( 1,338) ( 1,161) ( 1,262) ( 51) ( 431) ( 84) ( 4,720) Book value 278 1,004 824 586 436 174 21 3,322 Philips Group Intangible assets excluding goodwill in millions of EUR 2016 brand names customer relationships technology product development product development construction in progress software other total Balance as of January 1, 2016: Cost 1,102 3,324 1,977 1,668 522 522 135 9,251 Amortization/ impairments ( 582) ( 1,925) ( 1,373) ( 1,167) ( 31) ( 367) ( 112) ( 5,558) Book value 520 1,399 604 501 491 155 24 3,693 Changes in book value: Additions 41 318 56 5 420 Acquisitions 1 7 21 8 37 Amortization ( 50) ( 201) ( 98) ( 229) ( 55) ( 2) ( 635) Impairments ( 1) ( 20) ( 4) ( 2) - ( 27) Assets available for use 270 ( 270) Translations differences ( 15) 36 15 15 7 5 1 64 Total changes ( 65) ( 157) ( 21) 36 51 4 11 ( 141) Balance as of December 31, 2016: Cost 1,088 3,429 2,074 1,899 578 580 134 9,782 Amortization/ impairments ( 633) ( 2,188) ( 1,491) ( 1,362) ( 36) ( 421) ( 99) ( 6,230) Book value 455 1,241 583 537 542 159 34 3,552
Estimated amortization expense for other intangible assets [Text block]	Philips Group Estimated amortization expense for other intangible assets in millions of EUR 2018 252 2019 243 2020 218 2021 192 2022 185
Expected useful lives of the intangible assets excluding goodwill [Text block]	Philips Group Expected useful lives of intangible assets excluding goodwill in years Brand names 2-20 Customer relationships 2-25 Technology 3-20 Other 1-10 Software 1-10 Product development 3-7

Other financial assets (Tables)

Other financial assets (Tables)	12 Months Ended
	Dec. 31, 2017
Disclosure of other financial assets [Abstract]
Disclosure of other non-current financial assets [Text block]	Philips Group Other non-current financial assets in millions of EUR 2017 available-for-sale financial assets loans and receivables held-to-maturity investments financial assets at fair value through profit or loss total Balance as of January 1, 2017 172 134 2 27 335 Changes: Reclassifications (1) 2 - 1 2 Acquisitions/additions 368 5 - - 374 Sales/redemptions (23) (8) - (3) (34) Impairment (1) - (1) Value adjustments (46) - 8 (39) Translation differences and other (24) (20) (1) (6) (50) Balance as of December 31, 2017 446 114 1 27 587 Philips Group Other non-current financial assets in millions of EUR 2016 available-for-sale financial assets loans and receivables held-to-maturity investments financial assets at fair value through profit or loss total Balance as of January 1, 2016 232 222 2 33 489 Changes: Reclassifications (56) (100) - (156) Acquisitions/additions 44 26 - 3 73 Sales/redemptions (3) (22) (1) (26) Impairment (27) - - (27) Value adjustments (19) (2) (8) (29) Translation differences and other 1 10 - - 11 Balance as of December 31, 2016 172 134 2 27 335

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2017
Disclosure of Inventories [Abstract]
Disclosure of inventories [Table text block]	Philips Group Inventories in millions of EUR 2016 - 2017 2016 2017 Raw materials and supplies 1,040 715 Work in process 446 358 Finished goods 1,906 1,280 Inventories 3,392 2,353

Receivables (Tables)

Receivables (Tables)	12 Months Ended
	Dec. 31, 2017
Trade and other receivables [Abstract]
Account receivables-net [Text block]	Philips Group Accounts receivables-net in millions of EUR 2016 - 2017 2016 2017 Personal Health 1,266 1,341 Diagnosis & Treatment 1,476 1,489 Connected Care & Health Informatics 664 706 HealthTech Other 81 72 Lighting 1,477 Legacy Items 28 Accounts receivable-net 4,992 3,609
Aging analysis [Text block]	Philips Group Aging analysis in millions of EUR 2016 - 2017 2016 2017 Current 4,273 3,046 Overdue 1-30 days 267 256 Overdue 31-180 days 310 242 Overdue > 180 days 142 63 Accounts receivable-net 4,992 3,609
Allowance for doubtful accounts receivable [Text block]	Philips Group Allowance for doubtful accounts receivable in millions of EUR 2015 - 2017 2015 2016 2017 Balance as of January 1 227 301 318 Additions charged to expense 78 76 41 Deductions from allowance 1 ) ( 25) ( 64) ( 36) Transfer to assets held for sale ( 92) Other movements 21 5 ( 16) Balance as of December 31 301 318 215 1)

Equity (Tables)

Equity (Tables)	12 Months Ended
	Dec. 31, 2017
Disclosure of equity [Abstract]
Outstanding number of shares [Text block]	Philips Group Outstanding number of shares in number of shares 2015 - 2017 2015 2016 2017 Balance as of January 1 914,388,869 917,103,586 922,436,563 Dividend distributed 17,671,990 17,344,462 11,264,163 Purchase of treasury shares ( 20,296,016) ( 25,193,411) ( 19,841,595) Re-issuance of treasury shares 5,338,743 13,181,926 12,332,592 Balance as of December 31 917,103,586 922,436,563 926,191,723
Employee option and share plan transactions [Text block]	Philips Group Employee option and share plan transactions 2015 - 2017 2015 2016 2017 Shares acquired 8,601,426 15,222,662 Average market price EUR 24.73 EUR 31.81 Amount paid EUR 213 million EUR 484 million Shares delivered 5,338,743 13,181,926 12,332,592 Average price (FIFO) EUR 30.35 EUR 25.86 EUR 27.07 Cost of delivered shares EUR 162 million EUR 341 million EUR 334 million Total shares in treasury at year-end 11,788,801 7,208,301 10,098,371 Total cost EUR 308 million EUR 181 million EUR 331 million
Share capital transactions [Text block]	Philips Group Share capital transactions 2015 - 2017 2015 2016 2017 Shares acquired 20,296,016 16,591,985 4,618,933 Average market price EUR 24.39 EUR 23.84 EUR 32.47 Amount paid EUR 495 million EUR 396 million EUR 150 million Reduction of treasury shares (shares) 21,361,016 18,829,985 Cancellation of treasury shares EUR 517 million EUR 450 million Total shares in treasury at year-end 2,238,000 4,618,933 Total cost EUR 55 million EUR 150 million
Composition of net debt and group equity [Text block]	Philips Group Composition of net debt and group equity in millions of EUR unless otherwise stated 2015-2017 2015 2016 2017 Long-term debt 4,095 4,021 4,044 Short-term debt 1,665 1,585 672 Total debt 5,760 5,606 4,715 Cash and cash equivalents 1,766 2,334 1,939 Net debt 3,994 3,272 2,776 Shareholders’ equity 11,607 12,546 11,999 Non-controlling interest 118 907 24 Group equity 11,725 13,453 12,023 Net debt : group equity ratio 25:75 20:80 19:81 Philips Group Composition of net debt and group equity in millions of EUR unless otherwise stated 2015-2017 2015 2016 2017 Long-term debt 4,095 4,021 4,044 Short-term debt 1,665 1,585 672 Total debt 5,760 5,606 4,715 Cash and cash equivalents 1,766 2,334 1,939 Net debt 3,994 3,272 2,776 Shareholders’ equity 11,607 12,546 11,999 Non-controlling interests 118 907 24 Group equity 11,725 13,453 12,023 Net debt : group equity ratio 25:75 20:80 19:81

Debt (Tables)

Debt (Tables)	12 Months Ended
	Dec. 31, 2017
Disclosure of debt [Abstract]
Long-term debt [Text block]	Philips Group Long-term debt in millions of EUR unless otherwise stated 2016 - 2017 (range of) interest rates average rate of interest average remaining term (in years) amount outstanding in 2017 amount due in 1 year amount due after 1 year amount due after 5 years amount outstanding in 2016 USD bonds 3.8 - 7.8% 5.4% 13.3 2,137 2,137 1,305 3,608 EUR bonds 0.0 - 0.5% 0.3% 3.7 997 997 496 Bank borrowings 0.2 - 11.0% 1.3% 2.1 190 52 138 1,470 Other long-term debt 0.0 - 2.6% 0.9% 1.1 20 19 1 - 39 Institutional financing 3,344 71 3,273 1,801 5,117 Finance leases 0 - 16.1% 3.4% 4.8 281 87 195 24 279 Forward contracts 1.2 970 394 576 Long-term debt 2.8% 7.6 4,595 552 4,044 1,825 5,396 Corresponding data of previous year 4.1% 7.8 5,396 1,375 4,021 2,454 4,245
Long-term debts due in the next five years [Text block]	Philips Group Long-term debt due in the next five years in millions of EUR 2016 - 2017 2018 552 2019 1,190 2020 103 2021 80 2022 846 Long-term debt 2,770 Corresponding amount of previous year 2,942
Unsecured Bonds [Text block]	Philips Group Unsecured Bonds in millions of EUR unless otherwise stated 2016 - 2017 effective rate 2016 2017 Unsecured EUR Bonds Due 9/06/2023; 1/2% 0.634% 500 Due 9/06/2019; 3M Euribor +20bps 500 Unsecured USD Bonds Due 5/15/25; 7 3/4% 7.429% 60 53 Due 6/01/26; 7 1/5% 6.885% 130 114 Due 5/15/25; 7 1/8% 6.794% 80 70 Due 3/11/18; 5 3/4% 1 ) 1,187 Due 3/11/38; 6 7/8% 7.210% 758 668 Due 3/15/22; 3 3/4% 3.906% 949 837 Due 3/15/42; 5% 5.273% 475 418 Adjustments 2 ) ( 31) ( 26) Unsecured Bonds 3,608 3,134 1) 2)
Finance lease liabilities [Text block]	Philips Group Finance lease liabilities in millions of EUR 2016 - 2017 2016 2017 future minimum lease payments interest present value of minimum lease payments future minimum lease payments interest present value of minimum lease payments Less than one year 93 8 85 93 6 87 Between one and five years 181 15 166 184 14 170 More than five years 33 5 28 29 4 24 Finance lease 307 28 279 306 24 281
Short-term debt [Text block]	Philips Group Short-term debt in millions of EUR 2016 - 2017 2016 2017 Short-term bank borrowings 207 71 Forward contracts 49 Other short-term loans 3 Current portion of long-term debt 1,375 552 Short-term debt 1,585 672

Provisions (Tables)

Provisions (Tables)	12 Months Ended
	Dec. 31, 2017
Disclosure of provisions [Abstract]
Provision [Text block]	Philips Group Provisions in millions of EUR 2016 - 2017 2016 2017 long-term short-term total long-term short-term total Post-employment benefit 20 1,996 1,996 973 973 Product warranty 66 193 259 44 157 201 Environmental provisions 252 69 321 140 19 160 Restructuring-related provisions 27 174 201 25 87 112 Litigation provisions 40 56 96 26 24 50 Other provisions 545 188 733 451 113 564 Provisions 2,926 680 3,606 1,659 400 2,059
Provisions for product warranty [Text block]	Philips Group Provisions for product warranty in millions of EUR 2015 - 2017 2015 2016 2017 Balance as of January 1 302 289 259 Changes: Additions 327 325 283 Utilizations ( 357) ( 357) ( 270) Transfer to liabilities directly associated with assets held for sale ( 56) Translation differences and other 17 2 ( 16) Balance as of December 31 289 259 201
Environmental provisions [Text block]	Philips Group Environmental provisions in millions of EUR 2015 - 2017 2015 2016 2017 Balance as of January 1 360 335 321 Changes: Additions 27 18 18 Utilizations ( 24) ( 24) ( 21) Releases ( 36) ( 36) ( 8) Changes in discount rate ( 7) 11 11 Accretion 7 7 6 Translation differences and other 8 10 ( 20) Transfer to liabilities directly associated with assets held for sale ( 146) Balance as of December 31 335 321 160
Restructuring-related provisions [Text block]	Philips Group Restructuring-related provisions in millions of EUR 2017 Jan. 1, 2017 additions utilizations releases other changes 1 ) Dec. 31, 2017 Personal Health 5 14 ( 5) ( 6) ( 1) 7 Diagnosis & Treatment 13 46 ( 16) ( 5) ( 1) 38 Connected Care & Health Informatics 13 27 ( 12) ( 6) ( 1) 20 HealthTech Other 37 55 ( 27) ( 16) ( 1) 47 Lighting 133 9 ( 35) ( 3) ( 104) Philips Group 201 150 ( 96) ( 37) ( 107) 112 1) Philips Group Restructuring-related provisions in millions of EUR 2016 Jan. 1, 2016 additions utilizations releases other changes 1 ) Dec. 31, 2016 Personal Health 32 7 ( 29) ( 2) ( 3) 5 Diagnosis & Treatment 28 11 ( 19) ( 6) ( 1) 13 Connected Care & Health Informatics 21 11 ( 14) ( 6) 1 13 HealthTech Other 38 35 ( 16) ( 19) ( 1) 37 Lighting 178 95 ( 118) ( 27) 5 133 Legacy Items ( 1) ( 1) ( 1) 3 Philips Group 297 158 ( 197) ( 61) 4 201 1) Philips Group Restructuring-related provisions in millions of EUR 2015 Jan. 1, 2015 additions utilizations releases other changes 1 ) Dec. 31, 2015 Personal Health 13 30 ( 7) ( 4) 32 Diagnosis & Treatment 29 30 ( 24) ( 7) 28 Connected Care & Health Informatics 16 20 ( 12) ( 3) 21 HealthTech Other 87 25 ( 32) ( 41) ( 1) 38 Lighting 235 89 ( 114) ( 33) 1 178 Legacy Items Philips Group 380 194 ( 189) ( 88) 297 1)
Litigation provisions [Text block]	Philips Group Litigation provisions in millions of EUR 2015 - 2017 2015 2016 2017 Balance as of January 1 653 578 96 Changes: Additions 66 31 40 Utilizations 1 ) ( 186) ( 313) ( 52) Releases ( 25) ( 98) ( 11) Reclassifications 1 ) - ( 125) 2 Changes in discount rate 8 5 Accretion 12 8 3 Translation differences 50 10 ( 7) Transfer to liabilities directly associated with assets held for sale ( 21) Balance as of December 31 578 96 50 1)
Other provisions [Text block]	Philips Group Other provisions in millions of EUR 2015 - 2017 2015 2016 2017 Balance as of January 1 575 604 733 Changes: Additions 198 183 304 Utilizations ( 186) ( 167) ( 238) Releases ( 35) ( 61) ( 88) Reclassification 14 142 4 Transfer to liabilities directly associated with assets held for sale ( 156) Accretion 7 8 - Acquisitions 24 - 62 Translation differences and other 7 24 ( 56) Balance as of December 31 604 733 564

Post-employment benefits (Table

Post-employment benefits (Tables)	12 Months Ended
	Dec. 31, 2017
Disclosure of post-employment benefits [Abstract]
Pre-tax costs for post-employment benefits [Text block]	Philips Group Pre-tax costs for post-employment benefits in millions of EUR 2015 - 2017 2015 2016 2017 Defined-benefit plans 566 58 95 included in Income from operations 467 ( 19) 1 ) 32 included in Financial expense 70 48 37 included in Discontinued operations 29 29 26 Defined-contribution plans 299 392 397 included in Income from operations 240 299 315 included in Discontinued operations 59 93 82 Post-employment benefits costs 865 450 492 1)
Disclosure of net defined benefit obligations [Text block]	Philips Group Defined-benefit obligations in millions of EUR 2016 - 2017 2016 2017 Balance as of January 1 4,757 4,987 Service cost 44 34 Interest cost 189 126 Employee contributions 5 4 Actuarial (gains) / losses demographic assumptions ( 45) ( 14) financial assumptions 208 75 experience adjustment ( 7) ( 15) (Negative) past service cost ( 8) 1 Settlements ( 85) ( 348) Benefits paid from plan ( 239) ( 172) Benefits paid directly by employer ( 76) ( 52) Transfer to Liabilities directly associated with assets held for sale 1 ) ( 1,210) Translation differences and other 244 ( 307) Balance as of December 31 4,987 3,109 Present value of funded obligations at December 31 3,850 2,476 Present value of unfunded obligations at December 31 1,137 633 1)
Disclosure of net defined benefit plan assets [Text block]	Philips Group Plan assets in millions of EUR 2016 - 2017 2016 2017 Balance as of January 1 2,710 3,095 Interest income on plan assets 137 87 Admin expenses paid ( 3) ( 2) Return on plan assets excluding interest income 41 70 Employee contributions 5 4 Employer contributions 246 263 Settlements ( 33) ( 348) Benefits paid from plan ( 239) ( 172) Transfer to Liabilities directly associated with assets held for sale 1 ) ( 642) Translation differences and other 231 ( 218) Balance as of December 31 3,095 2,137 Funded status ( 1,892) ( 972) Unrecognized net assets ( 105) Net balance sheet position ( 1,997) ( 972) 1)
Changes in the effect of the asset ceiling [Text block]	Philips Group Changes in the effect of the asset ceiling in millions of EUR 2016 - 2017 2016 2017 Balance as of January 1 90 105 Interest on unrecognized assets 14 4 Remeasurements ( 21) ( 100) Translation differences 22 ( 9) Balance as of December 31 105
Plan assets allocation [Text block]	Philips Group Plan assets allocation in millions of EUR 2016 - 2017 2016 2017 Assets quoted in active markets Debt securities 1,085 1,142 Equity securities 91 69 Other 126 137 Assets not quoted in active markets Debt securities 561 14 Equity securities 811 457 Other 421 318 Total assets 3,095 2,137
Assumptions used to calculate the defined-benefit obligations [Text block]	Philips Group Assumptions used for defined-benefit obligations in % 2016 - 2017 2016 2017 Discount rate 3.8% 2.8% Inflation rate 2.6% 2.1% Salary increase 3.3% 2.4%
Sensitivity of key assumptions [Text block]	Philips Group Sensitivity of key assumptions in millions of EUR 2017 Defined benefit obligation Increase Discount rate (1% movement) ( 323) Inflation rate (1% movement) 85 Salary increase (1% movement) 20 Longevity (see explanation) 72 Decrease Discount rate (1% movement) 394 Inflation rate (1% movement) ( 86) Salary increase (1% movement) ( 19) Philips Group Sensitivity of key assumptions in millions of EUR 2016 Defined benefit obligation Increase Discount rate (1% movement) ( 544) Inflation rate (1% movement) 139 Salary increase (1% movement) 27 Longevity (see explanation) 143 Decrease Discount rate (1% movement) 645 Inflation rate (1% movement) ( 126) Salary increase (1% movement) ( 23)

Accrued liabilities (Tables)

Accrued liabilities (Tables)	12 Months Ended
	Dec. 31, 2017
Disclosure of accrued liabilities [Abstract]
Accrued liabilities [Text block]	Philips Group Accrued liabilities in millions of EUR 2016 - 2017 2016 2017 Personnel-related costs: Salaries and wages 684 529 Accrued holiday entitlements 154 109 Other personnel-related costs 108 71 Fixed-asset-related costs: Gas, water, electricity, rent and other 52 52 Communication and IT costs 75 42 Distribution costs 123 83 Sales-related costs: Commission payable 22 7 Advertising and marketing-related costs 183 174 Other sales-related costs 55 38 Material-related costs 142 110 Interest-related accruals 68 38 Deferred income 957 791 Other accrued liabilities 411 273 Accrued liabilities 3,034 2,319

Other liabilities (Tables)

Other liabilities (Tables)	12 Months Ended
	Dec. 31, 2017
Disclosure of other liabilities [Abstract]
Other non-current liabilities [Text block]	Philips Group Other non-current liabilities in millions of EUR 2016 - 2017 2016 2017 Deferred income 251 249 Other tax liability 417 161 Other liabilities 73 65 Other non-current liabilities 741 474
Other current liabilities [Text block]	Philips Group Other current liabilities in millions of EUR 2016 - 2017 2016 2017 Accrued customer rebates that cannot be offset with accounts receivables for those customers 593 435 Advances received from customers on orders not covered by work in process 451 372 Other taxes including social security premiums 208 164 Other liabilities 120 155 Other current liabilities 1,372 1,126

Cash flow statement supplemen59

Cash flow statement supplementary information (Tables)	12 Months Ended
	Dec. 31, 2017
Disclosure of cash flow statement supplementary information (obsolete) [Abstract]
Reconciliation of liabilities arising from financing activities [Text block]	Philips Group Reconciliation of liabilities arising from financing activities in millions of EUR 2016 - 2017 Balance as of Dec. 31, 2016 Cash flow 1 ) Transfer to liabilities directly associated with assets held for sale Currency effects and consolidation change Other non-cash Balance as of Dec. 31, 2017 Long-term debt 2 ) 5,396 ( 217) ( 1,255) ( 327) 998 4,595 USD bonds 3,608 ( 1,184) ( 287) 1 2,137 EUR bonds 997 - 997 Bank borrowings 1,470 ( 22) ( 1,238) ( 21) - 190 Other long-term debt 39 ( 20) - 1 ( 1) 20 Finance leases 279 12 ( 18) ( 20) 29 281 Forward contracts 3 ) 970 970 Short-term debt 2 ) 210 ( 4) ( 86) ( 49) 49 120 Short-term bank borrowings 207 ( 3) ( 84) ( 49) 71 Other short-term loans 2 ( 1) ( 2) - Forward contracts 3 ) 49 49 Equity ( 181) 168 ( 1,487) ( 1,500) Sale of Lighting shares net of costs 1,060 ( 1,060) Dividend payable ( 478) 478 Forward contracts 3 ) ( 1,018) ( 1,018) Treasury shares ( 181) ( 414) 114 ( 481) 1) 2) 3)

Related-party transactions (Tab

Related-party transactions (Tables)	12 Months Ended
	Dec. 31, 2017
Disclosure of related-party transactions [Abstract]
Related-party transactions [Text block]	Philips Group Related-party transactions in millions of EUR 2015 - 2017 2015 2016 2017 Sales of goods and services 222 207 196 Purchases of goods and services 87 81 62 Receivables from related parties 16 33 127 Payables to related parties 4 3 36

Share-based compensation (Table

Share-based compensation (Tables)	12 Months Ended
	Dec. 31, 2017
Disclosure of share-based compensation [Abstract]
Performance shares [Text block]	Philips Group Performance shares 2017 shares 1 ) weighted average grant-date fair value EUR-denominated Outstanding at January 1, 2017 2 ) 7,866,754 25.24 Granted 1,419,518 38.02 Vested/Issued 2,853,745 22.48 Forfeited 557,229 27.80 Adjusted Quantity 3 ) 526,142 26.69 Outstanding at December 31, 2017 6,401,440 29.20 USD-denominated Outstanding at January 1, 2017 2 ) 5,162,084 29.56 Granted 953,897 41.69 Vested/Issued 1,901,252 30.07 Forfeited 441,395 30.83 Adjusted Quantity 3 ) 341,279 30.23 Outstanding at December 31, 2017 4,114,615 32.06 1) 2) 3)
Restricted shares [Text block]	Philips Group Restricted shares 2017 shares 1 ) 2 ) weighted average grant-date fair value EUR-denominated Outstanding at January 1, 2017 1,666,960 24.40 Granted 754,374 32.84 Vested/Issued 557,603 25.04 Forfeited 133,031 25.51 Outstanding at December 31, 2017 1,730,699 27.79 USD-denominated Outstanding at January 1, 2017 1,711,903 27.78 Granted 758,368 36.61 Vested/Issued 521,055 28.63 Forfeited 266,590 28.74 Outstanding at December 31, 2017 1,682,625 31.35 1) 2)
Options on listed share [Text block]	Philips Group Options on EUR-denominated listed share 2017 options weighted average exercise price Outstanding at January 1, 2017 7,052,065 22.49 Exercised 2,591,755 20.42 Forfeited 60,027 20.55 Expired 1,628,073 30.96 Outstanding at December 31, 2017 2,772,210 19.49 Exercisable at December 31, 2017 2,772,210 19.49 Philips Group Options on USD-denominated listed share 2017 options weighted average exercise price Outstanding at January 1, 2017 7,725,221 31.27 Exercised 2,818,363 29.12 Forfeited 122,154 32.82 Expired 1,474,938 41.66 Outstanding at December 31, 2017 3,309,766 28.41 Exercisable at December 31, 2017 3,309,766 28.41
Oustanding options [Text block]	Philips Group Outstanding options 2017 exercise price options intrinsic value in millions weighted average remaining contractual term EUR-denominated 10-15 1,013,941 17.4 3.7 yrs 15-20 27,042 0.4 4.0 yrs 20-25 1,731,227 15.6 2.6 yrs Outstanding options 2,772,210 33.4 3.0 yrs USD-denominated 15-20 993,732 18.8 3.6 yrs 20-25 42,728 0.7 3.4 yrs 25-30 860,950 7.0 3.3 yrs 30-35 834,242 3.8 1.9 yrs 35-40 578,114 0.7 0.3 yrs Outstanding options 3,309,766 31.1 2.5 yrs
Accelerate! options [Text block]	Philips Group Accelerate! options 2017 options weighted average exercise price EUR-denominated Outstanding at January 1, 2017 860,300 16.02 Exercised 379,100 15.97 Outstanding at December 31, 2017 481,200 16.06 Exercisable at December 31, 2017 481,200 16.06 USD-denominated Outstanding at January 1, 2017 257,800 20.02 Exercised 87,000 20.02 Outstanding at December 31, 2017 170,800 20.02 Exercisable at December 31, 2017 170,800 20.02

Information on remuneration (Ta

Information on remuneration (Tables)	12 Months Ended
	Dec. 31, 2017
Disclosure of information on remuneration [Abstract]
Remuneration costs of the Executive Committee [Text block]	Philips Group Remuneration costs of the Executive Committee 1 ) in EUR 2015 - 2017 2015 2016 2017 Base salary/Base compensation 5,974,928 6,388,667 8,089,063 Annual incentive 2 ) 2,705,560 5,746,347 6,345,576 Performance shares 3 ) 2,740,004 5,943,782 6,371,297 Stock options 3 ) 88,775 - - Restricted share rights 3 ) 91,339 764,311 885,343 Pension allowances 4 ) 2,193,409 1,854,129 1,886,963 Pension scheme costs 209,462 180,077 408,695 Other compensation 5 ) 1,094,546 1,556,514 1,861,803 1) 2) 3) 4) 5)
Remuneration costs of individual members of the Board of Management [Text block]	Philips Group Remuneration costs of individual members of the Board of Management in EUR 2015 - 2017 base salary annual 1 ) perfor­ 2 ) stock 2 ) restricted share 2 ) pension 3 ) pension other 4 ) total 2017 F.A. van Houten 1,205,000 1,270,166 1,975,277 - 4,034 537,621 25,278 84,053 5,101,429 A. Bhattacharya 687,500 553,392 669,396 - 888 210,450 25,278 100,918 2,247,822 P.A.J. Nota 5 ) 606,250 429,886 ( 1,203,992) - ( 188) 236,208 21,065 63,576 152,805 M.J. van Ginneken 91,667 69,168 100,022 - 75 27,796 4,213 13,120 306,061 2,590,417 2,322,612 1,540,703 - 4,809 1,012,075 75,834 261,667 7,808,117 2016 F.A. van Houten 1,197,500 1,354,227 1,423,538 - 12,041 536,195 24,838 126,703 4,675,042 A. Bhattacharya 650,000 540,072 362,758 - 3,341 201,524 24,838 73,642 1,856,175 P.A.J. Nota 702,500 619,745 683,101 - 9,251 277,649 24,838 56,558 2,373,642 2,550,000 2,514,044 2,469,397 - 24,633 1,015,368 74,514 256,903 8,904,859 2015 F.A. van Houten 1,168,750 768,920 1,273,940 17,713 28,279 529,387 25,241 78,035 3,890,265 A. Bhattacharya 23,551 11,937 8,968 - 183 7,315 886 998 53,838 R.H. Wirahadiraksa 664,583 239,250 ( 652,049) 12,045 ( 37,210) 290,772 24,002 29,477 570,870 P.A.J. Nota 672,500 383,112 605,749 12,045 21,964 270,529 26,302 104,918 2,097,119 2,529,384 1,403,219 1,236,608 41,803 13,216 1,098,003 76,431 213,428 6,612,092 1) 2017 Annual Incentive 2) 3) 4) 5)
Number of performance shares (holdings) [Text block]	Philips Group Number of performance shares (holdings) in number of shares 2017 January 1, awarded awarded realized December 31, vesting date F.A. van Houten 65,299 - - 69,544 - 04.28.2017 58,636 - 1,476 - 60,112 05.05.2018 61,336 - 1,544 - 62,880 04.29.2019 - 73,039 1,839 - 74,878 05.11.2020 A. Bhattacharya 11,830 1 ) - - 12,598 - 04.28.2017 12,476 1 ) - 314 - 12,790 05.05.2018 27,571 - 694 - 28,265 04.29.2019 - 31,822 801 - 32,623 05.11.2020 M.J. van Ginneken 16,267 1 ) - - 19,150 - 04.28.2017 18,714 1 ) - 471 - 19,185 05.05.2018 21,697 1 ) - 546 - 22,243 04.29.2019 - 18,563 1 ) 467 - 19,030 05.11.2020 Performance shares (holdings 293,826 123,424 8,152 101,292 332,006 1)
Stock options (holdings) [Text block]	Philips Group Stock options (holdings) in number of shares 2017 January 1, 2017 granted exercised expired December 31, 2017 grant share (closing) price on exercise date expiry date F.A. van Houten 20,400 1 ) - - - 20,400 22.88 - 10.18.2020 75,000 - - - 75,000 20.90 - 04.18.2021 75,000 - - - 75,000 14.82 - 04.23.2022 55,000 - - - 55,000 22.43 - 01.29.2023 A. Bhattacharya 16,500 1 ) - - - 16,500 22.88 - 10.18.2020 16,500 1 ) - - - 16,500 20.90 - 04.18.2021 20,000 1 ) - - - 20,000 15.24 - 01.30.2022 16,500 1 ) - - - 16,500 14.82 - 04.23.2022 M.J. van Ginneken 5,250 1 ) - - - 5,250 12.63 - 04.14.2019 6,720 1 ) - - - 6,720 24.90 - 04.19.2020 8,400 1 ) - - - 8,400 20.90 - 04.18.2021 10,000 1 ) - - - 10,000 15.24 - 01.30.2022 8,400 1 ) - - - 8,400 14.82 - 04.23.2022 Stock options (holdings) 333,670 - - - 333,670 1)
Accumulated annual pension entitlements and pension-related costs [Text block]	Philips Group Accumulated annual pension entitlements and pension-related costs in EUR 2017 age at December 31, 2017 accumulated annual pension as of December 31, 2017 1 ) total 2 ) F.A. van Houten 57 295,007 562,899 A. Bhattacharya 56 25,539 235,728 P.A.J. Nota 53 45,442 257,273 M.J. van Ginneken 44 37,359 32,009 Pension costs 1,087,909 1) 2)
Remuneration of the Supervisory Board [Text block]	Philips Group Remuneration of the Supervisory Board in EUR 2015 - 2017 membership committees other compensation 1 ) total 2017 2 ) J.A. van der Veer 135,000 25,000 7,000 167,000 C. Poon 90,000 32,500 17,000 139,500 H. von Prondzynski 80,000 32,500 19,500 132,000 J.P. Tai 80,000 32,500 32,000 144,500 N. Dhawan 80,000 13,000 27,000 120,000 O. Gadiesh 80,000 13,000 19,500 112,500 D.E.I. Pyott 80,000 23,000 32,000 135,000 625,000 171,500 154,000 950,500 2016 2 ) J.A. van der Veer 135,000 26,667 7,000 168,667 C. Poon 90,000 32,500 22,000 144,500 C.J.A. van Lede (Jan.-May) 3 ) 33,333 4,375 2,000 39,708 E. Kist (Jan.-May) 40,000 4,167 2,000 46,167 H. von Prondzynski 80,000 25,000 19,500 124,500 J.P. Tai 80,000 34,167 32,000 146,167 N. Dhawan 80,000 13,000 27,000 120,000 O. Gadiesh 80,000 13,000 19,500 112,500 D.E.I. Pyott 80,000 23,000 32,000 135,000 698,333 175,876 163,000 1,037,209 2015 2 ) J.A. van der Veer 135,000 31,667 7,000 173,667 C. Poon 90,000 17,500 15,000 122,500 C.J.A. van Lede 80,000 14,333 7,000 101,333 E. Kist 80,000 10,000 2,000 92,000 H. von Prondzynski 80,000 26,833 19,500 126,333 J.P. Tai 80,000 29,167 35,000 144,167 N. Dhawan 80,000 13,000 20,000 113,000 O. Gadiesh 80,000 13,000 17,000 110,000 D.E.I. Pyott (May-Dec.) 80,000 8,667 12,000 100,667 785,000 164,167 134,500 1,083,667 1) 2) 3)
Shares held by Board members [Text block]	Philips Group Shares held by Board members 1 ) in number of shares 2017 December 31, 2016 December 31, 2017 J. van der Veer 18,366 18,366 H. von Prondzynski 3,758 3,851 J.P. Tai 3,844 3,844 F.A. van Houten 189,824 233,119 A. Bhattacharya 42,913 53,974 M.J. van Ginneken 19,792 30,246 1)

Fair value of financial asset63

Fair value of financial assets and liabilities (Tables)	12 Months Ended
	Dec. 31, 2017
Disclosure of fair value of financial assets and liabilities [Abstract]
Fair value of financial assets and liabilities with hierarchy [Text block]	Philips Group Fair value of financial assets and liabilities in millions of EUR 2017 carrying amount estimated fair value Level 1 Level 2 Level 3 Financial assets Carried at fair value: Available-for-sale financial assets 446 446 49 29 368 Securities classified as assets held for sale 1,264 1,264 1,264 Fair value through profit and loss 27 27 23 4 Derivative financial instruments 78 78 78 Financial assets carried at fair value 1,815 1,815 1,313 130 372 Carried at (amortized) cost: Cash and cash equivalents 1,939 Loans and receivables Current loans receivable 2 Other non-current loans and receivables 114 Receivables - current 3,909 Receivables - non-current 130 Held-to-maturity investments 1 Financial assets carried at (amortized) costs 6,095 Total financial assets 7,909 1,815 1,313 130 372 Financial liabilities Carried at fair value: Derivative Financial instruments ( 383) ( 383) ( 383) Financial liabilities carried at fair value ( 383) ( 383) ( 383) Carried at (amortized) cost: Accounts payable ( 2,090) Interest accrual ( 38) Debt (Corporate bond and finance lease) ( 3,378) ( 3,860) ( 3,579) ( 281) Debt (other bank loans, overdraft, forward contracts etc.) ( 1,337) Financial liabilities carried at (amortized) costs ( 6,843) ( 3,860) ( 3,579) ( 281) Total financial liabilities ( 7,226) ( 4,243) ( 3,579) ( 665) Philips Group Fair value of financial assets and liabilities in millions of EUR 2016 carrying amount estimated fair value Level 1 Level 2 Level 3 Carried at fair value: Available-for-sale financial assets 172 172 36 29 107 Securities classified as assets held for sale 1 1 1 Fair value through profit and loss 27 27 24 3 Derivative financial instruments 160 160 160 Financial assets carried at fair value 360 360 36 213 111 Carried at (amortized) cost: Cash and cash equivalents 2,334 Loans and receivables Current loans receivable 101 101 101 Non-current loans and receivables 134 Loans to investment in associates Loans held for sale Receivables - current 5,327 Receivables - non-current 155 Held-to-maturity investments 2 Financial assets carried at (amortized) costs 8,053 101 101 Total financial assets 8,413 461 36 314 111 Financial liabilities Carried at fair value: Derivative financial instruments ( 873) ( 873) ( 873) Financial liabilities carried at fair value ( 873) ( 873) ( 873) Carried at (amortized) cost: Accounts payable ( 2,848) Interest accrual ( 68) Debt (Corporate bond and finance lease) ( 5,095) ( 5,474) ( 3,990) ( 1,484) Debt (other bank loans, overdraft etc.) ( 511) Financial liabilities carried at (amortized) costs ( 8,522) ( 5,474) ( 3,990) ( 1,484) Total financial liabilities ( 9,395) ( 6,347) ( 3,990) ( 2,357)
Reconciliation of the fair value hierarchy [Text block]	Philips Group Reconciliation of the fair value hierarchy in millions of EUR 2017 financial assets Balance as of January 1, 2017 111 Gains and losses recognized in: in profit or loss 2 in other comprehensive income ( 83) Purchase 356 Sales ( 10) Transfer to assets held for sale ( 4) Balance as of December 31, 2017 372
Financial assets subject to offsetting, enforcable master netting arrangements or similar agreements [Text block]	Philips Group Financial assets subject to offsetting, enforceable master netting arrangements or similar agreements in millions of EUR 2016 - 2017 2016 2017 Derivatives Gross amounts of recognized financial assets 160 78 Gross amounts of recognized financial liabilities offset in the balance sheet Net amounts of financial assets presented in the balance sheet 160 78 Related amounts not offset in the balance sheet Financial instruments ( 92) ( 38) Cash collateral received Net amount 68 39
Financial liabilities subject to offsetting, enforcable master netting arrangements or similar agreements [Text block]	Philips Group Financial liabilities subject to offsetting, enforceable master netting arrangements or similar agreements in millions of EUR 2016 - 2017 2016 2017 Derivatives Gross amounts of recognized financial liabilities ( 873) ( 383) Gross amounts of recognized financial assets offset in the balance sheet Net amounts of financial liabilities presented in the balance sheet ( 873) ( 383) Related amounts not offset in the balance sheet Financial instruments 92 38 Cash collateral received Net amount ( 781) ( 345)

Details of treasury risks (Tabl

Details of treasury risks (Tables)	12 Months Ended
	Dec. 31, 2017
Disclosure of details of treasury risks [Abstract]
Contractual cash obligations [Text block]	Philips Group Contractual cash obligations 1 2 ) in millions of EUR 2017 payments due by period total less than 1 year 1-3 years 3-5 years after 5 years Long-term debt 3 ) 4,314 465 1,170 878 1,801 Finance lease obligations 306 93 131 53 29 Short-term debt 120 120 Operating leases 741 172 226 147 196 Derivative liabilities 370 167 109 95 Interest on debt 1,785 132 252 226 1,175 Purchase obligations 4 ) 480 145 217 86 31 Trade and other payables 2,090 2,090 Contractual cash obligations 10,205 3,383 2,105 1,389 3,328 1) 2) 3) 4)
Estimated transaction exposure and related hedges [Text block]	Philips Group Estimated transaction exposure and related hedges in millions of EUR 2017 Receivables Payables exposure hedges exposure hedges Balance as of December 31, 2017 Exposure currency USD 1,217 ( 857) ( 583) 488 JPY 666 ( 369) ( 6) 5 CAD 272 ( 153) ( 8) 8 GBP 245 ( 147) ( 20) 20 CNY 178 ( 98) ( 86) 86 AUD 175 ( 100) CHF 117 ( 65) ( 1) 1 PLN 122 ( 73) SEK 73 ( 42) ( 1) 1 CZK 45 ( 25) RUB 41 ( 41) ( 2) 1 Others 244 ( 219) ( 160) 150 Total 2017 3,395 ( 2,189) ( 867) 760 Total 2016 4,211 ( 2,412) ( 1,764) 1,344
Credit risk with number of counterparties [Text block]	Philips Group Credit risk with number of counterparties for deposits above EUR 10 million 2017 10-100 million 100-500 million AA- rated bank counterparties 2 A+ rated bank counterparties 2 A rated bank counterparties 1 3 A- rated bank counterparties 1 1 8

Significant accounting polici65

Significant accounting policies - Text details (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Disclosure of significant accounting policies [Line items]
Impact on net income due to tax adjustments			€ 20
Impact on opening retained earnings due to tax adjustments		€ 55
Company [Member]
Disclosure of significant accounting policies [Line items]
Classification and measurement remaining available for sale equity investments carried at FVOCI	€ 130
IFRS 9 [Member]
Disclosure of significant accounting policies [Line items]
Redesignated financial asset as at fair value through profit or loss	21
Reclassification fair value OCI to retained earnings, available-for-sale financial assets	5
Classification and measurement remaining available for sale equity investments carried at FVOCI	396
Classification and measurement debt investments classified as available-for-sale impact	29
Classification and measurement debt investments classified as held-to-maturity measured at amortized cost impact	0.6
Classification and measurement impact on hold to collect and sell factored receivables	48
IFRS 9 [Member] | Company [Member]
Disclosure of significant accounting policies [Line items]
Redesignated financial asset as at fair value through profit or loss	14
Reclassification fair value OCI to retained earnings, available-for-sale financial assets	5
Classification and measurement debt investments classified as available-for-sale impact
Classification and measurement debt investments classified as held-to-maturity measured at amortized cost impact
Classification and measurement impact on hold to collect and sell factored receivables
IFRS 15 - Costs of obtaining a contract [Member]
Disclosure of significant accounting policies [Line items]
Impact on equity	51
Costs of obtaining a contract gross impact	68
Costs of obtaining a contract tax impact	17
IFRS 15 - Royalty income [Member]
Disclosure of significant accounting policies [Line items]
Deferred revenue recorded as an increase in retained earnings	34
Release of deferred tax assets	7
Impact on equity	25
IFRS 16 [Member]
Disclosure of significant accounting policies [Line items]
Off-balance operating lease obligations (undiscounted)	€ 741
Bottom of range [Member]
Disclosure of significant accounting policies [Line items]
Presumed significant influence, voting rights	20.00%
Top of range [Member]
Disclosure of significant accounting policies [Line items]
Presumed significant influence, voting rights	50.00%

Information by segment and ma66

Information by segment and main country - Text details (Detail)	12 Months Ended
	Dec. 31, 2017
Disclosure of operating segments [Abstract]
Share of sales for single customer	10.00%

Information by segment and ma67

Information by segment and main country - Information on income statement (Detail) - EUR (€) € in Millions		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Disclosure of operating segments [Line items]
Sales	[1]	€ 17,780	€ 17,422	€ 16,806
Sales including intercompany		17,780	17,422	16,806
Depreciation and amortization	[2]	1,025	976	972
Adjusted EBITA	[3]	2,153	1,921	1,688
Personal Health [Member]
Disclosure of operating segments [Line items]
Sales		7,310	7,099	6,751
Sales including intercompany		7,333	7,119	6,764
Depreciation and amortization	[2]	371	385	375
Adjusted EBITA	[3]	1,221	1,108	966
Diagnosis & Treatment [Member]
Disclosure of operating segments [Line items]
Sales		6,891	6,686	6,484
Sales including intercompany		6,953	6,741	6,531
Depreciation and amortization	[2]	267	229	249
Adjusted EBITA	[3]	716	631	515
Connected Care & Health Informatics [Member]
Disclosure of operating segments [Line items]
Sales		3,163	3,158	3,022
Sales including intercompany		3,200	3,213	3,080
Depreciation and amortization	[2]	208	184	198
Adjusted EBITA	[3]	372	324	294
HealthTech Other [Member]
Disclosure of operating segments [Line items]
Sales		415	478	503
Sales including intercompany		559	635	670
Depreciation and amortization	[2]	177	177	156
Adjusted EBITA	[3]	(109)	(66)	8
Legacy Items [Member]
Disclosure of operating segments [Line items]
Sales		1	1	46
Sales including intercompany		6	6	84
Depreciation and amortization	[2]	2	2	(7)
Adjusted EBITA	[3]	(48)	(76)	(95)
Inter-segment eliminations [Member]
Disclosure of operating segments [Line items]
Sales including intercompany		€ (269)	€ (292)	€ (323)
[1]	The sales are reported based on country of destination.
[2]	Includes impairments.
[3]	For reconciliation Adjusted EBITA, refer to the table below.

Information by segment and ma68

Information by segment and main country - Net income to Adjusted EBITA (Detail) - EUR (€) € in Millions		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Net income to Adjusted EBITA [Line items]
Net income		€ 1,870	€ 1,491	€ 638
Income from discontinued operations		(843)	(660)	(479)
Investments in associates, net of income taxes		(4)	11	30
Income tax expense continuing operations		349	203	169
Financial expenses		263	507	453
Financial income		126	65	94
Income (loss) from operations		1,517	1,464	658
Amortization of acquired intangible assets		260	242	273
Impairment of goodwill		9	1
EBITA		1,787	1,707	931
Restructuring and acquisition-related charges		316	94	186
Other items		50	120	571
Adjusted EBITA	[1]	2,153	1,921	1,688
Personal Health [Member]
Net income to Adjusted EBITA [Line items]
Income (loss) from operations		1,075	953	736
Amortization of acquired intangible assets		135	139	149
EBITA		1,211	1,092	885
Restructuring and acquisition-related charges		11	16	37
Other items				44
Adjusted EBITA	[1]	1,221	1,108	966
Diagnosis & Treatment [Member]
Net income to Adjusted EBITA [Line items]
Income (loss) from operations		488	546	322
Amortization of acquired intangible assets		55	48	55
EBITA		543	594	377
Restructuring and acquisition-related charges		151	37	131
Other items		22		7
Adjusted EBITA	[1]	716	631	515
Connected Care & Health Informatics [Member]
Net income to Adjusted EBITA [Line items]
Income (loss) from operations		206	275	173
Amortization of acquired intangible assets		44	46	54
Impairment of goodwill			1
EBITA		250	322	227
Restructuring and acquisition-related charges		91	14	38
Other items		31	(12)	29
Adjusted EBITA	[1]	372	324	294
HealthTech Other [Member]
Net income to Adjusted EBITA [Line items]
Income (loss) from operations		(149)	(129)	49
Amortization of acquired intangible assets		26	9	15
Impairment of goodwill		9
EBITA		(114)	(120)	64
Restructuring and acquisition-related charges		64	28	(19)
Other items		(59)	26	(37)
Adjusted EBITA	[1]	(109)	(66)	8
Legacy Items [Member]
Net income to Adjusted EBITA [Line items]
Income (loss) from operations		(103)	(181)	(622)
EBITA		(103)	(181)	(622)
Restructuring and acquisition-related charges			(1)	(1)
Other items		55	106	528
Adjusted EBITA	[1]	€ (48)	€ (76)	€ (95)
[1]	For reconciliation Adjusted EBITA, refer to the table below.

Information by segment and ma69

Information by segment and main country - Main countries (Detail) - EUR (€) € in Millions		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Disclosure of geographical areas [Line items]
Sales	[1]	€ 17,780	€ 17,422	€ 16,806
Tangible and intangible assets	[2]	12,644	14,605	14,538
Netherlands [Member]
Disclosure of geographical areas [Line items]
Sales	[1]	414	393	374
Tangible and intangible assets	[2]	1,154	1,007	970
United States [Member]
Disclosure of geographical areas [Line items]
Sales	[1]	6,084	5,948	5,742
Tangible and intangible assets	[2]	8,408	9,425	9,291
China [Member]
Disclosure of geographical areas [Line items]
Sales	[1]	2,322	2,210	2,132
Tangible and intangible assets	[2]	959	1,167	1,194
Germany [Member]
Disclosure of geographical areas [Line items]
Sales	[1]	1,011	965	929
Tangible and intangible assets	[2]	270	201	170
Japan [Member]
Disclosure of geographical areas [Line items]
Sales	[1]	1,059	1,103	962
Tangible and intangible assets	[2]	457	492	455
France [Member]
Disclosure of geographical areas [Line items]
Sales	[1]	530	513	487
Tangible and intangible assets	[2]	33	45	48
India [Member]
Disclosure of geographical areas [Line items]
Sales	[1]	425	399	431
Tangible and intangible assets	[2]	100	121	134
Other countries [Member]
Disclosure of geographical areas [Line items]
Sales	[1]	5,935	5,891	5,749
Tangible and intangible assets	[2]	€ 1,263	€ 2,147	€ 2,276
[1]	The sales are reported based on country of destination.
[2]	Consists of Property plant and equipment, Intangible assets excluding goodwill and Goodwill

Discontinued operations - Text

Discontinued operations - Text details (Detail) - EUR (€)	1 Months Ended		4 Months Ended	11 Months Ended	12 Months Ended
	Nov. 30, 2017	Jun. 30, 2017	Apr. 30, 2017	Nov. 28, 2017	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Discontinued operations [Line items]
Profit (loss) from discontinued operations					€ 843,000,000	€ 660,000,000	€ 479,000,000
Proceeds from disposal of non-current assets or disposal groups classified as held for sale and discontinued operations			€ 1,060,000,000
Reclassification adjustments on exchange differences on translation, before tax					191,000,000		(1,000,000)
Other non-current financial assets					587,000,000	335,000,000
Currency translation differences					393,000,000	1,234,000,000
Liabilities directly associated with assets held for sale					8,000,000	525,000,000
Impairment property, plant and equipment					(44,000,000)	(78,000,000)
Impairment of goodwill					9,000,000	1,000,000
Cash flows from (used in) financing activities, discontinued operations					(144,000,000)	1,226,000,000	(20,000,000)
Tax expense relating to profit (loss) from ordinary activities of discontinued operations					182,000,000	181,000,000	144,000,000
Cash flows from (used in) investing activities, discontinued operations					856,000,000	(112,000,000)	(203,000,000)
Current financial assets					2,000,000	101,000,000
Funai arbitration [Member]
Discontinued operations [Line items]
Cash flows from (used in) investing activities, discontinued operations						144,000,000
Discontinued operations [Member]
Discontinued operations [Line items]
Profit (loss) from discontinued operations					843,000,000	660,000,000	479,000,000
Discontinued operations [Member] | Deconsolidation Philips Lighting [Member]
Discontinued operations [Line items]
Cash flows from (used in) investing activities, discontinued operations				€ (175,000,000)
Discontinued operations [Member] | Property, plant and equipment [Member]
Discontinued operations [Line items]
Assets classified as held for sale					40,000,000
Discontinued operations [Member] | Net business impact [Member]
Discontinued operations [Line items]
Assets and liabilities directly associated with assets held for sale					44,000,000
Combined Lumileds and Automotive Lighting businesses [Member]
Discontinued operations [Line items]
Sale of stake		80.10%
Result on the sale of discontinued operations					(72,000,000)
Profit (loss) from discontinued operations					(29,000,000)	282,000,000	233,000,000
Income tax on the sale of discontinued operations					26,000,000
Proceeds from disposal of non-current assets or disposal groups classified as held for sale and discontinued operations	€ 1,067,000,000	€ 1,067,000,000
Profit (loss) before tax, discontinued operations					76,000,000	335,000,000	299,000,000
Reclassification adjustments on exchange differences on translation, before tax		63,000,000
Other non-current financial assets		305,000,000
Valuation step up to measure retained interest at its fair value					13,000,000
Gain (loss) discontinued operations tax		26,000,000			(72,000,000)
Assets and liabilities directly associated with assets held for sale		€ 1,533,000,000
Tax expense relating to profit (loss) from ordinary activities of discontinued operations					(25,000,000)	€ (53,000,000)	(66,000,000)
Operational result					159,000,000
Combined Lumileds and Automotive Lighting businesses [Member] | US Tax Cuts and Jobs Act [Member]
Discontinued operations [Line items]
Tax expense relating to profit (loss) from ordinary activities of discontinued operations					€ (107,000,000)
Philips Lighting [Member]
Discontinued operations [Line items]
Proportion of ownership in company					29.01%	71.23%
Result on the sale of discontinued operations				599,000,000
Profit (loss) from discontinued operations					€ 896,000,000	€ 244,000,000	247,000,000
Income tax on the sale of discontinued operations	€ 61,000,000				(61,000,000)
Proceeds from disposal of non-current assets or disposal groups classified as held for sale and discontinued operations				545,000,000
Profit (loss) before tax, discontinued operations					977,000,000	368,000,000	324,000,000
Derecognition non-controlling interest				1,481,000,000
Reclassification adjustments on exchange differences on translation, before tax				282,000,000
Non-current assets or disposal groups classified as held for sale				1,368,000,000
Valuation step up to measure retained interest at its fair value				638,000,000
Valuation loss related to retained earnings					104,000,000
Assets classified as held for sale				2,513,000,000
Net cash and cash equivalents of disposed asset held for sale				720,000,000
Cash flows from (used in) financing activities, discontinued operations						(1,200,000,000)
Tax expense relating to profit (loss) from ordinary activities of discontinued operations					150,000,000	124,000,000	77,000,000
Share price				€ 32.975	30.60
Philips Lighting [Member] | Retained earnings [Member]
Discontinued operations [Line items]
Non-current assets or disposal groups classified as held for sale					1,264,000,000
Other operations [Member]
Discontinued operations [Line items]
Profit (loss) from discontinued operations					€ (24,000,000)	134,000,000	€ (1,000,000)
Other operations [Member] | Audio, video, media and accessories business Funai contract breach [Member]
Discontinued operations [Line items]
Profit (loss) from discontinued operations						€ 144,000,000

Discontinued operations - Net o

Discontinued operations - Net of income taxes (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Discontinued operations [Line items]
Profit (loss) from discontinued operations	€ 843	€ 660	€ 479
Discontinued operations [Member]
Discontinued operations [Line items]
Profit (loss) from discontinued operations	843	660	479
Philips Lighting [Member]
Discontinued operations [Line items]
Profit (loss) from discontinued operations	896	244	247
Combined Lumileds and Automotive Lighting businesses [Member]
Discontinued operations [Line items]
Profit (loss) from discontinued operations	(29)	282	233
Other operations [Member]
Discontinued operations [Line items]
Profit (loss) from discontinued operations	€ (24)	€ 134	€ (1)

Discontinued operations - Resul

Discontinued operations - Results Lighting (Detail) - EUR (€) € in Millions	1 Months Ended	11 Months Ended	12 Months Ended
	Nov. 30, 2017	Nov. 28, 2017	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Discontinued operations [Line items]
Income tax expense, discontinued operations			€ 182	€ 181	€ 144
Results from discontinued operations			843	660	479
Discontinued operations [Member]
Discontinued operations [Line items]
Results from discontinued operations			843	660	479
Philips Lighting [Member]
Discontinued operations [Line items]
Sales			6,319	7,094	7,438
Costs and expenses			5,776	6,726	7,114
Result on the sale of discontinued operations		€ 599
Result on the sale of discontinued operations excluding income tax			538
Fair value adjustment retained interest			104
Income before taxes			977	368	324
Income tax expense, discontinued operations			150	124	77
Income tax on the sale of discontinued operations	€ 61		(61)
US tax reform act			8
Results from discontinued operations			€ 896	€ 244	€ 247

Discontinued operations - Res73

Discontinued operations - Results of combined Lumileds and Automative Lighting businesses (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Discontinued operations [Line items]
Income tax expense, discontinued operations	€ 182	€ 181	€ 144
Income from discontinued operations	843	660	479
Discontinued operations [Member]
Discontinued operations [Line items]
Income from discontinued operations	843	660	479
Combined Lumileds and Automotive Lighting businesses [Member]
Discontinued operations [Line items]
Sales	804	1,711	1,619
Costs and expenses	(630)	(1,376)	(1,320)
Result on the sale of discontinued operations net of tax	(98)
Income before taxes	76	335	299
Income tax expense, discontinued operations	(25)	(53)	(66)
Income tax on the sale of discontinued operations	26
US tax reform act	(107)
Income from discontinued operations	€ (29)	€ 282	€ 233

Discontinued operations - Cash

Discontinued operations - Cash flows (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Disclosure of discontinued operations [Abstract]
Cash flows from operating activities, discontinued operations	€ 350	€ 1,037	€ 761
Cash flows from investing activities, discontinued operations	856	(112)	(203)
Cash flows from financing activities, discontinued operations	(144)	1,226	(20)
Total discontinued operations cash flows	€ 1,063	€ 2,151	€ 537

Acquisitions and divestments -

Acquisitions and divestments - Text details (Detail) € in Millions		1 Months Ended	5 Months Ended	12 Months Ended
		Aug. 31, 2017EUR (€)	Dec. 31, 2017EUR (€)	Dec. 31, 2017EUR (€)	Dec. 31, 2016EUR (€)	Dec. 31, 2015EUR (€)	Aug. 09, 2017EUR (€)	Aug. 09, 2017$ / shares	Dec. 31, 2014EUR (€)
Acquisitions [Abstract]
Purchase of businesses, net of cash acquired				€ (2,344)	€ (197)	€ (1,118)
Aggregated net cash outflow for acquisitions				2,333	168
Aggregated impact on goodwill				1,548
Aggregated impact on other intangible assets				926
Goodwill			€ 7,731	7,731	8,898
Overall cash position (cash and cash equivalents)			1,939	1,939	2,334	1,766			€ 1,873
Sales	[1]			17,780	17,422	16,806
Income (loss) from operations				1,517	1,464	658
Profit (loss) of acquiree			(37)
Divestments [Abstract]
Aggregated net cash consideration for divestments				54	43
Proceeds from sale of interests in businesses, net of cash disposed of				€ 64	€ 0	€ 71
The Spectranetics Corporation [Member]
Acquisitions [Abstract]
Purchase of businesses, paid in cash, per share | $ / shares								$ 38.50
Net cash outflow for acquisitions		€ 1,908
Number of employees							900
Countries of presence		11
Cash transferred							€ 1,441
Payoff of certain debt		€ 378
Settlement of various other items		48
Settlement of outstanding stock options		€ 94
Goodwill							1,255
Cash and cash equivalents recognised as of acquisition date							53
Receivable and other current assets value adjustment							€ 3
Acquisition-related costs			25
Revenue (loss) of acquiree			€ 114
The Spectranetics Corporation [Member] | Customer relationships [Member]
Acquisitions [Abstract]
Cash flows associated with incremental profits related to excess earnings, discount rate				10.50%
The Spectranetics Corporation [Member] | Technology-based [Member] | Bottom of range [Member]
Acquisitions [Abstract]
Discount rate applied to cashflows				11.50%
The Spectranetics Corporation [Member] | Technology-based [Member] | Top of range [Member]
Acquisitions [Abstract]
Discount rate applied to cashflows				13.00%
Remaining nine acquisitions [Member]
Acquisitions [Abstract]
Aggregated net cash outflow for acquisitions				€ 425
Aggregated impact on goodwill				293
Aggregated impact on other intangible assets				252
Remaining nine acquisitions [Member] | Bottom of range [Member]
Acquisitions [Abstract]
Individual net cash outflow for acquisitions				3
Remaining nine acquisitions [Member] | Top of range [Member]
Acquisitions [Abstract]
Individual net cash outflow for acquisitions				€ 117
[1]	The sales are reported based on country of destination.

Acquisitions and divestments 76

Acquisitions and divestments - Spectranetics - Balance sheet (Detail) - The Spectranetics Corporation [Member] € in Millions	Aug. 09, 2017EUR (€)
Disclosure of acquisitions and divestments [Line items]
Goodwill as of acquisition date	€ 1,255
Intangible assets excluding goodwill	674
Property, plant and equipment	69
Deferred tax assets	135
Inventories	38
Receivables and other current assets as of acquisition date	42
Cash	53
Accounts payable and other payables	(49)
Deferred tax liabilities	(257)
Total assets and liabilities	1,960
Financed by equity at acquisition date	€ (1,960)

Acquisitions and divestments 77

Acquisitions and divestments - Spectranetics - Other intangible assets (Detail) - The Spectranetics Corporation [Member] € in Millions	Aug. 09, 2017EUR (€)
Disclosure of acquisitions and divestments [Line items]
Intangible assets excluding goodwill	€ 674
Customer relationships [Member]
Disclosure of acquisitions and divestments [Line items]
Intangible assets excluding goodwill	€ 372
Amortization period in years	20
Technology-based [Member]
Disclosure of acquisitions and divestments [Line items]
Intangible assets excluding goodwill	€ 297
Amortization period in years	15
Brand names [Member]
Disclosure of acquisitions and divestments [Line items]
Intangible assets excluding goodwill	€ 5
Amortization period in years	3

Acquisitions and divestments 78

Acquisitions and divestments - Pro-forma Statements of income for Spectranetics acquisition (unaudited) (Detail) - EUR (€) € in Millions		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Disclosure of acquisitions and divestments [Line items]
Sales	[1]	€ 17,780	€ 17,422	€ 16,806
Net income		1,870	€ 1,491	€ 638
Pro-forma adjustments for Spectranetics acquisition [Member]
Disclosure of acquisitions and divestments [Line items]
Sales		156
Net income		(40)
Pro-forma Philips Group after Spectranetics asjustments [Member]
Disclosure of acquisitions and divestments [Line items]
Sales		17,936
Net income		€ 1,830
[1]	The sales are reported based on country of destination.

Interests in entities - Text de

Interests in entities - Text details (Detail) - EUR (€) € in Millions	1 Months Ended	3 Months Ended	4 Months Ended	11 Months Ended	12 Months Ended
	Nov. 30, 2017	Apr. 28, 2017	Apr. 30, 2017	Nov. 28, 2017	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Unconsolidated structured entities [Line items]
Proceeds from disposal of non-current assets or disposal groups classified as held for sale and discontinued operations			€ 1,060
Increase (decrease) through changes in ownership interests in subsidiaries that do not result in loss of control, equity					€ 1,039	€ 825
Non-controlling interests					€ 24	€ 907	€ 118
Number of consolidated subsidiaries not wholly owned					4	5
Materiality threshold on group sales, income from operations or net income					5.00%
Philips Lighting [Member]
Unconsolidated structured entities [Line items]
Interest in entity					29.01%	71.23%
Number of shares sold	17,100,000	48,250,000
Increase (decrease) through changes in ownership interests in subsidiaries that do not result in loss of control, equity					€ 327
Difference between the proceeds and the carrying value of the shares sold in a transaction that do not result in loss of control					352
Costs related to the accelerated bookbuild in a transaction that do not result in loss of control					6
Certain reallocations of currency translation adjustments to non-controlling interests in a transaction that do not result in loss of control					19
Gain (loss) recognised on measurement to fair value less costs to sell or on disposal of assets or disposal groups constituting discontinued operation				€ 599
Philips Medical Capital LLC [Member]
Unconsolidated structured entities [Line items]
Stake in unconsolidated structured entity					€ 29	€ 25

Interests in entities - Interes

Interests in entities - Interest in group companies (Detail)	12 Months Ended
	Dec. 31, 2017
370 West Trimble Road LLC [Member]
Interests in group companies [Line items]
Legal entity name	370 West Trimble Road LLC
Principal country of business	United States
Metaaldraadlampenfabriek Volt B.V. [Member]
Interests in group companies [Line items]
Legal entity name	Metaaldraadlampenfabriek “Volt” B.V.
Principal country of business	Netherlands
Philips (China) Investment Company Ltd [Member]
Interests in group companies [Line items]
Legal entity name	Philips (China) Investment Company, Ltd.
Principal country of business	China
Philips Consumer Lifestyle BV [Member]
Interests in group companies [Line items]
Legal entity name	Philips Consumer Lifestyle B.V.
Principal country of business	Netherlands
Philips Domestic Appliances and Personal Care Company of Zhuhai SEZ, Ltd [Member]
Interests in group companies [Line items]
Legal entity name	Philips Domestic Appliances and Personal Care Company of Zhuhai SEZ, Ltd.
Principal country of business	China
Philips Electronics Hong Kong Limited [Member]
Interests in group companies [Line items]
Legal entity name	Philips Electronics Hong Kong Limited
Principal country of business	Hong Kong
Philips Electronics Nederland BV [Member]
Interests in group companies [Line items]
Legal entity name	Philips Electronics Nederland B.V.
Principal country of business	Netherlands
Philips Electronics UK Limited [Member]
Interests in group companies [Line items]
Legal entity name	Philips Electronics UK Limited
Principal country of business	United Kingdom
Philips GmbH [Member]
Interests in group companies [Line items]
Legal entity name	Philips GmbH
Principal country of business	Germany
Philips Japan Ltd [Member]
Interests in group companies [Line items]
Legal entity name	Philips Japan, Ltd.
Principal country of business	Japan
Philips Medical Systems Nederland BV [Member]
Interests in group companies [Line items]
Legal entity name	Philips Medical Systems Nederland B.V.
Principal country of business	Netherlands
Philips Medizin Systeme Hofheim-Wallau GmbH [Member]
Interests in group companies [Line items]
Legal entity name	Philips Medizin Systeme Hofheim-Wallau GmbH
Principal country of business	Germany
Philips North America LLC [Member]
Interests in group companies [Line items]
Legal entity name	Philips North America LLC
Principal country of business	United States
Philips Oral Healthcare LLC [Member]
Interests in group companies [Line items]
Legal entity name	Philips Oral Healthcare, LLC
Principal country of business	United States
Philips Ultrasound Inc [Member]
Interests in group companies [Line items]
Legal entity name	Philips Ultrasound, Inc.
Principal country of business	United States
Respironics Inc [Member]
Interests in group companies [Line items]
Legal entity name	Respironics, Inc.
Principal country of business	United States
RI Finance Inc [Member]
Interests in group companies [Line items]
Legal entity name	RI Finance, Inc.
Principal country of business	United States
RIC Investments LLC [Member]
Interests in group companies [Line items]
Legal entity name	RIC Investments, LLC
Principal country of business	United States

Interests in entities - Summari

Interests in entities - Summarized financial information for Philips Lighting (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Non-controlling interests [Line items]
Net income	€ 1,870	€ 1,491	€ 638
Philips Lighting [Member]
Non-controlling interests [Line items]
Sales to thirds	6,965	7,115
Net income	€ 281	€ 185

Interests in entities - Summa82

Interests in entities - Summarized income statement of Philips Lighting (unaudited) (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Non-controlling interests [Line items]
Income before taxes	€ 1,377	€ 1,034	€ 329
Net financial income and expense	(137)	(442)	(359)
Income tax expense continuing operations	349	203	169
Net income	1,870	1,491	€ 638
Philips Lighting [Member]
Non-controlling interests [Line items]
Sales to thirds	6,965	7,115
Income before taxes	441
Net financial income and expense	(43)
Income tax expense continuing operations	(117)
Net income	€ 281	€ 185

Interests in entities - Summa83

Interests in entities - Summarized net asset value of Philips Lighting (unaudited) (Detail) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Non-controlling interests [Line items]
Current assets	€ 10,117	€ 14,075
Non-current assets	15,198	18,195
Total assets	25,315	32,270
Current liabilities	6,866	10,473
Non-current liabilities	6,426	€ 8,344
Philips Lighting [Member]
Non-controlling interests [Line items]
Current assets	3,372
Non-current assets	3,306
Total assets	6,678
Current liabilities	(2,216)
Non-current liabilities	(2,140)
Total assets and liabilities	€ 2,321

Income from operations - Text d

Income from operations - Text details (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Income from operations [Line items]
Impairment of goodwill	€ 9	€ 1
Land and buildings [Member] | United States [Member]
Income from operations [Line items]
Income on disposal of fixed assets	€ 59

Income from operations - Sales

Income from operations - Sales and costs by nature (Detail) - EUR (€) € in Millions		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income from operations [Abstract]
Sales	[1]	€ 17,780	€ 17,422	€ 16,806
Raw materials and supplies		4,918	5,030	5,188
Employee benefit expenses		5,824	5,298	5,638
Depreciation and amortization	[2]	1,025	976	972
Shipping and handling		602	545	547
Advertising and promotion		939	915	862
Lease expenses, net		227	223	250
Other operational costs		2,804	2,963	2,751
Other business income (expense)		76	(6)	60
Income (loss) from operations		€ 1,517	€ 1,464	€ 658
[1]	The sales are reported based on country of destination.
[2]	Includes impairments.

Income from operations - Sale86

Income from operations - Sales and costs by nature (Detail Parenthetical) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income from operations [Abstract]
Lease-related fuel, electricity and taxes	€ 38	€ 30	€ 33
Government grants recognized	€ 90	€ 79	€ 58

Income from operations - Sale87

Income from operations - Sales composition (Detail) - EUR (€) € in Millions		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income from operations [Abstract]
Sales from goods		€ 13,974	€ 13,568	€ 13,175
Sales from services		3,477	3,478	3,215
Sales from royalties		329	375	416
Sales	[1]	€ 17,780	€ 17,422	€ 16,806
[1]	The sales are reported based on country of destination.

Income from operations - Sale88

Income from operations - Sales composition (Detail Parenthetical) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Income from operations [Abstract]
Revenue from sale of goods and services, presentation adjustment	€ 403	€ 178

Income from operations - Employ

Income from operations - Employee benefit expenses (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income from operations [Abstract]
Salaries and wages	€ 4,856	€ 4,422	€ 4,342
Post-employment benefits costs	347	279	705
Other social security and similar charges [Abstract]
Required by law	514	489	480
Voluntary	108	108	110
Employee benefit expenses	€ 5,824	€ 5,298	€ 5,638

Income from operations - Empl90

Income from operations - Employee benefit expenses (Detail Parenthetical) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Employee benefit expenses [Line items]
Employee benefits expense	€ 5,824	€ 5,298	€ 5,638
Share-based compensation expenses [Member]
Employee benefit expenses [Line items]
Employee benefits expense	€ 122	€ 95	€ 82

Income from operations - Empl91

Income from operations - Employees in FTEs (Detail)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income from operations [Line items]
Average number of employees	115,392	113,572	114,211
Continuing operations [Member]
Income from operations [Line items]
Average number of employees	71,895	69,602	65,882
Continuing operations [Member] | Employees [Member]
Income from operations [Line items]
Average number of employees	63,798	61,552	57,982
Continuing operations [Member] | Production [Member]
Income from operations [Line items]
Average number of employees	27,697	27,899	26,524
Continuing operations [Member] | Research & development [Member]
Income from operations [Line items]
Average number of employees	9,787	9,087	8,242
Continuing operations [Member] | Other [Member]
Income from operations [Line items]
Average number of employees	26,314	24,565	23,216
Continuing operations [Member] | 3rd party workers [Member]
Income from operations [Line items]
Average number of employees	8,098	8,050	7,900
Discontinued operations [Member]
Income from operations [Line items]
Average number of employees	43,497	43,971	48,330

Income from operations - Empl92

Income from operations - Employees per geographical location (Detail)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Number of employees [Line items]
Average number of employees	115,392	113,572	114,211
Continuing operations [Member]
Number of employees [Line items]
Average number of employees	71,895	69,602	65,882
Discontinued operations [Member]
Number of employees [Line items]
Average number of employees	43,497	43,971	48,330
Country of domicile [Member] | Continuing operations [Member]
Number of employees [Line items]
Average number of employees	11,308	11,199	7,589
Foreign countries [Member] | Continuing operations [Member]
Number of employees [Line items]
Average number of employees	60,587	58,403	58,292

Income from operations - Deprec

Income from operations - Depreciation and amortization (Detail) - EUR (€) € in Millions		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Depreciation and amortization [Line items]
Depreciation and amortization	[1]	€ 1,025	€ 976	€ 972
Property, plant and equipment [Member]
Depreciation and amortization [Line items]
Depreciation		437	458	422
Software [Member]
Depreciation and amortization [Line items]
Amortization		50	49	35
Other intangible assets [Member]
Depreciation and amortization [Line items]
Amortization		260	244	273
Product development [Member]
Depreciation and amortization [Line items]
Amortization		€ 277	€ 225	€ 242
[1]	Includes impairments.

Income from operations - Audit

Income from operations - Audit fees (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Audit fees [Line items]
Audit fees	€ 16.7	€ 18.4	€ 15.3
Audit-related fees	1.5	2.3	4.9
Tax fees	0	0	1.1
Other audit fees	0	0	0
Total audit fees	18.3	20.7	21.3
Consolidated financial statements [Member]
Audit fees [Line items]
Audit fees	12.5	13.4	9.8
Statutory financial statement [Member]
Audit fees [Line items]
Audit fees	4.2	5	5.5
Acquisitions and divestments [Member]
Audit fees [Line items]
Audit-related fees	0	0.9	3.6
Sustainability assurance [Member]
Audit fees [Line items]
Audit-related fees	0.7	0.7	0.6
Tax compliance services [Member]
Audit fees [Line items]
Tax fees	0	0	1.1
Other services [Member]
Audit fees [Line items]
Audit-related fees	0.8	0.7	0.7
Other audit fees	€ 0	€ 0	€ 0

Income from operations - Audi95

Income from operations - Audit fees (Detail Parenthetical) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Audit fees [Line items]
Audit-related fees	€ 1.5	€ 2.3	€ 4.9
Netherlands [Member]
Audit fees [Line items]
Audit-related fees	€ 9.2

Income from operations - Other

Income from operations - Other business income (expenses) (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Result on disposal of businesses [Abstract]
Income	€ 15	€ 1	€ 1
Expense	5	4	2
Result on disposal of fixed assets [Abstract]
Income	96	4	44
Expense	1	1	1
Result on other remaining businesses [Abstract]
Gains on disposals of other remaining business	41	13	44
Losses on disposals of other remaining business	62	17	27
Impairment of goodwill	(9)	(1)
Other business income (expense)	76	(6)	60
Other business income	152	17	89
Other business expenses	€ 76	€ 23	€ 30

Financial income and expenses -

Financial income and expenses - Text details (Detail) - EUR (€) € in Millions	1 Months Ended		12 Months Ended
	Jan. 31, 2017	Oct. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Financial income and expenses [Abstract]
Net financial income and expense			€ (137)	€ (442)	€ (359)
Increase (decrease) in financial income expense			(305)
Increase (decrease) in net interest expense			(117)	(2)
Impairment loss on financial assets			2	24	46
Financial charges related to early redemption of bonds	€ 62	€ 91
Finance income			126	65	94
Interest income			€ 40	€ 43	€ 44

Financial income and expenses98

Financial income and expenses - Financial income and expenses (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Financial income and expenses [Abstract]
Interest income		€ 40	€ 43	€ 44
Interest income from loans and receivables		12	15	18
Interest income from cash and cash equivalents		28	28	26
Dividend income from available for sale financial assets		64	4	6
Net gains from disposal of financial assets		1	3	20
Net change in fair value of financial assets at fair value through profit or loss		7		4
Other financial income		14	15	20
Financial income		126	65	94
Interest expense	€ 25	222	342	344
Interest on debt and borrowings		177	288	267
Finance charges under finance lease contract		8	7	6
Interest expenses - pensions		37	48	70
Provision-related accretion and interest		22	(44)	31
Net foreign exchange losses		2	1	10
Impairment loss on financial assets		2	24	46
Gains (losses) on financial assets at fair value through profit or loss			4
Other financial expenses		15	180	23
Financial expenses		263	507	453
Financial income and expenses		€ (137)	€ (442)	€ (359)

Income taxes - Text details (De

Income taxes - Text details (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Disclosure of income tax expense [Line items]
Income tax expense continuing operations	€ 349	€ 203	€ 169
Income tax expense, discontinued operations	€ 182	€ 181	€ 144
Maximum statutory tax rate	40.00%
Netherlands' statutory tax rate	25.00%	25.00%	25.00%
Average effective tax rate	25.30%	19.90%	56.40%
Weighted average statutory income tax rate	24.50%	23.30%	43.60%
Net deferred tax assets	€ 1,565	€ 2,692
Deferred tax assets	1,598	2,759
Deferred tax assets (rounded)		2,758
Deferred tax liabilities	33	66
Deferred tax asset when utilisation is dependent on future taxable profits in excess of profits from reversal of taxable temporary differences and entity has suffered loss in jurisdiction to which deferred tax asset relates	161	2,054
Decrease of net deferred tax assets	1,127
Temporary differences associated with investments in subsidiaries branches and associates and interests in joint ventures	290	685
Deductible temporary differences for which no deferred tax asset is recognised	42	€ 868
Deconsolidation Philips Lighting [Member]
Disclosure of income tax expense [Line items]
Decrease of net deferred tax assets	437
US Tax Cuts and Jobs Act [Member]
Disclosure of income tax expense [Line items]
Decrease of net deferred tax assets	200
US Tax Cuts and Jobs Act [Member] | Recognized in the equity statement [Member]
Disclosure of income tax expense [Line items]
Decrease of net deferred tax assets	29
US Tax Cuts and Jobs Act [Member] | Recognized in net income [Member]
Disclosure of income tax expense [Line items]
Decrease of net deferred tax assets	171
US Tax Cuts and Jobs Act [Member] | Discontinued operations [Member] | Recognized in net income [Member]
Disclosure of income tax expense [Line items]
Decrease of net deferred tax assets	99
Acquisitions [Member]
Disclosure of income tax expense [Line items]
Decrease of net deferred tax assets	186
Foreign currency translation [Member]
Disclosure of income tax expense [Line items]
Decrease of net deferred tax assets	€ 177

Income taxes - Income tax expen

Income taxes - Income tax expense (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Disclosure of income tax expense [Line items]
Income before taxes continuing operations	€ 1,381	€ 1,023	€ 299
Current tax (expense) benefit	(272)	(145)	(110)
Deferred tax (expense) benefit	(77)	(58)	(59)
Income tax expense continuing operations	349	203	169
Netherlands [Member]
Disclosure of income tax expense [Line items]
Income before taxes continuing operations	929	137	93
Current tax (expense) benefit	(15)	10	47
Deferred tax (expense) benefit	(150)	(95)	6
Income tax expense continuing operations	165	85	(53)
Foreign countries [Member]
Disclosure of income tax expense [Line items]
Income before taxes continuing operations	451	886	206
Current tax (expense) benefit	(258)	(155)	(157)
Deferred tax (expense) benefit	73	37	(65)
Income tax expense continuing operations	€ 184	€ 118	€ 222

Income taxes - Current income t

Income taxes - Current income tax expense (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income taxes [Abstract]
Current year tax (expense) benefit	€ (275)	€ (165)	€ (121)
Prior year tax (expense) benefit	3	20	11
Current tax (expense) benefit	€ (272)	€ (145)	€ (110)

Income taxes - Deferred income

Income taxes - Deferred income tax expense (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income taxes [Abstract]
Recognition of previously unrecognized tax loss and credit carryforwards	€ 32	€ 19	€ 4
Unrecognized tax loss and credit carryforwards	(9)	(56)	(9)
Unrecognized (Recognition of) temporary differences	35	31	(35)
Prior year tax	6	(1)	(6)
Tax rate changes	(72)	5	(19)
Origination and reversal of temporary differences, tax losses and tax credits	(69)	(56)	6
Deferred tax (expense) benefit	€ (77)	€ (58)	€ (59)

Income taxes - Effective income

Income taxes - Effective income tax rate (Detail)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income taxes [Abstract]
Weighted average statutory income tax rate	24.50%	23.30%	43.60%
Recognition of previously unrecognized tax loss and credit carryforwards rate	(2.30%)	(1.90%)	(1.40%)
Unrecognized tax loss and credit carryforwards rate	0.60%	5.50%	2.90%
Unrecognized (Recognition of) temporary differences rate	(2.60%)	(3.10%)	11.40%
Non-taxable income and tax incentives	(9.80%)	(8.20%)	(35.50%)
Non-deductible expenses	6.40%	9.30%	33.80%
Withholding and other taxes	4.00%	1.20%	8.30%
Tax rate changes	5.20%	(0.50%)	5.90%
Prior year tax	(0.60%)	(1.80%)	1.00%
Tax expenses (benefit) due to other tax liabilities	(1.70%)	(2.60%)	(12.70%)
Others, net	1.50%	(1.30%)	(1.00%)
Effective income tax rate	25.30%	19.90%	56.40%

Income taxes - Deferred tax ass

Income taxes - Deferred tax assets and liabilities (Detail) - EUR (€) € in Millions		12 Months Ended
		Dec. 31, 2017		Dec. 31, 2016		Dec. 31, 2015
Deferred tax assets and liabilities [Line items]
Deferred tax (expense) benefit		€ (77)		€ (58)		€ (59)
Net deferred tax assets		1,565		2,692
Intangible assets and goodwill [Member]
Deferred tax assets and liabilities [Line items]
Deferred tax liability (asset), beginning of period		(676)		(1,089)
Deferred tax (expense) benefit		549		450
Transfer to assets classified as held for sale		(28)
Other changes in deferred tax assets and liabilities		(228)	[1]	(36)	[2]
Deferred tax liability (asset), end of period		(383)		(676)		(1,089)
Net deferred tax assets		423		542
Net deferred tax liabilities		(806)		(1,218)
Property, plant and equipment [Member]
Deferred tax assets and liabilities [Line items]
Deferred tax liability (asset), beginning of period		10		19
Deferred tax (expense) benefit		15		1
Other changes in deferred tax assets and liabilities		(2)	[1]	(10)	[2]
Deferred tax liability (asset), end of period		23		10		19
Net deferred tax assets		39		64
Net deferred tax liabilities		(16)		(54)
Inventories [Member]
Deferred tax assets and liabilities [Line items]
Deferred tax liability (asset), beginning of period		347		312
Deferred tax (expense) benefit		(34)		24
Transfer to assets classified as held for sale		(52)
Other changes in deferred tax assets and liabilities		(29)	[1]	11	[2]
Deferred tax liability (asset), end of period		231		347		312
Net deferred tax assets		235		353
Net deferred tax liabilities		(4)		(6)
Other assets [Member]
Deferred tax assets and liabilities [Line items]
Deferred tax liability (asset), beginning of period		138		68
Deferred tax (expense) benefit		7		32
Transfer to assets classified as held for sale		(82)
Other changes in deferred tax assets and liabilities		12	[1]	37	[2]
Deferred tax liability (asset), end of period		74		138		68
Net deferred tax assets		96		161
Net deferred tax liabilities		(22)		(23)
Pensions and other employee benefits [Member]
Deferred tax assets and liabilities [Line items]
Deferred tax liability (asset), beginning of period		597		707
Deferred tax (expense) benefit		(126)		(138)
Transfer to assets classified as held for sale		(149)
Other changes in deferred tax assets and liabilities		(57)	[1]	27	[2]
Deferred tax liability (asset), end of period		265		597		707
Net deferred tax assets		265		598
Net deferred tax liabilities		0		(1)
Other liabilities [Member]
Deferred tax assets and liabilities [Line items]
Deferred tax liability (asset), beginning of period		989		981
Deferred tax (expense) benefit		(288)		(32)
Transfer to assets classified as held for sale		(8)
Other changes in deferred tax assets and liabilities		(158)	[1]	40	[2]
Deferred tax liability (asset), end of period		536		989		981
Net deferred tax assets		596		1,107
Net deferred tax liabilities		(61)		(118)
Deferred tax assets on taxLoss carryforwards [Member]
Deferred tax assets and liabilities [Line items]
Deferred tax liability (asset), beginning of period		1,288		1,562
Deferred tax (expense) benefit		(201)		(368)
Transfer to assets classified as held for sale		(125)
Other changes in deferred tax assets and liabilities		(144)	[1]	93	[2]
Deferred tax liability (asset), end of period		819		1,288		1,562
Net deferred tax assets		819		1,288
Net deferred tax liabilities		0		0
Set-off deffered tax positions [Member]
Deferred tax assets and liabilities [Line items]
Other changes in deferred tax assets and liabilities	[1]	0
Net deferred tax assets		(876)		(1,355)
Net deferred tax liabilities		876		1,355
Net deferred tax assets [Member]
Deferred tax assets and liabilities [Line items]
Deferred tax liability (asset), beginning of period		2,692		2,560
Deferred tax (expense) benefit		(77)		(30)
Transfer to assets classified as held for sale		(444)
Other changes in deferred tax assets and liabilities		(606)	[1]	162	[2]
Deferred tax liability (asset), end of period		1,565		2,692		€ 2,560
Net deferred tax assets		1,598		2,758
Net deferred tax liabilities		€ (33)		€ (66)
[1]	Other includes the movements of assets and liabilities recognized in OCI, which includes foreign currency translation differences and acquisitions, as well as the effects of US Tax Cuts and Jobs Act.
[2]	Other includes the movements of assets and liabilities recognized in OCI, which includes foreign currency translation differences, and acquisitions and divestments.

Income taxes - Expiry years of

Income taxes - Expiry years of net operating loss carryforwards (Detail) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Expiry years of net operating loss carryforwards [Line items]
Net operating loss carryforwards	€ 5,827	€ 5,830
Net operating loss and tax credit carryforwards for which no deferred tax asset has been recognized	3,351	1,170
2017 [Member]
Expiry years of net operating loss carryforwards [Line items]
Net operating loss carryforwards	0	14
Net operating loss and tax credit carryforwards for which no deferred tax asset has been recognized	0	0
2018 [Member]
Expiry years of net operating loss carryforwards [Line items]
Net operating loss carryforwards	3	4
Net operating loss and tax credit carryforwards for which no deferred tax asset has been recognized	3	3
2019 [Member]
Expiry years of net operating loss carryforwards [Line items]
Net operating loss carryforwards	5	58
Net operating loss and tax credit carryforwards for which no deferred tax asset has been recognized	2	10
2020 [Member]
Expiry years of net operating loss carryforwards [Line items]
Net operating loss carryforwards	15	137
Net operating loss and tax credit carryforwards for which no deferred tax asset has been recognized	6	21
2021 [Member]
Expiry years of net operating loss carryforwards [Line items]
Net operating loss carryforwards	14	37
Net operating loss and tax credit carryforwards for which no deferred tax asset has been recognized	2	3
2022 [Member]
Expiry years of net operating loss carryforwards [Line items]
Net operating loss carryforwards	1,843	0
Net operating loss and tax credit carryforwards for which no deferred tax asset has been recognized	1,809	0
Later than five years [Member]
Expiry years of net operating loss carryforwards [Line items]
Net operating loss carryforwards	2,134	3,503
Net operating loss and tax credit carryforwards for which no deferred tax asset has been recognized	410	14
Unlimited [Member]
Expiry years of net operating loss carryforwards [Line items]
Net operating loss carryforwards	1,812	2,077
Net operating loss and tax credit carryforwards for which no deferred tax asset has been recognized	€ 1,118	€ 1,118

Earnings per share - Earnings p

Earnings per share - Earnings per share (Detail) - EUR (€) € / shares in Units, € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Earnings per share [Abstract]
Income from continuing operations	€ 1,028	€ 831	€ 160
Net income attributable to non-controlling interests	214	43	14
Income from continuing operations attributable to shareholders	814	788	146
Income from discontinued operations	843	660	479
Net income attributable to shareholders	€ 1,657	€ 1,448	€ 624
Weighted average number of common shares	928,797,650	918,015,863	916,086,943
Incremental shares from assumed conversions [Abstract]
Incremental shares from assumed conversions of options	3,161,267	2,456,616	3,565,682
Incremental shares from assumed conversions of performance shares	10,757,785	6,985,509	2,479,923
Incremental shares from assumed conversions of restricted share rights	2,008,162	1,331,163	1,491,960
Incremental shares from assumed conversions of forward contracts	407,193
Dilutive potential common shares	16,334,406	10,773,289	7,537,565
Diluted weighted average number of shares (after deduction of treasury shares) during the year	945,132,056	928,789,152	923,624,508
Basic earnings per common share [Abstract]
Income from continuing operations	€ 1.11	€ 0.90	€ 0.17
Income from discontinued operations	0.91	0.72	0.52
Income from continuing operations attributable to shareholders	0.88	0.86	0.16
Net income attributable to shareholders	1.78	1.58	0.68
Diluted earnings per common share [Abstract]
Diluted earnings from continuing operations	1.09	0.89	0.17
Diluted earnings from discontinued operations	0.89	0.71	0.52
Income from continuing operations attributable to shareholders	0.86	0.85	0.16
Diluted earnings per commons share	1.75	1.56	0.68
Dividend paid per common share	€ 0.80	€ 0.80	€ 0.80

Earnings per share - Earning107

Earnings per share - Earnings per share (Detail Parenthetical) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Earnings per share [Abstract]
Securities potentially diluting basic EPS that were not included because the effect would have been antidilutive	€ 0	€ 9	€ 12

Property, plant and equipment -

Property, plant and equipment - Text details (Detail) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Property, plant and equipment [Abstract]
Land	€ 50	€ 73
Finance lease assets included in property, plant and equipment	281	271
Operating lease payments for sale-and-leaseback arrangements	€ 31	€ 32

Property, plant and equipmen109

Property, plant and equipment - Property, plant and equipment (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Property, plant and equipment [Line items]
Property, plant and equipment, beginning of period	€ 2,155	€ 2,322
Changes in property, plant and equipment [Abstract]
Capital expenditures	551	575
Assets available for use	0
Acquisitions	74
Depreciation	(434)	(528)
Impairment property, plant and equipment	(44)	(78)
Reclassifications	4
Transfer (to) from assets classified as held for sale	(596)	(100)
Translations differences and other	(120)	(36)
Total changes	(564)	(167)
Property, plant and equipment, end of period	1,591	2,155
Cost
Property, plant and equipment [Line items]
Property, plant and equipment, beginning of period	7,064	7,217
Changes in property, plant and equipment [Abstract]
Property, plant and equipment, end of period	4,408	7,064
Accumulated depreciation and amortisation [Member]
Property, plant and equipment [Line items]
Property, plant and equipment, beginning of period	(4,909)	(4,895)
Changes in property, plant and equipment [Abstract]
Property, plant and equipment, end of period	(2,818)	(4,909)
Land and buildings [Member]
Property, plant and equipment [Line items]
Property, plant and equipment, beginning of period	854	913
Changes in property, plant and equipment [Abstract]
Capital expenditures	17	14
Assets available for use	63	112
Acquisitions	0
Depreciation	(60)	(80)
Impairment property, plant and equipment	(1)	(25)
Reclassifications	39
Transfer (to) from assets classified as held for sale	(284)	(92)
Translations differences and other	(44)	12
Total changes	(270)	(59)
Property, plant and equipment, end of period	584	854
Land and buildings [Member] | Cost
Property, plant and equipment [Line items]
Property, plant and equipment, beginning of period	1,766	1,864
Changes in property, plant and equipment [Abstract]
Property, plant and equipment, end of period	1,111	1,766
Land and buildings [Member] | Accumulated depreciation and amortisation [Member]
Property, plant and equipment [Line items]
Property, plant and equipment, beginning of period	(912)	(951)
Changes in property, plant and equipment [Abstract]
Property, plant and equipment, end of period	(527)	(912)
Machinery and installations [Member]
Property, plant and equipment [Line items]
Property, plant and equipment, beginning of period	676	735
Changes in property, plant and equipment [Abstract]
Capital expenditures	128	142
Assets available for use	117	108
Acquisitions	71
Depreciation	(205)	(257)
Impairment property, plant and equipment	(32)	(40)
Reclassifications	(47)
Transfer (to) from assets classified as held for sale	(186)	(4)
Translations differences and other	(32)	(8)
Total changes	(185)	(59)
Property, plant and equipment, end of period	491	676
Machinery and installations [Member] | Cost
Property, plant and equipment [Line items]
Property, plant and equipment, beginning of period	3,222	3,260
Changes in property, plant and equipment [Abstract]
Property, plant and equipment, end of period	1,708	3,222
Machinery and installations [Member] | Accumulated depreciation and amortisation [Member]
Property, plant and equipment [Line items]
Property, plant and equipment, beginning of period	(2,546)	(2,525)
Changes in property, plant and equipment [Abstract]
Property, plant and equipment, end of period	(1,217)	(2,546)
Other equipment [Member]
Property, plant and equipment [Line items]
Property, plant and equipment, beginning of period	446	454
Changes in property, plant and equipment [Abstract]
Capital expenditures	86	101
Assets available for use	129	137
Acquisitions	3
Depreciation	(169)	(191)
Impairment property, plant and equipment	(11)	(13)
Reclassifications	9
Transfer (to) from assets classified as held for sale	(82)	(2)
Translations differences and other	(35)	(40)
Total changes	(70)	(8)
Property, plant and equipment, end of period	376	446
Other equipment [Member] | Cost
Property, plant and equipment [Line items]
Property, plant and equipment, beginning of period	1,897	1,873
Changes in property, plant and equipment [Abstract]
Property, plant and equipment, end of period	1,449	1,897
Other equipment [Member] | Accumulated depreciation and amortisation [Member]
Property, plant and equipment [Line items]
Property, plant and equipment, beginning of period	(1,451)	(1,419)
Changes in property, plant and equipment [Abstract]
Property, plant and equipment, end of period	(1,074)	(1,451)
Prepayments and construction in progress [Member]
Property, plant and equipment [Line items]
Property, plant and equipment, beginning of period	179	220
Changes in property, plant and equipment [Abstract]
Capital expenditures	320	318
Assets available for use	(309)	(357)
Impairment property, plant and equipment	0	0
Reclassifications	3
Transfer (to) from assets classified as held for sale	(44)	(2)
Translations differences and other	(9)	0
Total changes	(39)	(41)
Property, plant and equipment, end of period	140	179
Prepayments and construction in progress [Member] | Cost
Property, plant and equipment [Line items]
Property, plant and equipment, beginning of period	179	220
Changes in property, plant and equipment [Abstract]
Property, plant and equipment, end of period	€ 140	€ 179

Property, plant and equipmen110

Property, plant and equipment - Useful lives of property, plant and equipment (Detail)	12 Months Ended
	Dec. 31, 2017
Land and buildings [Member]
Property, plant and equipment [Line items]
Useful lives or depreciation rates property, plant and equipment	from 5 to 50 years
Machinery and installations [Member]
Property, plant and equipment [Line items]
Useful lives or depreciation rates property, plant and equipment	from 3 to 20 years
Other equipment [Member]
Property, plant and equipment [Line items]
Useful lives or depreciation rates property, plant and equipment	from 1 to 10 years

Property, plant and equipmen111

Property, plant and equipment - Operating lease - minimum payments under sale-and-leaseback arrangements (Detail) € in Millions	Dec. 31, 2017EUR (€)
2018 [Member]
Contractual obligations [Line items]
Minimum payments under sale-and-leaseback arrangements	€ 31
2019 [Member]
Contractual obligations [Line items]
Minimum payments under sale-and-leaseback arrangements	30
2020 [Member]
Contractual obligations [Line items]
Minimum payments under sale-and-leaseback arrangements	24
2021 [Member]
Contractual obligations [Line items]
Minimum payments under sale-and-leaseback arrangements	23
2022 [Member]
Contractual obligations [Line items]
Minimum payments under sale-and-leaseback arrangements	20
Thereafter [Member]
Contractual obligations [Line items]
Minimum payments under sale-and-leaseback arrangements	€ 91

Goodwill - Text details (Detail

Goodwill - Text details (Detail) € in Millions	12 Months Ended
	Dec. 31, 2017EUR (€)	Dec. 31, 2016EUR (€)	Aug. 09, 2017EUR (€)
Goodwill [Line items]
Acquisitions through business combinations, intangible assets and goodwill	€ 1,548	€ 140
Increase (decrease) through net exchange differences, intangible assets and goodwill	(836)	248
Goodwill	€ 7,731	€ 8,898
Home Monitoring [Member]
Goodwill [Line items]
Sensitivity pre-tax discount rate	90
Sensitivity compound long-term sales growth	(140)
Sensitivity terminal value	(12.00%)
Intangible assets and goodwill	€ 32
Population Health Management [Member]
Goodwill [Line items]
Sensitivity pre-tax discount rate	120
Sensitivity compound long-term sales growth	(400)
Sensitivity terminal value	(24.00%)
Intangible assets and goodwill	€ 187
Healthcare Informatics [Member]
Goodwill [Line items]
Sensitivity pre-tax discount rate	70
Sensitivity compound long-term sales growth	(150)
Sensitivity terminal value	(11.00%)
Intangible assets and goodwill	€ 174
The Spectranetics Corporation [Member]
Goodwill [Line items]
Acquisitions through business combinations, intangible assets and goodwill	1,255
Goodwill			€ 1,255
Remaining acquisitions (excluding Spectranetics) [Member]
Goodwill [Line items]
Acquisitions through business combinations, intangible assets and goodwill	€ 293

Goodwill - Goodwill (Detail)

Goodwill - Goodwill (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Goodwill [Line items]
Goodwill, beginning of period	€ 8,898
Changes in book value [Abstract]
Acquisitions	1,548	€ 140
Translation differences and other	(836)	248
Goodwill, end of period	7,731	8,898
Goodwill [Member]
Goodwill [Line items]
Goodwill, beginning of period	8,898	8,523
Changes in book value [Abstract]
Acquisitions	1,548	140
Divestments and transfers to assets classified as held for sale	(1,878)	(13)
Translation differences and other	(836)	248
Goodwill, end of period	7,731	8,898
Goodwill [Member] | Cost
Goodwill [Line items]
Goodwill, beginning of period	11,151	10,704
Changes in book value [Abstract]
Goodwill, end of period	9,074	11,151
Goodwill [Member] | Accumulated impairment [Member]
Goodwill [Line items]
Goodwill, beginning of period	(2,253)	(2,181)
Changes in book value [Abstract]
Goodwill, end of period	€ (1,343)	€ (2,253)

Goodwill - Goodwill allocated t

Goodwill - Goodwill allocated to the cash-generating units (Detail) - Goodwill [Member] - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Goodwill [Line items]
Intangible assets including goodwill	€ 7,731	€ 8,898	€ 8,523
Respiratory Care & Sleep Management [Member]
Goodwill [Line items]
Intangible assets including goodwill	1,819	1,958
Image-Guided Therapy [Member]
Goodwill [Line items]
Intangible assets including goodwill	2,242	1,106
Patient Care & Monitoring Solutions [Member]
Goodwill [Line items]
Intangible assets including goodwill	1,349	1,506
Professional [Member]
Goodwill [Line items]
Intangible assets including goodwill		1,671
Other (units carrying a non-significant goodwill balance) [Member]
Goodwill [Line items]
Intangible assets including goodwill	€ 2,321	€ 2,657

Goodwill - Impairment assumptio

Goodwill - Impairment assumptions (Detail)		12 Months Ended
		Dec. 31, 2017		Dec. 31, 2016
Image-Guided Therapy [Member]
Goodwill [Line items]
Initial forecast period		5.30%	[1]	7.10%	[2]
Extra-polation period		4.00%	[1],[3]	5.60%	[2],[4]
Used to calculate terminal value		2.30%	[1],[5]	2.70%	[2],[6]
Pre-tax discount rates		10.90%		12.10%
Patient Care & Monitoring Solutions [Member]
Goodwill [Line items]
Initial forecast period		3.80%	[1]	6.40%	[2]
Extra-polation period		4.80%	[1],[3]	4.60%	[2],[4]
Used to calculate terminal value		2.30%	[1],[5]	2.70%	[2],[6]
Pre-tax discount rates		12.30%		14.30%
Sleep & Respiratory Care [Member]
Goodwill [Line items]
Initial forecast period		7.20%	[1]	6.80%	[2]
Extra-polation period		5.60%	[1],[3]	4.60%	[2],[4]
Used to calculate terminal value		2.30%	[1],[5]	2.70%	[2],[6]
Pre-tax discount rates		12.10%		12.60%
Professional [Member]
Goodwill [Line items]
Initial forecast period	[2]			5.00%
Extra-polation period	[2],[4]			4.30%
Used to calculate terminal value	[2],[6]			2.70%
Pre-tax discount rates				13.90%
[1]	Compound sales growth rate is the annualized steady growth rate over the forecast period
[2]	Compound sales growth rate is the annualized steady growth rate over the forecast period
[3]	Also referred to later in the text as compound long-term sales growth rate
[4]	Also referred to later in the text as compound long-term sales growth rate
[5]	The historical long-term growth rate is only applied to the first year after the 5 year extrapolation period, after which no further growth is assumed for the terminal value calculation
[6]	The historical long-term growth rate is only applied to the first year after the 5 year extrapolation period, after which no further growth is assumed for the terminal value calculation

Intangible assets excluding 116

Intangible assets excluding goodwill - Text details (Detail) € in Millions	12 Months Ended
	Dec. 31, 2017EUR (€)	Dec. 31, 2016EUR (€)	Dec. 31, 2015EUR (€)
Intangible assets excluding goodwill [Line items]
Additions through internally generated assets for software	€ 450	€ 420
Intangible assets other than goodwill	3,322	3,552	€ 3,693
Computer software [Member]
Intangible assets excluding goodwill [Line items]
Additions through internally generated assets for software	86	56
Intangible assets other than goodwill	174	159	155
Computer software [Member] | Internally generated [Member]
Intangible assets excluding goodwill [Line items]
Additions through internally generated assets for software	77	52
Customer-related intangible assets [Member]
Intangible assets excluding goodwill [Line items]
Additions through internally generated assets for software	0
Intangible assets other than goodwill	€ 1,004	€ 1,241	1,399
Brand names, customer relationships, technology and other intangible assets [Member]
Intangible assets excluding goodwill [Line items]
Weighted average expected remaining life	9.6	7.9
Other intangible assets [Member]
Intangible assets excluding goodwill [Line items]
Additions through internally generated assets for software	€ 3	€ 5
Intangible assets other than goodwill	€ 21	€ 34	€ 24
Sleep & Respiratory Care [Member] | Customer-related intangible assets [Member]
Intangible assets excluding goodwill [Line items]
Amortization period in years	6	7.2
Intangible assets other than goodwill	€ 315	€ 427

Intangible assets excluding 117

Intangible assets excluding goodwill - Intangible assets excluding goodwill (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill, beginning of period	€ 3,552	€ 3,693
Changes in book value [Abstract]
Additions	450	420
Acquisitions	926	37
Amortization of intangible assets	(550)	(635)
Impairments	(83)	(27)
Assets available for use	0
Divestments and transfer to assets classified as held for sales	(721)
Translation differences	(252)	64
Total changes	(230)	(141)
Intangible assets excluding goodwill, end of period	3,322	3,552
Cost
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill, beginning of period	9,782	9,251
Changes in book value [Abstract]
Intangible assets excluding goodwill, end of period	8,042	9,782
Accumulated amortisation and impairment [Member]
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill, beginning of period	(6,230)	(5,558)
Changes in book value [Abstract]
Intangible assets excluding goodwill, end of period	(4,720)	(6,230)
Brand names [Member]
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill, beginning of period	455	520
Changes in book value [Abstract]
Acquisitions	7	1
Amortization of intangible assets	(40)	(50)
Divestments and transfer to assets classified as held for sales	(120)
Translation differences	(24)	(15)
Total changes	(178)	(65)
Intangible assets excluding goodwill, end of period	278	455
Brand names [Member] | Cost
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill, beginning of period	1,088	1,102
Changes in book value [Abstract]
Intangible assets excluding goodwill, end of period	670	1,088
Brand names [Member] | Accumulated amortisation and impairment [Member]
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill, beginning of period	(633)	(582)
Changes in book value [Abstract]
Intangible assets excluding goodwill, end of period	(392)	(633)
Customer relationships [Member]
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill, beginning of period	1,241	1,399
Changes in book value [Abstract]
Additions	0
Acquisitions	431	7
Amortization of intangible assets	(142)	(201)
Divestments and transfer to assets classified as held for sales	(438)
Translation differences	(89)	36
Total changes	(238)	(157)
Intangible assets excluding goodwill, end of period	1,004	1,241
Customer relationships [Member] | Cost
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill, beginning of period	3,429	3,324
Changes in book value [Abstract]
Intangible assets excluding goodwill, end of period	2,342	3,429
Customer relationships [Member] | Accumulated amortisation and impairment [Member]
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill, beginning of period	(2,188)	(1,925)
Changes in book value [Abstract]
Intangible assets excluding goodwill, end of period	(1,338)	(2,188)
Technology-based [Member]
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill, beginning of period	583	604
Changes in book value [Abstract]
Additions	23	41
Acquisitions	470	21
Amortization of intangible assets	(100)	(98)
Impairments	(12)	(1)
Divestments and transfer to assets classified as held for sales	(103)
Translation differences	(37)	15
Total changes	241	(21)
Intangible assets excluding goodwill, end of period	824	583
Technology-based [Member] | Cost
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill, beginning of period	2,074	1,977
Changes in book value [Abstract]
Intangible assets excluding goodwill, end of period	1,985	2,074
Technology-based [Member] | Accumulated amortisation and impairment [Member]
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill, beginning of period	(1,491)	(1,373)
Changes in book value [Abstract]
Intangible assets excluding goodwill, end of period	(1,161)	(1,491)
Product development [Member]
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill, beginning of period	537	501
Changes in book value [Abstract]
Amortization of intangible assets	(213)	(229)
Impairments	(43)	(20)
Assets available for use	363	270
Divestments and transfer to assets classified as held for sales	(23)
Translation differences	(35)	15
Total changes	49	36
Intangible assets excluding goodwill, end of period	586	537
Product development [Member] | Cost
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill, beginning of period	1,899	1,668
Changes in book value [Abstract]
Intangible assets excluding goodwill, end of period	1,848	1,899
Product development [Member] | Accumulated amortisation and impairment [Member]
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill, beginning of period	(1,362)	(1,167)
Changes in book value [Abstract]
Intangible assets excluding goodwill, end of period	(1,262)	(1,362)
Product development construction in progress [Member]
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill, beginning of period	542	491
Changes in book value [Abstract]
Additions	338	318
Amortization of intangible assets	0
Impairments	(27)	(4)
Assets available for use	(363)	(270)
Divestments and transfer to assets classified as held for sales	(11)
Translation differences	(43)	7
Total changes	(106)	51
Intangible assets excluding goodwill, end of period	436	542
Product development construction in progress [Member] | Cost
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill, beginning of period	578	522
Changes in book value [Abstract]
Intangible assets excluding goodwill, end of period	487	578
Product development construction in progress [Member] | Accumulated amortisation and impairment [Member]
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill, beginning of period	(36)	(31)
Changes in book value [Abstract]
Intangible assets excluding goodwill, end of period	(51)	(36)
Software [Member]
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill, beginning of period	159	155
Changes in book value [Abstract]
Additions	86	56
Acquisitions	2
Amortization of intangible assets	(52)	(55)
Impairments	(1)	(2)
Divestments and transfer to assets classified as held for sales	(19)
Translation differences	(1)	5
Total changes	15	4
Intangible assets excluding goodwill, end of period	174	159
Software [Member] | Cost
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill, beginning of period	580	522
Changes in book value [Abstract]
Intangible assets excluding goodwill, end of period	605	580
Software [Member] | Accumulated amortisation and impairment [Member]
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill, beginning of period	(421)	(367)
Changes in book value [Abstract]
Intangible assets excluding goodwill, end of period	(431)	(421)
Other intangible assets [Member]
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill, beginning of period	34	24
Changes in book value [Abstract]
Additions	3	5
Acquisitions	16	8
Amortization of intangible assets	(3)	(2)
Impairments		0
Divestments and transfer to assets classified as held for sales	(6)
Translation differences	(23)	1
Total changes	(13)	11
Intangible assets excluding goodwill, end of period	21	34
Other intangible assets [Member] | Cost
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill, beginning of period	134	135
Changes in book value [Abstract]
Intangible assets excluding goodwill, end of period	105	134
Other intangible assets [Member] | Accumulated amortisation and impairment [Member]
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill, beginning of period	(99)	(112)
Changes in book value [Abstract]
Intangible assets excluding goodwill, end of period	€ (84)	€ (99)

Intangible assets excluding 118

Intangible assets excluding goodwill - Estimated amortization expense for other intangible assets (Detail) - EUR (€) € in Millions		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Intangible assets excluding goodwill [Line items]
Depreciation and amortization	[1]	€ 1,025	€ 976	€ 972
Intangible assets excluding goodwill		3,322	€ 3,552	€ 3,693
2018 [Member]
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill		252
2019 [Member]
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill		243
2020 [Member]
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill		218
2021 [Member]
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill		192
2022 [Member]
Intangible assets excluding goodwill [Line items]
Intangible assets excluding goodwill		€ 185
[1]	Includes impairments.

Intangible assets excluding 119

Intangible assets excluding goodwill - Expected useful lives of the intangible assets excluding goodwill (Detail)	12 Months Ended
	Dec. 31, 2017
Brand names [Member]
Intangible assets excluding goodwill [Line items]
Expected useful lives of the intangible assets excluding goodwill	2-20
Customer relationships [Member]
Intangible assets excluding goodwill [Line items]
Expected useful lives of the intangible assets excluding goodwill	2-25
Technology-based [Member]
Intangible assets excluding goodwill [Line items]
Expected useful lives of the intangible assets excluding goodwill	3-20
Other intangible assets [Member]
Intangible assets excluding goodwill [Line items]
Expected useful lives of the intangible assets excluding goodwill	1-10
Software [Member]
Intangible assets excluding goodwill [Line items]
Expected useful lives of the intangible assets excluding goodwill	1-10
Product development [Member]
Intangible assets excluding goodwill [Line items]
Expected useful lives of the intangible assets excluding goodwill	3-7

Other financial assets - Text d

Other financial assets - Text details (Detail) - EUR (€) € in Millions	6 Months Ended	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Contractual obligations [Abstract]
Contractual capital commitments	€ 83	€ 83	€ 90
Current financial assets [Abstract]
Current financial assets	2	2	101
Changes in current financial assets		€ (99)
Combined Lumileds and Automotive Lighting businesses [Member] | Financial assets available-for-sale, category [Member]
Available-for-sale financial assets [Abstract]
Proportion of ownership interest in associate		19.10%
Financial assets available-for-sale	243	€ 243
Value adjustment	(49)
TPV Technology Limited [Member]
Current financial assets [Abstract]
Current financial assets	€ 90	90		€ 121
Changes in current financial assets		€ (90)

Other financial assets - Other

Other financial assets - Other non-current financial assets (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Other financial assets [Line items]
Other non-current financial assets, beginning of year	€ 335
Reclassifications	4
Other non-current financial assets, end of year	587	€ 335
Other non-current financial assets [Member]
Other financial assets [Line items]
Other non-current financial assets, beginning of year	335	489
Reclassifications	2
Acquisitions	374	73
Translation differences and other		11
Other non-current financial assets, end of year	587	335
Financial assets available-for-sale [Member]
Other financial assets [Line items]
Other non-current financial assets, end of year	446
Financial assets available-for-sale [Member] | Other non-current financial assets [Member]
Other financial assets [Line items]
Other non-current financial assets, beginning of year	172	232
Acquisitions	368	44
Translation differences and other		1
Other non-current financial assets, end of year		172
Loans and receivables [Member] | Other non-current financial assets [Member]
Other financial assets [Line items]
Other non-current financial assets, beginning of year	134	222
Reclassifications	2
Acquisitions	5	26
Translation differences and other		10
Other non-current financial assets, end of year	114	134
Held-to-maturity investments [Member] | Other non-current financial assets [Member]
Other financial assets [Line items]
Other non-current financial assets, beginning of year	2	2
Other non-current financial assets, end of year	1	2
Financial assets at fair value through profit or loss [Member] | Other non-current financial assets [Member]
Other financial assets [Line items]
Other non-current financial assets, beginning of year	27	33
Reclassifications	1
Acquisitions		3
Value adjustment	8
Other non-current financial assets, end of year	€ 27	€ 27

Other assets - Text details (De

Other assets - Text details (Detail) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Current assets [Member]
Other assets [Line items]
Prepaid expenses	€ 206	€ 258
Accrued income	186	228
Non-current assets [member]
Other assets [Line items]
Non-current prepaid expenses	€ 74	€ 90

Inventories - Text details (Det

Inventories - Text details (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Inventories [Abstract]
Inventory write-down	€ 150	€ 105

Inventories - Inventories (Deta

Inventories - Inventories (Detail) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Inventories [Abstract]
Raw materials and supplies	€ 715	€ 1,040
Work in process	358	446
Finished goods	1,280	1,906
Inventories	€ 2,353	€ 3,392

Receivables - Text details (Det

Receivables - Text details (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Receivables [Line items]
Current trade receivables	€ 3,609	€ 4,992
Other current receivables	278
Financial assets individually assessed for credit losses [Member]
Receivables [Line items]
Allowance account for credit losses of financial assets	197	289	€ 272
Diagnosis & Treatment [Member]
Receivables [Line items]
Customer financing	47	47
Current trade receivables	1,489	1,476
Legacy items US [Member]
Receivables [Line items]
Insurance receivables	47	€ 55
Investment in associates [Member]
Receivables [Line items]
Other current receivables	€ 22

Receivables - Accounts receivab

Receivables - Accounts receivables-net (Detail) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Receivables [Line items]
Accounts receivable	€ 3,609	€ 4,992
Personal Health [Member]
Receivables [Line items]
Accounts receivable	1,341	1,266
Diagnosis & Treatment [Member]
Receivables [Line items]
Accounts receivable	1,489	1,476
Connected Care & Health Informatics [Member]
Receivables [Line items]
Accounts receivable	706	664
HealthTech Other [Member]
Receivables [Line items]
Accounts receivable	€ 72	81
Lighting [Member]
Receivables [Line items]
Accounts receivable		1,477
Legacy Items [Member]
Receivables [Line items]
Accounts receivable		€ 28

Receivables - Aging analysis (D

Receivables - Aging analysis (Detail) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Disclosure of receivables [Line items]
Accounts receivable	€ 3,609	€ 4,992
Current [Member]
Disclosure of receivables [Line items]
Accounts receivable	3,046	4,273
Overdue 1-30 days [Member]
Disclosure of receivables [Line items]
Accounts receivable	256	267
Overdue 31-180 days [Member]
Disclosure of receivables [Line items]
Accounts receivable	242	310
Overdue > 180 days [Member]
Disclosure of receivables [Line items]
Accounts receivable	€ 63	€ 142

Receivables - Allowance for dou

Receivables - Allowance for doubtful accounts receivable (Detail) - Doubtful accounts receivable [Member] - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Disclosure of receivables [Line items]
Allowance to doubtful accounts, beginning of period	€ 318	€ 301	€ 227
Additions charged to expense	41	76	78
Deductions from allowance	(36)	(64)	(25)
Transfer to assets classified as held for sale	(92)
Other movements	(16)	5	21
Allowance to doubtful accounts, end of period	€ 215	€ 318	€ 301

Equity - Text details (Detail)

Equity - Text details (Detail) - EUR (€) € / shares in Units, € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Forward share repurchase contracts [Abstract]
Increase (decrease) in retained earnings	€ 61
Number of long-term-incentive-related shares purchased	2,250,000
Dividend distribution [Abstract]
Dividend paid per common share	€ 0.80	€ 0.80	€ 0.80
Limitations in the distribution of shareholders' equity [Abstract]
Group equity	€ 12,023	€ 13,453	€ 11,725	€ 10,933
Shareholder equity subject to limitations	€ 1,306	€ 2,181
Ordinary shares	188,000,000	186,000,000
Unrealized losses from available-for-sale financial assets	€ 30	€ 36
Legal reserves required by Dutch law	703	715
Currency translation differences	393	1,234
Cash flow hedges	€ 23	€ 10
EUR [Member]
Share call options [Abstract]
Number of call options unwound	5,268,741
Number of options outstanding	3,287,125
USD [Member]
Share call options [Abstract]
Number of call options unwound	2,661,016
Number of options outstanding	2,974,344
Common shares [Member]
Common shares [Abstract]
Number of shares issued and fully paid	940,909,027	929,644,864	931,130,387
Number of shares authorised	2,000,000,000	2,000,000,000	2,000,000,000
Par value per share	€ 0.20
Treasury shares [Member]
Limitations in the distribution of shareholders' equity [Abstract]
Group equity	€ (481)	€ (181)	€ (363)	(547)
Treasury shares [Member] | EUR [Member]
Treasury shares [Abstract]
Cash outflow for share purchase transactions related to employee option and share plans and reduction of share capital	642
Cash inflow for settlement of share-based compensation plans	€ 227
Preference shares [Member]
Common shares [Abstract]
Number of shares authorised	2,000,000,000	2,000,000,000	2,000,000,000
Purchased call options [Member]
Share call options [Abstract]
The net amount paid for number of shares bought back as a result of unwinding options and buying back shares	€ 160
The number of shares bought back after selling (unwinding) of options	7,929,757
Dividend distribution [Member]
Dividend distribution [Abstract]
Dividend paid per common share	€ 0.80	€ 0.80	€ 0.80
Dividend paid on common shares		€ 732	€ 730
Percentage of shareholders electing share dividend	48.00%	55.00%	59.00%
Number of shares issued	11,264,163	17,344,462	17,671,990
Settlement of cash dividend	€ 384	€ 330	€ 298
Proposed dividend per common share	€ 0.80
Dividend distribution [Member] | Bottom of range [Member]
Capital management [Abstract]
Dividend payout ratio	40.00%
Dividend distribution [Member] | Top of range [Member]
Capital management [Abstract]
Dividend payout ratio	50.00%
Dividend distribution [Member] | EUR [Member]
Dividend distribution [Abstract]
Dividend paid on common shares	€ 742
Non-controlling interests [Member]
Limitations in the distribution of shareholders' equity [Abstract]
Group equity	24	€ 907	€ 118	€ 101
Forward share repurchase contracts [Member]
Forward share repurchase contracts [Abstract]
Forward share buy-back initial	€ 81
Price per share for the unsettled part	€ 27.03
Forward price for unsettled (open) forward contracts	€ 998,000,000
Number of shares for the unsettled (open) forward contracts	31,020,000
Number of unsettled (open-committed) shares	750,000
Forward share repurchase contracts [Member] | Weighted average [Member]
Forward share repurchase contracts [Abstract]
Price per share for the unsettled part	€ 32.22

Equity - Outstanding number of

Equity - Outstanding number of shares (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Equity [Line items]
Purchase of treasury shares	€ (318)	€ (589)	€ (507)
Common shares [Member]
Equity [Line items]
Number of shares outstanding at beginning of period	922,436,563	917,103,586	914,388,869
Dividend distributed	11,264,163	17,344,462	17,671,990
Purchase of treasury shares, number of	(19,841,595)	(25,193,411)	(20,296,016)
Re-issuance of treasury shares, number of	12,332,592	13,181,926	5,338,743
Number of shares outstanding at end of period	926,191,723	922,436,563	917,103,586

Equity - Employee option and sh

Equity - Employee option and share plan transactions (Detail) - EUR (€) € / shares in Units, € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Equity [Line items]
Purchase of treasury shares	€ (318)	€ (589)	€ (507)
Treasury shares for share-based payments [Member]
Equity [Line items]
Shares acquired	15,222,662	8,601,426
Average market price	€ 31.81	€ 24.73
Purchase of treasury shares	€ 484	€ 213
Shares delivered	12,332,592	13,181,926	5,338,743
Average price (FIFO)	€ 27.07	€ 25.86	€ 30.35
Cost of delivered shares	€ 334	€ 341	€ 162
Number of treasury shares	10,098,371	7,208,301	11,788,801
Cost of treasury shares for employee options	€ 331	€ 181	€ 308

Equity - Share capital transact

Equity - Share capital transactions (Detail) - EUR (€) € / shares in Units, € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Equity [Line items]
Purchase of treasury shares	€ (318)	€ (589)	€ (507)
Treasury shares transactions [Member]
Equity [Line items]
Shares acquired	4,618,933	16,591,985	20,296,016
Average market price	€ 32.47	€ 23.84	€ 24.39
Purchase of treasury shares	€ 150	€ 396	€ 495
Reduction of treasury shares		18,829,985	21,361,016
Cancellation of treasury shares		€ 450	€ 517
Number of treasury shares	4,618,933		2,238,000
Total cost	€ 150		€ 55

Equity - Composition of net deb

Equity - Composition of net debt and group equity (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Equity [Abstract]
Long-term debt	€ 4,044	€ 4,021	€ 4,095
Short-term debt	672	1,585	1,665
Total debt	4,715	5,606	5,760
Cash and cash equivalents	1,939	2,334	1,766	€ 1,873
Net debt	2,776	3,272	3,994
Shareholders' equity	11,999	12,546	11,607
Non-controlling interests	24	907	118
Group equity	€ 12,023	€ 13,453	€ 11,725	€ 10,933
Net debt and group equity ratio	19:81 19:81	20:80 20:80	25:75 25:75

Debt - Text details (Detail)

Debt - Text details (Detail) € in Millions, $ in Millions

1 Months Ended

May 31, 2017EUR (€)

Jan. 31, 2017USD ($)

Dec. 31, 2017EUR (€)

Dec. 31, 2017USD ($)

Sep. 30, 2017EUR (€)

Aug. 31, 2017EUR (€)

Jun. 28, 2017EUR (€)

Apr. 21, 2017EUR (€)

Apr. 20, 2017EUR (€)

Jan. 31, 2017EUR (€)

Jan. 31, 2017USD ($)

Dec. 31, 2016

Debt [Line items]

Revolving credit facility (undrawn)

€ 1,000

Change of Control Triggering Event, potentially required purchase price related to principal amount

101.00%

101.00%

Credit facility entered with a consortium of international banks [Member]

Debt [Line items]

Notional amount

€ 300

$ 1,000

Borrowings, amount drawn | $

$ 1,000

Bonds due 2018 [Member]

Debt [Line items]

Borrowings, interest rate

5.75%

5.75%

Bonds due 2018, early redemption [Member]

Debt [Line items]

Notional amount | $

$ 1,250

Loan for the purpose of financing The Spectranetics Corporation acquisition and for general purposes [Member]

Debt [Line items]

Notional amount

€ 1,000

Floating-rate bonds issued [Member]

Debt [Line items]

Notional amount

€ 500

Fixed-rate bonds issued [Member]

Debt [Line items]

Notional amount

€ 500

Share buyback program anounced [Member]

Debt [Line items]

Notional amount

€ 1,500

Purchased forward contracts related to the share buyback program [Member]

Debt [Line items]

Notional amount

€ 998

Bank borrowings [Member] | Weighted average [Member]

Debt [Line items]

Borrowings, interest rate

3.30%

3.30%

5.40%

Philips Lighting [Member]

Debt [Line items]

Debt transferred to liabilities directly associated with assets held for sale

€ 1,341

Royal Philips NV [Member] | Commercial Paper Programme, undrawn [Member]

Debt [Line items]

Notional amount | $

$ 2,500

Royal Philips NV [Member] | Committed revolving credit facility [Member]

Debt [Line items]

Revolving credit facility (undrawn)

€ 1,000

Royal Philips NV [Member] | Former facility [Member]

Debt [Line items]

Revolving credit facility (undrawn)

€ 1,800

Debt - Long-term debt (Detail)

Debt - Long-term debt (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Disclosure of debt [Line items]
Current portion of non-current borrowings	€ 552	€ 1,375
Long-term debt	4,044	4,021	€ 4,095
Long-term borrowings including current portion of long-term borrowings [Member]
Disclosure of debt [Line items]
Current portion of non-current borrowings	552	1,375
Long-term debt including current portion of long-term debt	4,595	5,396	€ 4,245
Institutional financing [Member]
Disclosure of debt [Line items]
Current portion of non-current borrowings	71
Long-term debt including current portion of long-term debt	3,344	5,117
Bonds [Member] | EUR [Member]
Disclosure of debt [Line items]
Long-term debt including current portion of long-term debt	997
Bonds [Member] | USD [Member]
Disclosure of debt [Line items]
Long-term debt including current portion of long-term debt	2,137	3,608
Bank borrowings [Member]
Disclosure of debt [Line items]
Current portion of non-current borrowings	52
Long-term debt including current portion of long-term debt	190	1,470
Other long-term debt [Member]
Disclosure of debt [Line items]
Current portion of non-current borrowings	19
Long-term debt including current portion of long-term debt	20	39
Finance leases [Member]
Disclosure of debt [Line items]
Current portion of non-current borrowings	87
Long-term debt including current portion of long-term debt	281	279
Forward contract [Member]
Disclosure of debt [Line items]
Current portion of non-current borrowings	394
Long-term debt including current portion of long-term debt	970
2018 [Member]
Disclosure of debt [Line items]
Current portion of non-current borrowings	552
Later than one year [Member] | Long-term borrowings including current portion of long-term borrowings [Member]
Disclosure of debt [Line items]
Long-term debt	4,044	4,021
Later than one year [Member] | Institutional financing [Member]
Disclosure of debt [Line items]
Long-term debt	3,273
Later than one year [Member] | Bonds [Member] | EUR [Member]
Disclosure of debt [Line items]
Long-term debt	997
Later than one year [Member] | Bonds [Member] | USD [Member]
Disclosure of debt [Line items]
Long-term debt	2,137
Later than one year [Member] | Bank borrowings [Member]
Disclosure of debt [Line items]
Long-term debt	138
Later than one year [Member] | Other long-term debt [Member]
Disclosure of debt [Line items]
Long-term debt	1
Later than one year [Member] | Finance leases [Member]
Disclosure of debt [Line items]
Long-term debt	195
Later than one year [Member] | Forward contract [Member]
Disclosure of debt [Line items]
Long-term debt	576
Due in the next five years [Member]
Disclosure of debt [Line items]
Long-term debt including current portion of long-term debt	2,770	2,942
Later than five years [Member] | Long-term borrowings including current portion of long-term borrowings [Member]
Disclosure of debt [Line items]
Long-term debt	1,825	€ 2,454
Later than five years [Member] | Institutional financing [Member]
Disclosure of debt [Line items]
Long-term debt	1,801
Later than five years [Member] | Bonds [Member] | EUR [Member]
Disclosure of debt [Line items]
Long-term debt	496
Later than five years [Member] | Bonds [Member] | USD [Member]
Disclosure of debt [Line items]
Long-term debt	1,305
Later than five years [Member] | Other long-term debt [Member]
Disclosure of debt [Line items]
Long-term debt	0
Later than five years [Member] | Finance leases [Member]
Disclosure of debt [Line items]
Long-term debt	€ 24
Weighted average [Member] | Long-term borrowings including current portion of long-term borrowings [Member]
Disclosure of debt [Line items]
Borrowings, maturity	7.6	7.8
Interest rate	2.80%	4.10%
Weighted average [Member] | Institutional financing [Member]
Disclosure of debt [Line items]
Borrowings, maturity
Weighted average [Member] | Bonds [Member] | EUR [Member]
Disclosure of debt [Line items]
Borrowings, maturity	3.7
Interest rate	0.30%
Weighted average [Member] | Bonds [Member] | USD [Member]
Disclosure of debt [Line items]
Borrowings, maturity	13.3
Interest rate	5.40%
Weighted average [Member] | Bank borrowings [Member]
Disclosure of debt [Line items]
Borrowings, maturity	2.1
Interest rate	1.30%
Weighted average [Member] | Other long-term debt [Member]
Disclosure of debt [Line items]
Borrowings, maturity	1.1
Interest rate	0.90%
Weighted average [Member] | Finance leases [Member]
Disclosure of debt [Line items]
Borrowings, maturity	4.8
Interest rate	3.40%
Weighted average [Member] | Forward contract [Member]
Disclosure of debt [Line items]
Borrowings, maturity	1.2

Debt - Long-term debts due in t

Debt - Long-term debts due in the next five years (Detail) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Disclosure of debt [Line items]
Long-term debt	€ 4,044	€ 4,021	€ 4,095
Current portion of non-current borrowings	552	1,375
2018 [Member]
Disclosure of debt [Line items]
Current portion of non-current borrowings	552
2019 [Member]
Disclosure of debt [Line items]
Long-term debt	1,190
2020 [Member]
Disclosure of debt [Line items]
Long-term debt	103
2021 [Member]
Disclosure of debt [Line items]
Long-term debt	80
2022 [Member]
Disclosure of debt [Line items]
Long-term debt	846
Due in the next five years [Member]
Disclosure of debt [Line items]
Long-term debt including current portion of long-term debt	€ 2,770	€ 2,942

Debt - Unsecured Bonds (Detail)

Debt - Unsecured Bonds (Detail) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Disclosure of debt [Line items]
Long-term debt	€ 4,044	€ 4,021	€ 4,095
Unsecured bonds [Member]
Disclosure of debt [Line items]
Long-term debt	3,134	3,608
Unsecured bonds adjustments	(26)	(31)
Unsecured bonds [Member] | EUR [Member] | Due 9/06/2023; 1/2% [Member]
Disclosure of debt [Line items]
Long-term debt	€ 500
Unsecured bonds [Member] | EUR [Member] | Due 9/06/2023; 1/2% [Member] | Effective interest rate [Member]
Disclosure of debt [Line items]
Interest rate	0.634%
Unsecured bonds [Member] | EUR [Member] | Due 9/06/2019; 3M Euribor +20bps [Member]
Disclosure of debt [Line items]
Long-term debt	€ 500
Unsecured bonds [Member] | USD [Member] | Due 5/15/25; 7 3/4% [Member]
Disclosure of debt [Line items]
Long-term debt	€ 53	60
Unsecured bonds [Member] | USD [Member] | Due 5/15/25; 7 3/4% [Member] | Effective interest rate [Member]
Disclosure of debt [Line items]
Interest rate	7.429%
Unsecured bonds [Member] | USD [Member] | Due 6/01/26; 7 1/5% [Member]
Disclosure of debt [Line items]
Long-term debt	€ 114	130
Unsecured bonds [Member] | USD [Member] | Due 6/01/26; 7 1/5% [Member] | Effective interest rate [Member]
Disclosure of debt [Line items]
Interest rate	6.885%
Unsecured bonds [Member] | USD [Member] | Due 5/15/25; 7 1/8% [Member]
Disclosure of debt [Line items]
Long-term debt	€ 70	80
Unsecured bonds [Member] | USD [Member] | Due 5/15/25; 7 1/8% [Member] | Effective interest rate [Member]
Disclosure of debt [Line items]
Interest rate	6.794%
Unsecured bonds [Member] | USD [Member] | Due 3/11/18; 5 3/4% [Member]
Disclosure of debt [Line items]
Long-term debt		1,187
Unsecured bonds [Member] | USD [Member] | Due 3/11/38; 6 7/8% [Member]
Disclosure of debt [Line items]
Long-term debt	€ 668	758
Unsecured bonds [Member] | USD [Member] | Due 3/11/38; 6 7/8% [Member] | Effective interest rate [Member]
Disclosure of debt [Line items]
Interest rate	7.21%
Unsecured bonds [Member] | USD [Member] | Due 3/15/22; 3 3/4% [Member]
Disclosure of debt [Line items]
Long-term debt	€ 837	949
Unsecured bonds [Member] | USD [Member] | Due 3/15/22; 3 3/4% [Member] | Effective interest rate [Member]
Disclosure of debt [Line items]
Interest rate	3.906%
Unsecured bonds [Member] | USD [Member] | Due 3/15/42; 5% [Member]
Disclosure of debt [Line items]
Long-term debt	€ 418	€ 475
Unsecured bonds [Member] | USD [Member] | Due 3/15/42; 5% [Member] | Effective interest rate [Member]
Disclosure of debt [Line items]
Interest rate	5.273%

Debt - Finance lease liabilitie

Debt - Finance lease liabilities (Detail) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Finance lease liabilities [Line items]
Future minimum lease payments	€ 306	€ 307
Interest on lease	24	28
Present value of minimum lease	281	279
Less than one year [Member]
Finance lease liabilities [Line items]
Future minimum lease payments	93	93
Interest on lease	6	8
Present value of minimum lease	87	85
Between one and five years [Member]
Finance lease liabilities [Line items]
Future minimum lease payments	184	181
Interest on lease	14	15
Present value of minimum lease	170	166
Later than five years [Member]
Finance lease liabilities [Line items]
Future minimum lease payments	29	33
Interest on lease	4	5
Present value of minimum lease	€ 24	€ 28

Debt - Short-term debt (Detail)

Debt - Short-term debt (Detail) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Disclosure of debt [Abstract]
Short-term bank borrowings	€ 71	€ 207
Forward contracts	49
Other short-term loans		3
Current portion of long-term debt	552	1,375
Short-term debt	€ 672	€ 1,585	€ 1,665

Provisions - Text details (Deta

Provisions - Text details (Detail) € in Millions, $ in Millions	1 Months Ended			12 Months Ended
	Nov. 30, 2016EUR (€)	Nov. 30, 2016USD ($)	Oct. 31, 2014USD ($)	Dec. 31, 2017EUR (€)		Dec. 31, 2016EUR (€)		Dec. 31, 2015EUR (€)	Nov. 30, 2016USD ($)	Nov. 05, 2016USD ($)	Dec. 31, 2014EUR (€)
Disclosure of other provisions [Line items]
Unused provision reversed, other provisions				€ 88
Provisions				2,059		€ 3,606
Warranty provision [Member]
Disclosure of other provisions [Line items]
Provision used, other provisions				€ (270)		(357)		€ (357)
Provision utilization period				next year
Provisions				€ 201		259
Other provisions				201		259		289			€ 302
Other environment related provision [Member]
Disclosure of other provisions [Line items]
Provision used, other provisions				€ (21)		(24)		(24)
Provision utilization period				five years
Unused provision reversed, other provisions				€ (8)		(36)		(36)
Provisions				160		321
Other provisions				160		321		335			360
Other environment related provision [Member] | Not later than five years [Member]
Disclosure of other provisions [Line items]
Provision used, other provisions				55
Restructuring provision [Member]
Disclosure of other provisions [Line items]
Provision used, other provisions				(96)		(197)		(189)
Unused provision reversed, other provisions				(37)		(61)		(88)
Increase (decrease) through transfers and other changes, other provisions				(107)	[1]	4	[2]
Provisions				112		201
Other provisions				112		201		297			380
Legal proceedings provision [Member]
Disclosure of other provisions [Line items]
Provision used, other provisions				€ (52)		(313)		(186)
Provision utilization period				three years
Unused provision reversed, other provisions				€ (11)		(98)		(25)
Increase (decrease) through transfers and other changes, other provisions				2		(125)		0
Provisions				50		96
Other provisions				€ 50		96		€ 578			€ 653
Legal proceedings provision [Member] | Masimo Corporation [Member]
Disclosure of other provisions [Line items]
Losses on litigation settlements | $		$ 467	$ 467
Cash transferred	€ 280								$ 305	$ 300
Unused provision reversed, other provisions	79	86
Increase (decrease) through transfers and other changes, other provisions	€ 125	136
Donations and subsidies expense | $		5
Commitment for sales targets, marketing and product integration | $		$ 136
Other provisions [Member]
Disclosure of other provisions [Line items]
Provision utilization period				five years
Provisions for possible taxes, social security [Member]
Disclosure of other provisions [Line items]
Other provisions				€ 97		131
Provisions for rights of return [Member]
Disclosure of other provisions [Line items]
Provision utilization period				year
Other provisions				€ 37		46
Onerous contracts provision [Member]
Disclosure of other provisions [Line items]
Other provisions				€ 31		85
Provisions for employee jubilee funds [Member]
Disclosure of other provisions [Line items]
Provision utilization period				five years
Other provisions				€ 57		84
Self-insurance provisions [Member]
Disclosure of other provisions [Line items]
Other provisions				€ 48		77
Provisions for decommissioning, restoration and rehabilitation costs [Member]
Disclosure of other provisions [Line items]
Provision utilization period				five years
Other provisions				€ 32		48
Provisions for other employee benefits and obligatory severance payments [Member]
Disclosure of other provisions [Line items]
Other provisions				€ 24		38
Provisions for contingent considerations [Member]
Disclosure of other provisions [Line items]
Provision utilization period				five years
Other provisions				€ 66		€ 11
[1]	Other changes primarily relate to translation differences and reclassifications to liabilities directly associated with assets held for sale.
[2]	Other changes primarily relate to translation differences and transfers between segments

Provisions - Provisions (Detail

Provisions - Provisions (Detail) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Provisions [Line items]
Long-term provisions	€ 1,659	€ 2,926
Short-term provisions	400	680
Provisions	2,059	3,606
Post-employement benefit [Member]
Provisions [Line items]
Long-term provisions	973	1,996
Provisions	973	1,996
Warranty provision [Member]
Provisions [Line items]
Long-term provisions	44	66
Short-term provisions	157	193
Provisions	201	259
Other environment related provision [Member]
Provisions [Line items]
Long-term provisions	140	252
Short-term provisions	19	69
Provisions	160	321
Restructuring provision [Member]
Provisions [Line items]
Long-term provisions	25	27
Short-term provisions	87	174
Provisions	112	201
Legal proceedings provision [Member]
Provisions [Line items]
Long-term provisions	26	40
Short-term provisions	24	56
Provisions	50	96
Other provisions [Member]
Provisions [Line items]
Long-term provisions	451	545
Short-term provisions	113	188
Provisions	€ 564	€ 733

Provisions - Provisions for pro

Provisions - Provisions for product warranty (Detail) - Warranty provision [Member] - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Provisions [Line items]
Other provisions at beginning of period	€ 259	€ 289	€ 302
Changes [Abstract]
Additional provisions other provisions	283	325	327
Utilizations	(270)	(357)	(357)
Transfer to assets classified as held for sale	(56)
Translation differences and other	(16)	2	17
Other provisions at end of period	€ 201	€ 259	€ 289

Provisions - Environmental prov

Provisions - Environmental provisions (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Changes [Abstract]
Releases	€ 88
Reclassifications	4
Provisions for decommissioning, restoration and rehabilitation costs [Member]
Disclosure of other provisions [Line items]
Other provisions at beginning of period	48
Changes [Abstract]
Other provisions at end of period	32	€ 48
Other environment related provision [Member]
Disclosure of other provisions [Line items]
Other provisions at beginning of period	321	335	€ 360
Changes [Abstract]
Additional provisions other provisions	18	18	27
Utilizations	(21)	(24)	(24)
Releases	(8)	(36)	(36)
Changes in discount rate	11	11	(7)
Accretion	6	7	7
Translation differences and other	(20)	10	8
Transfer to assets classified as held for sale	(146)
Other provisions at end of period	€ 160	€ 321	€ 335

Provisions - Restructuring rela

Provisions - Restructuring related provisions (Detail) - EUR (€) € in Millions		12 Months Ended
		Dec. 31, 2017		Dec. 31, 2016		Dec. 31, 2015
Provisions [Line items]
Releases		€ 88
Restructuring provision [Member]
Provisions [Line items]
Other provisions at beginning of period		201		€ 297		€ 380
Additional provisions other provisions		150		158		194
Utilizations		(96)		(197)		(189)
Releases		(37)		(61)		(88)
Other changes		(107)	[1]	4	[2]
Other provisions at end of period		112		201		297
Personal Health [Member] | Restructuring provision [Member]
Provisions [Line items]
Other provisions at beginning of period		5		32		13
Additional provisions other provisions		14		7		30
Utilizations		(5)		(29)		(7)
Releases		(6)		(2)		(4)
Other changes		(1)	[1]	(3)	[2]
Other provisions at end of period		7		5		32
Diagnosis & Treatment [Member] | Restructuring provision [Member]
Provisions [Line items]
Other provisions at beginning of period		13		28		29
Additional provisions other provisions		46		11		30
Utilizations		(16)		(19)		(24)
Releases		(5)		(6)		(7)
Other changes		(1)	[1]	(1)	[2]
Other provisions at end of period		38		13		28
Connected Care & Health Informatics [Member] | Restructuring provision [Member]
Provisions [Line items]
Other provisions at beginning of period		13		21		16
Additional provisions other provisions		27		11		20
Utilizations		(12)		(14)		(12)
Releases		(6)		(6)		(3)
Other changes		(1)	[1]	1	[2]
Other provisions at end of period		20		13		21
HealthTech Other [Member] | Restructuring provision [Member]
Provisions [Line items]
Other provisions at beginning of period		37		38		87
Additional provisions other provisions		55		35		25
Utilizations		(27)		(16)		(32)
Releases		(16)		(19)		(41)
Other changes		(1)	[1]	(1)	[2]	(1)	[3]
Other provisions at end of period		47		37		38
Lighting [Member] | Restructuring provision [Member]
Provisions [Line items]
Other provisions at beginning of period		133		178		235
Additional provisions other provisions		9		95		89
Utilizations		(35)		(118)		(114)
Releases		(3)		(27)		(33)
Other changes		€ (104)	[1]	5	[2]	1	[3]
Other provisions at end of period				133		€ 178
Legacy Items [Member] | Restructuring provision [Member]
Provisions [Line items]
Additional provisions other provisions				(1)
Utilizations				(1)
Releases				(1)
Other changes	[2]			€ 3
[1]	Other changes primarily relate to translation differences and reclassifications to liabilities directly associated with assets held for sale.
[2]	Other changes primarily relate to translation differences and transfers between segments
[3]	Other changes primarily relate to translation differences and transfers between segments

Provisions - Litigation provisi

Provisions - Litigation provisions (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Changes [Abstract]
Releases	€ 88
Legal proceedings provision [Member]
Provisions [Line items]
Other provisions at beginning of period	96	€ 578	€ 653
Changes [Abstract]
Additional provisions other provisions	40	31	66
Utilizations	(52)	(313)	(186)
Releases	(11)	(98)	(25)
Other changes	2	(125)	0
Changes in discount rate		5	8
Accretion	3	8	12
Translation differences and other	(7)	10	50
Transfer to assets classified as held for sale	(21)
Other provisions at end of period	€ 50	€ 96	€ 578

Provisions - Other provisions (

Provisions - Other provisions (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Changes [Abstract]
Releases	€ 88
Other provisions [Member]
Provisions [Line items]
Other provisions at beginning of period	733	€ 604	€ 575
Changes [Abstract]
Additional provisions other provisions	304	183	198
Utilizations	(238)	(167)	(186)
Releases	(88)	(61)	(35)
Other changes	4	142	14
Liabilities directly associated with assets held for sale	(156)
Accretion	0	8	7
Acquisitions	62	0	24
Translation differences and other	(56)	24	7
Other provisions at end of period	€ 564	€ 733	€ 604

Post-employment benefits - Text

Post-employment benefits - Text details (Detail) € in Millions	12 Months Ended
	Dec. 31, 2018EUR (€)	Dec. 31, 2017EUR (€)	Dec. 31, 2016EUR (€)	Dec. 31, 2015EUR (€)
Post-employment benefits [Line items]
Post-employment benefit expense defined benefit plans		€ 95	€ 58	€ 566
Post-employment benefit expense defined contribution plans		€ 397	€ 392	299
Employer contributions	€ 30
Percentage of unquoted assets		37.00%	58.00%
Weighted average duration of defined-benefit obligation		12	11
Service cost	28
Interest expense	25	€ 222	€ 342	€ 344
Percentage of reasonably possible increase in actuarial assumption		1.00%
Actuarial assumption of mortality rates		10
Actuarial assumption of life expectancy after retirement		0.5
Cash outflow		€ 399
Unfunded defined-benefit plans [Member]
Post-employment benefits [Line items]
Cash outflow		40
Defined contribution plans [Member]
Post-employment benefits [Line items]
Employer contributions		329
Brazil [Member]
Post-employment benefits [Line items]
Gains (losses) arising from settlements net defined-benefit liability asset		1
Decrease of defined-benefit obligation due to settlement		345
Germany [Member]
Post-employment benefits [Line items]
Employer contributions	23
Germany [Member] | Unfunded defined-benefit plans [Member]
Post-employment benefits [Line items]
Cash outflow		19
Netherlands [Member] | Defined contribution plans [Member]
Post-employment benefits [Line items]
Employer contributions	166
United States [Member]
Post-employment benefits [Line items]
Employer contributions	0
De-risking contributions paid into pension plan		219
United States [Member] | Unfunded defined-benefit plans [Member]
Post-employment benefits [Line items]
Cash outflow		€ 9
United States [Member] | Defined contribution plans [Member]
Post-employment benefits [Line items]
Employer contributions	109
US and Germany [Member]
Post-employment benefits [Line items]
Percentage of total DBO that relate to the largest DB plans in these countries		89.00%
Other countries [Member]
Post-employment benefits [Line items]
Employer contributions	€ 7
Other countries [Member] | Unfunded defined-benefit plans [Member]
Post-employment benefits [Line items]
Cash outflow		€ 12
Other countries [Member] | Defined contribution plans [Member]
Post-employment benefits [Line items]
Employer contributions		€ 54

Post-employment benefits - Pre-

Post-employment benefits - Pre-tax costs for post-employment benefits (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016		Dec. 31, 2015
Disclosure of post-employment benefits [Line items]
Post-employment benefit expense defined benefit plans	€ 95	€ 58		€ 566
Post-employment benefit expense defined contribution plans	397	392		299
Post-employment benefits costs, pre-tax	492	450		865
Included in income from operations [Member]
Disclosure of post-employment benefits [Line items]
Post-employment benefit expense defined benefit plans	32	(19)	[1]	467
Post-employment benefit expense defined contribution plans	315	299		240
Included in financial expense [Member]
Disclosure of post-employment benefits [Line items]
Post-employment benefit expense defined benefit plans	37	48		70
Included in discontinued operations [Member]
Disclosure of post-employment benefits [Line items]
Post-employment benefit expense defined benefit plans	26	29		29
Post-employment benefit expense defined contribution plans	€ 82	€ 93		€ 59
[1]	The net income mainly relates to the settlement of the pension related legal claim in the UK.

Post-employment benefits - Defi

Post-employment benefits - Defined-benefit obligations (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Disclosure of post-employment benefits [Line items]
Interest expenses - pensions	€ 37	€ 48	€ 70
Present value of defined benefit obligation [Member]
Disclosure of post-employment benefits [Line items]
Net defined benefit liability (asset) beginning of period	4,987	4,757
Service cost	34	44
Interest expenses - pensions	126	189
Employee contributions	4	5
Actuarial gains (losses) [Abstract]
Demographic assumptions	(14)	(45)
Financial assumptions	75	208
Experience adjustment	(15)	(7)
(Negative) past service cost	1	(8)
Gains (losses) arising from settlements net defined-benefit liability asset	(348)	(85)
Benefits paid from plan	(172)	(239)
Benefits paid directly by employer	(52)	(76)
Transfer to Liabilities directly associated with assets held for sale	(1,210)
Translation differences and other	(307)	244
Net defined benefit liability (asset) end of period	3,109	4,987	€ 4,757
Present value of funded obligations, end of period	2,476	3,850
Present value of unfunded obligations	€ 633	€ 1,137

Post-employment benefits - Plan

Post-employment benefits - Plan assets (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Disclosure of post-employment benefits [Line items]
Interest expenses - pensions	€ 37	€ 48	€ 70
Plan assets [Member]
Disclosure of post-employment benefits [Line items]
Net defined benefit liability (asset) beginning of period	3,095	2,710
Interest expenses - pensions	87	137
Service cost	(2)	(3)
Return on plan assets excluding interest income	70	41
Employee contributions	4	5
Contributions to plan by employer net defined-benefit liability asset	263	246
Gains (losses) arising from settlements net defined-benefit liability asset	(348)	(33)
Benefits paid from plan	(172)	(239)
Transfer to assets classified as held for sale	(642)
Translation differences and other	(218)	231
Net defined benefit liability (asset) end of period	2,137	3,095	€ 2,710
Funded status	(972)	(1,892)
Unrecognized net assets		(105)
Net balance sheet position	€ (972)	€ (1,997)

Post-employment benefits - Chan

Post-employment benefits - Changes in the effect of the asset ceiling (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Disclosure of post-employment benefits [Line items]
Interest expenses - pensions	€ 37	€ 48	€ 70
Effect of asset ceiling [Member]
Disclosure of post-employment benefits [Line items]
Net defined benefit liability (asset) beginning of period	105	90
Interest expenses - pensions	4	14
Remeasurements	(100)	(21)
Translation differences and other	€ (9)	22
Net defined benefit liability (asset) end of period		€ 105	€ 90

Post-employment benefits - P152

Post-employment benefits - Plan assets allocation (Detail) - Plan assets [Member] - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Disclosure of post-employment benefits [Line items]
Liability asset of defined-benefit plans	€ 2,137	€ 3,095	€ 2,710
Assets quoted in active market [Member]
Disclosure of post-employment benefits [Line items]
Debt securities	1,142	1,085
Equity securities	69	91
Other	137	126
Assets not quoted in active market [Member]
Disclosure of post-employment benefits [Line items]
Debt securities	14	561
Equity securities	457	811
Other	€ 318	€ 421

Post-employment benefits - Assu

Post-employment benefits - Assumptions used to calculate the defined-benefit obligations (Detail)	Dec. 31, 2017	Dec. 31, 2016
Disclosure of post-employment benefits [Abstract]
Discount rate	2.80%	3.80%
Inflation rate	2.10%	2.60%
Salary increase	2.40%	3.30%

Post-employment benefits - Sens

Post-employment benefits - Sensitivity of key assumptions (Detail) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Discount rate (1% movement) [Member]
Sensitivity analysis for actuarial assumptions [Line items]
Increase	€ (323)	€ (544)
Decrease	394	645
Inflation rate (1% movement) [Member]
Sensitivity analysis for actuarial assumptions [Line items]
Increase	85	139
Decrease	(86)	(126)
Salary increase (1% movement) [Member]
Sensitivity analysis for actuarial assumptions [Line items]
Increase	20	27
Decrease	(19)	(23)
Longevity (1% movement) [Member]
Sensitivity analysis for actuarial assumptions [Line items]
Increase	€ 72	€ 143

Accrued liabilities - Accrued l

Accrued liabilities - Accrued liabilities (Detail) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Accrued liabilities [Line items]
Accruals	€ 2,319	€ 3,034
Salaries and wages [Member]
Accrued liabilities [Line items]
Accruals	529	684
Holiday entitlements [Member]
Accrued liabilities [Line items]
Accruals	109	154
Other personnel-related costs [Member]
Accrued liabilities [Line items]
Accruals	71	108
Gas, water, electricity, rent and other [Member]
Accrued liabilities [Line items]
Accruals	52	52
Communication and IT costs [Member]
Accrued liabilities [Line items]
Accruals	42	75
Distribution costs [Member]
Accrued liabilities [Line items]
Accruals	83	123
Commission payable [Member]
Accrued liabilities [Line items]
Accruals	7	22
Advertising and marketing-related costs [Member]
Accrued liabilities [Line items]
Accruals	174	183
Other sales-related costs [Member]
Accrued liabilities [Line items]
Accruals	38	55
Material-related costs [Member]
Accrued liabilities [Line items]
Accruals	110	142
Interest-related accruals [Member]
Accrued liabilities [Line items]
Accruals	38	68
Deferred income [Member]
Accrued liabilities [Line items]
Accruals	791	957
Other accrued liabilities [Member]
Accrued liabilities [Line items]
Accruals	€ 273	€ 411

Other liabilities - Other non-c

Other liabilities - Other non-current liabilities (Detail) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Other liabilities [Abstract]
Deferred income	€ 249	€ 251
Other tax liability	161	417
Other non-current liabilities	65	73
Other non-current liabilities	€ 474	€ 741

Other liabilities - Other curre

Other liabilities - Other current liabilities (Detail) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Other liabilities [Abstract]
Accrued customer rebates that cannot be offset with accounts receivables for those customers	€ 435	€ 593
Advances received from customers on orders not covered by work in process	372	451
Other taxes including social security premiums	164	208
Other current liabilities	155	120
Other current non-financial liabilities	€ 1,126	€ 1,372

Cash flow statement suppleme158

Cash flow statement supplementary information - Text details (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Cash flow statement [Line items]
Cash used for foreign exchange derivative contracts related to activities for liquidity management and funding	€ (295)	€ (128)	€ (194)
Net cash inflow from non-current financial assets	(36)	(39)	19
Current financial assets	2	101
TPV Technology Limited [Member]
Cash flow statement [Line items]
Current financial assets	€ 90		€ 121

Cash flow statement suppleme159

Cash flow statement supplementary information - Reconciliation of liabilities arising from financing activities (Detail) € in Millions	12 Months Ended
	Dec. 31, 2017EUR (€)
Long-term borrowings including current portion of long-term borrowings [Member]
Disclosure of reconciliation of liabilities arising from financing activities [Line items]
Liabilities arising from financing activities beginning of period	€ 5,396
Changes in liabilities arising from financing activities [Abstract]
Cash flow	(217)	[1]
Transfer to liabilities directly associated with assets held for sale	(1,255)
Currency effects and consolidation changes	(327)
Other non-cash	998
Liabilities arising from financing activities end of period	4,595
Bonds [Member] | EUR [Member]
Changes in liabilities arising from financing activities [Abstract]
Cash flow	997	[1]
Other non-cash	0
Liabilities arising from financing activities end of period	997
Bonds [Member] | USD [Member]
Disclosure of reconciliation of liabilities arising from financing activities [Line items]
Liabilities arising from financing activities beginning of period	3,608
Changes in liabilities arising from financing activities [Abstract]
Cash flow	(1,184)	[1]
Currency effects and consolidation changes	(287)
Other non-cash	1
Liabilities arising from financing activities end of period	2,137
Bank borrowings [Member]
Disclosure of reconciliation of liabilities arising from financing activities [Line items]
Liabilities arising from financing activities beginning of period	1,470
Changes in liabilities arising from financing activities [Abstract]
Cash flow	(22)	[1]
Transfer to liabilities directly associated with assets held for sale	(1,238)
Currency effects and consolidation changes	(21)
Other non-cash	0
Liabilities arising from financing activities end of period	190
Other long-term debt [Member]
Disclosure of reconciliation of liabilities arising from financing activities [Line items]
Liabilities arising from financing activities beginning of period	39
Changes in liabilities arising from financing activities [Abstract]
Cash flow	(20)	[1]
Transfer to liabilities directly associated with assets held for sale	0
Currency effects and consolidation changes	1
Other non-cash	(1)
Liabilities arising from financing activities end of period	20
Finance leases [Member]
Disclosure of reconciliation of liabilities arising from financing activities [Line items]
Liabilities arising from financing activities beginning of period	279
Changes in liabilities arising from financing activities [Abstract]
Cash flow	12	[1]
Transfer to liabilities directly associated with assets held for sale	(18)
Currency effects and consolidation changes	(20)
Other non-cash	29
Liabilities arising from financing activities end of period	281
Forward contracts long term [Member]
Changes in liabilities arising from financing activities [Abstract]
Other non-cash	970
Liabilities arising from financing activities end of period	970
Short-term borrowings [Member]
Disclosure of reconciliation of liabilities arising from financing activities [Line items]
Liabilities arising from financing activities beginning of period	210
Changes in liabilities arising from financing activities [Abstract]
Cash flow	(4)	[1]
Transfer to liabilities directly associated with assets held for sale	(86)
Currency effects and consolidation changes	(49)
Other non-cash	49
Liabilities arising from financing activities end of period	120
Short-term bank borrowings [Member]
Disclosure of reconciliation of liabilities arising from financing activities [Line items]
Liabilities arising from financing activities beginning of period	207
Changes in liabilities arising from financing activities [Abstract]
Cash flow	(3)	[1]
Transfer to liabilities directly associated with assets held for sale	(84)
Currency effects and consolidation changes	(49)
Liabilities arising from financing activities end of period	71
Other short-term loans [Member]
Disclosure of reconciliation of liabilities arising from financing activities [Line items]
Liabilities arising from financing activities beginning of period	2
Changes in liabilities arising from financing activities [Abstract]
Cash flow	(1)	[1]
Transfer to liabilities directly associated with assets held for sale	(2)
Currency effects and consolidation changes	0
Forward contracts short term [Member]
Changes in liabilities arising from financing activities [Abstract]
Other non-cash	49
Liabilities arising from financing activities end of period	49
Equity [Member]
Disclosure of reconciliation of liabilities arising from financing activities [Line items]
Liabilities arising from financing activities beginning of period	(181)
Changes in liabilities arising from financing activities [Abstract]
Cash flow	168	[1]
Other non-cash	(1,487)
Liabilities arising from financing activities end of period	(1,500)
Sale of Lighting shares net of costs [Member]
Changes in liabilities arising from financing activities [Abstract]
Cash flow	1,060	[1]
Other non-cash	(1,060)
Dividend payable [Member]
Changes in liabilities arising from financing activities [Abstract]
Cash flow	(478)	[1]
Other non-cash	478
Forward contracts equity [Member]
Changes in liabilities arising from financing activities [Abstract]
Other non-cash	(1,018)
Liabilities arising from financing activities end of period	(1,018)
Treasury shares [Member]
Disclosure of reconciliation of liabilities arising from financing activities [Line items]
Liabilities arising from financing activities beginning of period	(181)
Changes in liabilities arising from financing activities [Abstract]
Cash flow	(414)	[1]
Other non-cash	114
Liabilities arising from financing activities end of period	€ (481)
[1]	Cash flow includes cash movements related to Lighting from January to April 2017, and therefore does not equal cash flow from financing activities in the consolidated statements of cash flows.

Contingent assets and liabil160

Contingent assets and liabilities - Text details (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2012	Dec. 05, 2012
Contingent liabilities [Line items]
Fair value of guarantees recognized on the balance sheet
Increase (decrease) of off-balance-sheet business and credit-related guarantees provided on behalf of third parties and associates	(11)
Off-balance-sheet business and credit-related guarantees provided on behalf of third parties and associates	€ 17	€ 28
Cathode Ray Tubes (CRT) [Member]
Contingent liabilities [Line items]
Fine imposed				€ 313
Company and LG Electronics Inc [Member]
Contingent liabilities [Line items]
Fine imposed				€ 392
Legal proceedings [Member] | Company and LG Electronics Inc [Member]
Contingent liabilities [Line items]
Fine payable recognized			€ 509

Related-party transactions - Te

Related-party transactions - Text details (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Related party transactions [Abstract]
Non-recourse third-party receivables sold to PMC US	€ 151	€ 139	€ 129

Related-party transactions - Re

Related-party transactions - Related-party transactions (Detail) - EUR (€) € in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Related party transactions [Abstract]
Sales of goods and services	€ 196	€ 207	€ 222
Purchases of goods and services	62	81	87
Receivables from related parties	127	33	16
Payables to related parties	€ 36	€ 3	€ 4

Share-based compensation - Text

Share-based compensation - Text details (Detail)	1 Months Ended	12 Months Ended
	Jan. 31, 2013	Dec. 31, 2017EUR (€)shares	Dec. 31, 2017USD ($)shares	Dec. 31, 2016EUR (€)	Dec. 31, 2015EUR (€)	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)
Disclosure of share-based compensation [Line items]
Share-based compensation costs		€ 122,000,000		€ 95,000,000
Percentage of additional premium shares	20.00%
Top of range [Member]
Disclosure of share-based compensation [Line items]
Share-based compensation costs					€ 82,000,000
EUR [Member]
Disclosure of share-based compensation [Line items]
Weighted average remaining contractual life of outstanding share options		3				3
Intrinsic value of liabilities from share-based payment transactions for which counterparty's right to cash or other assets vested		€ 33.4
EUR [Member] | Top of range [Member]
Disclosure of share-based compensation [Line items]
Expense from share-based payment transactions with employees		151,000,000
Employee stock purchase plan		€ 7,000,000
USD [Member]
Disclosure of share-based compensation [Line items]
Weighted average remaining contractual life of outstanding share options		2.5				2.5
Intrinsic value of liabilities from share-based payment transactions for which counterparty's right to cash or other assets vested		€ 31.1
Combined Lumileds and Automotive Lighting businesses [Member] | EUR [Member] | Top of range [Member]
Disclosure of share-based compensation [Line items]
Share-based compensation costs		€ 42,000,000
Performance share plans [Member]
Disclosure of share-based compensation [Line items]
Risk free interest rate, share options granted		(0.60%)	(0.60%)
Expected volatility, share options granted		23.00%	23.00%
Performance share plans [Member] | Top of range [Member]
Disclosure of share-based compensation [Line items]
Comparison group for performance shares		20	20	20	21
Cost recognition period (weighted average)		1.7	1.7
Performance share plans [Member] | EUR [Member]
Disclosure of share-based compensation [Line items]
Dividend declared on outstanding shares | shares		402,240	402,240
Performance share plans [Member] | EUR [Member] | Top of range [Member]
Disclosure of share-based compensation [Line items]
Unrecognized compensation costs related to non-vested shares		€ 103,000,000
Performance share plans [Member] | USD [Member]
Disclosure of share-based compensation [Line items]
Dividend declared on outstanding shares | shares		258,493	258,493
Restricted shares [Member]
Disclosure of share-based compensation [Line items]
Percentage of additional premium shares		20.00%	20.00%
Restricted shares [Member] | Top of range [Member]
Disclosure of share-based compensation [Line items]
Unrecognized compensation costs related to non-vested shares		€ 40,000,000
Restricted shares [Member] | EUR [Member]
Disclosure of share-based compensation [Line items]
Dividend declared on outstanding shares | shares		83,184	83,184
Restricted shares [Member] | USD [Member]
Disclosure of share-based compensation [Line items]
Dividend declared on outstanding shares | shares		79,537	79,537
Restricted shares [Member] | Philips Group [Domain] | Top of range [Member]
Disclosure of share-based compensation [Line items]
Cost recognition period (weighted average)		1.4	1.4
Option plans [Member] | EUR [Member]
Disclosure of share-based compensation [Line items]
Weighted average remaining contractual life of outstanding share options		3				3
Option plans [Member] | EUR [Member] | Bottom of range [Member]
Disclosure of share-based compensation [Line items]
Exercise price of outstanding share options		€ 12.63
Option plans [Member] | EUR [Member] | Top of range [Member]
Disclosure of share-based compensation [Line items]
Exercise price of outstanding share options		32.04
Option plans [Member] | Philips Group [Domain] | EUR [Member]
Disclosure of share-based compensation [Line items]
Intrinsic value of liabilities from share-based payment transactions for which counterparty's right to cash or other assets vested		29,000,000		€ 20,000,000	€ 21,000,000
Aggregate intrinsic value of liabilities from share-pased payments		33,000,000
Cash received from exercises		128,000,000		65,000,000	72,000,000
Tax deductions realized as a result of option exercises		€ 5,000,000		2,000,000	€ 3,000,000
Option plans [Member] | Philips Group [Domain] | USD [Member]
Disclosure of share-based compensation [Line items]
Weighted average remaining contractual life of outstanding share options		2.5				2.5
Intrinsic value of liabilities from share-based payment transactions for which counterparty's right to cash or other assets vested | $						$ 22,000,000	$ 6,000,000	$ 8,000,000
Aggregate intrinsic value of liabilities from share-pased payments | $			$ 31,000,000
Option plans [Member] | Philips Group [Domain] | USD [Member] | Bottom of range [Member]
Disclosure of share-based compensation [Line items]
Exercise price of outstanding share options | $						16.76
Option plans [Member] | Philips Group [Domain] | USD [Member] | Top of range [Member]
Disclosure of share-based compensation [Line items]
Exercise price of outstanding share options | $						$ 44.15
Accelerate options [Member] | Philips Group [Domain] | EUR [Member]
Disclosure of share-based compensation [Line items]
Weighted average remaining contractual life of outstanding share options		4.2				4.2
Intrinsic value of liabilities from share-based payment transactions for which counterparty's right to cash or other assets vested		€ 6,000,000		4,000,000
Aggregate intrinsic value of liabilities from share-pased payments		7,000,000
Cash received from exercises		8,000,000		9,000,000
Tax deductions realized as a result of option exercises		300,000		€ 300,000
Accelerate options [Member] | Philips Group [Domain] | EUR [Member] | Bottom of range [Member]
Disclosure of share-based compensation [Line items]
Exercise price of outstanding share options		15.24
Accelerate options [Member] | Philips Group [Domain] | EUR [Member] | Top of range [Member]
Disclosure of share-based compensation [Line items]
Exercise price of outstanding share options		€ 22.43
Accelerate options [Member] | Philips Group [Domain] | USD [Member]
Disclosure of share-based compensation [Line items]
Weighted average remaining contractual life of outstanding share options		4.1				4.1
Intrinsic value of liabilities from share-based payment transactions for which counterparty's right to cash or other assets vested | $						$ 1,000,000	$ 1,000,000
Aggregate intrinsic value of liabilities from share-pased payments | $			$ 3,000,000
Exercise price of outstanding share options | $						$ 20.02

Share-based compensation - Perf

Share-based compensation - Performance share plans (Detail)	12 Months Ended
	Dec. 31, 2017EUR (€)
EUR [Member]
Disclosure of share-based compensation [Line items]
Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement	€ 25.04
Weighted average exercise price of other equity instruments forfeited in share-based payment arrangement	€ 25.51
Number of other equity instruments outstanding, end of year	1,730,699	[1],[2]
EUR [Member] | Performance share plans [Member]
Disclosure of share-based compensation [Line items]
Weighted average exercise price beginning of year	€ 25.24
Number of other equity instruments outstanding, beginning of year	7,866,754	[3]
Weighted average exercise price of other equity instruments granted in share-based payment arrangement	€ 38.02
Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement	22.48
Weighted average exercise price of other equity instruments forfeited in share-based payment arrangement	27.80
Weighted average exercise price of other equity instruments adjusted quantity	€ 26.69
Granted	1,419,518	[3]
Vested issued	2,853,745	[3]
Forfeited	557,229	[3]
Adjusted quantity	526,142	[3]
Weighted average exercise price end of year	€ 29.20
Number of other equity instruments outstanding, end of year	6,401,440	[3]
USD [Member] | Performance share plans [Member]
Disclosure of share-based compensation [Line items]
Number of other equity instruments outstanding, beginning of year	5,162,084	[3]
Weighted average exercise price of other equity instruments granted in share-based payment arrangement	€ 41.69
Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement	30.07
Weighted average exercise price of other equity instruments forfeited in share-based payment arrangement	30.83
Weighted average exercise price of other equity instruments adjusted quantity	€ 30.23
Granted	953,897	[3]
Vested issued	1,901,252	[3]
Forfeited	441,395	[3]
Adjusted quantity	341,279	[3]
Weighted average exercise price end of year	€ 32.06
Number of other equity instruments outstanding, end of year	4,114,615	[3]
[1]	Excludes dividend declared on outstanding shares between grant date and vesting date that will be issued in shares (EUR-denominated: 83,184 shares and USD-denominated: 79,537 shares).
[2]	Excludes premium shares on Restricted shares granted before 2013. ( 20% additional (premium) shares that may be received if shares delivered under the plan are not sold for a three-year period).
[3]	Excludes dividend declared on outstanding shares between grant date and vesting date that will be issued in shares (EUR-denominated: 402,240 shares and USD-denominated: 258,493 shares)

Share-based compensation - Rest

Share-based compensation - Restricted shares (Detail)	12 Months Ended
	Dec. 31, 2017EUR (€)
EUR [Member]
Disclosure of share-based compensation [Line items]
Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement	€ 25.04
Weighted average exercise price of other equity instruments forfeited in share-based payment arrangement	€ 25.51
Number of other equity instruments outstanding, end of year	1,730,699	[1],[2]
EUR [Member] | Restricted shares [Member]
Disclosure of share-based compensation [Line items]
Weighted average exercise price beginning of year	€ 24.40
Number of other equity instruments outstanding, beginning of year	1,666,960	[1],[2]
Weighted average exercise price of other equity instruments granted in share-based payment arrangement	€ 754,374	[1],[2]
Granted	32.84
Vested issued	557,603	[1],[2]
Forfeited	133,031	[1],[2]
Weighted average exercise price end of year	€ 27.79
USD [Member] | Restricted shares [Member]
Disclosure of share-based compensation [Line items]
Weighted average exercise price beginning of year	€ 27.78
Number of other equity instruments outstanding, beginning of year	1,711,903	[1],[2]
Weighted average exercise price of other equity instruments granted in share-based payment arrangement	€ 36.61
Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement	28.63
Weighted average exercise price of other equity instruments forfeited in share-based payment arrangement	€ 28.74
Granted	758,368	[1],[2]
Vested issued	521,055	[1],[2]
Forfeited	266,590	[1],[2]
Weighted average exercise price end of year	€ 31.35
Number of other equity instruments outstanding, end of year	1,682,625	[1],[2]
[1]	Excludes dividend declared on outstanding shares between grant date and vesting date that will be issued in shares (EUR-denominated: 83,184 shares and USD-denominated: 79,537 shares).
[2]	Excludes premium shares on Restricted shares granted before 2013. ( 20% additional (premium) shares that may be received if shares delivered under the plan are not sold for a three-year period).

Share-based compensation - Opti

Share-based compensation - Options on EUR-denominated listed share (Detail) - EUR [Member]	12 Months Ended
	Dec. 31, 2017EUR (€)
Share-based compensation [Line items]
Outstanding at end of year	2,772,210
Option plans [Member]
Share-based compensation [Line items]
Outstanding at beginning of year	7,052,065
Weighted average exercise price beginning of year	€ 22.49
Number of share options exercised in share-based payment arrangement	2,591,755
Weighted average exercise price of share options exercised in share-based payment arrangement	€ 20.42
Number of share options forfeited in share-based payment arrangement	60,027
Weighted average exercise price of share options forfeited in share-based payment arrangement	€ 20.55
Number of share options expired in share-based payment arrangement	1,628,073
Weighted average exercise price of share options expired in share-based payment arrangement	€ 30.96
Outstanding at end of year	2,772,210
Weighted average exercise price end of year	€ 19.49
Number of share options exercisable in share-based payment arrangement	2,772,210
Weighted average exercise price of share options in share-based payment arrangement exercised during period at date of exercise	€ 19.49

Share-based compensation - O167

Share-based compensation - Options on USD-denominated listed share (Detail) - USD [Member]	12 Months Ended
	Dec. 31, 2017EUR (€)
Share-based compensation [Line items]
Outstanding at end of year	3,309,766
Number of share options exercisable in share-based payment arrangement	170,800
Option plans [Member]
Share-based compensation [Line items]
Outstanding at beginning of year	7,725,221
Weighted average exercise price beginning of year	€ 31.27
Number of share options exercised in share-based payment arrangement	2,818,363
Weighted average exercise price of share options exercised in share-based payment arrangement	€ 29.12
Number of share options forfeited in share-based payment arrangement	122,154
Weighted average exercise price of share options forfeited in share-based payment arrangement	€ 32.82
Number of share options expired in share-based payment arrangement	1,474,938
Weighted average exercise price of share options expired in share-based payment arrangement	€ 41.66
Outstanding at end of year	3,309,766
Weighted average exercise price end of year	€ 28.41
Number of share options exercisable in share-based payment arrangement	3,309,766
Weighted average exercise price of share options in share-based payment arrangement exercised during period at date of exercise	€ 28.41

Share-based compensation - Outs

Share-based compensation - Outstanding options (Detail)	Dec. 31, 2017EUR (€)	Dec. 31, 2016
EUR [Member]
Disclosure of range of exercise prices of outstanding share options [Line items]
Number of outstanding share options	2,772,210
Intrinsic value of liabilities from share-based payment transactions for which counterparty's right to cash or other assets vested	€ 33.4
Weighted average remaining contractual life of outstanding share options	3
USD [Member]
Disclosure of range of exercise prices of outstanding share options [Line items]
Number of outstanding share options	3,309,766
Intrinsic value of liabilities from share-based payment transactions for which counterparty's right to cash or other assets vested	€ 31.1
Weighted average remaining contractual life of outstanding share options	2.5
Price range one [Member] | EUR [Member]
Disclosure of range of exercise prices of outstanding share options [Line items]
Number of outstanding share options	1,013,941
Intrinsic value of liabilities from share-based payment transactions for which counterparty's right to cash or other assets vested	€ 17.4
Weighted average remaining contractual life of outstanding share options	3.7
Price range one [Member] | USD [Member]
Disclosure of range of exercise prices of outstanding share options [Line items]
Number of outstanding share options	993,732
Intrinsic value of liabilities from share-based payment transactions for which counterparty's right to cash or other assets vested	€ 18.8
Weighted average remaining contractual life of outstanding share options	3.6
Price range two [Member] | EUR [Member]
Disclosure of range of exercise prices of outstanding share options [Line items]
Number of outstanding share options	27,042
Intrinsic value of liabilities from share-based payment transactions for which counterparty's right to cash or other assets vested	€ 0.4
Weighted average remaining contractual life of outstanding share options	4
Price range two [Member] | USD [Member]
Disclosure of range of exercise prices of outstanding share options [Line items]
Number of outstanding share options	42,728
Intrinsic value of liabilities from share-based payment transactions for which counterparty's right to cash or other assets vested	€ 0.7
Weighted average remaining contractual life of outstanding share options	3.4
Price range three [Member] | EUR [Member]
Disclosure of range of exercise prices of outstanding share options [Line items]
Number of outstanding share options	1,731,227
Intrinsic value of liabilities from share-based payment transactions for which counterparty's right to cash or other assets vested	€ 15.6
Weighted average remaining contractual life of outstanding share options	2.6
Price range three [Member] | USD [Member]
Disclosure of range of exercise prices of outstanding share options [Line items]
Number of outstanding share options	860,950
Intrinsic value of liabilities from share-based payment transactions for which counterparty's right to cash or other assets vested	€ 7
Weighted average remaining contractual life of outstanding share options	3.3
Price range four [Member] | USD [Member]
Disclosure of range of exercise prices of outstanding share options [Line items]
Number of outstanding share options	834,242
Intrinsic value of liabilities from share-based payment transactions for which counterparty's right to cash or other assets vested	€ 3.8
Weighted average remaining contractual life of outstanding share options	1.9
Price range five [Member] | USD [Member]
Disclosure of range of exercise prices of outstanding share options [Line items]
Number of outstanding share options	578,114
Intrinsic value of liabilities from share-based payment transactions for which counterparty's right to cash or other assets vested	€ 0.7
Weighted average remaining contractual life of outstanding share options	0.3
Option plans [Member] | EUR [Member]
Disclosure of range of exercise prices of outstanding share options [Line items]
Number of outstanding share options	2,772,210	7,052,065
Weighted average remaining contractual life of outstanding share options	3
Option plans [Member] | USD [Member]
Disclosure of range of exercise prices of outstanding share options [Line items]
Number of outstanding share options	3,309,766	7,725,221

Share-based compensation - Acce

Share-based compensation - Accelerate options (Detail)	12 Months Ended
	Dec. 31, 2017EUR (€)
EUR [Member]
Share-based compensation [Line items]
Outstanding at end of year	2,772,210
USD [Member]
Share-based compensation [Line items]
Outstanding at end of year	3,309,766
Number of share options exercisable in share-based payment arrangement	170,800
Accelerate options [Member] | EUR [Member]
Share-based compensation [Line items]
Outstanding at beginning of year	860,300
Weighted average exercise price beginning of year	€ 16.02
Number of share options exercised in share-based payment arrangement	379,100
Weighted average exercise price of share options exercised in share-based payment arrangement	€ 15.97
Outstanding at end of year	481,200
Weighted average exercise price end of year	€ 16.06
Number of share options exercisable in share-based payment arrangement	481,200
Weighted average exercise price of share options exercisable in share-based payment arrangement	€ 16.06
Accelerate options [Member] | USD [Member]
Share-based compensation [Line items]
Outstanding at beginning of year	257,800
Weighted average exercise price beginning of year	€ 20.02
Number of share options exercised in share-based payment arrangement	87,000
Weighted average exercise price of share options exercised in share-based payment arrangement	€ 20.02
Outstanding at end of year	170,800
Weighted average exercise price end of year	€ 20.02
Weighted average exercise price of share options exercisable in share-based payment arrangement	€ 20.02

Information on remuneration - T

Information on remuneration - Text details (Detail)	12 Months Ended
	Dec. 31, 2017EUR (€)	Dec. 31, 2016EUR (€)	Dec. 31, 2015EUR (€)
Supervisory board [Member]
Information on remuneration [Line items]
Key management personnel compensation	€ 950,500	€ 1,037,209	€ 1,083,667
Board of management [Member]
Information on remuneration [Line items]
Key management personnel compensation	7,808,117	8,904,859	6,612,092
Weighted average exercise price of share options outstanding in share-based payment arrangement	€ 18.99	€ 19.47	€ 19.52
Number of share options outstanding in share-based payment arrangement	333,670	476,200	479,881
Executive committee [Member]
Information on remuneration [Line items]
Key management personnel compensation	€ 25,848,741	€ 22,433,827	€ 15,098,023
Weighted average exercise price of share options outstanding in share-based payment arrangement	€ 19.82	€ 21.17	€ 18.67
Number of share options outstanding in share-based payment arrangement	541,400	750,631	843,461
F.A. van Houten [Member] | Board of management [Member]
Information on remuneration [Line items]
Key management personnel compensation	€ 5,101,429	€ 4,675,042	€ 3,890,265
Number of premium share options outstanding in share-based payment arrangement	1,334
A. Bhattacharya [Member] | Board of management [Member]
Information on remuneration [Line items]
Key management personnel compensation	€ 2,247,822	1,856,175	53,838
Number of premium share options outstanding in share-based payment arrangement	140
M.J. van Ginneken [Member] | Board of management [Member]
Information on remuneration [Line items]
Key management personnel compensation	€ 306,061
Number of premium share options outstanding in share-based payment arrangement	150
P.A.J. Nota [Member] | Board of management [Member]
Information on remuneration [Line items]
Key management personnel compensation	€ 152,805	€ 2,373,642	€ 2,097,119

Information on remuneration - R

Information on remuneration - Remuneration costs of the Executive Committee (Detail) - Executive committee [Member] - EUR (€)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Information on remuneration [Line items]
Key management personnel compensation other	€ 1,861,803	€ 1,556,514	€ 1,094,546
Base salary [Member]
Information on remuneration [Line items]
Key management personnel compensation short-term employee benefits	8,089,063	6,388,667	5,974,928
Annual incentive [Member]
Information on remuneration [Line items]
Key management personnel compensation short-term employee benefits	6,345,576	5,746,347	2,705,560
Performance share plans [Member]
Information on remuneration [Line items]
Key management personnel compensation share-based payment	6,371,297	5,943,782	2,740,004
Stock options [Member]
Information on remuneration [Line items]
Key management personnel compensation share-based payment	0	0	88,775
Restricted shares [Member]
Information on remuneration [Line items]
Key management personnel compensation share-based payment	885,343	764,311	91,339
Pension allowances [Member]
Information on remuneration [Line items]
Key management personnel compensation post-employment benefits	1,886,963	1,854,129	2,193,409
Pension scheme costs [Member]
Information on remuneration [Line items]
Key management personnel compensation post-employment benefits	€ 408,695	€ 180,077	€ 209,462

Information on remuneration 172

Information on remuneration - Remuneration costs of the Executive Committee (Detail Parenthetical)	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Executive committee [Member]
Information on remuneration [Line items]
Number of members	12	12	8

Information on remuneration 173

Information on remuneration - Remuneration costs of individual members of the Board of Management (Detail) - Board of management [Member] - EUR (€)		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Information on remuneration [Line items]
Key management personnel compensation other	[1]	€ 261,667	€ 256,903	€ 213,428
Key management personnel compensation		7,808,117	8,904,859	6,612,092
Base salary [Member]
Information on remuneration [Line items]
Key management personnel compensation short-term employee benefits		2,590,417	2,550,000	2,529,384
Annual incentive [Member]
Information on remuneration [Line items]
Key management personnel compensation short-term employee benefits	[2]	2,322,612	2,514,044	1,403,219
Performance share plans [Member]
Information on remuneration [Line items]
Key management personnel compensation share-based payment	[3]	1,540,703	2,469,397	1,236,608
Stock options [Member]
Information on remuneration [Line items]
Key management personnel compensation share-based payment	[3]	0	0	41,803
Restricted shares [Member]
Information on remuneration [Line items]
Key management personnel compensation share-based payment	[3]	4,809	24,633	13,216
Pension allowances [Member]
Information on remuneration [Line items]
Key management personnel compensation post-employment benefits	[4]	1,012,075	1,015,368	1,098,003
Pension scheme costs [Member]
Information on remuneration [Line items]
Key management personnel compensation post-employment benefits		75,834	74,514	76,431
F.A. van Houten [Member]
Information on remuneration [Line items]
Key management personnel compensation other	[1]	84,053	126,703	78,035
Key management personnel compensation		5,101,429	4,675,042	3,890,265
F.A. van Houten [Member] | Base salary [Member]
Information on remuneration [Line items]
Key management personnel compensation short-term employee benefits		1,205,000	1,197,500	1,168,750
F.A. van Houten [Member] | Annual incentive [Member]
Information on remuneration [Line items]
Key management personnel compensation short-term employee benefits	[2]	1,270,166	1,354,227	768,920
F.A. van Houten [Member] | Performance share plans [Member]
Information on remuneration [Line items]
Key management personnel compensation share-based payment	[3]	1,975,277	1,423,538	1,273,940
F.A. van Houten [Member] | Stock options [Member]
Information on remuneration [Line items]
Key management personnel compensation share-based payment	[3]	0	0	17,713
F.A. van Houten [Member] | Restricted shares [Member]
Information on remuneration [Line items]
Key management personnel compensation share-based payment	[3]	4,034	12,041	28,279
F.A. van Houten [Member] | Pension allowances [Member]
Information on remuneration [Line items]
Key management personnel compensation post-employment benefits	[4]	537,621	536,195	529,387
F.A. van Houten [Member] | Pension scheme costs [Member]
Information on remuneration [Line items]
Key management personnel compensation post-employment benefits		25,278	24,838	25,241
A. Bhattacharya [Member]
Information on remuneration [Line items]
Key management personnel compensation other	[1]	100,918	73,642	998
Key management personnel compensation		2,247,822	1,856,175	53,838
A. Bhattacharya [Member] | Base salary [Member]
Information on remuneration [Line items]
Key management personnel compensation short-term employee benefits		687,500	650,000	23,551
A. Bhattacharya [Member] | Annual incentive [Member]
Information on remuneration [Line items]
Key management personnel compensation short-term employee benefits	[2]	553,392	540,072	11,937
A. Bhattacharya [Member] | Performance share plans [Member]
Information on remuneration [Line items]
Key management personnel compensation share-based payment	[3]	669,396	362,758	8,968
A. Bhattacharya [Member] | Stock options [Member]
Information on remuneration [Line items]
Key management personnel compensation share-based payment	[3]	0	0	0
A. Bhattacharya [Member] | Restricted shares [Member]
Information on remuneration [Line items]
Key management personnel compensation share-based payment	[3]	888	3,341	183
A. Bhattacharya [Member] | Pension allowances [Member]
Information on remuneration [Line items]
Key management personnel compensation post-employment benefits	[4]	210,450	201,524	7,315
A. Bhattacharya [Member] | Pension scheme costs [Member]
Information on remuneration [Line items]
Key management personnel compensation post-employment benefits		25,278	24,838	886
P.A.J. Nota [Member]
Information on remuneration [Line items]
Key management personnel compensation other	[1]	63,576	56,558	104,918
Key management personnel compensation		152,805	2,373,642	2,097,119
P.A.J. Nota [Member] | Base salary [Member]
Information on remuneration [Line items]
Key management personnel compensation short-term employee benefits		606,250	702,500	672,500
P.A.J. Nota [Member] | Annual incentive [Member]
Information on remuneration [Line items]
Key management personnel compensation short-term employee benefits	[2]	429,886	619,745	383,112
P.A.J. Nota [Member] | Performance share plans [Member]
Information on remuneration [Line items]
Key management personnel compensation share-based payment	[3]	(1,203,992)	683,101	605,749
P.A.J. Nota [Member] | Stock options [Member]
Information on remuneration [Line items]
Key management personnel compensation share-based payment	[3]	0	0	12,045
P.A.J. Nota [Member] | Restricted shares [Member]
Information on remuneration [Line items]
Key management personnel compensation share-based payment	[3]	(188)	9,251	21,964
P.A.J. Nota [Member] | Pension allowances [Member]
Information on remuneration [Line items]
Key management personnel compensation post-employment benefits	[4]	236,208	277,649	270,529
P.A.J. Nota [Member] | Pension scheme costs [Member]
Information on remuneration [Line items]
Key management personnel compensation post-employment benefits		21,065	€ 24,838	26,302
M.J. van Ginneken [Member]
Information on remuneration [Line items]
Key management personnel compensation other	[1]	13,120
Key management personnel compensation		306,061
M.J. van Ginneken [Member] | Base salary [Member]
Information on remuneration [Line items]
Key management personnel compensation short-term employee benefits		91,667
M.J. van Ginneken [Member] | Annual incentive [Member]
Information on remuneration [Line items]
Key management personnel compensation short-term employee benefits	[2]	69,168
M.J. van Ginneken [Member] | Performance share plans [Member]
Information on remuneration [Line items]
Key management personnel compensation share-based payment	[3]	100,022
M.J. van Ginneken [Member] | Stock options [Member]
Information on remuneration [Line items]
Key management personnel compensation share-based payment	[3]	0
M.J. van Ginneken [Member] | Restricted shares [Member]
Information on remuneration [Line items]
Key management personnel compensation share-based payment	[3]	75
M.J. van Ginneken [Member] | Pension allowances [Member]
Information on remuneration [Line items]
Key management personnel compensation post-employment benefits	[4]	27,796
M.J. van Ginneken [Member] | Pension scheme costs [Member]
Information on remuneration [Line items]
Key management personnel compensation post-employment benefits		€ 4,213
R.H. Wirahadiraksa [Member]
Information on remuneration [Line items]
Key management personnel compensation other	[1]			29,477
Key management personnel compensation				570,870
R.H. Wirahadiraksa [Member] | Base salary [Member]
Information on remuneration [Line items]
Key management personnel compensation short-term employee benefits				664,583
R.H. Wirahadiraksa [Member] | Annual incentive [Member]
Information on remuneration [Line items]
Key management personnel compensation short-term employee benefits	[2]			239,250
R.H. Wirahadiraksa [Member] | Performance share plans [Member]
Information on remuneration [Line items]
Key management personnel compensation share-based payment	[3]			(652,049)
R.H. Wirahadiraksa [Member] | Stock options [Member]
Information on remuneration [Line items]
Key management personnel compensation share-based payment	[3]			12,045
R.H. Wirahadiraksa [Member] | Restricted shares [Member]
Information on remuneration [Line items]
Key management personnel compensation share-based payment	[3]			(37,210)
R.H. Wirahadiraksa [Member] | Pension allowances [Member]
Information on remuneration [Line items]
Key management personnel compensation post-employment benefits	[4]			290,772
R.H. Wirahadiraksa [Member] | Pension scheme costs [Member]
Information on remuneration [Line items]
Key management personnel compensation post-employment benefits				€ 24,002
[1]	The stated amounts mainly concern (share of) allowances to members of the Board of Management that can be considered as remuneration. In a situation where such a share of an allowance can be considered as (indirect) remuneration (for example, private use of the company car), then the share is both valued and accounted for here. The method employed by the fiscal authorities is the starting point for the value stated
[2]	The annual incentives are related to the performance in the year reported which are paid out in the subsequent year. For more details on the annual incentives, see 2017 Annual Incentive
[3]	Costs of performance shares, stock options and restricted share rights are based on accounting standards (IFRS) and do not reflect the value of stock options at the end of the lock up period and the value of performance shares and restricted share rights at the vesting/release date
[4]	Pension allowances are gross taxable allowances paid to members of the Board of Management. These allowances are part of the pension arrangement as agreed upon in the services contracts.

Information on remuneration - N

Information on remuneration - Number of performance shares (holdings) (Detail)	12 Months Ended
	Dec. 31, 2017
Performance share plans [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	293,826
Number of share options granted in share-based payment arrangement	123,424
Number of share options awarded dividend shares	8,152
Number of share options exercised in share-based payment arrangement	101,292
Outstanding at end of year	332,006
Board of management [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	476,200
Outstanding at end of year	333,670
F.A. van Houten [Member] | Performance share plans [Member] | Vesting date 2017-04-28 [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	65,299
Number of share options granted in share-based payment arrangement	0
Number of share options awarded dividend shares	0
Number of share options exercised in share-based payment arrangement	69,544
Outstanding at end of year	0
Vesting date	Apr. 28, 2017
F.A. van Houten [Member] | Performance share plans [Member] | Vesting date 2018-05-05 [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	58,636
Number of share options granted in share-based payment arrangement	0
Number of share options awarded dividend shares	1,476
Number of share options exercised in share-based payment arrangement	0
Outstanding at end of year	60,112
Vesting date	May 5, 2018
F.A. van Houten [Member] | Performance share plans [Member] | Vesting date 2019-04-29 [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	61,336
Number of share options granted in share-based payment arrangement	0
Number of share options awarded dividend shares	1,544
Number of share options exercised in share-based payment arrangement	0
Outstanding at end of year	62,880
Vesting date	Apr. 29, 2019
F.A. van Houten [Member] | Performance share plans [Member] | Vesting date 2020-05-11 [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	0
Number of share options granted in share-based payment arrangement	73,039
Number of share options awarded dividend shares	1,839
Number of share options exercised in share-based payment arrangement	0
Outstanding at end of year	74,878
Vesting date	May 11, 2020
A. Bhattacharya [Member] | Performance share plans [Member] | Vesting date 2017-04-28 [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	11,830	[1]
Number of share options granted in share-based payment arrangement	0
Number of share options awarded dividend shares	0
Number of share options exercised in share-based payment arrangement	12,598
Outstanding at end of year	0
Vesting date	Apr. 28, 2017
A. Bhattacharya [Member] | Performance share plans [Member] | Vesting date 2018-05-05 [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	12,476	[1]
Number of share options granted in share-based payment arrangement	0
Number of share options awarded dividend shares	314
Number of share options exercised in share-based payment arrangement	0
Outstanding at end of year	12,790
Vesting date	May 5, 2018
A. Bhattacharya [Member] | Performance share plans [Member] | Vesting date 2019-04-29 [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	27,571
Number of share options granted in share-based payment arrangement	0
Number of share options awarded dividend shares	694
Number of share options exercised in share-based payment arrangement	0
Outstanding at end of year	28,265
Vesting date	Apr. 29, 2019
A. Bhattacharya [Member] | Performance share plans [Member] | Vesting date 2020-05-11 [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	0
Number of share options granted in share-based payment arrangement	31,822
Number of share options awarded dividend shares	801
Number of share options exercised in share-based payment arrangement	0
Outstanding at end of year	32,623
Vesting date	May 11, 2020
M.J. van Ginneken [Member] | Performance share plans [Member] | Vesting date 2017-04-28 [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	16,267	[1]
Number of share options granted in share-based payment arrangement	0
Number of share options awarded dividend shares	0
Number of share options exercised in share-based payment arrangement	19,150
Outstanding at end of year	0
Vesting date	Apr. 28, 2017
M.J. van Ginneken [Member] | Performance share plans [Member] | Vesting date 2018-05-05 [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	18,714	[1]
Number of share options granted in share-based payment arrangement	0
Number of share options awarded dividend shares	471
Number of share options exercised in share-based payment arrangement	0
Outstanding at end of year	19,185
Vesting date	May 5, 2018
M.J. van Ginneken [Member] | Performance share plans [Member] | Vesting date 2019-04-29 [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	21,697	[1]
Number of share options granted in share-based payment arrangement	0
Number of share options awarded dividend shares	546
Number of share options exercised in share-based payment arrangement	0
Outstanding at end of year	22,243
Vesting date	Apr. 29, 2019
M.J. van Ginneken [Member] | Performance share plans [Member] | Vesting date 2020-05-11 [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	0
Number of share options granted in share-based payment arrangement	18,563	[1]
Number of share options awarded dividend shares	467
Number of share options exercised in share-based payment arrangement	0
Outstanding at end of year	19,030
Vesting date	May 11, 2020
[1]	Awarded before date of appointment as a member of the Board of Management

Information on remuneration - S

Information on remuneration - Stock options (holdings) (Detail) - Board of management [Member]	12 Months Ended
	Dec. 31, 2017EUR (€)
Information on remuneration [Line items]
Outstanding at beginning of year	476,200
Outstanding at end of year	333,670
Option plans [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	333,670
Number of share options granted in share-based payment arrangement	0
Number of share options exercised in share-based payment arrangement	0
Number of share options expired in share-based payment arrangement	0
Outstanding at end of year	333,670
F.A. van Houten [Member] | Option plans [Member] | Expiry date 2020-10-18 [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	20,400	[1]
Number of share options granted in share-based payment arrangement	0
Number of share options exercised in share-based payment arrangement	0
Number of share options expired in share-based payment arrangement	0
Outstanding at end of year	20,400
Exercise price, share options granted	€ 22.88
Share price on exercise date	€ 0
Expiry date	Oct. 18, 2020
F.A. van Houten [Member] | Option plans [Member] | Expiry date 2021-04-18 [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	75,000
Number of share options granted in share-based payment arrangement	0
Number of share options exercised in share-based payment arrangement	0
Number of share options expired in share-based payment arrangement	0
Outstanding at end of year	75,000
Exercise price, share options granted	€ 20.90
Share price on exercise date	€ 0
Expiry date	Apr. 18, 2021
F.A. van Houten [Member] | Option plans [Member] | Expiry date 2022-04-23 [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	75,000
Number of share options granted in share-based payment arrangement	0
Number of share options exercised in share-based payment arrangement	0
Number of share options expired in share-based payment arrangement	0
Outstanding at end of year	75,000
Exercise price, share options granted	€ 14.82
Share price on exercise date	€ 0
Expiry date	Apr. 23, 2022
F.A. van Houten [Member] | Option plans [Member] | Expiry date 2023-01-29 [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	55,000
Number of share options granted in share-based payment arrangement	0
Number of share options exercised in share-based payment arrangement	0
Number of share options expired in share-based payment arrangement	0
Outstanding at end of year	55,000
Exercise price, share options granted	€ 22.43
Share price on exercise date	€ 0
Expiry date	Jan. 29, 2023
A. Bhattacharya [Member] | Option plans [Member] | Expiry date 2020-10-18 [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	16,500	[1]
Number of share options granted in share-based payment arrangement	0
Number of share options exercised in share-based payment arrangement	0
Number of share options expired in share-based payment arrangement	0
Outstanding at end of year	16,500
Exercise price, share options granted	€ 22.88
Share price on exercise date	€ 0
Expiry date	Oct. 18, 2020
A. Bhattacharya [Member] | Option plans [Member] | Expiry date 2021-04-18 [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	16,500	[1]
Number of share options granted in share-based payment arrangement	0
Number of share options exercised in share-based payment arrangement	0
Number of share options expired in share-based payment arrangement	0
Outstanding at end of year	16,500
Exercise price, share options granted	€ 20.90
Share price on exercise date	€ 0
Expiry date	Apr. 18, 2021
A. Bhattacharya [Member] | Option plans [Member] | Expiry date 2022-01-30 [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	20,000	[1]
Number of share options granted in share-based payment arrangement	0
Number of share options exercised in share-based payment arrangement	0
Number of share options expired in share-based payment arrangement	0
Outstanding at end of year	20,000
Exercise price, share options granted	€ 15.24
Share price on exercise date	€ 0
Expiry date	Jan. 30, 2022
A. Bhattacharya [Member] | Option plans [Member] | Expiry date 2022-04-23 [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	16,500	[1]
Number of share options granted in share-based payment arrangement	0
Number of share options exercised in share-based payment arrangement	0
Number of share options expired in share-based payment arrangement	0
Outstanding at end of year	16,500
Exercise price, share options granted	€ 14.82
Share price on exercise date	€ 0
Expiry date	Apr. 23, 2022
M.J. van Ginneken [Member] | Option plans [Member] | Expiry date 2019-04-14 [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	5,250	[1]
Number of share options granted in share-based payment arrangement	0
Number of share options exercised in share-based payment arrangement	0
Number of share options expired in share-based payment arrangement	0
Outstanding at end of year	5,250
Exercise price, share options granted	€ 12.63
Share price on exercise date	€ 0
Expiry date	Apr. 14, 2019
M.J. van Ginneken [Member] | Option plans [Member] | Expiry date 2020-10-18 [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	6,720	[1]
Number of share options granted in share-based payment arrangement	0
Number of share options exercised in share-based payment arrangement	0
Number of share options expired in share-based payment arrangement	0
Outstanding at end of year	6,720
Exercise price, share options granted	€ 24.90
Share price on exercise date	€ 0
Expiry date	Apr. 19, 2020
M.J. van Ginneken [Member] | Option plans [Member] | Expiry date 2021-04-18 [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	8,400	[1]
Number of share options granted in share-based payment arrangement	0
Number of share options exercised in share-based payment arrangement	0
Number of share options expired in share-based payment arrangement	0
Outstanding at end of year	8,400
Exercise price, share options granted	€ 20.90
Share price on exercise date	€ 0
Expiry date	Apr. 18, 2021
M.J. van Ginneken [Member] | Option plans [Member] | Expiry date 2022-01-30 [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	10,000	[1]
Number of share options granted in share-based payment arrangement	0
Number of share options exercised in share-based payment arrangement	0
Number of share options expired in share-based payment arrangement	0
Outstanding at end of year	10,000
Exercise price, share options granted	€ 15.24
Share price on exercise date	€ 0
Expiry date	Jan. 30, 2022
M.J. van Ginneken [Member] | Option plans [Member] | Expiry date 2022-04-23 [Member]
Information on remuneration [Line items]
Outstanding at beginning of year	8,400	[1]
Number of share options granted in share-based payment arrangement	0
Number of share options exercised in share-based payment arrangement	0
Number of share options expired in share-based payment arrangement	0
Outstanding at end of year	8,400
Exercise price, share options granted	€ 14.82
Share price on exercise date	€ 0
Expiry date	Apr. 23, 2022
[1]	Awarded before date of appointment as a member of the Board of Management

Information on remuneration - A

Information on remuneration - Accumulated annual pension entitlements and pension-related costs (Detail) - Board of management [Member]	Dec. 31, 2017EUR (€)
Information on remuneration [Line items]
Total pension-related costs	€ 1,087,909	[1]
F.A. van Houten [Member]
Information on remuneration [Line items]
Age	57
Accumulated annual pension	€ 295,007	[2]
Total pension-related costs	€ 562,899	[1]
A. Bhattacharya [Member]
Information on remuneration [Line items]
Age	56
Accumulated annual pension	€ 25,539	[2]
Total pension-related costs	€ 235,728	[1]
P.A.J. Nota [Member]
Information on remuneration [Line items]
Age	53
Accumulated annual pension	€ 45,442	[2]
Total pension-related costs	€ 257,273	[1]
M.J. van Ginneken [Member]
Information on remuneration [Line items]
Age	44
Accumulated annual pension	€ 37,359	[2]
Total pension-related costs	€ 32,009	[1]
[1]	Cost related to period of board membership and include paid pension allowances as well as pension premium paid by employer to Collective Defined Contribution plan
[2]	Total of entitlements under Philips pension scheme, including - if applicable - transferred pension entitlements under pension scheme(s) of previous employer(s)

Information on remuneration 177

Information on remuneration - Remuneration of the Supervisory Board (Detail) - Supervisory board [Member] - EUR (€)		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits		€ 950,500	€ 1,037,209	€ 1,083,667
Membership [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits		625,000	698,333	785,000
Committees [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits		171,500	175,876	164,167
Other compensation [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits	[1]	154,000	163,000	134,500
J.A. van der Veer [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits		167,000	168,667	173,667
J.A. van der Veer [Member] | Membership [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits		135,000	135,000	135,000
J.A. van der Veer [Member] | Committees [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits		25,000	26,667	31,667
J.A. van der Veer [Member] | Other compensation [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits	[1]	7,000	7,000	7,000
C. Poon [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits		139,500	144,500	122,500
C. Poon [Member] | Membership [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits		90,000	90,000	90,000
C. Poon [Member] | Committees [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits		32,500	32,500	17,500
C. Poon [Member] | Other compensation [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits	[1]	17,000	22,000	15,000
C.J.A. van Lede [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits			39,708	101,333
C.J.A. van Lede [Member] | Membership [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits			33,333	80,000
C.J.A. van Lede [Member] | Committees [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits			4,375	14,333
C.J.A. van Lede [Member] | Other compensation [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits	[1]		2,000	7,000
E. Kist [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits			46,167	92,000
E. Kist [Member] | Membership [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits			40,000	80,000
E. Kist [Member] | Committees [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits			4,167	10,000
E. Kist [Member] | Other compensation [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits	[1]		2,000	2,000
H. von Prondzynski [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits		132,000	124,500	126,333
H. von Prondzynski [Member] | Membership [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits		80,000	80,000	80,000
H. von Prondzynski [Member] | Committees [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits		32,500	25,000	26,833
H. von Prondzynski [Member] | Other compensation [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits	[1]	19,500	19,500	19,500
J.P. Tai [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits		144,500	146,167	144,167
J.P. Tai [Member] | Membership [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits		80,000	80,000	80,000
J.P. Tai [Member] | Committees [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits		32,500	34,167	29,167
J.P. Tai [Member] | Other compensation [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits	[1]	32,000	32,000	35,000
N. Dhawan [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits		120,000	120,000	113,000
N. Dhawan [Member] | Membership [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits		80,000	80,000	80,000
N. Dhawan [Member] | Committees [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits		13,000	13,000	13,000
N. Dhawan [Member] | Other compensation [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits	[1]	27,000	27,000	20,000
O. Gadiesh [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits		112,500	112,500	110,000
O. Gadiesh [Member] | Membership [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits		80,000	80,000	80,000
O. Gadiesh [Member] | Committees [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits		13,000	13,000	13,000
O. Gadiesh [Member] | Other compensation [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits	[1]	19,500	19,500	17,000
D.E.I. Pyott [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits		135,000	135,000	100,667
D.E.I. Pyott [Member] | Membership [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits		80,000	80,000	80,000
D.E.I. Pyott [Member] | Committees [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits		23,000	23,000	8,667
D.E.I. Pyott [Member] | Other compensation [Member]
Information on remuneration [Line items]
Key management personnel compensation, short-term employee benefits	[1]	€ 32,000	€ 32,000	€ 12,000
[1]	The amounts mentioned under other compensation relate to the fee for intercontinental travel, inter-European travel (effective 2015) and the entitlement of EUR 2,000 under the Philips product arrangement

Information on remuneration 178

Information on remuneration - Remuneration of the Supervisory Board (Detail Parenthetical)	12 Months Ended
	Dec. 31, 2017EUR (€)
Supervisory board [Member]
Information on remuneration [Line items]
Other compensation, product arrangement entitlement	€ 2,000

Information on remuneration 179

Information on remuneration - Shares held by Board members (Detail) - Board of management [Member] - shares	Dec. 31, 2017	Dec. 31, 2016
J.A. van der Veer [Member]
Information on remuneration [Line items]
Shares held	18,366	18,366
H. von Prondzynski [Member]
Information on remuneration [Line items]
Shares held	3,851	3,758
J.P. Tai [Member]
Information on remuneration [Line items]
Shares held	3,844	3,844
F.A. van Houten [Member]
Information on remuneration [Line items]
Shares held	233,119	189,824
A. Bhattacharya [Member]
Information on remuneration [Line items]
Shares held	53,974	42,913
M.J. van Ginneken [Member]
Information on remuneration [Line items]
Shares held	30,246	19,792

Fair value of financial asse180

Fair value of financial assets and liabilities - Text details (Detail) € in Millions	Dec. 31, 2017EUR (€)
Level 1 of fair value hierarchy [Member]
Disclosure of fair value of financial assets and liabilities [Line items]
Available-for-sale financial assets	€ 49
Combined Lumileds and Automotive Lighting businesses [Member] | Level 3 of fair value hierarchy [Member]
Disclosure of fair value of financial assets and liabilities [Line items]
Available-for-sale financial assets	€ 243
Instantaneous increase in assumed earnings	10.00%
Increase in fair value of the asset when earnings increase by 10%	28.00%
Instantaneous decrease in assumed earnings	(10.00%)
Decrease in fair value of the asset when earnings decrease by 10%	(26.00%)
Instantaneous increase in valuation multiples	10.00%
Increase in fair value of the asset when valuation multiples increase by 10%	18.00%
Instantaneous decrease in valuation multiples	(10.00%)
Decrease in fair value of the asset when valuation multiples decrease by 10%	(17.00%)

Fair value of financial asse181

Fair value of financial assets and liabilities - Fair value of financial assets and liabilities (Detail) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Financial assets [Abstract]
Cash and cash equivalents	€ 1,939	€ 2,334	€ 1,766	€ 1,873
Receivables - current	3,909	5,327
Receivables - non-current	130	155
Total financial assets	372
Carried at (amortized) cost [Abstract]
Accounts and notes payable	2,090	2,848
Level 1 of fair value hierarchy [Member]
Financial assets [Abstract]
Available-for-sale financial assets - non-current	49	36
Securities classified as assets held for sale	1,264
Financial assets, at fair value	1,313	36
Total financial assets	1,313	36
Carried at (amortized) cost [Abstract]
Debt (Corporate bond and finance lease)	(3,579)	(3,990)
Financial liabilities carried at (amortized) costs	(3,579)	(3,990)
Total financial liabilities	(3,579)	(3,990)
Level 2 of fair value hierarchy [Member]
Financial assets [Abstract]
Available-for-sale financial assets - non-current	29	29
Fair value through profit and loss	23	24
Derivative financial instruments	78	160
Financial assets, at fair value	130	213
Current loans receivable		101
Financial assets carried at (amortized) costs		101
Total financial assets	130	314
Carried at fair value [Abstract]
Derivative financial instruments	(383)	(873)
Financial liabilities carried at fair value	(383)	(873)
Carried at (amortized) cost [Abstract]
Debt (Corporate bond and finance lease)	(281)	(1,484)
Financial liabilities carried at (amortized) costs	(281)	(1,484)
Total financial liabilities	(665)	(2,357)
Level 3 of fair value hierarchy [Member]
Financial assets [Abstract]
Available-for-sale financial assets - non-current	368	107
Securities classified as assets held for sale		1
Fair value through profit and loss	4	3
Financial assets, at fair value	372	111
Total financial assets	372	111
Carrying amount [Member]
Financial assets [Abstract]
Available-for-sale financial assets - non-current	446	172
Securities classified as assets held for sale	1,264	1
Fair value through profit and loss	27	27
Derivative financial instruments	78	160
Financial assets, at fair value	1,815	360
Cash and cash equivalents	1,939	2,334
Current loans receivable	2	101
Non-current loans and receivables	114	134
Receivables - current	3,909	5,327
Receivables - non-current	130	155
Held-to-maturity investments	1	2
Financial assets carried at (amortized) costs	6,095	8,053
Total financial assets	7,909	8,413
Carried at fair value [Abstract]
Derivative financial instruments	(383)	(873)
Financial liabilities carried at fair value	(383)	(873)
Carried at (amortized) cost [Abstract]
Accounts and notes payable	(2,090)	(2,848)
Interest accrual	(38)	(68)
Debt (Corporate bond and finance lease)	(3,378)	(5,095)
Debt (Bank loans, overdrafts etc.)	(1,337)	(511)
Financial liabilities carried at (amortized) costs	(6,843)	(8,522)
Total financial liabilities	(7,226)	(9,395)
Estimated fair value [Member]
Financial assets [Abstract]
Available-for-sale financial assets - non-current	446	172
Securities classified as assets held for sale	1,264	1
Fair value through profit and loss	27	27
Derivative financial instruments	78	160
Financial assets, at fair value	1,815	360
Current loans receivable		101
Financial assets carried at (amortized) costs		101
Total financial assets	1,815	461
Carried at fair value [Abstract]
Derivative financial instruments	(383)	(873)
Financial liabilities carried at fair value	(383)	(873)
Carried at (amortized) cost [Abstract]
Debt (Corporate bond and finance lease)	(3,860)	(5,474)
Financial liabilities carried at (amortized) costs	(3,860)	(5,474)
Total financial liabilities	€ (4,243)	€ (6,347)

Fair value of financial asse182

Fair value of financial assets and liabilities - Reconciliation of the fair value hierarchy (Detail) € in Millions	12 Months Ended
	Dec. 31, 2017EUR (€)
Gains and losses recognized [Abstract]
Financial assets, end of period	€ 372
Level 3 of fair value hierarchy [Member]
Disclosure of fair value of financial assets and liabilities [Line items]
Financial assets, beginning of period	111
Gains and losses recognized [Abstract]
Financial assets, end of period	372
Financial assets [Member] | Level 3 of fair value hierarchy [Member]
Gains and losses recognized [Abstract]
In profit or loss	2
In other comprehensive income	(83)
Purchase	356
Sales	(10)
Transfer to assets held for sale	€ (4)

Fair value of financial asse183

Fair value of financial assets and liabilities - Financial assets subject to offsetting (Detail) - Derivatives [Member] - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Disclosure of fair value of financial assets and liabilities [Line items]
Gross amounts of recognised financial assets	€ 78	€ 160
Net amounts of financial assets presented in the balance sheet	78	160
Related amounts not offset in the balance sheet [Abstract]
Financial instruments	(38)	(92)
Net amount	€ 39	€ 68

Fair value of financial asse184

Fair value of financial assets and liabilities - Financial liabilities subject to offsetting (Detail) - Derivatives [Member] - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Disclosure of fair value of financial assets and liabilities [Line items]
Gross amounts of recognised financial liabilities	€ (383)	€ (873)
Net amounts of financial liabilities presented in the balance sheet	(383)	(873)
Related amounts not offset in the balance sheet [Abstract]
Financial instruments	38	92
Net amount	€ (345)	€ (781)

Details of treasury risks - Tex

Details of treasury risks - Text details (Detail) € in Thousands, $ in Millions	12 Months Ended
	Dec. 31, 2017EUR (€)	Dec. 31, 2016EUR (€)	Dec. 31, 2015EUR (€)	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2014EUR (€)
Liquidity risk [Abstract]
Cash and cash equivalents	€ 1,939,000	€ 2,334,000	€ 1,766,000			€ 1,873,000
Short-term deposits	1,302,000	1,299,000
Commercial Paper Program | $				$ 2,500
Revolving credit facility (undrawn)	1,000,000
Accounts payable known to have been sold onwards under supplier finance arrangements	€ 286,000
Currency risk [Abstract]
Hedge tenor of net anticipated exposure	15 months
Net anticipated exposures hedge layer size	20.00%
Net anticipated exposures hedge maximum	80.00%
Gains (loss) deferred in equity related to anticipated exposures	€ 23,000	10,000
Net fair value of transactional hedges	€ 21,000	€ 15,000
Increase in the value of the EUR against all currencies	10.00%	10.00%
Change in the value of transactional hedges following a 10% increase in the value of the EUR against all currencies	€ 102,000	€ 98,000
Change in the value of financing derivatives following a 10% increase in the value of the EUR against all currencies	213,000	53,000
Change in the value of financing derivatives following a 10% increase in the value of a currency against EUR	102,000
Gain (loss) in income statement following a change in the value of transactional hedges due to 10% increase in the value of the EUR against all currencies	10,000
Gain (loss) in equity following a change in the value of transactional hedges due to 10% increase in the value of the EUR against all currencies	92,000
Other comprehensive income, before tax, exchange differences on translation	(1,177,000)	219,000	643,000
Fair value liability of cross-currency interest rate swaps designated as net investment hedges	330,000	726,000
External bond funding for a nominal value designated as net investment hedges | $				$ 2,535	$ 3,774
Net fair value of financing derivatives	326,000	728,000
Interest rate risk [Abstract]
Borrowings	4,715,000	5,606,000	5,760,000
Cash and cash equivalents	1,939,000	2,334,000	1,766,000			€ 1,873,000
Long-term debt	4,044,000	4,021,000	4,095,000
Short-term debt	672,000	1,585,000	€ 1,665,000
Credit risk [Abstract]
Threshold of cash and short term deposits with A- credit rating	10,000
Country risk [Abstract]
Country risk exposure threshold	500,000
Other insurable risks [Abstract]
Retained re-insurance captive per occurrence for property damage and business interruption losses	2,500
Retained re-insurance captive per occurrence for property damage and business interruption losses, aggregate	5,000
Captive retained per claim for general and product liability claims	1,500
Captive retained per claim for general and product liability claims, aggregate	6,000
Captive retained per claim for general, product and cyber liability claims	5,000
Captive retained per claim for general, product and cyber liability claims, aggregate	10,000
Bottom of range [Member]
Other insurable risks [Abstract]
Policy deductibles per occurrence	250
Top of range [Member]
Other insurable risks [Abstract]
Policy deductibles per occurrence	5,000
Netherlands [Member]
Country risk [Abstract]
Country risk exposure	4,400,000
China [Member]
Country risk [Abstract]
Country risk exposure	1,300,000
United States [Member]
Country risk [Abstract]
Country risk exposure	9,300,000
Japan [Member]
Country risk [Abstract]
Country risk exposure	598,000
Germany [Member] | Bottom of range [Member]
Country risk [Abstract]
Country risk exposure threshold	300,000
Germany [Member] | Top of range [Member]
Country risk [Abstract]
Country risk exposure threshold	500,000
United Kingdom [Member]
Country risk [Abstract]
Country risk exposure	534,000
Cash flow hedges [Member]
Currency risk [Abstract]
Gain (loss) on hedge ineffectiveness recognised in income statement	100	5,000
Hedges of net investment in foreign operations [Member]
Currency risk [Abstract]
Gain (loss) on hedge ineffectiveness recognised in income statement	1,400	200
Level 1 of fair value hierarchy [Member]
Liquidity risk [Abstract]
Financial assets available-for-sale	49,000
Securities classified as assets held for sale	1,264,000
Equity price risk [Abstract]
Financial assets at fair value through profit or loss	1,313,000	36,000
Financial assets, at fair value	1,313,000	36,000
Non-current financial assets available-for-sale	49,000	36,000
Level 2 and 3 of fair value hierarchy [Member]
Equity price risk [Abstract]
Non-current financial assets available-for-sale	397,000
Philips Lighting NV [Member]
Liquidity risk [Abstract]
Securities classified as assets held for sale	1,264,000
AUD [Member]
Currency risk [Abstract]
Change in the value of transactional hedges following a 10% increase in the value of the EUR against all currencies		5,000
CHF [Member]
Currency risk [Abstract]
Change in the value of transactional hedges following a 10% increase in the value of the EUR against all currencies	5,000
GBP [Member]
Currency risk [Abstract]
Change in the value of transactional hedges following a 10% increase in the value of the EUR against all currencies	10,000	10,000
JPY [Member]
Currency risk [Abstract]
Change in the value of transactional hedges following a 10% increase in the value of the EUR against all currencies	17,000	18,000
PLN [Member]
Currency risk [Abstract]
Change in the value of transactional hedges following a 10% increase in the value of the EUR against all currencies	6,000
USD [Member]
Currency risk [Abstract]
Change in the value of transactional hedges following a 10% increase in the value of the EUR against all currencies	53,000	46,000
Change in the value of financing derivatives following a 10% increase in the value of the EUR against all currencies		62,000
Change in the value of financing derivatives following a 10% increase in the value of a currency against EUR	208,000
Interest rate risk [Member]
Liquidity risk [Abstract]
Cash and cash equivalents	1,939,000	2,334,000
Interest rate risk [Abstract]
Borrowings	4,715,000	5,606,000
Cash and cash equivalents	1,939,000	2,334,000
Long-term debt	4,044,000	4,021,000
Short-term debt	€ 672,000	€ 1,585,000
Ratio of fixed-rate long-term debt to total outstanding debt	72.00%	47.00%		72.00%	47.00%
Instantaneous decrease in long-term interest rates	1.00%	1.00%		1.00%	1.00%
Increase in the value of the fixed rate long term debt excluding forward contracts driven by 1% interest decrease	€ 271,000	€ 260,000
Instantaneous increase in long-term interest rates	1.00%	1.00%		1.00%	1.00%
Decrease in the value of the fixed rate long term debt excluding forward contracts driven by 1% interest increase	€ 271,000	€ (259,000)
Decrease (increase) in annualized net interest expense driven by 1% interest increase	€ 12,000	€ 7,000

Details of treasury risks - Con

Details of treasury risks - Contractual cash obligations (Detail) - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Disclosure of details of treasury risks [Line items]
Long-term debt including current portion of long-term debt and excluding finance lease obligations	€ 4,314
Finance lease obligations	306	€ 307
Short-term debt excluding current portion of long-term debt	120
Operating leases	741
Derivate liabilities, notional	370
Interest on debt	1,785
Purchase obligations	480
Trade and other current payables	2,090	2,848
Contractual cash obligations	10,205
Not later than one year [Member]
Disclosure of details of treasury risks [Line items]
Long-term debt including current portion of long-term debt and excluding finance lease obligations	465
Finance lease obligations	93	93
Short-term debt excluding current portion of long-term debt	120
Operating leases	172
Derivate liabilities, notional	167
Interest on debt	132
Purchase obligations	145
Trade and other current payables	2,090
Contractual cash obligations	3,383
Later than one year and not later than three years [Member]
Disclosure of details of treasury risks [Line items]
Long-term debt including current portion of long-term debt and excluding finance lease obligations	1,170
Finance lease obligations	131
Operating leases	226
Derivate liabilities, notional	109
Interest on debt	252
Purchase obligations	217
Contractual cash obligations	2,105
Later than three years and not later than five years [Member]
Disclosure of details of treasury risks [Line items]
Long-term debt including current portion of long-term debt and excluding finance lease obligations	878
Finance lease obligations	53
Operating leases	147
Interest on debt	226
Purchase obligations	86
Contractual cash obligations	1,389
Later than five years [Member]
Disclosure of details of treasury risks [Line items]
Long-term debt including current portion of long-term debt and excluding finance lease obligations	1,801
Finance lease obligations	29	€ 33
Operating leases	196
Derivate liabilities, notional	95
Interest on debt	1,175
Purchase obligations	31
Contractual cash obligations	€ 3,328

Details of treasury risks - Est

Details of treasury risks - Estimated transaction exposure and related hedges (Detail) - Cash flow hedges [Member] - EUR (€) € in Millions	Dec. 31, 2017	Dec. 31, 2016
Receivables cash flow [Member]
Disclosure of details of treasury risks [Line items]
Transaction exposure	€ 3,395	€ 4,211
Hedge of transaction exposure	(2,189)	(2,412)
Receivables cash flow [Member] | USD [Member]
Disclosure of details of treasury risks [Line items]
Transaction exposure	1,217
Hedge of transaction exposure	(857)
Receivables cash flow [Member] | JPY [Member]
Disclosure of details of treasury risks [Line items]
Transaction exposure	666
Hedge of transaction exposure	(369)
Receivables cash flow [Member] | CAD [Member]
Disclosure of details of treasury risks [Line items]
Transaction exposure	272
Hedge of transaction exposure	(153)
Receivables cash flow [Member] | GBP [Member]
Disclosure of details of treasury risks [Line items]
Transaction exposure	245
Hedge of transaction exposure	(147)
Receivables cash flow [Member] | CNY [Member]
Disclosure of details of treasury risks [Line items]
Transaction exposure	178
Hedge of transaction exposure	(98)
Receivables cash flow [Member] | AUD [Member]
Disclosure of details of treasury risks [Line items]
Transaction exposure	175
Hedge of transaction exposure	(100)
Receivables cash flow [Member] | CHF [Member]
Disclosure of details of treasury risks [Line items]
Transaction exposure	117
Hedge of transaction exposure	(65)
Receivables cash flow [Member] | PLN [Member]
Disclosure of details of treasury risks [Line items]
Transaction exposure	122
Hedge of transaction exposure	(73)
Receivables cash flow [Member] | SEK [Member]
Disclosure of details of treasury risks [Line items]
Transaction exposure	73
Hedge of transaction exposure	(42)
Receivables cash flow [Member] | CZK [Member]
Disclosure of details of treasury risks [Line items]
Transaction exposure	45
Hedge of transaction exposure	(25)
Receivables cash flow [Member] | RUB [Member]
Disclosure of details of treasury risks [Line items]
Transaction exposure	41
Hedge of transaction exposure	(41)
Receivables cash flow [Member] | Others [Member]
Disclosure of details of treasury risks [Line items]
Transaction exposure	244
Hedge of transaction exposure	(219)
Payables cash flow [Member]
Disclosure of details of treasury risks [Line items]
Transaction exposure	(867)	(1,764)
Hedge of transaction exposure	760	€ 1,344
Payables cash flow [Member] | USD [Member]
Disclosure of details of treasury risks [Line items]
Transaction exposure	(583)
Hedge of transaction exposure	488
Payables cash flow [Member] | JPY [Member]
Disclosure of details of treasury risks [Line items]
Transaction exposure	(6)
Hedge of transaction exposure	5
Payables cash flow [Member] | CAD [Member]
Disclosure of details of treasury risks [Line items]
Transaction exposure	(8)
Hedge of transaction exposure	8
Payables cash flow [Member] | GBP [Member]
Disclosure of details of treasury risks [Line items]
Transaction exposure	(20)
Hedge of transaction exposure	20
Payables cash flow [Member] | CNY [Member]
Disclosure of details of treasury risks [Line items]
Transaction exposure	(86)
Hedge of transaction exposure	86
Payables cash flow [Member] | CHF [Member]
Disclosure of details of treasury risks [Line items]
Transaction exposure	(1)
Hedge of transaction exposure	1
Payables cash flow [Member] | SEK [Member]
Disclosure of details of treasury risks [Line items]
Transaction exposure	(1)
Hedge of transaction exposure	1
Payables cash flow [Member] | RUB [Member]
Disclosure of details of treasury risks [Line items]
Transaction exposure	(2)
Hedge of transaction exposure	1
Payables cash flow [Member] | Others [Member]
Disclosure of details of treasury risks [Line items]
Transaction exposure	(160)
Hedge of transaction exposure	€ 150

Details of treasury risks - Cre

Details of treasury risks - Credit risk with number of counterparties (Detail)	Dec. 31, 2017
10-100 million [Member] | A- rated and above [Member]
Disclosure of details of treasury risks [Line items]
Counterparties	1
10-100 million [Member] | A rated [Member]
Disclosure of details of treasury risks [Line items]
Counterparties	1
100-500 million [Member] | A- rated and above [Member]
Disclosure of details of treasury risks [Line items]
Counterparties	8
100-500 million [Member] | AA- rated [Member]
Disclosure of details of treasury risks [Line items]
Counterparties	2
100-500 million [Member] | A+ rated [Member]
Disclosure of details of treasury risks [Line items]
Counterparties	2
100-500 million [Member] | A rated [Member]
Disclosure of details of treasury risks [Line items]
Counterparties	3
100-500 million [Member] | A- rated [Member]
Disclosure of details of treasury risks [Line items]
Counterparties	1

Uncategorized Items - phg-20171

Label	Element	Value
USD [Member] | Performance share plans [Member]
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement	ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement	€ 29.56
Other non-current financial assets [Member]
Other non-current financial assets	ifrs-full_OtherNoncurrentFinancialAssets	335,000,000
Financial assets available-for-sale, category [Member] | Other non-current financial assets [Member]
Other non-current financial assets	ifrs-full_OtherNoncurrentFinancialAssets	172,000,000
Loans and receivables, category [Member] | Other non-current financial assets [Member]
Other non-current financial assets	ifrs-full_OtherNoncurrentFinancialAssets	134,000,000
Financial assets at fair value through profit or loss, category [Member] | Other non-current financial assets [Member]
Other non-current financial assets	ifrs-full_OtherNoncurrentFinancialAssets	27,000,000
Held-to-maturity investments, category [Member] | Other non-current financial assets [Member]
Other non-current financial assets	ifrs-full_OtherNoncurrentFinancialAssets	€ 2,000,000